,symbol,name,description__profile,ceo__profile,industry__profile,price__profile,currency__profile,mktCap__profile,image__profile,volAvg__profile,pe__quote,change__quote,volume__quote,ebitda__income_statement,netIncome__income_statement,annual_earnings,quaterly_earnings,eps__income_statement,epsdiluted__income_statement,totalAssets__balance_sheet_statement,totalCurrentAssets__balance_sheet_statement,cashAndShortTermInvestments__balance_sheet_statement,totalLiabilities__balance_sheet_statement,netReceivables__balance_sheet_statement,longTermInvestments__balance_sheet_statement,totalCurrentLiabilities__balance_sheet_statement,cashAndCashEquivalents__balance_sheet_statement,freeCashFlow__cash_flow_statement,growthEBITDA__income_statement_growth,growthNetIncome__income_statement_growth,growthEPS__income_statement_growth,dividend__historical-price-full/stock_dividend,date__historical-price-full/stock_dividend,derived__netIncomeMargin,derived__debtRatio
0,HBP,Huttig Building Products Inc. Common Stock,"Huttig Building Products, Inc., together with its subsidiaries, distributes millwork, building materials, and wood products for new residential construction, in-home improvement, remodeling, and repair works in the United States. The company offers various millwork products, including exterior and interior doors, pre-hung and factory finished door units, windows, patio doors, mouldings, frames, stair parts, and columns under the Therma-Tru, Masonite, Woodgrain, HB&G, Simpson Door, Final Frame, BrasPine, Arauco, Windsor Windows, and Rogue Valley Door brands. It also provides general building products, such as fasteners and connectors, roofing, siding, insulation, flashing, housewrap, decking, railings, and other miscellaneous building products under the Huttig-Grip, Louisiana-Pacific, Simpson Strong-Tie, TimberTech, AZEK, RDI, GAF Roofing, Maibec, Knauf, GCP Technologies, Fiberon, Alpha Protech, MFM, Lomanco, and Fortifiber brands. In addition, the company offers wood products comprising engineered wood products used in floor systems, wood panels, and lumber; and value-added services, such as floor system take-offs, cut-to-length packages and just-in-time, and cross-dock delivery under the Louisiana-Pacific and Rosboro brands. It markets and sells its products through a network of 25 wholesale distribution centers serving approximately 41 states to building materials dealers, national buying groups, home centers, and industrial users comprising makers of manufactured homes. Huttig Building Products, Inc. was founded in 1865 and is headquartered in St. Louis, Missouri.",Mr. Jon Vrabely,Home Improvement,10.7,USD,0,https://images.financialmodelingprep.com/symbol/HBP.png,402873,6.065759637188209,0,304279,52004000,49000000,"[{'period': '2021', 'revenue': 937.0, 'unit': 'M', 'net_profit': 49.0}, {'period': '2020', 'revenue': 792300.0, 'unit': 'K', 'net_profit': -900.0}, {'period': '2019', 'revenue': 812.0, 'unit': 'M', 'net_profit': -21.3}, {'period': '2018', 'revenue': 839.6, 'unit': 'M', 'net_profit': -6.4}]","[{'period': ""Q1 '22"", 'revenue': 272.7, 'unit': 'M', 'net_profit': 15.5}, {'period': ""Q4 '21"", 'revenue': 230.0, 'unit': 'M', 'net_profit': 7.0}, {'period': ""Q3 '21"", 'revenue': 245.3, 'unit': 'M', 'net_profit': 18.7}, {'period': ""Q2 '21"", 'revenue': 247.4, 'unit': 'M', 'net_profit': 14.9}, {'period': ""Q1 '21"", 'revenue': 214.7, 'unit': 'M', 'net_profit': 8.1}, {'period': ""Q4 '20"", 'revenue': 184600.0, 'unit': 'K', 'net_profit': 300.0}]",1.78,1.78,309000000,239000000,3000000,216000000,88000000,0,116000000,3000000,27000,5.5005,55.44444444444444,52.445086705202314,__nan__,__nan__,__nan__,0.6990291262135923
1,HBT,HBT Financial Inc. Common Stock,"HBT Financial, Inc. operates as the bank holding company for Heartland Bank and Trust Company that provides business, commercial, and retail banking products and services to individuals, businesses, and municipal entities. The company's deposits accounts consist of noninterest-bearing demand deposits, interest-bearing transaction accounts, money market accounts, savings accounts, certificates of deposits, health savings accounts, and individual retirement accounts. Its loan offering comprises owner and non-owner occupied commercial real estate; construction and land development and multi-family; commercial and industrial; agricultural and farmland; and one-to-four family residential loans, as well as municipal, consumer, and other loans. The company also offers wealth management services, including financial planning to consumers, trusts, and estates; trustee and custodial; investment management; corporate retirement plan consulting and administration; and retail brokerage services. In addition, it provides farmland management, farmland sales, and crop insurance services; and treasury management services, as well as originates and sells residential mortgage loans. Further, the company offers digital banking services, such as online and mobile banking, and digital payment services, as well as personal financial management tools. It operates through 57 branch locations in Central and Northeastern Illinois and four locations in Eastern Iowa. The company was formerly known as Heartland Bancorp, Inc. and changed its name to HBT Financial, Inc. in September 2019. HBT Financial, Inc. was founded in 1920 and is headquartered in Bloomington, Illinois.",Mr. J. Lance Carter,Banks - Regional,22.43,USD,707877342,https://images.financialmodelingprep.com/symbol/HBT.png,36427,9.92,1.04,69230,0,71780000,"[{'period': '2024', 'revenue': 251.7, 'unit': 'M', 'net_profit': 71.78}, {'period': '2023', 'revenue': 230.17, 'unit': 'M', 'net_profit': 65.84}, {'period': '2022', 'revenue': 179.54, 'unit': 'M', 'net_profit': 56.46}, {'period': '2021', 'revenue': 158.41, 'unit': 'M', 'net_profit': 56.27}]","[{'period': ""Q4 '24"", 'revenue': 58.38, 'unit': 'M', 'net_profit': 20.27}, {'period': ""Q3 '24"", 'revenue': 72.67, 'unit': 'M', 'net_profit': 18.18}, {'period': ""Q2 '24"", 'revenue': 72.52, 'unit': 'M', 'net_profit': 18.07}, {'period': ""Q1 '24"", 'revenue': 67.58, 'unit': 'M', 'net_profit': 15.26}, {'period': ""Q4 '23"", 'revenue': 70.62, 'unit': 'M', 'net_profit': 18.45}, {'period': ""Q3 '23"", 'revenue': 57.42, 'unit': 'M', 'net_profit': 19.71}]",2.27,2.26,5032902000,752371000,727601000,4488297000,24770000,1614000,0,29552000,27882000,-1.0,0.09018559582029707,0.09134615384615381,"[0.21, 0.15]","['2025-02-04', '2020-02-07']",__nan__,0.8917910581211397
2,HCAP,Harvest Capital Credit Corporation Common Stock,,,,,,,,,,,,505269,1664179,"[{'period': '2020', 'revenue': 11.19, 'unit': 'M', 'net_profit': 1.66}, {'period': '2019', 'revenue': 10.31, 'unit': 'M', 'net_profit': -1.21}, {'period': '2018', 'revenue': 15.7, 'unit': 'M', 'net_profit': 5.07}, {'period': '2017', 'revenue': 10.64, 'unit': 'M', 'net_profit': 1.63}]","[{'period': ""Q1 '21"", 'revenue': 4.51, 'unit': 'M', 'net_profit': 4.45}, {'period': ""Q4 '20"", 'revenue': 11190.0, 'unit': '', 'net_profit': 1.66}, {'period': ""Q3 '20"", 'revenue': 348.38, 'unit': 'K', 'net_profit': -382.8}, {'period': ""Q2 '20"", 'revenue': 436.52, 'unit': 'K', 'net_profit': -760.01}, {'period': ""Q1 '20"", 'revenue': 3.2, 'unit': 'M', 'net_profit': -3.68}, {'period': ""Q4 '19"", 'revenue': 1020.0, 'unit': 'K', 'net_profit': -310.4}]",0.28,0.28,65945667,8011714,7905299,3729146,106415,89554573,474217,7905299,27954819,1.4188029441506556,2.3793901165392968,2.4,__nan__,__nan__,__nan__,0.056548764606475205
3,HCAPZ,Harvest Capital Credit Corporation 6.125% Notes due 2022,,None,,25.1505,USD,0,https://images.financialmodelingprep.com/symbol/HCAPZ.png,2286,0,0.00049973,2099,,,[],[],,,,,,,,,,,,,,,"[0.383, 0.383]","['2021-02-26', '2021-02-26']",__nan__,__nan__
4,HCAQ,HealthCor Catalio Acquisition Corp. Class A Ordinary Shares,"HealthCor Catalio Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in New York, New York.",,Shell Companies,10.92,USD,0,https://images.financialmodelingprep.com/symbol/HCAQ.png,180911,0,0.48999977,159209,0,0,"[{'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -897.75}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.43}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]",0,0,304412,0,0,284412,0,0,284412,0,,0,0,0,__nan__,__nan__,__nan__,0.9342995676911554
5,HCAR,Healthcare Services Acquisition Corporation Class A Common Stock,"Healthcare Services Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. Healthcare Services Acquisition Corporation was incorporated in 2020 and is based in Bethesda, Maryland.",,Shell Companies,10.1,USD,0,https://images.financialmodelingprep.com/symbol/HCAR.png,140713,0,0,6551,10616510,25343856,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 25.34}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -115.99}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.53}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.39}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.67}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.96}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.73}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.85}]",3.06,3.06,332240900,977290,742500,28424081,0,331263610,233467,742500,-908511,92.53268497922163,219.50788888314108,1093.857142857143,__nan__,__nan__,__nan__,0.08555262461665616
6,HCARU,Healthcare Services Acquisition Corporation Unit,"Healthcare Services Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. Healthcare Services Acquisition Corporation was incorporated in 2020 and is based in Bethesda, Maryland.",Mr. David T. Blair,Shell Companies,10.1,USD,0,https://images.financialmodelingprep.com/symbol/HCARU.png,457,142.25352112676057,0,0,10616510,25343856,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 25.34}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -115.99}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.53}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.39}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.67}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.96}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.73}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.85}]",3.06,3.06,332240900,977290,742500,28424081,0,331263610,233467,742500,-908511,92.53268497922163,219.50788888314108,1093.857142857143,__nan__,__nan__,__nan__,0.08555262461665616
7,HCARW,Healthcare Services Acquisition Corporation Warrant,,,Shell Companies,0.0003,USD,0,https://images.financialmodelingprep.com/symbol/HCARW.png,0,0,0,100027,10616510,25343856,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 25.34}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -115.99}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.53}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.39}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.67}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.96}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.73}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.85}]",3.06,3.06,332240900,977290,742500,28424081,0,331263610,233467,742500,-908511,92.53268497922163,219.50788888314108,1093.857142857143,__nan__,__nan__,__nan__,0.08555262461665616
8,HCAT,Health Catalyst Inc Common Stock,"Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accuracy; population health management identifies improvement across the care continuum as well as actionable guidance for success and automated workflows; financial transformation providing costing and labor productivity insights and revenue capture; quality and safety improvement using clinical quality and patient safety data, analytics, and expert services; and national data ecosystem for thought leadership and mutual knowledge exchange to transform care delivery through next-gen insights. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.",Mr. Daniel D. Burton,Medical - Healthcare Information Services,4.02,USD,282247014,https://images.financialmodelingprep.com/symbol/HCAT.png,850668,-3.5,0.2,1045544,-27101000,-69502000,"[{'period': '2024', 'revenue': 306.58, 'unit': 'M', 'net_profit': -69.5}, {'period': '2023', 'revenue': 295.94, 'unit': 'M', 'net_profit': -118.15}, {'period': '2022', 'revenue': 276.24, 'unit': 'M', 'net_profit': -137.4}, {'period': '2021', 'revenue': 241.93, 'unit': 'M', 'net_profit': -153.21}]","[{'period': ""Q4 '24"", 'revenue': 79.61, 'unit': 'M', 'net_profit': -20.67}, {'period': ""Q3 '24"", 'revenue': 76.35, 'unit': 'M', 'net_profit': -14.73}, {'period': ""Q2 '24"", 'revenue': 75.9, 'unit': 'M', 'net_profit': -13.52}, {'period': ""Q1 '24"", 'revenue': 74.72, 'unit': 'M', 'net_profit': -20.59}, {'period': ""Q4 '23"", 'revenue': 75.08, 'unit': 'M', 'net_profit': -30.31}, {'period': ""Q3 '23"", 'revenue': 73.77, 'unit': 'M', 'net_profit': -22.03}]",-1.15,-1.15,858929000,465650000,392000000,493722000,57182000,0,325850000,249645000,12943000,0.6030960296422138,0.4117328412909342,0.44976076555023925,__nan__,__nan__,__nan__,0.5748111892833982
9,HCCC,Healthcare Capital Corp. Class A common stock,"As of March 7, 2022, Healthcare Capital Corp. was acquired by Alpha Tau Medical Ltd., in a reverse merger transaction. Healthcare Capital Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Wilmington, Delaware.",Mr. William  Johns,Shell Companies,12.74,USD,0,https://images.financialmodelingprep.com/symbol/HCCC.png,334029,0,1.2399998,374717,50460,-1.411562,"[{'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': -1.41}, {'period': '2019', 'revenue': 6820.0, 'unit': 'K', 'net_profit': -724.39}, {'period': '2018', 'revenue': 7550.0, 'unit': 'K', 'net_profit': -554.01}, {'period': '2017', 'revenue': 6350.0, 'unit': 'K', 'net_profit': 8.9}]","[{'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 249.97}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.47}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.58}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -87.11}, {'period': ""Q2 '20"", 'revenue': -1670.0, 'unit': 'K', 'net_profit': -973.33}]",0,0,709894,85852,7102,686268,0,0,686268,7102,-412583,1.1583327057760373,0.9999980513864711,1,__nan__,__nan__,__nan__,0.9667189749455553
10,HCCCU,Healthcare Capital Corp. Unit,"As of March 7, 2022, Healthcare Capital Corp. was acquired by Alpha Tau Medical Ltd., in a reverse merger transaction. Healthcare Capital Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Wilmington, Delaware.",,Shell Companies,12.875,USD,0,https://images.financialmodelingprep.com/symbol/HCCCU.png,5834,0,1.475,1739,50460,-1.411562,"[{'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': -1.41}, {'period': '2019', 'revenue': 6820.0, 'unit': 'K', 'net_profit': -724.39}, {'period': '2018', 'revenue': 7550.0, 'unit': 'K', 'net_profit': -554.01}, {'period': '2017', 'revenue': 6350.0, 'unit': 'K', 'net_profit': 8.9}]","[{'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 249.97}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.47}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.58}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -87.11}, {'period': ""Q2 '20"", 'revenue': -1670.0, 'unit': 'K', 'net_profit': -973.33}]",0,0,709894,85852,7102,686268,0,0,686268,7102,-412583,1.1583327057760373,0.9999980513864711,1,__nan__,__nan__,__nan__,0.9667189749455553
11,HCCCW,Healthcare Capital Corp. Warrant,"Healthcare Capital Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in Wilmington, Delaware.",Mr. William  Johns,Shell Companies,0.49,USD,0,https://images.financialmodelingprep.com/symbol/HCCCW.png,0,0,0.07,1023467,50460,-1.411562,"[{'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': -1.41}, {'period': '2019', 'revenue': 6820.0, 'unit': 'K', 'net_profit': -724.39}, {'period': '2018', 'revenue': 7550.0, 'unit': 'K', 'net_profit': -554.01}, {'period': '2017', 'revenue': 6350.0, 'unit': 'K', 'net_profit': 8.9}]","[{'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 249.97}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.47}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.58}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -87.11}, {'period': ""Q2 '20"", 'revenue': -1670.0, 'unit': 'K', 'net_profit': -973.33}]",0,0,709894,85852,7102,686268,0,0,686268,7102,-412583,1.1583327057760373,0.9999980513864711,1,__nan__,__nan__,__nan__,0.9667189749455553
12,HCCI,Heritage-Crystal Clean Inc. Common Stock,"Heritage-Crystal Clean, Inc., through its subsidiary, Heritage-Crystal Clean, LLC, provides parts cleaning, hazardous and non-hazardous waste, and used oil collection services to small and mid-sized customers in the industrial and vehicle maintenance sectors in the United States and Canada. It operates through two segments, Environmental Services and Oil Business. The Environmental Services segment offers parts cleaning, containerized waste management, wastewater vacuum, antifreeze recycling, and field services. The Oil Business segment engages in the collection of used oil, the sale of recycled fuel oil, and used oil filter removal and disposal activities, as well as the re-refining of used oil into lubricant base oil and other products. The company also collects and disposes wastewater. As of January 1, 2022, it operated through 91 branches serving approximately 95,000 customer locations. Heritage-Crystal Clean, Inc. was incorporated in 2007 and is headquartered in Elgin, Illinois.",Mr. Brian J. Recatto,Waste Management,45.51,USD,1107836277,https://images.financialmodelingprep.com/symbol/HCCI.png,389909,14.221875,0.04,2167860,154128000,84759000,"[{'period': '2022', 'revenue': 709.33, 'unit': 'M', 'net_profit': 84.76}, {'period': '2021', 'revenue': 515.33, 'unit': 'M', 'net_profit': 60.95}, {'period': '2020', 'revenue': 405.95, 'unit': 'M', 'net_profit': 11.94}, {'period': '2019', 'revenue': 444.43, 'unit': 'M', 'net_profit': 8.36}]","[{'period': ""Q2 '23"", 'revenue': 192.17, 'unit': 'M', 'net_profit': 8.64}, {'period': ""Q1 '23"", 'revenue': 193.48, 'unit': 'M', 'net_profit': 16.59}, {'period': ""Q4 '22"", 'revenue': 241.1, 'unit': 'M', 'net_profit': 27.57}, {'period': ""Q3 '22"", 'revenue': 172.22, 'unit': 'M', 'net_profit': 23.2}, {'period': ""Q2 '22"", 'revenue': 156.65, 'unit': 'M', 'net_profit': 21.11}, {'period': ""Q1 '22"", 'revenue': 139.37, 'unit': 'M', 'net_profit': 12.88}]",3.6,3.58,794241000,191302000,22053000,364013000,114408000,15219000,115751000,22053000,44908000,0.44668149691662207,0.39067729868084267,0.3846153846153846,__nan__,__nan__,__nan__,0.45831554905878696
13,HCDI,Harbor Custom Development Inc. Common Stock,"Harbor Custom Development, Inc. operates as a real estate development company in Washington, California, Texas, and Florida. The company is involved in land acquisition, entitlements, development, construction of project infrastructure, single and multi-family vertical construction, marketing, sales, and management of various residential projects. It undertakes projects, such as residential lots, home communities, townhomes, and multi-story condominium or apartment properties The company was formerly known as Harbor Custom Homes, Inc. and changed its name to Harbor Custom Development, Inc. in August 2019. Harbor Custom Development, Inc. was incorporated in 2014 and is based in Gig Harbor, Washington.",Mr. Jeffrey B. Habersetzer,Real Estate - Development,0.199,USD,463535,https://images.financialmodelingprep.com/symbol/HCDI.png,1576531,-0.00532370251471375,-0.12,1057128,-14236400,-16922200,"[{'period': '2022', 'revenue': 55.41, 'unit': 'M', 'net_profit': -16.92}, {'period': '2021', 'revenue': 72.35, 'unit': 'M', 'net_profit': 8.86}, {'period': '2020', 'revenue': 50.4, 'unit': 'M', 'net_profit': -3.76}, {'period': '2019', 'revenue': 30950.0, 'unit': 'K', 'net_profit': 235.6}]","[{'period': ""Q3 '23"", 'revenue': 5.54, 'unit': 'M', 'net_profit': -18.27}, {'period': ""Q2 '23"", 'revenue': 19.84, 'unit': 'M', 'net_profit': -4.38}, {'period': ""Q1 '23"", 'revenue': 9.18, 'unit': 'M', 'net_profit': -4.86}, {'period': ""Q4 '22"", 'revenue': 4.8, 'unit': 'M', 'net_profit': -10.64}, {'period': ""Q3 '22"", 'revenue': 11.75, 'unit': 'M', 'net_profit': -3.41}, {'period': ""Q2 '22"", 'revenue': 10.29, 'unit': 'M', 'net_profit': -4.51}]",-24.19,-24.19,236166400,16495200,9665300,160610500,6232300,0,39515600,9665300,-96520100,-2.159344283655138,-2.9102782638144156,-3.9753997539975394,__nan__,__nan__,__nan__,0.6800734566813907
14,HCIC,Hennessy Capital Investment Corp. V Class A Common Stock,"Hennessy Capital Investment Corp. V does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company focuses on the industrial technology and infrastructure sectors. The company was formerly known as Hennessy Capital Acquisition Corp. V and changed its name to Hennessy Capital Investment Corp. V in November 2020. Hennessy Capital Investment Corp. V was incorporated in 2020 and is based in Wilson, Wyoming.",Mr. Daniel Joseph Hennessy,Shell Companies,10.05,USD,0,https://images.financialmodelingprep.com/symbol/HCIC.png,145598,29.558823529411764,0,6691,1437000,12297000,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 12.3}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -552.0}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.78}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 12.94}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 12.47}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 24.87}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.78}]",0.28,0.28,345952,913,913,32516,0,345039,7528,913,-1965000,0,0,0,__nan__,__nan__,__nan__,0.09398991767644066
15,HCICU,Hennessy Capital Investment Corp. V Units ,"Hennessy Capital Investment Corp. V does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company focuses on the industrial technology and infrastructure sectors. The company was formerly known as Hennessy Capital Acquisition Corp. V and changed its name to Hennessy Capital Investment Corp. V in November 2020. Hennessy Capital Investment Corp. V was incorporated in 2020 and is based in Wilson, Wyoming.",Mr. Daniel Joseph Hennessy,Shell Companies,10.05,USD,0,https://images.financialmodelingprep.com/symbol/HCICU.png,5740,43.13304721030043,0,345,1437000,12297000,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 12.3}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -552.0}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.78}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 12.94}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 12.47}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 24.87}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.78}]",0.28,0.28,345952,913,913,32516,0,345039,7528,913,-1965000,0,0,0,__nan__,__nan__,__nan__,0.09398991767644066
16,HCICW,Hennessy Capital Investment Corp. V Warrant,"Hennessy Capital Investment Corp. V is a blank check company. The company was formerly known as Hennessy Capital Acquisition Corp. V and changed its name to Hennessy Capital Investment Corp. V in November 2020. Hennessy Capital Investment Corp. V was founded in 2020 and is based in Wilson, Wyoming.",Mr. Daniel Joseph Hennessy,Shell Companies,0.0004,USD,0,https://images.financialmodelingprep.com/symbol/HCICW.png,40833,0,-0.0053,2450,1437000,12297000,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 12.3}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -552.0}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.78}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 12.94}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 12.47}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 24.87}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.78}]",0.28,0.28,345952,913,913,32516,0,345039,7528,913,-1965000,0,0,0,__nan__,__nan__,__nan__,0.09398991767644066
17,HCII,Hudson Executive Investment Corp. II Class A Common Stock,"Hudson Executive Investment Corp. II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company was formerly known as Hudson Executive Investment Corp. III and changed its name to Hudson Executive Investment Corp. II in December 2020. Hudson Executive Investment Corp. II was incorporated in 2020 and is based in New York, New York.",Mr. Douglas Lee Braunstein J.D.,Shell Companies,10.08,USD,0,https://images.financialmodelingprep.com/symbol/HCII.png,190012,30.545454545454547,-0.02,25812,4106992,10180136,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 10.18}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.21}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.84}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.3}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 18.61}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.45}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.25}]",0.33,0.33,250957,870.582,829.503,16923,0,250035,858.7,829.503,-760553,0,0,0,__nan__,__nan__,__nan__,0.06743386317177844
18,HCIIU,Hudson Executive Investment Corp. II Unit,"Hudson Executive Investment Corp. II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company was formerly known as Hudson Executive Investment Corp. III and changed its name to Hudson Executive Investment Corp. II in December 2020. Hudson Executive Investment Corp. II was incorporated in 2020 and is based in New York, New York.",,Shell Companies,10.07,USD,0,https://images.financialmodelingprep.com/symbol/HCIIU.png,8458,95.9047619047619,0,500,4106992,10180136,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 10.18}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.21}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.84}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.3}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 18.61}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.45}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.25}]",0.33,0.33,250957,870.582,829.503,16923,0,250035,858.7,829.503,-760553,0,0,0,__nan__,__nan__,__nan__,0.06743386317177844
19,HCIIW,Hudson Executive Investment Corp. II Warrant,"Hudson Executive Investment Corp. II is a blank check company. Hudson Executive Investment Corp. II was formerly known as Hudson Executive Investment Corp. III. The company was incorporated in 2020 and is based in New York, New York.",Mr. Douglas Lee Braunstein J.D.,Shell Companies,0.0003,USD,0,https://images.financialmodelingprep.com/symbol/HCIIW.png,0,0,-0.0004,108732,4142420,10215564,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 10.22}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.21}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.84}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.26}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.34}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.45}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.25}]",0.44,0.41,250957635,870582,829503,16923959,0,0,858700,829503,-760553,0,0,0,__nan__,__nan__,__nan__,0.06743751390548448
20,HCKT,Hackett Group Inc (The). Common Stock,"The Hackett Group, Inc. operates as a strategic advisory and technology consulting firm primarily in North America and internationally. It offers best practice intelligence center, an online searchable repository; best practice accelerators that provide web-based access to best practices, customized software configuration tools, and best practice process flows; advisor inquiry for access to fact-based advice on proven approaches and methods; best practice research that provides insights into the proven approaches; and peer interaction comprising member-led webcasts, annual best practice conferences, annual member forums, membership performance surveys, and client-submitted content, as well as intellectual property as-a-service and Hackett Institute programs. The company's benchmarking services conduct studies for selling, general and administrative, finance, human resources, information technology, procurement, enterprise performance management, and shared services; and business transformation practices to help clients develop coordinated strategy for achieving performance enhancements across the enterprise. It also provides Oracle EEA solutions for core financial close and consolidation, integrated business planning, and reporting/advanced analytics areas. In addition, the company offers SAP solutions, including planning, architecture, and vendor evaluation and selection through implementation, customization, testing, and integration; post-implementation support, change management, exception management, process transparency, system documentation, and end-user training; off-shore application development, and application maintenance and support services; and OneStream practice that helps clients choose and deploy OneStream XF Platform and Market Place solutions. The company was formerly known as Answerthink, Inc. and changed its name to The Hackett Group, Inc. in 2008. The Hackett Group, Inc. was founded in 1991 and is headquartered in Miami, Florida.",Mr. Ted A. Fernandez,Information Technology Services,26.9,USD,743704300,https://images.financialmodelingprep.com/symbol/HCKT.png,123716,25.62,0.87,217018,44588000,29630000,"[{'period': '2024', 'revenue': 313.86, 'unit': 'M', 'net_profit': 29.63}, {'period': '2023', 'revenue': 296.59, 'unit': 'M', 'net_profit': 34.15}, {'period': '2022', 'revenue': 293.74, 'unit': 'M', 'net_profit': 40.8}, {'period': '2021', 'revenue': 278.81, 'unit': 'M', 'net_profit': 41.55}]","[{'period': ""Q4 '24"", 'revenue': 79.23, 'unit': 'M', 'net_profit': 3.56}, {'period': ""Q3 '24"", 'revenue': 79.78, 'unit': 'M', 'net_profit': 8.59}, {'period': ""Q2 '24"", 'revenue': 77.66, 'unit': 'M', 'net_profit': 8.75}, {'period': ""Q1 '24"", 'revenue': 77.19, 'unit': 'M', 'net_profit': 8.73}, {'period': ""Q4 '23"", 'revenue': 72.4, 'unit': 'M', 'net_profit': 7.85}, {'period': ""Q3 '23"", 'revenue': 75.86, 'unit': 'M', 'net_profit': 9.42}]",1.08,1.05,191877000,76346000,16366000,76303000,57079000,0,53128000,16366000,43650000,-0.15365487918303816,-0.13238265350941408,-0.1428571428571428,"[0.12, 0.1]","['2025-03-21', '2012-12-18']",__nan__,0.3976662132511974
21,HCM,HUTCHMED (China) Limited American Depositary Shares,"HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and renal cell carcinoma, colorectal cancer (CRC), and gastric cancer (GC); and Fruquintinib, an inhibitor for CRC, breast cancer, GC, endometrial cancer (EMC), NSCLC, hepatocellular carcinoma, and gastrointestinal and solid tumors. It also develops Surufatinib, an inhibitor for neuroendocrine tumors (NET), pancreatic NET, non-pancreatic NET, biliary tract cancer, sarcoma, neuroendocrine neoplasm, esophageal cancer, small cell lung cancer, GC, thyroid cancer, EMC, NSCLC, and solid tumors; HMPL-523, a spleen tyrosine kinase inhibitor for hematological cancers and certain chronic immune diseases; and HMPL-689 for isoform PI3Kd (phosphoinositide 3'-kinase delta). In addition, it develops Tazemetostat, an inhibitor of EZH2 for the treatment of certain epithelioid sarcoma and follicular lymphoma patients; HMPL-306, an inhibitor for hematological malignancies, gliomas, and solid tumors; HMPL-760, an Bruton's tyrosine kinase inhibitor; HMPL-453, an inhibitor for intrahepatic cholangiocarcinoma; HMPL-295 for solid tumors; HMPL-653 for metastatic solid tumors and tenosynovial giant cell tumors; and Epitinib (HMPL-813) and Theliatinib (HMPL-309) inhibitors. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, BeiGene, Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics Co., Inc., Genor Biopharma Co. Ltd., Shanghai Junshi Biosciences Co. Ltd., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. The company was incorporated in 2000 and is headquartered in Central, Hong Kong.","Dr. Wei-Guo  Su B.Sc., Ph.D.",Drug Manufacturers - Specialty & Generic,12.78,USD,2227812412,https://images.financialmodelingprep.com/symbol/HCM.png,96798,63.9,0.97,226127,14106000,37729000,"[{'period': '2024', 'revenue': 630.2, 'unit': 'M', 'net_profit': 37.73}, {'period': '2023', 'revenue': 838.0, 'unit': 'M', 'net_profit': 100.78}, {'period': '2022', 'revenue': 426.41, 'unit': 'M', 'net_profit': -410.14}, {'period': '2021', 'revenue': 356.13, 'unit': 'M', 'net_profit': -227.66}]","[{'period': ""Q4 '24"", 'revenue': 162.26, 'unit': 'M', 'net_profit': 5.96}, {'period': ""Q3 '24"", 'revenue': 162.26, 'unit': 'M', 'net_profit': 5.96}, {'period': ""Q2 '24"", 'revenue': 152.84, 'unit': 'M', 'net_profit': 12.9}, {'period': ""Q1 '24"", 'revenue': 152.84, 'unit': 'M', 'net_profit': 12.9}, {'period': ""Q4 '23"", 'revenue': 152.56, 'unit': 'M', 'net_profit': -33.89}, {'period': ""Q3 '23"", 'revenue': 152.56, 'unit': 'M', 'net_profit': -33.89}]",0.04,0.0432,1274196000,1066555000,836110000,502343000,1081000,-599387000,376562000,153958000,-17436000,-0.44743027264180507,-0.6256300853343918,-0.6610169491525423,__nan__,__nan__,__nan__,0.3942431148740068
22,HCSG,Healthcare Services Group Inc. Common Stock,"Healthcare Services Group, Inc. provides management, administrative, and operating services to the housekeeping, laundry, linen, facility maintenance, and dietary service departments of nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States. It operates through two segments, Housekeeping and Dietary. The Housekeeping segment engages in the cleaning, disinfecting, and sanitizing of resident rooms and common areas of the client's facility, as well as laundering and processing of the bed linens, uniforms, resident personal clothing, and other assorted linen items utilized at a client's facility. The Dietary segment provides food purchasing, meal preparation, and professional dietitian services, which include the development of menus that meet the dietary needs of residents. This segment also offers on-site management and clinical consulting services to facilities. As of December 31, 2021, the company provided its services to approximately 3,000 facilities. Healthcare Services Group, Inc. was incorporated in 1976 and is based in Bensalem, Pennsylvania.",Mr. Theodore  Wahl CPA,Medical - Care Facilities,10.05,USD,738551385,https://images.financialmodelingprep.com/symbol/HCSG.png,486724,18.96,0.41,567939,73964000,39471000,"[{'period': '2024', 'revenue': 1720.0, 'unit': 'M', 'net_profit': 39.47}, {'period': '2023', 'revenue': 1670.0, 'unit': 'M', 'net_profit': 38.39}, {'period': '2022', 'revenue': 1690.0, 'unit': 'M', 'net_profit': 34.24}, {'period': '2021', 'revenue': 1640.0, 'unit': 'M', 'net_profit': 48.54}]","[{'period': ""Q4 '24"", 'revenue': 437.81, 'unit': 'M', 'net_profit': 11.92}, {'period': ""Q3 '24"", 'revenue': 428.15, 'unit': 'M', 'net_profit': 14.03}, {'period': ""Q2 '24"", 'revenue': 426.29, 'unit': 'M', 'net_profit': -1.79}, {'period': ""Q1 '24"", 'revenue': 423.43, 'unit': 'M', 'net_profit': 15.31}, {'period': ""Q4 '23"", 'revenue': 423.84, 'unit': 'M', 'net_profit': 22.6}, {'period': ""Q3 '23"", 'revenue': 411.39, 'unit': 'M', 'net_profit': -5.49}]",0.54,0.53,802772000,556652000,107311000,302845000,382336000,0,192547000,56776000,24466000,-0.016593096846247938,0.02826551346845204,0.03846153846153849,"[0.215, 0.05]","['2022-11-17', '1989-03-28']",__nan__,0.37724908193110873
23,HDSN,Hudson Technologies Inc. Common Stock,"Hudson Technologies, Inc. a refrigerant services company, provides solutions to recurring problems within the refrigeration industry primarily in the United States. The company's products and services include refrigerant and industrial gas sales; refrigerant management services consisting primarily of reclamation of refrigerants, re-usable cylinder refurbishment, and hydrostatic testing services; and RefrigerantSide services comprising system decontamination to remove moisture, oils, and other contaminants. It also offers SmartEnergy OPS service, a web-based real time continuous monitoring service for facility's refrigeration systems and other energy systems applications; and Chiller Chemistry and Chill Smart services. In addition, the company participates in the generation of carbon offset projects. It serves commercial, industrial, and governmental customers, as well as refrigerant wholesalers, distributors, contractors, and refrigeration equipment manufacturers. Hudson Technologies, Inc. was incorporated in 1991 and is headquartered in Woodcliff Lake, New Jersey.",Mr. Brian F. Coleman,Chemicals - Specialty,5.63,USD,247861313,https://images.financialmodelingprep.com/symbol/HDSN.png,435254,10.83,0.36,586844,29301000,24388000,"[{'period': '2024', 'revenue': 237.12, 'unit': 'M', 'net_profit': 24.39}, {'period': '2023', 'revenue': 289.02, 'unit': 'M', 'net_profit': 52.25}, {'period': '2022', 'revenue': 325.23, 'unit': 'M', 'net_profit': 103.8}, {'period': '2021', 'revenue': 192.75, 'unit': 'M', 'net_profit': 32.26}]","[{'period': ""Q4 '24"", 'revenue': 34.64, 'unit': 'M', 'net_profit': -2.56}, {'period': ""Q3 '24"", 'revenue': 61.94, 'unit': 'M', 'net_profit': 7.81}, {'period': ""Q2 '24"", 'revenue': 75.28, 'unit': 'M', 'net_profit': 9.59}, {'period': ""Q1 '24"", 'revenue': 65.25, 'unit': 'M', 'net_profit': 9.56}, {'period': ""Q4 '23"", 'revenue': 44.86, 'unit': 'M', 'net_profit': 3.94}, {'period': ""Q3 '23"", 'revenue': 76.5, 'unit': 'M', 'net_profit': 13.58}]",0.54,0.52,302652000,195512000,70134000,56802000,13629000,0,47809000,70134000,86511000,-0.6509874455058723,-0.5332172182134859,-0.5304347826086956,__nan__,__nan__,__nan__,0.1876809008366044
24,HEAR,Turtle Beach Corporation Common Stock,"Turtle Beach Corporation operates as an audio technology company. It develops, commercializes, and markets gaming headset solutions for various platforms, including video game and entertainment consoles, personal computers, handheld consoles, tablets, and mobile devices under the Turtle Beach brand. The company also offers gaming headsets, keyboards, mice, mousepads, and other accessories for the personal computer peripherals market under the brand of ROCCAT, as well as digital USB and analog microphones under the Neat Microphones brand. It serves retailers, distributors, and other customers in North America, the United Kingdom, Europe, and internationally. The company was founded in 1975 and is headquartered in White Plains, New York.",Mr. Cristopher  Keirn,Consumer Electronics,17.8,USD,357411540,https://images.financialmodelingprep.com/symbol/HEAR.png,93774,57.41935483870968,0.43,29518,-11998000,-17679000,"[{'period': '2023', 'revenue': 258.12, 'unit': 'M', 'net_profit': -17.68}, {'period': '2022', 'revenue': 240.17, 'unit': 'M', 'net_profit': -59.55}, {'period': '2021', 'revenue': 366.35, 'unit': 'M', 'net_profit': 17.72}, {'period': '2020', 'revenue': 360.09, 'unit': 'M', 'net_profit': 38.75}]","[{'period': ""Q3 '24"", 'revenue': 94.36, 'unit': 'M', 'net_profit': 3.41}, {'period': ""Q2 '24"", 'revenue': 76.48, 'unit': 'M', 'net_profit': -7.52}, {'period': ""Q1 '24"", 'revenue': 55850.0, 'unit': 'K', 'net_profit': 155.0}, {'period': ""Q4 '23"", 'revenue': 99.54, 'unit': 'M', 'net_profit': 8.55}, {'period': ""Q3 '23"", 'revenue': 59.16, 'unit': 'M', 'net_profit': -3.61}, {'period': ""Q2 '23"", 'revenue': 47.98, 'unit': 'M', 'net_profit': -15.92}]",-1.03,-1.03,149967000,124855000,18726000,64890000,54390000,0,56332000,18726000,24885000,0.7469683868654702,0.7031034830215296,0.7154696132596684,__nan__,__nan__,__nan__,0.43269519294244735
25,HEC,Hudson Executive Investment Corp. Class A Common Stock,,,,,,,,,,,,,,[],"[{'period': ""Q2 '21"", 'revenue': 30.98, 'unit': 'M', 'net_profit': 30.44}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 10.36}]",,,,,,,,,,,,,,,__nan__,__nan__,__nan__,__nan__
26,HECCU,Hudson Executive Investment Corp. Units,"Hudson Executive Investment Corp. focuses on entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.",Mr. Douglas G. Bergeron,Shell Companies,9,USD,1432350000,https://images.financialmodelingprep.com/symbol/HECCU.png,6951,0,0.3,8725,-4497000,-5739000,"[{'period': '2024', 'revenue': 187.59, 'unit': 'M', 'net_profit': -5.74}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.56}]","[{'period': ""Q4 '24"", 'revenue': 48720.0, 'unit': 'K', 'net_profit': -616.0}, {'period': ""Q3 '24"", 'revenue': 47.4, 'unit': 'M', 'net_profit': -1.7}, {'period': ""Q2 '24"", 'revenue': 46.06, 'unit': 'M', 'net_profit': -3.04}, {'period': ""Q2 '21"", 'revenue': 30.98, 'unit': 'M', 'net_profit': 30.44}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.56}]",0,0,415525183,1296902,415406658,16131460,0,0,1641460,1178377,11704000,0,0,0,__nan__,__nan__,__nan__,0.038821858842668505
27,HECCW,Hudson Executive Investment Corp. Warrant,,,,1.35,USD,0,https://images.financialmodelingprep.com/symbol/HECCW.png,0,0,0,104930,-4497000,-5739000,"[{'period': '2024', 'revenue': 187.59, 'unit': 'M', 'net_profit': -5.74}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.56}]","[{'period': ""Q4 '24"", 'revenue': 48720.0, 'unit': 'K', 'net_profit': -616.0}, {'period': ""Q3 '24"", 'revenue': 47.4, 'unit': 'M', 'net_profit': -1.7}, {'period': ""Q2 '24"", 'revenue': 46.06, 'unit': 'M', 'net_profit': -3.04}, {'period': ""Q2 '21"", 'revenue': 30.98, 'unit': 'M', 'net_profit': 30.44}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.56}]",0,0,415525183,1296902,415406658,16131460,0,0,1641460,1178377,11704000,0,0,0,__nan__,__nan__,__nan__,0.038821858842668505
28,HEES,H&E Equipment Services Inc. Common Stock,"H&E Equipment Services, Inc. operates as an integrated equipment services company. The company operates in five segments: Equipment Rentals, Used Equipment Sales, New Equipment Sales, Parts Sales, and Repair and Maintenance Services. The Equipment Rentals segment provides construction and industrial equipment for rent on a daily, weekly, and monthly basis through a fleet of approximately 42,725 pieces of equipment. The Used Equipment Sales segment sells used equipment through retail sales force primarily from its rental fleet, as well as inventoried equipment that are acquired through trade-ins from equipment customers. The New Equipment Sales segment sells new construction equipment through a professional in-house retail sales force. The Parts Sales segment sells parts for the equipment customers, as well as offers for its rental fleet. The Repair and Maintenance Services segment serves its rental fleet and equipment owned customers, as well as offers ongoing preventative maintenance services to industrial customers. It also provides ancillary equipment support activities, including transportation, hauling, parts shipping, and loss damage waivers. The company's rental fleet consists of hi-lift or aerial work platforms, cranes, earthmoving and material handling equipment, and others. It serves industrial and commercial companies, construction contractors, manufacturers, public utilities, municipalities, maintenance contractors, and various other industrial account customers. As of December 31, 2021, the company had a network of 102 service facilities in the Pacific Northwest, West Coast, Intermountain, Southwest, Gulf Coast, Southeast, and Mid-Atlantic regions of the United States. H&E Equipment Services, Inc. was founded in 1961 and is headquartered in Baton Rouge, Louisiana.",Mr. Bradley W. Barber,Rental & Leasing Services,93.64,USD,3428460048,https://images.financialmodelingprep.com/symbol/HEES.png,1227649,27.79,2.65,2383277,219646000,122982000,"[{'period': '2024', 'revenue': 1520.0, 'unit': 'M', 'net_profit': 122.98}, {'period': '2023', 'revenue': 1470.0, 'unit': 'M', 'net_profit': 169.29}, {'period': '2022', 'revenue': 1240.0, 'unit': 'M', 'net_profit': 132.17}, {'period': '2021', 'revenue': 1060.0, 'unit': 'M', 'net_profit': 60.56}]","[{'period': ""Q4 '24"", 'revenue': 384.08, 'unit': 'M', 'net_profit': 32.76}, {'period': ""Q3 '24"", 'revenue': 384.86, 'unit': 'M', 'net_profit': 31.07}, {'period': ""Q2 '24"", 'revenue': 376.28, 'unit': 'M', 'net_profit': 33.26}, {'period': ""Q1 '24"", 'revenue': 371.36, 'unit': 'M', 'net_profit': 25.89}, {'period': ""Q4 '23"", 'revenue': 385.81, 'unit': 'M', 'net_profit': 53.52}, {'period': ""Q3 '23"", 'revenue': 400.7, 'unit': 'M', 'net_profit': 48.88}]",3.39,3.37,2958715000,16413000,16413000,2173050000,0,0,0,16413000,44343000,-0.6733898189150367,-0.27355531534085875,-0.27718550106609813,"[0.275, 7]","['2025-02-18', '2012-09-20']",__nan__,0.7344573573324906
29,HELE,Helen of Troy Limited Common Stock,"Helen of Troy Limited provides various consumer products in the United States, Canada, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. The company operates through three segments: Home & Outdoor, Health & Wellness, and Beauty. The Home & Outdoor segment offers food preparation tools and gadgets, storage containers, and organization products; coffee makers, grinders, manual pour overs, and tea kettles; household cleaning products, shower organization, and bathroom accessories; feeding and drinking products, child seating products, cleaning tools, and nursery accessories; insulated water bottles, hydration packs, drinkware, mugs, food containers, lunch containers, insulated totes, soft coolers, and accessories; and technical and outdoor sports packs, travel packs, luggage, daypacks, and everyday packs. The Health & Wellness segment provides thermometers, blood pressure monitors, pulse oximeters, nasal aspirators, and humidifiers; faucet mount water-filtration systems and pitcher-based water filtration systems; and air purifiers, heaters, fans, and humidifiers. The Beauty segment offers grooming brushes, tools, and decorative hair accessories; and shampoos, liquid hair styling, and treatment and conditioning products, as well as hair appliances. The company sells its products through mass merchandisers, drugstore chains, warehouse clubs, home improvement stores, grocery and specialty stores, beauty supply and e-commerce retailers, wholesalers, and various types of distributors, as well as directly to consumers under the OXO, Good Grips, Hydro Flask, Soft Works, OXO tot, OXO Brew, OXO Strive, OXO Outdoor, Osprey, PUR, Honeywell, Braun, Vicks, Drybar, Hot Tools, Revlon, and Bed Head brands. Helen of Troy Limited was incorporated in 1968 and is headquartered in El Paso, Texas.",Ms. Noel M. Geoffroy,Household & Personal Products,39.97,USD,913542329,https://images.financialmodelingprep.com/symbol/HELE.png,461311,8.11,3.72,1368027,313606000,168594000,"[{'period': '2024', 'revenue': 2009.9999999999998, 'unit': 'M', 'net_profit': 168.59}, {'period': '2023', 'revenue': 2070.0, 'unit': 'M', 'net_profit': 143.27}, {'period': '2022', 'revenue': 2220.0, 'unit': 'M', 'net_profit': 223.76}, {'period': '2021', 'revenue': 2100.0, 'unit': 'M', 'net_profit': 253.95}]","[{'period': ""Q3 '25"", 'revenue': 530.71, 'unit': 'M', 'net_profit': 49.62}, {'period': ""Q2 '25"", 'revenue': 474.22, 'unit': 'M', 'net_profit': 17.01}, {'period': ""Q1 '25"", 'revenue': 416.66, 'unit': 'M', 'net_profit': 6.2}, {'period': ""Q4 '24"", 'revenue': 489.38, 'unit': 'M', 'net_profit': 42.73}, {'period': ""Q3 '24"", 'revenue': 549.61, 'unit': 'M', 'net_profit': 75.9}, {'period': ""Q2 '24"", 'revenue': 491.56, 'unit': 'M', 'net_profit': 27.38}]",7.06,7.03,2838622000,843918000,18501000,1201180000,402410000,1190000,450811000,18501000,269423000,0.177730208802764,0.17673253160051092,0.18060200668896306,__nan__,__nan__,__nan__,0.4231560242962959
30,HEPA,Hepion Pharmaceuticals Inc. Common Stock,"Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease; and is in clinical-phase development for the treatment of non-alcoholic steatohepatitis (NASH), as well as in nonclinical studies to reduce liver fibrosis and hepatocellular carcinoma tumor burden in experimental models of NASH, and has demonstrated antiviral activities towards hepatitis B, C, and D viruses through several mechanisms. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey.",Mr. John Patrick Brancaccio CPA,Biotechnology,0.4878,USD,529268,https://images.financialmodelingprep.com/symbol/HEPA.png,3640529,,0.0778,84322781,-19346578,-13192420,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -13.19}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -48.93}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -42.2}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -32.72}]","[{'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.87}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.93}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.85}, {'period': ""Q4 '23"", 'revenue': 0.10973000000000001, 'unit': 'M', 'net_profit': -11.06}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.53}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.08}]",-107.35,-107.35,1613737,1613737,406408,3477075,0,0,3143886,406408,-18216303,0.6072436113928675,0.7303599584041562,-7.713474025974026,__nan__,__nan__,__nan__,2.1546726635133235
31,HERA,FTAC Hera Acquisition Corp. Class A Ordinary Shares,"FTAC Hera Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Philadelphia, Pennsylvania.",Mr. Daniel Gideon Cohen,Shell Companies,10.19,USD,1107938300,https://images.financialmodelingprep.com/symbol/HERA.png,846611,46.31818181818182,0,785072,-9022660,6105749,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.11}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 17.71}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 11.85}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 21.8}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.88}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 432.47}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.38}]",0.28,0.0634,852897654,1350555,965671,51765795,0,0,268994,965671,-1603945,0,0,0,__nan__,__nan__,__nan__,0.06069402906342148
32,HERAU,FTAC Hera Acquisition Corp. Units,"FTAC Hera Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Philadelphia, Pennsylvania.",Mr. Daniel Gideon Cohen,Shell Companies,10.16,USD,1057595040,https://images.financialmodelingprep.com/symbol/HERAU.png,2484,0,0,2,-9022660,6105749,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.11}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 17.71}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 11.85}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 21.8}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.88}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 432.47}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.38}]",0.28,0.0634,852897654,1350555,965671,51765795,0,0,268994,965671,-1603945,0,0,0,__nan__,__nan__,__nan__,0.06069402906342148
33,HERAW,FTAC Hera Acquisition Corp. Warrant,"FTAC Hera Acquisition Corp. is a blank check company. The company was incorporated in 2021 and is based in Philadelphia, Pennsylvania.",Mr. Daniel Gideon Cohen,Shell Companies,0.0005,USD,1107938300,https://images.financialmodelingprep.com/symbol/HERAW.png,0,0,-0.0001,230127,-9022660,6105749,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.11}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 17.71}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 11.85}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 21.8}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.88}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 432.47}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.38}]",0.28,0.0634,852897654,1350555,965671,51765795,0,0,268994,965671,-1603945,0,0,0,__nan__,__nan__,__nan__,0.06069402906342148
34,HFBL,Home Federal Bancorp Inc. of Louisiana Common StocK,"Home Federal Bancorp, Inc. of Louisiana operates as the holding company for Home Federal Bank that provides various financial services to individuals, corporate entities, and other organizations. The company accepts various deposits, such as passbook savings, certificates of deposit, and demand deposit accounts. Its loan products include one-to-four family residential real estate loans; commercial real estate secured loans; multi-family residential loans; commercial business loans; land loans; construction loans; home equity and second mortgage loans; equity lines of credit; and consumer non-real estate loans, including loans secured by deposit accounts, automobile loans, overdrafts, and other unsecured loans. As of August 25, 2021, it operated seven full-service banking offices. The company was founded in 1924 and is based in Shreveport, Louisiana.",Mr. James R. Barlow,Banks - Regional,13.73,USD,43012795,https://images.financialmodelingprep.com/symbol/HFBL.png,2324,12.6,0.55,5370,5347000,3593000,"[{'period': '2024', 'revenue': 20.38, 'unit': 'M', 'net_profit': 3.59}, {'period': '2023', 'revenue': 23.45, 'unit': 'M', 'net_profit': 5.7}, {'period': '2022', 'revenue': 20.61, 'unit': 'M', 'net_profit': 4.87}, {'period': '2021', 'revenue': 22.03, 'unit': 'M', 'net_profit': 5.37}]","[{'period': ""Q2 '25"", 'revenue': 7.66, 'unit': 'M', 'net_profit': 1.02}, {'period': ""Q1 '25"", 'revenue': 4700.0, 'unit': 'K', 'net_profit': 941.0}, {'period': ""Q4 '24"", 'revenue': 4830.0, 'unit': 'K', 'net_profit': 638.0}, {'period': ""Q3 '24"", 'revenue': 8400.0, 'unit': 'K', 'net_profit': 732.0}, {'period': ""Q2 '24"", 'revenue': 8.22, 'unit': 'M', 'net_profit': 1.0}, {'period': ""Q1 '24"", 'revenue': 5.66, 'unit': 'M', 'net_profit': 1.22}]",1.18,1.17,637512000,34948000,34948000,584709000,0,95953000,0,15248000,-368000,-0.30003927215604137,-0.3700911640953717,-0.37566137566137564,"[0.13, 0.06]","['2025-01-27', '2007-07-23']",__nan__,0.9171733237962579
35,HFFG,HF Foods Group Inc. Common Stock,"HF Foods Group Inc., through its subsidiaries, operates as a food service distributor to Asian restaurants located in the Southeastern, Pacific, and Mountain West regions of the United States. It distributes Asian specialty food items, meat and poultry products, seafood, fresh produce, packaging and other items, and commodities. The company also provides design and printing services, as well as logistic and food processing services. In addition, it is involved in real estate holding activities. The company is headquartered in City of Industry, California.",Mr. Xi  Lin,Food Distribution,4.22,USD,222553094,https://images.financialmodelingprep.com/symbol/HFFG.png,167700,-4.59,0.26,369636,-8035000,-48511000,"[{'period': '2024', 'revenue': 1200.0, 'unit': 'M', 'net_profit': -48.51}, {'period': '2023', 'revenue': 1150.0, 'unit': 'M', 'net_profit': -2.17}, {'period': '2022', 'revenue': 1170000.0, 'unit': 'K', 'net_profit': 235.0}, {'period': '2021', 'revenue': 796.88, 'unit': 'M', 'net_profit': 22.14}]","[{'period': ""Q4 '24"", 'revenue': 305.28, 'unit': 'M', 'net_profit': -43.89}, {'period': ""Q3 '24"", 'revenue': 297.62, 'unit': 'M', 'net_profit': -3.94}, {'period': ""Q2 '24"", 'revenue': 302340.0, 'unit': 'K', 'net_profit': 17.0}, {'period': ""Q1 '24"", 'revenue': 295650.0, 'unit': 'K', 'net_profit': -694.0}, {'period': ""Q4 '23"", 'revenue': 280.87, 'unit': 'M', 'net_profit': 2.73}, {'period': ""Q3 '23"", 'revenue': 280.63, 'unit': 'M', 'net_profit': 1.88}]",-0.92,-0.92,549991000,178103000,14467000,308697000,54346000,2350000,145199000,14467000,10089000,-1.231056793673616,-21.314167433302668,-21.772277227722775,__nan__,__nan__,__nan__,0.5612764572511186
36,HFWA,Heritage Financial Corporation Common Stock,"Heritage Financial Corporation operates as the bank holding company for Heritage Bank that provides various financial services to small and medium sized businesses and individuals in the United States. The company accepts various deposit products, such as noninterest demand deposits, interest bearing demand deposits, money market accounts, savings accounts, personal checking accounts, and certificates of deposit. Its loan portfolio includes commercial and industrial loans, owner-occupied and non-owner occupied commercial real estate loans, one-to-four family residential loans, real estate construction and land development loans, consumer loans, commercial business loans, lines of credit, term equipment financing, and term real estate loans, as well as commercial business loans to a range of businesses in industries that include real estate and rental and leasing, healthcare, accommodation and food services, retail trade, and construction. The company also originates loans that are guaranteed by the U.S. Small Business Administration; and offers trust services, as well as objective advice. As of January 27, 2022, it had a network of 49 banking offices located in Washington and Oregon. The company was formerly known as Heritage Financial Corporation, M.H.C. and changed its name to Heritage Financial Corporation in 1998. Heritage Financial Corporation was founded in 1927 and is headquartered in Olympia, Washington.",Mr. Jeffrey J. Deuel,Banks - Regional,22.26,USD,756635208,https://images.financialmodelingprep.com/symbol/HFWA.png,280731,17.95,0.92,371128,0,43258000,"[{'period': '2024', 'revenue': 309.71, 'unit': 'M', 'net_profit': 43.26}, {'period': '2023', 'revenue': 239.54, 'unit': 'M', 'net_profit': 61.76}, {'period': '2022', 'revenue': 248.98, 'unit': 'M', 'net_profit': 81.88}, {'period': '2021', 'revenue': 240.4, 'unit': 'M', 'net_profit': 98.03}]","[{'period': ""Q4 '24"", 'revenue': 57.05, 'unit': 'M', 'net_profit': 11.93}, {'period': ""Q3 '24"", 'revenue': 54.8, 'unit': 'M', 'net_profit': 11.42}, {'period': ""Q2 '24"", 'revenue': 81.83, 'unit': 'M', 'net_profit': 14.16}, {'period': ""Q1 '24"", 'revenue': 71.45, 'unit': 'M', 'net_profit': 5.75}, {'period': ""Q4 '23"", 'revenue': 71.11, 'unit': 'M', 'net_profit': 6.23}, {'period': ""Q3 '23"", 'revenue': 61.89, 'unit': 'M', 'net_profit': 18.22}]",1.26,1.24,7106278000,5592353000,823215000,6242751000,4769138000,0,0,58821000,61024000,0,-0.2995223058861631,-0.2840909090909091,"[0.24, 0.1]","['2025-02-06', '1998-07-01']",__nan__,0.8784839264661473
37,HGBL,Heritage Global Inc. Common Stock,"Heritage Global, Inc., together with its subsidiaries, operates as an asset services company with focus on financial and industrial asset transactions. The company provides market making, acquisitions, dispositions, valuations, and secured lending services. It focuses on identifying, valuing, acquiring, and monetizing underlying tangible and intangible assets. Heritage Global Inc. acts as an adviser, as well as a principal, acquiring, or brokering manufacturing facilities; surplus industrial machinery and equipment; industrial inventories; accounts receivable portfolios; intellectual property; and business enterprises. The company was formerly known as Counsel RB Capital Inc. and changed its name to Heritage Global, Inc. in August 2013. Heritage Global, Inc. was incorporated in 1983 and is headquartered in San Diego, California.",Mr. Ross M. Dove,Financial - Capital Markets,2.08,USD,73829808,https://images.financialmodelingprep.com/symbol/HGBL.png,56165,14.86,0.06,50608,9471000,5182000,"[{'period': '2024', 'revenue': 45.36, 'unit': 'M', 'net_profit': 5.18}, {'period': '2023', 'revenue': 60.55, 'unit': 'M', 'net_profit': 12.47}, {'period': '2022', 'revenue': 46.91, 'unit': 'M', 'net_profit': 15.49}, {'period': '2021', 'revenue': 25.79, 'unit': 'M', 'net_profit': 3.05}]","[{'period': ""Q4 '24"", 'revenue': 10770.0, 'unit': 'K', 'net_profit': -203.0}, {'period': ""Q3 '24"", 'revenue': 10.41, 'unit': 'M', 'net_profit': 1.09}, {'period': ""Q2 '24"", 'revenue': 12.02, 'unit': 'M', 'net_profit': 2.5}, {'period': ""Q1 '24"", 'revenue': 12.16, 'unit': 'M', 'net_profit': 1.8}, {'period': ""Q4 '23"", 'revenue': 15.28, 'unit': 'M', 'net_profit': 4.89}, {'period': ""Q3 '23"", 'revenue': 15.55, 'unit': 'M', 'net_profit': 1.98}]",0.14,0.14,81309000,33128000,21749000,16108000,4975000,20892000,14598000,21749000,7608000,-0.3614912694667296,-0.5846092184368737,-0.5882352941176471,__nan__,__nan__,__nan__,0.19810845047903677
38,HGEN,Humanigen Inc. Common Stock,"Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called 'cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with COVID-19 for which it has completed a Phase 3 study and is the focus of a Phase 2/3 study sponsored by the NIH. It is also developing lenzilumab, which is also being studied in conjunction with CD19-targeted CAR-T cell therapies, as well as exploring the effectiveness of lenzilumab in other inflammatory conditions, such as acute Graft versus Host Disease in patients undergoing allogeneic hematopoietic stem cell transplantation and in eosinophilic asthma, and rheumatoid arthritis. In addition, the company focuses on studying lenzilumab for patients with chronic myelomonocytic leukemia exhibiting RAS pathway mutations. Its pipeline also includes two other Humaneered monoclonal antibodies, ifabotuzumab, which binds to EphA3, and HGEN005, which targets EMR1. Ifabotuzumab has been evaluated in a Phase 1 study of glioblastoma multiforme that showed tumor specific targeting of all known tumor sites with no normal tissue uptake. HGEN005 is being explored as a treatment for a range of eosinophilic diseases, including eosinophilic leukemia as an optimized naked antibody and as the backbone for a novel CAR-T construct. Humanigen, Inc. was incorporated in 2000 and is headquartered in Short Hills, New Jersey.","Dr. Cameron  Durrant M.D., MBA",Biotechnology,0.0002,USD,0,https://images.financialmodelingprep.com/symbol/HGEN.png,341846,-0.000392156862745098,-0.0011,2063685,-67812000,-70238000,"[{'period': '2022', 'revenue': 2.51, 'unit': 'M', 'net_profit': -70.24}, {'period': '2021', 'revenue': 3.6, 'unit': 'M', 'net_profit': -238.91}, {'period': '2020', 'revenue': 0.312, 'unit': 'M', 'net_profit': -90.87}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.64}]","[{'period': ""Q1 '23"", 'revenue': 0.221, 'unit': 'M', 'net_profit': -4.15}, {'period': ""Q4 '22"", 'revenue': 0.221, 'unit': 'M', 'net_profit': 4.39}, {'period': ""Q3 '22"", 'revenue': 0.221, 'unit': 'M', 'net_profit': -23.37}, {'period': ""Q2 '22"", 'revenue': 1.04, 'unit': 'M', 'net_profit': -30.18}, {'period': ""Q1 '22"", 'revenue': 1.04, 'unit': 'M', 'net_profit': -21.29}, {'period': ""Q4 '21"", 'revenue': 1.04, 'unit': 'M', 'net_profit': -33.54}]",-1.18,-1.18,11195000,11105000,10155000,57960000,0,0,56194000,10155000,-76698000,0.7106811442711778,0.7060101375814627,0.7107843137254902,__nan__,__nan__,__nan__,5.177311299687361
39,HGSH,China HGS Real Estate Inc. Common Stock,"China HGS Real Estate Inc., through its subsidiaries, develops real estate properties in the People's Republic of China. It engages in the construction and sale of residential apartments, parking lots, and commercial properties. The company also develops multi-layer, sub-high-rise, and high-rise apartment buildings, as well as office buildings. In addition, it offers various services, such as land acquisition, project planning, design and construction management, sales and marketing, and property management, as well as pre-sale and after sale activities. The company was founded in 1995 and is headquartered in Hanzhong, the People's Republic of China.",Mr. Xiaojun Zhu,Real Estate - Development,3.02,USD,168495766,https://images.financialmodelingprep.com/symbol/HGSH.png,601545,11.57088122605364,0.03999996,46899,8905494,6375438,"[{'period': '2021', 'revenue': 58.49, 'unit': 'M', 'net_profit': 6.38}, {'period': '2020', 'revenue': 10080.0, 'unit': 'K', 'net_profit': 981.44}, {'period': '2019', 'revenue': 39.58, 'unit': 'M', 'net_profit': 3.7}, {'period': '2018', 'revenue': 64.24, 'unit': 'M', 'net_profit': 5.24}]","[{'period': ""Q4 '21"", 'revenue': 2820.0, 'unit': 'K', 'net_profit': 364.31}, {'period': ""Q3 '21"", 'revenue': 5970.0, 'unit': 'K', 'net_profit': 233.96}, {'period': ""Q2 '21"", 'revenue': 31.63, 'unit': 'M', 'net_profit': 3.63}, {'period': ""Q1 '21"", 'revenue': 18.16, 'unit': 'M', 'net_profit': 2.22}, {'period': ""Q4 '20"", 'revenue': 2730.0, 'unit': 'K', 'net_profit': 291.59}, {'period': ""Q3 '20"", 'revenue': 2940.0, 'unit': 'K', 'net_profit': 4.44}]",0.27,0.27,385000563,3465189,170001,194302852,0,0,49631721,170001,-604167,3.5397883622697988,5.496017068831653,5.192660550458716,__nan__,__nan__,__nan__,0.5046819944520444
40,HHR,HeadHunter Group PLC American Depositary Shares,"HeadHunter Group PLC, together with its subsidiaries, operates an online recruitment platform in Russia, Kazakhstan, Belarus, and internationally. The company offers employers and recruiters paid access to its curriculum vitae database and job postings platform; and job seekers and employers with value-added services. It provides its services for businesses that are looking for job seekers to fill vacancies inside their organizations. The company was formerly known as Zemenik Trading Limited and changed its name to HeadHunter Group PLC in March 2018. The company was founded in 2000 and is headquartered in Moscow, Russia.",Mr. Dmitry  Sergienkov,Staffing & Employment Services,15.03,USD,761054571,https://images.financialmodelingprep.com/symbol/HHR.png,0,9.05421686746988,0,1,8492789000,3651810000,"[{'period': '2022', 'revenue': 18.09, 'unit': 'B', 'net_profit': 3.65}, {'period': '2021', 'revenue': 15.97, 'unit': 'B', 'net_profit': 5.39}, {'period': '2020', 'revenue': 8.28, 'unit': 'B', 'net_profit': 1.75}, {'period': '2019', 'revenue': 7.79, 'unit': 'B', 'net_profit': 1.45}]","[{'period': ""Q1 '23"", 'revenue': 5.55, 'unit': 'B', 'net_profit': 2.19}, {'period': ""Q4 '22"", 'revenue': 4.94, 'unit': 'B', 'net_profit': 2.03}, {'period': ""Q3 '22"", 'revenue': 4.74, 'unit': 'B', 'net_profit': 1.4}, {'period': ""Q2 '22"", 'revenue': 3950.0, 'unit': 'M', 'net_profit': -320.63}, {'period': ""Q1 '22"", 'revenue': 4450.0, 'unit': 'M', 'net_profit': 552.62}, {'period': ""Q4 '21"", 'revenue': 4.53, 'unit': 'B', 'net_profit': 1.52}]",72.65,70.86,23900880000,9692246000,9348691000,17037195000,134470000,385933000,13343775000,9348691000,7219260000,-0.01527298185369582,-0.3225693173603241,-0.3194379391100702,"[0.714, 0.36]","['2022-01-21', '2019-06-13']",__nan__,0.7128271009268278
41,HIBB,Hibbett Sports Inc. Common Stock,"Hibbett, Inc. together with its subsidiaries, engages in the retail of athletic-inspired fashion products in small and mid-sized communities in the United States. Its stores offer a range of merchandise, including athletic footwear, athletic and fashion apparel, team sports equipment, and related accessories. As of January 29, 2022, the company operated approximately 1,096 retail stores, which include 900 Hibbett Sports stores, 179 City Gear stores, and 17 Sports Additions athletic shoe stores. It also sells its products through online channels. Hibbett, Inc. was founded in 1945 and is headquartered in Birmingham, Alabama.",Mr. Michael E. Longo,Apparel - Retail,87.49,USD,1045330520,https://images.financialmodelingprep.com/symbol/HIBB.png,539726,10.801234567901234,0.01,1055180,57606000,35875000,"[{'period': '2024', 'revenue': 455.5, 'unit': 'M', 'net_profit': 35.88}, {'period': '2023', 'revenue': 1710.0, 'unit': 'M', 'net_profit': 128.06}, {'period': '2022', 'revenue': 1690.0, 'unit': 'M', 'net_profit': 174.31}, {'period': '2021', 'revenue': 1420.0, 'unit': 'M', 'net_profit': 74.27}]","[{'period': ""Q2 '24"", 'revenue': 374.88, 'unit': 'M', 'net_profit': 10.9}, {'period': ""Q1 '24"", 'revenue': 455.5, 'unit': 'M', 'net_profit': 35.88}, {'period': ""Q4 '23"", 'revenue': 458.3, 'unit': 'M', 'net_profit': 38.42}, {'period': ""Q3 '23"", 'revenue': 433.16, 'unit': 'M', 'net_profit': 25.57}, {'period': ""Q2 '23"", 'revenue': 392.81, 'unit': 'M', 'net_profit': 24.71}, {'period': ""Q1 '23"", 'revenue': 424.05, 'unit': 'M', 'net_profit': 39.35}]",2.8,2.74,939160000,473055000,16015000,562929000,12850000,0,327752000,16015000,10500,-0.7287061194887396,-0.7198513162107499,-0.7168857431749242,"[0.25, 0.25]","['2024-03-20', '2021-07-07']",__nan__,0.5993962690063461
42,HIFS,Hingham Institution for Savings Common Stock,"Hingham Institution for Savings provides various financial products and services to individuals and businesses in the United States. It offers savings, checking, money market, demand deposit, and negotiable order of withdrawal accounts, as well as certificates of deposit. The company also provides commercial and residential real estate, construction, home equity, commercial, and consumer loans. In addition, it offers ATMs, debit cards, and Internet-based banking services. The company offers its services through a network of six offices in Boston and eastern Massachusetts; and commercial lenders and relationship managers in Washington. Hingham Institution for Savings was incorporated in 1834 and is headquartered in Hingham, Massachusetts.",Mr. Robert H. Gaughen Jr.,Banks - Regional,238.25,USD,519444563,https://images.financialmodelingprep.com/symbol/HIFS.png,15542,18.53,16.44,13963,0,28191000,"[{'period': '2024', 'revenue': 65.85, 'unit': 'M', 'net_profit': 28.19}, {'period': '2023', 'revenue': 63.49, 'unit': 'M', 'net_profit': 26.37}, {'period': '2022', 'revenue': 80.91, 'unit': 'M', 'net_profit': 37.52}, {'period': '2021', 'revenue': 114.75, 'unit': 'M', 'net_profit': 67.46}]","[{'period': ""Q4 '24"", 'revenue': 22.22, 'unit': 'M', 'net_profit': 11.38}, {'period': ""Q3 '24"", 'revenue': 15.21, 'unit': 'M', 'net_profit': 5.85}, {'period': ""Q2 '24"", 'revenue': 51.77, 'unit': 'M', 'net_profit': 4.1}, {'period': ""Q1 '24"", 'revenue': 53.65, 'unit': 'M', 'net_profit': 6.87}, {'period': ""Q4 '23"", 'revenue': 52.51, 'unit': 'M', 'net_profit': 6.32}, {'period': ""Q3 '23"", 'revenue': 45.84, 'unit': 'M', 'net_profit': 3.3}]",12.95,12.85,4457771000,351830000,351830000,4026016000,8774000,119837000,0,351830000,11754000,-1,0.06901520609760722,0.056280587275693274,"[0.63, 0.07]","['2025-01-06', '1989-04-25']",__nan__,0.9031455406749248
43,HIHO,Highway Holdings Limited Common Stock,"Highway Holdings Limited, together with its subsidiaries, manufactures and supplies metal, plastic, electric, and electronic components, subassemblies, and finished products for original equipment manufacturers (OEMs) and contract manufacturers. It operates through two segments, Metal Stamping and Mechanical OEM; and Electric OEM. The company also trades in plastic injection products; and manufactures and assembles automation equipment. Its products are used in the manufacture of products, such as photocopiers, laser printers, print cartridges, electrical connectors, electrical circuits, vacuum cleaners, LED power supplies, stepping motors, pumps for dishwashers, and other washing machine components. In addition, the company assists customers in the design and development of the tooling used in the metal and plastic manufacturing process, as well as provides an array of other manufacturing and engineering services, including metal stamping, screen printing, plastic injection molding, pad printing, and electronic assembly of printed circuit boards. It operates in Hong Kong and China, Europe, North America, and other Asian countries. Highway Holdings Limited was incorporated in 1990 and is headquartered in Sheung Shui, Hong Kong.",Mr. Roland Walter  Kohl,Manufacturing - Metal Fabrication,1.4413,USD,6344343,https://images.financialmodelingprep.com/symbol/HIHO.png,4754,-8.48,0.0413,15599,-11000,-959000,"[{'period': '2024', 'revenue': 6320.0, 'unit': 'K', 'net_profit': -959.0}, {'period': '2023', 'revenue': 10240.0, 'unit': 'K', 'net_profit': -293.0}, {'period': '2022', 'revenue': 12370.0, 'unit': 'K', 'net_profit': 443.0}, {'period': '2021', 'revenue': 9170.0, 'unit': 'K', 'net_profit': -454.0}]","[{'period': ""Q3 '25"", 'revenue': 1930.0, 'unit': 'K', 'net_profit': 92.0}, {'period': ""Q2 '25"", 'revenue': 2120.0, 'unit': 'K', 'net_profit': 231.0}, {'period': ""Q1 '25"", 'revenue': 1880.0, 'unit': 'K', 'net_profit': 98.0}, {'period': ""Q4 '24"", 'revenue': -0.455, 'unit': 'M', 'net_profit': -1.14}, {'period': ""Q3 '24"", 'revenue': 4110.0, 'unit': 'K', 'net_profit': 302.0}, {'period': ""Q2 '24"", 'revenue': 1320.0, 'unit': 'K', 'net_profit': 213.0}]",-0.22,-0.22,11318000,9646000,6601000,4680000,1253000,95000,3837000,6601000,297000,-1.016566265060241,-2.273037542662116,-2.055555555555556,"[0.05, 0.0127]","['2024-12-12', '1997-08-28']",__nan__,0.4135006184838311
44,HIII,Hudson Executive Investment Corp. III Class A Common Stock,"Hudson Executive Investment Corp. III does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.",Mr. Douglas Lee Braunstein J.D.,Shell Companies,10.08,USD,0,https://images.financialmodelingprep.com/symbol/HIII.png,342464,48,-0.02,130001,9394923,19838785,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 19.84}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 936.09}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.55}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.55}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.52}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.27}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.48}]",0.26,0.26,601210,936.355,709.182,38307,0,600166,454.57,709.182,-847795,0,0,0,__nan__,__nan__,__nan__,0.06371650504815289
45,HIIIU,Hudson Executive Investment Corp. III Unit,"Hudson Executive Investment Corp. III does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.",Mr. Douglas Lee Braunstein J.D.,Shell Companies,10.09,USD,0,https://images.financialmodelingprep.com/symbol/HIIIU.png,13878,40.685483870967744,0.01,35232,9394923,19838785,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 19.84}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 936.09}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.55}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.55}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.52}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.27}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.48}]",0.26,0.26,601210,936.355,709.182,38307,0,600166,454.57,709.182,-847795,0,0,0,__nan__,__nan__,__nan__,0.06371650504815289
46,HIIIW,Hudson Executive Investment Corp. III Warrant,"Hudson Executive Investment Corp. III intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in a range of technology-driven companies. The company was incorporated in 2020 and is based in New York, New York.",Mr. Douglas Lee Braunstein J.D.,Shell Companies,0.0004,USD,0,https://images.financialmodelingprep.com/symbol/HIIIW.png,0,0,0,87008,9394923,19838785,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 19.84}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 936.09}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.55}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.55}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.52}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.27}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.48}]",0.26,0.26,601210,936.355,709.182,38307,0,600166,454.57,709.182,-847795,0,0,0,__nan__,__nan__,__nan__,0.06371650504815289
47,HIMX,Himax Technologies Inc. American Depositary Shares,"Himax Technologies, Inc., a fabless semiconductor company, provides display imaging processing technologies in China, Taiwan, the Philippines, Korea, Japan, Europe, and the United States. The company operates through two segments, Driver IC and Non-Driver Products. It offers display driver integrated circuits (ICs) and timing controllers that are used in televisions, laptops, monitors, mobile phones, tablets, automotive, digital cameras, car navigation, virtual reality devices, and other consumer electronic devices. The company also designs and provides controllers for touch sensor displays; in-cell touch and display driver integration single-chip solutions; light-emitting diode driver and power management ICs; and liquid crystal on silicon microdisplays for augmented reality (AR) devices and head-up displays for the automotive industry. In addition, it offers complementary metal-oxide-semiconductor image sensors and wafer-level optics for AR devices, 3D sensing, and ultra-low power AI image sensing, which are used in various applications, such as mobile phones, tablets, laptops, TV, PC camera, automobile, security, medical devices, home appliance, Internet of Things, etc. The company markets its display drivers and display-related products to panel manufacturers, agents or distributors, module manufacturers, and assembly houses; and non-driver products to camera module manufacturers, optical engine manufacturers, and television system manufacturers. Himax Technologies, Inc. was incorporated in 2001 and is headquartered in Tainan City, Taiwan.",Mr. Jordan  Wu,Semiconductors,6.66,USD,571019789,https://images.financialmodelingprep.com/symbol/HIMX.png,3996698,14.48,0.77,2381279,90575000,79755000,"[{'period': '2024', 'revenue': 906.8, 'unit': 'M', 'net_profit': 79.75}, {'period': '2023', 'revenue': 945.43, 'unit': 'M', 'net_profit': 50.62}, {'period': '2022', 'revenue': 1200.0, 'unit': 'M', 'net_profit': 236.98}, {'period': '2021', 'revenue': 1550.0, 'unit': 'M', 'net_profit': 436.9}]","[{'period': ""Q4 '24"", 'revenue': 237.22, 'unit': 'M', 'net_profit': 24.61}, {'period': ""Q3 '24"", 'revenue': 222.41, 'unit': 'M', 'net_profit': 13.02}, {'period': ""Q2 '24"", 'revenue': 238.74, 'unit': 'M', 'net_profit': 29.63}, {'period': ""Q1 '24"", 'revenue': 206.25, 'unit': 'M', 'net_profit': 12.42}, {'period': ""Q4 '23"", 'revenue': 230.72, 'unit': 'M', 'net_profit': 23.57}, {'period': ""Q3 '23"", 'revenue': 238.51, 'unit': 'M', 'net_profit': 11.24}]",0.228,0.228,1639521000,1168043000,224574000,743194000,236813000,60351000,706634000,218148000,102922000,0.5442781149832913,0.5756875296348981,0.5724137931034484,"[0.29, 0.2]","['2024-06-28', '2007-10-03']",__nan__,0.4532994697841626
48,HJLI,Hancock Jaffe Laboratories Inc. Common Stock,"Hancock Jaffe Laboratories, Inc. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. The company is headquartered in Irvine, California and currently employs 9 full-time employees. The firm is developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD). The firm is in the process of developing bioprosthetic implantable devices for cardiovascular disease. The Company’s Bioprosthetic Heart Valve (BHV), is a bioprosthetic, pig heart valve designed to function like a native heart valve, and designed to provide a patient greater functional performance than available devices. The Company’s product Venous Valve is a bioprosthetic, pig venous valve for patients with lower limb chronic venous insufficiency (CVI), which occurs because of damage to the valves of the veins in the legs after patients develop blood clots in the deep venous system.",Mr. Robert A. Berman,Medical - Devices,10.38,USD,98319360,https://images.financialmodelingprep.com/symbol/HJLI.png,777480,0,-0.21000004,221867,-23826000,-21819000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.82}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -23.52}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -24.3}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -16.2}]","[{'period': ""Q4 '24"", 'revenue': 0.812, 'unit': 'M', 'net_profit': -6.23}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.64}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.96}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.99}, {'period': ""Q4 '23"", 'revenue': 0.8240000000000001, 'unit': 'M', 'net_profit': -5.65}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.0}]",-1.27,-1.27,44954000,43734000,43153000,2795000,0,0,2095000,1754000,-16875000,0.04764569509952834,0.07216363327096445,0.3350785340314136,__nan__,__nan__,__nan__,0.062174667437825334
49,HJLIW,Hancock Jaffe Laboratories Inc. Warrants,,None,,0.56,USD,5304376,https://images.financialmodelingprep.com/symbol/HJLIW.png,21304,0,0.0948,10292,374836,-9135.486,"[{'period': '2020', 'revenue': 4.25, 'unit': 'K', 'net_profit': -9.14}, {'period': '2019', 'revenue': 0.03124, 'unit': 'M', 'net_profit': -7.63}, {'period': '2018', 'revenue': 0.18655000000000002, 'unit': 'M', 'net_profit': -13.04}, {'period': '2017', 'revenue': 0.42211000000000004, 'unit': 'M', 'net_profit': -7.79}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.38}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.77}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.97}, {'period': ""Q2 '20"", 'revenue': -0.00022799999999999999, 'unit': 'M', 'net_profit': -1.63}, {'period': ""Q1 '20"", 'revenue': -0.00263, 'unit': 'M', 'net_profit': -1.16}]",-0.0006,-0.0006,9968018,9569051,9334584,3439979,0,0,3186233,9334584,-7857501,1.0518536307612456,0.9988019658517452,0.99875,__nan__,__nan__,__nan__,0.3451016039497521
50,HLAH,Hamilton Lane Alliance Holdings I Inc. Class A Common Stock,"Hamilton Lane Alliance Holdings I, Inc. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. Hamilton Lane Alliance Holdings I, Inc. was incorporated in 2020 and is based in Conshohocken, Pennsylvania.",Ms. Andrea F. Kramer,Shell Companies,10.08,USD,0,https://images.financialmodelingprep.com/symbol/HLAH.png,266516,9.08108108108108,0.03,951917,2019255,5285440,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.29}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 783.94}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.1}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'T', 'net_profit': 8.82}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.39}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.35}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.32}]",0.16,0.16,276864436,855216,186941,18808568,0,276009220,761280,186941,-1828430,0,0,0,__nan__,__nan__,__nan__,0.06793421456268223
51,HLAHU,Hamilton Lane Alliance Holdings I Inc. Unit,"Hamilton Lane Alliance Holdings I, Inc. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. Hamilton Lane Alliance Holdings I, Inc. was incorporated in 2020 and is based in Conshohocken, Pennsylvania.",,Shell Companies,10.06,USD,0,https://images.financialmodelingprep.com/symbol/HLAHU.png,50867,63.67088607594937,0.015,3218,2019255,5285440,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.29}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 783.94}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.1}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'T', 'net_profit': 8.82}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.39}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.35}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.32}]",0.16,0.16,276864436,855216,186941,18808568,0,276009220,761280,186941,-1828430,0,0,0,__nan__,__nan__,__nan__,0.06793421456268223
52,HLAHW,Hamilton Lane Alliance Holdings I Inc. Warrant,,,Shell Companies,0.003,USD,0,https://images.financialmodelingprep.com/symbol/HLAHW.png,0,0,0.0027,128706,2019255,5285440,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.29}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 783.94}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.1}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'T', 'net_profit': 8.82}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.39}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.35}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.32}]",0.16,0.16,276864436,855216,186941,18808568,0,276009220,761280,186941,-1828430,0,0,0,__nan__,__nan__,__nan__,0.06793421456268223
53,HLG,Hailiang Education Group Inc. American Depositary Shares,"Hailiang Education Group Inc. provides K-12 educational and management services in the People's Republic of China. The company operates 14 affiliated schools; and 27 managed schools. It offers K-12 student management, high school curriculum education, and operation and management services, including branding, academic management, education resources, school culture, admission, finance, human resources, procurement, IT, internal audit, and property and logistics management services, as well as after-school enrichment, accommodations, and transportation services. The company also provides ancillary educational services, such as well-rounded education, academic subject tutoring, study trip, and overseas study consulting services; and hotel management services. In addition, its schools offer basic educational and international programs at the primary school, middle school, and high school levels; courses designed for students, such as A-levels courses for the United Kingdom universities, AP courses for the United States universities, Victorian Certificate of Education (VCE) courses for Australian universities, and International Baccalaureate (IB) courses for various countries in the world; and language courses, including Japanese, Korean, and Spanish. As of June 30, 2021, the company had 10,402 students enrolled in its affiliated schools; and 43,897 students enrolled in its managed schools. Hailiang Education Group Inc. was founded in 1995 and is based in Hangzhou, the People's Republic of China.",Mr. Ming Wang,Education & Training Services,14.29,USD,0,https://images.financialmodelingprep.com/symbol/HLG.png,0,5.292592592592593,-0.010000229,15278,571326000,235092000,"[{'period': '2021', 'revenue': 1380.0, 'unit': 'M', 'net_profit': 235.09}, {'period': '2020', 'revenue': 1480.0, 'unit': 'M', 'net_profit': 370.83}, {'period': '2019', 'revenue': 1500.0, 'unit': 'M', 'net_profit': 293.42}, {'period': '2018', 'revenue': 1170.0, 'unit': 'M', 'net_profit': 222.59}]","[{'period': ""Q4 '21"", 'revenue': 4.02, 'unit': 'M', 'net_profit': -132.75}, {'period': ""Q3 '21"", 'revenue': 434.77, 'unit': 'M', 'net_profit': 99.87}, {'period': ""Q2 '21"", 'revenue': 638.47, 'unit': 'M', 'net_profit': 241.08}, {'period': ""Q1 '21"", 'revenue': 298.53, 'unit': 'M', 'net_profit': 26.89}, {'period': ""Q4 '20"", 'revenue': 434.66, 'unit': 'M', 'net_profit': 106.97}, {'period': ""Q3 '20"", 'revenue': 298.54, 'unit': 'M', 'net_profit': 59.73}]",9.12,9.12,3270783000,849700000,756723000,1053923000,71119000,1420939000,1018534000,279420000,772866000,-0.13820910111139267,-0.36604176554342666,-0.3662265462126478,__nan__,__nan__,__nan__,0.3222234553622175
54,HLIO,Helios Technologies Inc. Common Stock,"Helios Technologies, Inc., together with its subsidiaries, develops, manufactures, and sells solutions for the hydraulics and electronics markets in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Hydraulics and Electronics. The Hydraulics segment offers cartridge valve technology products to control rates and direction of fluid flow, and to regulate and control pressures for industrial and mobile applications; quick release coupling solutions for the agriculture, construction equipment, and industrial markets; and hydraulic system design that provides engineered solutions for machine users, manufacturers, or designers. This segment sells its products under the Sun Hydraulics, Faster, and Custom Fluidpower brands. The Electronics segment offers displays, controls, and instrumentation products for off-highway, recreational and commercial marine, power sports and specialty vehicles, agriculture and water pumping, power generation, health and wellness, and engine-driven industrial equipment markets. This segment sells its products under the Enovation Controls, Murphy, and Balboa Water Group brands. It sells its hydraulic products primarily through value-add distributors, as well as directly to original equipment manufacturers; and electronic products to original equipment manufacturer customers. The company was formerly known as Sun Hydraulics Corporation and changed its name to Helios Technologies, Inc. in June 2019. Helios Technologies, Inc. was founded in 1970 and is headquartered in Sarasota, Florida.",Mr. Sean  Bagan,Industrial - Machinery,28.74,USD,956929914,https://images.financialmodelingprep.com/symbol/HLIO.png,207745,24.56,2.94,711593,81800000,39000000,"[{'period': '2024', 'revenue': 805.9, 'unit': 'M', 'net_profit': 39.0}, {'period': '2023', 'revenue': 835.6, 'unit': 'M', 'net_profit': 37.5}, {'period': '2022', 'revenue': 885.4, 'unit': 'M', 'net_profit': 98.4}, {'period': '2021', 'revenue': 869.18, 'unit': 'M', 'net_profit': 104.6}]","[{'period': ""Q4 '24"", 'revenue': 179.5, 'unit': 'M', 'net_profit': 4.8}, {'period': ""Q3 '24"", 'revenue': 194.5, 'unit': 'M', 'net_profit': 11.4}, {'period': ""Q2 '24"", 'revenue': 219.9, 'unit': 'M', 'net_profit': 13.6}, {'period': ""Q1 '24"", 'revenue': 212.0, 'unit': 'M', 'net_profit': 9.2}, {'period': ""Q4 '23"", 'revenue': 193.4, 'unit': 'M', 'net_profit': 3.4}, {'period': ""Q3 '23"", 'revenue': 201.4, 'unit': 'M', 'net_profit': 3.5}]",1.17,1.17,1505400000,384200000,44100000,641000000,119700000,0,138600000,44100000,95100000,-0.43273231622746183,0.04,0.026315789473684237,"[0.09, 0.035]","['2025-04-04', '1997-03-26']",__nan__,0.42580045170718744
55,HLIT,Harmonic Inc. Common Stock,"Harmonic Inc., together with its subsidiaries, provide video delivery software, products, system solutions, and services worldwide. The company operates in two segments, Video and Cable Access. The Video segment sells video processing, production, and playout solutions and services to cable operators, and satellite and telecommunications Pay-TV service providers, as well as to broadcast and media, including streaming media companies. This segment's video processing appliance solutions include network management and application software, and hardware products, such as encoders, video servers, high-density stream processing systems, and edge processors. This segment also provides software-as-a-service (SaaS) solutions, which enables the packaging and delivery of streaming services, including live streaming, video-on-demand, catch-up TV, start-over TV, network-DVR, and cloud-DVR services through HTTP streaming to various device along with dynamic and personal ad insertion. The Cable Access segment offers CableOS software-based cable access solutions; and CableOS central cloud services primarily to cable operators. Its products enable customers to create, prepare, store, playout, and deliver a range of broadcast and streaming video services to consumer devices, including televisions, personal computers, laptops, tablets, and smart phones. The company also provides technical support and professional services, such as maintenance and support, consulting, implementation, program management, technical design and planning, building and site preparation, integration and equipment installation, end-to-end system testing, and training. It sells its products through its direct sales force, as well as through independent resellers and systems integrators. The company was incorporated in 1988 and is headquartered in San Jose, California.",Mr. Nimrod  Ben-Natan,Communication Equipment,9.13,USD,1068693890,https://images.financialmodelingprep.com/symbol/HLIT.png,1341121,27.67,0.88,1312393,77398000,39217000,"[{'period': '2024', 'revenue': 678.72, 'unit': 'M', 'net_profit': 39.22}, {'period': '2023', 'revenue': 607.91, 'unit': 'M', 'net_profit': 83.99}, {'period': '2022', 'revenue': 624.96, 'unit': 'M', 'net_profit': 28.18}, {'period': '2021', 'revenue': 507.15, 'unit': 'M', 'net_profit': 13.25}]","[{'period': ""Q4 '24"", 'revenue': 222.17, 'unit': 'M', 'net_profit': 38.12}, {'period': ""Q3 '24"", 'revenue': 195.76, 'unit': 'M', 'net_profit': 21.72}, {'period': ""Q2 '24"", 'revenue': 138.74, 'unit': 'M', 'net_profit': -12.53}, {'period': ""Q1 '24"", 'revenue': 122.06, 'unit': 'M', 'net_profit': -8.09}, {'period': ""Q4 '23"", 'revenue': 167.09, 'unit': 'M', 'net_profit': 83.84}, {'period': ""Q3 '23"", 'revenue': 127.2, 'unit': 'M', 'net_profit': -6.5}]",0.34,0.33,796506000,366076000,101457000,331248000,178013000,0,167569000,101457000,52731000,1.2702686847354219,-0.5330976022096816,-0.5466666666666666,__nan__,__nan__,__nan__,0.4158763399145769
56,HLNE,Hamilton Lane Incorporated Class A Common Stock,"Hamilton Lane Incorporated is an investment firm specializing in direct and fund of fund investments. It provides following services: separate accounts (customized to each individual client and structured as single client vehicles); specialized strategies (fund-of-funds, secondaries, co-investments, taft-hartley, distribution management); advisory relationships (including due diligence, strategic portfolio planning, monitoring and reporting services); and reporting and analytics solutions. For direct investments, the firm invests in early, mid and late venture, mature companies, growth equity, emerging growth, distressed debt, later stage, turnarounds, bridge financing, mezzanine financing, and buyouts in middle market companies. For fund of fund investments, it invests in mezzanine, venture capital, private equity, turnaround, secondary investments, real estate, and special situation funds. The firm invests in real estate investments. It also invest in technology, healthcare, education, natural resources, energy and essential consumer goods sectors, cleantech, and environment, community development, and financial empowerment. It invests in private equity markets in North America, Latin America, United States, Western Europe, Middle East, Africa, United Kingdom, Asia, Japan, and Australia. The firm prefer to invest $1 million to $100 million in companies. It prefers to have majority stake in companies. Hamilton Lane Incorporated was founded in 1991 and is based in Conshohocken, Pennsylvania with additional offices across Europe, North America, and Asia.",Mr. Erik R. Hirsch,Asset Management,147.08,USD,8383834451,https://images.financialmodelingprep.com/symbol/HLNE.png,566865,27.14,20.43,1204890,301022000,140858000,"[{'period': '2024', 'revenue': 553.84, 'unit': 'M', 'net_profit': 140.86}, {'period': '2023', 'revenue': 528.75, 'unit': 'M', 'net_profit': 187.19}, {'period': '2022', 'revenue': 367.92, 'unit': 'M', 'net_profit': 247.25}, {'period': '2021', 'revenue': 341.63, 'unit': 'M', 'net_profit': 168.78}]","[{'period': ""Q3 '25"", 'revenue': 168.26, 'unit': 'M', 'net_profit': 52.97}, {'period': ""Q2 '25"", 'revenue': 150.0, 'unit': 'M', 'net_profit': 54.98}, {'period': ""Q1 '25"", 'revenue': 196.73, 'unit': 'M', 'net_profit': 58.96}, {'period': ""Q4 '24"", 'revenue': 176.66, 'unit': 'M', 'net_profit': 48.36}, {'period': ""Q3 '24"", 'revenue': 125.26, 'unit': 'M', 'net_profit': 19.51}, {'period': ""Q2 '24"", 'revenue': 126.88, 'unit': 'M', 'net_profit': 41.99}]",3.69,2.61,1271200000,257348000,114634000,595242000,126656000,632272000,247370000,114634000,109779000,0.2163340512277611,-0.24749312177792024,-0.26930693069306927,"[0.49, 0.175]","['2025-03-14', '2017-06-22']",__nan__,0.46825204531151665
57,HLXA,Helix Acquisition Corp. Class A Ordinary Shares,"Helix Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses or entities. The company was founded in 2020 and is based in Boston, Massachusetts.",Ms. Bihua  Chen,Shell Companies,13.25,USD,516453200,https://images.financialmodelingprep.com/symbol/HLXA.png,92829,-43.159609120521175,2.1899996,554068,-4542654,-4514963,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.51}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -90.84}]","[{'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.22}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.09}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -152.33}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -90.84}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]",-0.3,-0.3,115836314,793706,666790,7895251,0,0,3870251,666790,-611071,-49.00830049098395,-48.70346110658535,-48.18032786885246,__nan__,__nan__,__nan__,0.06815868640295306
58,HMCO,HumanCo Acquisition Corp. Class A Common Stock,"HumanCo Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on investing in and building a company within the health and wellness ecosystem. The company was incorporated in 2020 and is based in Austin, Texas.",,Shell Companies,10.06,USD,0,https://images.financialmodelingprep.com/symbol/HMCO.png,106077,27.944444444444443,0,80170,11717478,25601696,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 25.6}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -89.63}]","[{'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.86}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -30.31}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 13.9}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.31}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.59}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 277.12}]",0.67,0.67,313137998,623210,339570,28835315,0,312514788,997815,339570,-894481,131.731652348544,286.6375767042285,292.30434782608694,__nan__,__nan__,__nan__,0.09208500783734333
59,HMCOU,HumanCo Acquisition Corp. Unit,"HumanCo Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on investing in and building a company within the health and wellness ecosystem. The company was incorporated in 2020 and is based in Austin, Texas.",,Shell Companies,10.04,USD,0,https://images.financialmodelingprep.com/symbol/HMCOU.png,1964,33.804713804713806,0,1113,11717478,25601696,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 25.6}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -89.63}]","[{'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.86}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -30.31}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 13.9}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.31}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.59}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 277.12}]",0.67,0.67,313137998,623210,339570,28835315,0,312514788,997815,339570,-894481,131.731652348544,286.6375767042285,292.30434782608694,__nan__,__nan__,__nan__,0.09208500783734333
60,HMCOW,HumanCo Acquisition Corp. Warrant,,,,0.0002,USD,0,https://images.financialmodelingprep.com/symbol/HMCOW.png,32284,0,0,200,11717478,25601696,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 25.6}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -89.63}]","[{'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.86}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -30.31}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 13.9}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.31}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.59}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 277.12}]",0.67,0.67,313137998,623210,339570,28835315,0,312514788,997815,339570,-894481,131.731652348544,286.6375767042285,292.30434782608694,__nan__,__nan__,__nan__,0.09208500783734333
61,HMHC,Houghton Mifflin Harcourt Company Common Stock,"Houghton Mifflin Harcourt Company, a learning technology company, provides curriculum, supplemental, intervention solutions, and professional learning services worldwide. It offers education programs in disciplines including reading, literature, math, science, and social studies; and extensions, such as supplemental and intervention solutions, professional services, professional resources, and educational services for teachers under the Heinemann brand. The company was formerly known as HMH Holdings (Delaware), Inc. and changed its name to Houghton Mifflin Harcourt Company in October 2013. Houghton Mifflin Harcourt Company was founded in 1832 and is headquartered in Boston, Massachusetts. As of April 6, 2022, Houghton Mifflin Harcourt Company was taken private.",Mr. John Lynch,Education & Training Services,21.03,USD,0,https://images.financialmodelingprep.com/symbol/HMHC.png,5071321,12.54025044722719,0,9430628,461944000,2060000,"[{'period': '2021', 'revenue': 1050.0, 'unit': 'M', 'net_profit': 2.06}, {'period': '2020', 'revenue': 1030.0, 'unit': 'M', 'net_profit': -479.84}, {'period': '2019', 'revenue': 1390.0, 'unit': 'M', 'net_profit': -213.83}, {'period': '2018', 'revenue': 1320.0, 'unit': 'M', 'net_profit': -94.16}]","[{'period': ""Q4 '21"", 'revenue': 178.81, 'unit': 'M', 'net_profit': -46.43}, {'period': ""Q3 '21"", 'revenue': 417.13, 'unit': 'M', 'net_profit': 95.36}, {'period': ""Q2 '21"", 'revenue': 308.67, 'unit': 'M', 'net_profit': 218.63}, {'period': ""Q1 '21"", 'revenue': 146.19, 'unit': 'M', 'net_profit': -51.98}, {'period': ""Q4 '20"", 'revenue': 203.56, 'unit': 'M', 'net_profit': -83.14}, {'period': ""Q3 '20"", 'revenue': 386.59, 'unit': 'M', 'net_profit': -12.55}]",0.0156,0.0156,1974280000,759434000,463131000,1643856000,135495000,0,546011000,463131000,228576000,3.5051600622569783,1.0042931155931794,1.0040837696335079,__nan__,__nan__,__nan__,0.8326356950381911
62,HMNF,HMN Financial Inc. Common Stock,"HMN Financial, Inc. operates as a bank holding company for Home Federal Savings Bank that provides various retail banking products and services. The company offers various deposit accounts, such as savings, interest bearing checking, non-interest bearing checking, money market, and certificate accounts. Its loan products include single family residential loans; commercial real estate and multi-family mortgage loans; construction loans; consumer loans, such as home equity, automobile, recreational vehicle, mobile home, and lot loans, as well as loans secured by deposit accounts, and other loans for household and personal purposes; and commercial business loans. The company offers financial planning products and services; and invests in mortgage-backed and related securities, the United States government agency obligations, and other permissible investments. It operates through 14 full service branches located in Minnesota, Wisconsin, and Iowa; and two loan origination offices in Sartell, Minnesota and La Crosse, Wisconsin. HMN Financial, Inc. was founded in 1934 and is headquartered in Rochester, Minnesota.",Mr. Bradley C. Krehbiel,Banks - Regional,27.99,USD,124973951,https://images.financialmodelingprep.com/symbol/HMNF.png,8884,23.521008403361346,-0.61,156666,0,6005000,"[{'period': '2023', 'revenue': 43.48, 'unit': 'M', 'net_profit': 6.0}, {'period': '2022', 'revenue': 41.14, 'unit': 'M', 'net_profit': 8.04}, {'period': '2021', 'revenue': 44.47, 'unit': 'M', 'net_profit': 13.56}, {'period': '2020', 'revenue': 44.06, 'unit': 'M', 'net_profit': 10.3}]","[{'period': ""Q2 '24"", 'revenue': 14790.0, 'unit': 'K', 'net_profit': 970.0}, {'period': ""Q1 '24"", 'revenue': 13.91, 'unit': 'M', 'net_profit': 1.32}, {'period': ""Q4 '23"", 'revenue': 11.54, 'unit': 'M', 'net_profit': 1.45}, {'period': ""Q3 '23"", 'revenue': 11.53, 'unit': 'M', 'net_profit': 1.5}, {'period': ""Q2 '23"", 'revenue': 9.7, 'unit': 'M', 'net_profit': 1.42}, {'period': ""Q1 '23"", 'revenue': 9.99, 'unit': 'M', 'net_profit': 1.63}]",1.38,1.37,1107135000,14704000,11151000,999428000,0,1006000,251857000,11151000,6989000,0,-0.2535736482287135,-0.2540540540540541,"[0.1, 0.06]","['2024-08-16', '1998-05-22']",__nan__,0.9027155676588673
63,HMPT,Home Point Capital Inc Common Stock,"Home Point Capital Inc., together with its subsidiaries, operates as a residential mortgage originator and service provider. It operates through two segments, Origination and Servicing. The Origination segment sources loans through direct, wholesale, and correspondent channels. The Servicing segment offers collecting loan payments; remitting principal and interest payments to investors; managing escrow funds for the payment of mortgage-related expenses, such as taxes and insurance; and performing loss mitigation activities on behalf of investors and administering mortgage loans. The company was incorporated in 2014 and is headquartered in Ann Arbor, Michigan.",Mr. William Andrew Newman,Financial - Mortgages,2.325,USD,321945094,https://images.financialmodelingprep.com/symbol/HMPT.png,181482,-1.0379464285714286,0.005,7181,-61526000,-221004000,"[{'period': '2022', 'revenue': 255.65, 'unit': 'M', 'net_profit': -221.0}, {'period': '2021', 'revenue': 870.2, 'unit': 'M', 'net_profit': 166.3}, {'period': '2020', 'revenue': 1300.0, 'unit': 'M', 'net_profit': 607.0}, {'period': '2019', 'revenue': 167.37, 'unit': 'M', 'net_profit': -31.91}]","[{'period': ""Q1 '23"", 'revenue': -107.59, 'unit': 'M', 'net_profit': -221.04}, {'period': ""Q4 '22"", 'revenue': 63.2, 'unit': 'M', 'net_profit': -63.05}, {'period': ""Q3 '22"", 'revenue': 8.32, 'unit': 'M', 'net_profit': -132.35}, {'period': ""Q2 '22"", 'revenue': 70.01, 'unit': 'M', 'net_profit': -63.52}, {'period': ""Q1 '22"", 'revenue': 158.17, 'unit': 'M', 'net_profit': 25.78}, {'period': ""Q4 '21"", 'revenue': 163.3, 'unit': 'M', 'net_profit': 19.3}]",-1.58,-1.58,2438100000,221900000,97200000,1834700000,124700000,0,64300000,97200000,3629210000,-1.2624829351535836,-2.328947684906795,-2.327731092436975,"[0.04, 0.15]","['2022-05-23', '2021-08-19']",__nan__,0.7525122021246052
64,HMST,HomeStreet Inc. Common Stock,"HomeStreet, Inc. operates as the bank holding company for HomeStreet Bank that provides commercial, mortgage, and consumer/retail banking services primarily in the Western United States. The company offers personal and business checking, savings accounts, interest-bearing negotiable order of withdrawal accounts, money market accounts, and time certificates of deposit; credit cards; insurance; and treasury management products and services. Its loan products include commercial business and agriculture loans, single family residential mortgages, consumer loans, commercial loans secured by residential and commercial real estate, and construction loans for residential and commercial real estate development, as well as consumer installment loans and permanent loans on commercial real estate and single-family residences. In addition, the company offers its products and services through bank branches, loan production offices, and ATMs, as well as through online, mobile, and telephone banking. As of December 31, 2021, it operated 60 full-service bank branches located in Washington state, Northern and Southern California, the Portland, Oregon, and Hawaii; and five primary stand-alone commercial lending centers in Central Washington, Oregon, Southern California, Idaho, and Utah. HomeStreet, Inc. serves small and medium sized businesses, real estate investors, professional firms, and individuals. The company was formerly known as Continental Mortgage and Loan Company. HomeStreet, Inc. was incorporated in 1921 and is headquartered in Seattle, Washington.",Mr. John Matthias Michel CPA,Banks - Regional,11.35,USD,214751080,https://images.financialmodelingprep.com/symbol/HMST.png,197709,-1.48,0.47,152947,0,-144344000,"[{'period': '2024', 'revenue': 402.57, 'unit': 'M', 'net_profit': -144.34}, {'period': '2023', 'revenue': 178.77, 'unit': 'M', 'net_profit': -27.51}, {'period': '2022', 'revenue': 254.9, 'unit': 'M', 'net_profit': 66.54}, {'period': '2021', 'revenue': 319.12, 'unit': 'M', 'net_profit': 115.42}]","[{'period': ""Q4 '24"", 'revenue': 99.07, 'unit': 'M', 'net_profit': -123.33}, {'period': ""Q3 '24"", 'revenue': 31.93, 'unit': 'M', 'net_profit': -7.28}, {'period': ""Q2 '24"", 'revenue': 114.35, 'unit': 'M', 'net_profit': -6.24}, {'period': ""Q1 '24"", 'revenue': 102.54, 'unit': 'M', 'net_profit': -7.5}, {'period': ""Q4 '23"", 'revenue': 101.28, 'unit': 'M', 'net_profit': -3.42}, {'period': ""Q3 '23"", 'revenue': 41.8, 'unit': 'M', 'net_profit': 2.29}]",-7.65,-7.65,8123698000,1463606000,1463606000,7726701000,0,0,0,406600000,-46411000,0,-4.247346226552276,-4.239726027397261,"[0.1, 0.11]","['2023-11-07', '2013-04-09']",__nan__,0.9511309996998903
65,HMTV,Hemisphere Media Group Inc. Class A Common Stock,"Hemisphere Media Group, Inc. operates as the Spanish-language media company. The company operates Pantaya, a subscription streaming service of Spanish-language media with approximately million subscribers; Cinelatino, a cable movie network with approximately 17.1 million subscribers in the United States, Latin America, and Canada; WAPA, a broadcast television network and television content producer; WAPA.TV, a news and entertainment website, as well as mobile apps, featuring content produced by WAPA; and WAPA Deportes, a sports television network in Puerto Rico. It also operates WAPA America, a cable television network that serves approximately 3.3 million subscribers in the United States; and Pasiones, a cable television network, which showcases telenovelas and serialized dramas to approximately 3.7 million subscribers in the United States and 15.4 million subscribers in Latin America. In addition, the company operates Centroamerica TV, a cable television network that provides news and entertainment, and soccer programming to approximately 3.2 million subscribers in the United States; and Television Dominicana, a cable television network, which offers news and entertainment programs to approximately 2.2 million subscribers in the United States. Further, it operates Snap Media, a distributor of content to broadcast and cable television networks; and over-the-top, and subscription and advertising video-on-demand platforms in Latin America; and REMEZCLA: a digital media company targeting English-speaking and the bilingual U.S. Hispanic millennials. The company was incorporated in 2013 and is headquartered in Coral Gables, Florida. As of September 13, 2022, Hemisphere Media Group, Inc. was taken private.",Mr. Alan Sokol,Entertainment,7.15,USD,0,https://images.financialmodelingprep.com/symbol/HMTV.png,0,-7.988826815642458,0.11000013,2212842,30107000,11031000,"[{'period': '2021', 'revenue': 195.65, 'unit': 'M', 'net_profit': 11.03}, {'period': '2020', 'revenue': 151.18, 'unit': 'M', 'net_profit': -1.24}, {'period': '2019', 'revenue': 149.39, 'unit': 'M', 'net_profit': -3.37}, {'period': '2018', 'revenue': 147.08, 'unit': 'M', 'net_profit': -10.91}]","[{'period': ""Q2 '22"", 'revenue': 54.17, 'unit': 'M', 'net_profit': -3.91}, {'period': ""Q1 '22"", 'revenue': 48.8, 'unit': 'M', 'net_profit': -13.23}, {'period': ""Q4 '21"", 'revenue': -44.43, 'unit': 'M', 'net_profit': -1.21}, {'period': ""Q3 '21"", 'revenue': 50.79, 'unit': 'M', 'net_profit': -14.8}, {'period': ""Q2 '21"", 'revenue': 50.46, 'unit': 'M', 'net_profit': -6.29}, {'period': ""Q1 '21"", 'revenue': 37.58, 'unit': 'M', 'net_profit': 33.36}]",0.28,0.28,599911000,126364000,49477000,350363000,33738000,24171000,73271000,49477000,324000,-0.3594255319148936,9.931983805668017,9.945686900958467,__nan__,__nan__,__nan__,0.5840249637029493
66,HNNA,Hennessy Advisors Inc. Common Stock,"Hennessy Advisors, Inc. is publicly owned investment manager. It provides its services to Hennessy Funds and investment companies. The firm launches and manages equity, fixed income, and balanced mutual funds. It invests in the public equity and fixed income markets across the globe. The firm primarily invests in growth stocks of companies. It conducts in-house research to make its investments. Hennessy Advisors, Inc. was founded in 1989 and is based in Novato, California with additional offices in Boston, Massachusetts and Chapel Hill, North Carolina.",Mr. Neil Joseph Hennessy,Asset Management,9.4,USD,73167156,https://images.financialmodelingprep.com/symbol/HNNA.png,12118,8.39,0.435,15918,12223000,7097000,"[{'period': '2024', 'revenue': 29.65, 'unit': 'M', 'net_profit': 7.1}, {'period': '2023', 'revenue': 24.02, 'unit': 'M', 'net_profit': 4.77}, {'period': '2022', 'revenue': 29.67, 'unit': 'M', 'net_profit': 6.19}, {'period': '2021', 'revenue': 32.76, 'unit': 'M', 'net_profit': 7.9}]","[{'period': ""Q1 '25"", 'revenue': 9.71, 'unit': 'M', 'net_profit': 2.83}, {'period': ""Q4 '24"", 'revenue': 8.78, 'unit': 'M', 'net_profit': 2.33}, {'period': ""Q3 '24"", 'revenue': 7.78, 'unit': 'M', 'net_profit': 2.03}, {'period': ""Q2 '24"", 'revenue': 6.94, 'unit': 'M', 'net_profit': 1.54}, {'period': ""Q1 '24"", 'revenue': 6.14, 'unit': 'M', 'net_profit': 1.2}, {'period': ""Q4 '23"", 'revenue': 6.26, 'unit': 'M', 'net_profit': 1.34}]",0.92,0.92,152099000,68276000,63933000,60788000,562000,0,4954000,63922000,8964000,0.8621267519804997,0.4875288199538881,0.46031746031746035,"[0.1375, 0.1275]","['2025-02-24', '2006-02-10']",__nan__,0.39966074727644496
67,HNRG,Hallador Energy Company Common Stock,"Hallador Energy Company, through its subsidiaries, engages in the production of steam coal in the State of Indiana for the electric power generation industry. The company owns the Oaktown Mine 1 and Oaktown Mine 2 underground mines in Oaktown, Indiana; and Ace in the Hole mine located near Clay City, Indiana. It is also involved in gas exploration activities in Indiana. Hallador Energy Company was founded in 1949 and is headquartered in Terre Haute, Indiana.",Mr. Brent K. Bilsland,Coal,13,USD,554022300,https://images.financialmodelingprep.com/symbol/HNRG.png,632073,-2.27,1.89,2500779,-202597000,-215792000,"[{'period': '2024', 'revenue': 94.75, 'unit': 'M', 'net_profit': -215.79}, {'period': '2023', 'revenue': 634.48, 'unit': 'M', 'net_profit': 44.79}, {'period': '2022', 'revenue': 361.99, 'unit': 'M', 'net_profit': 18.11}, {'period': '2021', 'revenue': 247.67, 'unit': 'M', 'net_profit': -3.75}]","[{'period': ""Q4 '24"", 'revenue': 94.22, 'unit': 'M', 'net_profit': -215.79}, {'period': ""Q3 '24"", 'revenue': 105.04, 'unit': 'M', 'net_profit': 1.55}, {'period': ""Q2 '24"", 'revenue': 90.91, 'unit': 'M', 'net_profit': -10.2}, {'period': ""Q1 '24"", 'revenue': 108.39, 'unit': 'M', 'net_profit': -1.7}, {'period': ""Q4 '23"", 'revenue': 118.44, 'unit': 'M', 'net_profit': -10.25}, {'period': ""Q3 '23"", 'revenue': 165.77, 'unit': 'M', 'net_profit': 16.07}]",-5.06,-5.06,369120000,15438000,0,264835000,15438000,2607000,152903000,0,12567000,-2.535011819614499,-5.817538454669257,-4.640287769784172,"[0.04, 0.1]","['2020-01-30', '2010-07-07']",__nan__,0.7174767013437364
68,HNST,The Honest Company Inc. Common Stock,"The Honest Company, Inc. manufactures and sells diapers and wipes, skin and personal care, and household and wellness products. The company also offers baby clothing and nursery bedding products. It sells its products through digital and retail sales channels, such as its website and third-party ecommerce sites, as well as brick and mortar retailers. The company was incorporated in 2012 and is headquartered in Los Angeles, California.",Ms. Carla  Vernon,Specialty Retail,4.62,USD,503164200,https://images.financialmodelingprep.com/symbol/HNST.png,2680945,-77,0.42,3414546,-6331000,-6124000,"[{'period': '2024', 'revenue': 378.34, 'unit': 'M', 'net_profit': -6.12}, {'period': '2023', 'revenue': 344.37, 'unit': 'M', 'net_profit': -39.24}, {'period': '2022', 'revenue': 313.65, 'unit': 'M', 'net_profit': -49.02}, {'period': '2021', 'revenue': 318.64, 'unit': 'M', 'net_profit': -38.68}]","[{'period': ""Q4 '24"", 'revenue': 99840.0, 'unit': 'K', 'net_profit': -810.0}, {'period': ""Q3 '24"", 'revenue': 99240.0, 'unit': 'K', 'net_profit': 165.0}, {'period': ""Q2 '24"", 'revenue': 93.05, 'unit': 'M', 'net_profit': -4.08}, {'period': ""Q1 '24"", 'revenue': 86.22, 'unit': 'M', 'net_profit': -1.4}, {'period': ""Q4 '23"", 'revenue': 90.26, 'unit': 'M', 'net_profit': 1.14}, {'period': ""Q3 '23"", 'revenue': 86.17, 'unit': 'M', 'net_profit': -8.1}]",-0.0611,-0.0611,247393000,213918000,75435000,73086000,43476000,0,59889000,75435000,1011000,0.8248879792000885,0.8439268056475865,0.8545238095238096,__nan__,__nan__,__nan__,0.29542468865327637
69,HOFT,Hooker Furniture Corporation Common Stock,"Hooker Furnishings Corporation designs, manufactures, imports, and markets residential household, hospitality, and contract furniture. The company's Hooker Branded segment offers design categories, including home entertainment, home office, accent, dining, and bedroom furniture under the Hooker Furniture brand; and imported upholstered furniture under the Hooker Upholstery brand. Its Home Meridian segment provides home furnishings under the Accentrics Home brand; a range of bedroom, dining room, accent, display cabinet, home office, and youth furnishings under the Pulaski Furniture and Samuel Lawrence Furniture brands; and imported leather motion upholstery under the Prime Resources International brand. This segment also designs and supplies hotel furnishings for four and five-star hotels under the Samuel Lawrence Hospitality brand name; and ready-to-assemble furniture under the HMidea brand. The company's Domestic Upholstery segment offers motion and stationary leather furniture under the Bradington-Young brand; occasional chairs, settees, sofas, and sectional seating under the Sam Moore Furniture brand; and upholstered furniture, such as private label sectionals, modulars, sofas, chairs, ottomans, benches, beds, and dining chairs for lifestyle specialty retailers under the Shenandoah Furniture brand. It also supplies upholstered seating and casegoods to upscale senior living and assisted living facilities through designers, design firms, industry dealers, and distributors under the H Contract brand; and interior designer products under the Lifestyle Brands name. The company sells home furnishing products through retailers, including independent furniture stores, department stores, mass merchants, national chains, catalog merchants, interior designers, e-commerce retailers, and warehouse clubs primarily in North America. Hooker Furnishings Corporation was incorporated in 1924 and is headquartered in Martinsville, Virginia.",Mr. Jeremy R. Hoff,"Furnishings, Fixtures & Appliances",8.6,USD,92109440,https://images.financialmodelingprep.com/symbol/HOFT.png,64295,-9.45,0.26,134350,22967000,9865000,"[{'period': '2024', 'revenue': 433.23, 'unit': 'M', 'net_profit': 9.87}, {'period': '2023', 'revenue': 583.1, 'unit': 'M', 'net_profit': -4.31}, {'period': '2022', 'revenue': 593.61, 'unit': 'M', 'net_profit': 11.72}, {'period': '2021', 'revenue': 540.08, 'unit': 'M', 'net_profit': -10.43}]","[{'period': ""Q3 '25"", 'revenue': 104.35, 'unit': 'M', 'net_profit': -4.13}, {'period': ""Q2 '25"", 'revenue': 95.08, 'unit': 'M', 'net_profit': -1.95}, {'period': ""Q1 '25"", 'revenue': 93.57, 'unit': 'M', 'net_profit': -4.09}, {'period': ""Q4 '24"", 'revenue': 96780.0, 'unit': 'K', 'net_profit': 593.0}, {'period': ""Q3 '24"", 'revenue': 116.83, 'unit': 'M', 'net_profit': 7.04}, {'period': ""Q2 '24"", 'revenue': 97810.0, 'unit': 'K', 'net_profit': 785.0}]",0.89,0.88,343586000,164798000,43159000,117611000,54294000,0,41409000,43159000,48656000,6.179431072210066,3.2878014842300556,3.4054054054054053,"[0.23, 0.1]","['2025-03-17', '2002-08-13']",__nan__,0.34230440122705813
70,HOFV,Hall of Fame Resort & Entertainment Company Common Stock,"Hall of Fame Resort & Entertainment Company, a resort and entertainment company, doing business as the Pro Football Hall of Fame. It owns the premier sports, entertainment, and media enterprise surrounding the Pro Football Hall of Fame in Canton, Ohio. The company was founded in 2015 and is headquartered in Canton, Ohio. Hall of Fame Resort & Entertainment Company is a subsidiary of Industrial Realty Group, LLC.",Mr. Eric  Hess,Entertainment,0.838,USD,5613469,https://images.financialmodelingprep.com/symbol/HOFV.png,22519,-0.1,0.03,14402,-7361503,-55854047,"[{'period': '2024', 'revenue': 21.21, 'unit': 'M', 'net_profit': -55.85}, {'period': '2023', 'revenue': 24.13, 'unit': 'M', 'net_profit': -68.68}, {'period': '2022', 'revenue': 15.98, 'unit': 'M', 'net_profit': -55.12}, {'period': '2021', 'revenue': 10.77, 'unit': 'M', 'net_profit': -101.15}]","[{'period': ""Q4 '24"", 'revenue': 4.81, 'unit': 'M', 'net_profit': -21.32}, {'period': ""Q3 '24"", 'revenue': 7.5, 'unit': 'M', 'net_profit': -4.42}, {'period': ""Q2 '24"", 'revenue': 4.7, 'unit': 'M', 'net_profit': -15.49}, {'period': ""Q1 '24"", 'revenue': 4.19, 'unit': 'M', 'net_profit': -14.62}, {'period': ""Q4 '23"", 'revenue': 6.14, 'unit': 'M', 'net_profit': -19.9}, {'period': ""Q3 '23"", 'revenue': 8.74, 'unit': 'M', 'net_profit': -16.15}]",-8.39,-8.39,366705811,8400717,2865174,294474352,1520166,2228074,249149415,432174,-27310776,0.7650358408370064,0.18676768439915128,0.29908103592314117,__nan__,__nan__,__nan__,0.8030261402102515
71,HOFVW,Hall of Fame Resort &amp; Entertainment Company Warrant,"Hall of Fame Resort & Entertainment Company, a resort and entertainment company, doing business as the Pro Football Hall of Fame. It owns the premier sports, entertainment, and media enterprise surrounding the Pro Football Hall of Fame in Canton, Ohio. The company was founded in 2015 and is headquartered in Canton, Ohio. Hall of Fame Resort & Entertainment Company is a subsidiary of Industrial Realty Group, LLC.",Mr. Eric  Hess,Entertainment,0.0037,USD,24785,https://images.financialmodelingprep.com/symbol/HOFVW.png,20132.50943,,0.0016,2182,-7361503,-55854047,"[{'period': '2024', 'revenue': 21.21, 'unit': 'M', 'net_profit': -55.85}, {'period': '2023', 'revenue': 24.13, 'unit': 'M', 'net_profit': -68.68}, {'period': '2022', 'revenue': 15.98, 'unit': 'M', 'net_profit': -55.12}, {'period': '2021', 'revenue': 10.77, 'unit': 'M', 'net_profit': -101.15}]","[{'period': ""Q4 '24"", 'revenue': 4.81, 'unit': 'M', 'net_profit': -21.32}, {'period': ""Q3 '24"", 'revenue': 7.5, 'unit': 'M', 'net_profit': -4.42}, {'period': ""Q2 '24"", 'revenue': 4.7, 'unit': 'M', 'net_profit': -15.49}, {'period': ""Q1 '24"", 'revenue': 4.19, 'unit': 'M', 'net_profit': -14.62}, {'period': ""Q4 '23"", 'revenue': 6.14, 'unit': 'M', 'net_profit': -19.9}, {'period': ""Q3 '23"", 'revenue': 8.74, 'unit': 'M', 'net_profit': -16.15}]",-8.39,-8.39,366705811,8400717,2865174,294474352,1520166,2228074,249149415,432174,-27310776,0.7650358408370064,0.18676768439915128,0.29908103592314117,__nan__,__nan__,__nan__,0.8030261402102515
72,HOL,Holicity Inc. Class A Common Stock,"Holicity Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other related business combination with one or more businesses. The company was incorporated in 2020 and is based in Kirkland, Washington.",Mr. Craig O. McCaw,Shell Companies,12.35,USD,3303205112,https://images.financialmodelingprep.com/symbol/HOL.png,916512,0,-0.97999954,2299967,-655161,-655161,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -655.16}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -31.3}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -655.16}]",-0.0175,-0.0175,15761779,301037385,301037385,10761772,0,0,261772,990428,,0,0,0,__nan__,__nan__,__nan__,0.6827764810050947
73,HOLI,Hollysys Automation Technologies Ltd. Common Shares (British Virgin Islands),"Hollysys Automation Technologies Ltd. provides automation solutions in the People's Republic of China, Southeast Asia, India, and the Middle East. The company offers a suite of industrial automation systems, including hardware-centric products, such as instrumentation and actuators; proprietary software-centric distributed control systems/programmable logic controllers; and valued-added software packages comprising simulation training system, HolliAS asset management system, advanced process control, and manufacturing execution system, as well as HOLLiAS MACS-N DCS, a proprietary nuclear power non-safety automation and control system. It also provides train control center that monitors route condition, track status, train schedules, distance between trains, and the working status of other function devices, as well as generates control instructions and commands. In addition, the company offers automation train protection that operates as a train over-speed protection mechanism; and supervisory control and data acquisition system, an open software platform. Further, it offers research and development services; and offers integrated automation control system solutions, mechanical and electrical solutions, and installation services, as well as provides medicine and healthcare, industrial digitization, and industrial information security solutions. The company serves customers in the industrial, railway, subway, nuclear power, and mechanical and electronic industries. The company was formerly known as HLS Systems International Ltd. and changed its name to Hollysys Automation Technologies Ltd. in July 2009. Hollysys Automation Technologies Ltd. was founded in 1993 and is headquartered in Beijing, the People's Republic China.",Dr. Changli  Wang,Electrical Equipment & Parts,26.42,USD,1643316074,https://images.financialmodelingprep.com/symbol/HOLI.png,619389,21.834710743801654,0.01,2979060,102967000,106931000,"[{'period': '2023', 'revenue': 777.37, 'unit': 'M', 'net_profit': 106.93}, {'period': '2022', 'revenue': 707.46, 'unit': 'M', 'net_profit': 83.18}, {'period': '2021', 'revenue': 593.47, 'unit': 'M', 'net_profit': 89.71}, {'period': '2020', 'revenue': 503.33, 'unit': 'M', 'net_profit': 79.4}]","[{'period': ""Q3 '24"", 'revenue': 183.59, 'unit': 'M', 'net_profit': 3.91}, {'period': ""Q2 '24"", 'revenue': 238.49, 'unit': 'M', 'net_profit': 14.14}, {'period': ""Q1 '24"", 'revenue': 199.9, 'unit': 'M', 'net_profit': 31.64}, {'period': ""Q4 '23"", 'revenue': 194.96, 'unit': 'M', 'net_profit': 25.72}, {'period': ""Q3 '23"", 'revenue': 167.64, 'unit': 'M', 'net_profit': 11.57}, {'period': ""Q2 '23"", 'revenue': 244.73, 'unit': 'M', 'net_profit': 48.24}]",1.74,1.72,1684848000,1424935000,644834000,508615000,616369000,49164000,470145000,611632000,-17741000,-0.002895435089961846,0.28550647976725735,0.27941176470588225,"[0.32, 0.4]","['2022-04-01', '2015-02-19']",__nan__,0.3018758962232795
74,HOLUU,Holicity Inc. Unit,"Holicity Inc. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in Kirkland, Washington.",Mr. Craig O. McCaw,Shell Companies,13.65,USD,3650910914,https://images.financialmodelingprep.com/symbol/HOLUU.png,4640,0,-0.35,3914,-655161,-655161,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -655.16}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -31.3}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -655.16}]",-0.0175,-0.0175,15761779,301037385,301037385,10761772,0,0,261772,990428,,0,0,0,__nan__,__nan__,__nan__,0.6827764810050947
75,HOLUW,Holicity Inc. Warrant,,,,,,,,,,,,-655161,-655161,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -655.16}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -31.3}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -655.16}]",-0.09,-0.09,15761779,301037385,301037385,10761772,0,0,261772,990428,,0,0,0,__nan__,__nan__,__nan__,0.6827764810050947
76,HOLX,Hologic Inc. Common Stock,"Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.",Ms. Karleen M. Oberton CPA,Medical - Instruments & Supplies,59.31,USD,13308570900,https://images.financialmodelingprep.com/symbol/HOLX.png,2714095,18.77,0.85,4333237,1296200000,789500000,"[{'period': '2024', 'revenue': 4030.0000000000005, 'unit': 'M', 'net_profit': 789.5}, {'period': '2023', 'revenue': 4030.0000000000005, 'unit': 'M', 'net_profit': 456.0}, {'period': '2022', 'revenue': 4.86, 'unit': 'B', 'net_profit': 1.3}, {'period': '2021', 'revenue': 5.63, 'unit': 'B', 'net_profit': 1.87}]","[{'period': ""Q1 '25"", 'revenue': 1020.0, 'unit': 'M', 'net_profit': 201.0}, {'period': ""Q4 '24"", 'revenue': 987.9, 'unit': 'M', 'net_profit': 178.6}, {'period': ""Q3 '24"", 'revenue': 1010.0, 'unit': 'M', 'net_profit': 194.5}, {'period': ""Q2 '24"", 'revenue': 1020.0, 'unit': 'M', 'net_profit': 169.9}, {'period': ""Q1 '24"", 'revenue': 1010.0, 'unit': 'M', 'net_profit': 246.5}, {'period': ""Q4 '23"", 'revenue': 945.3, 'unit': 'M', 'net_profit': 90.6}]",3.35,3.32,9156000000,3823300000,2333600000,4026000000,600400000,96400000,1037200000,2160200000,1145000000,0.1671168737619305,0.731359649122807,0.8108108108108107,__nan__,__nan__,__nan__,0.4397116644823067
77,HOMB,Home BancShares Inc. Common Stock,"Home Bancshares, Inc. (Conway, AR) operates as the bank holding company for Centennial Bank that provides commercial and retail banking, and related financial services to businesses, real estate developers and investors, individuals, and municipalities. Its deposit products include checking, savings, and money market accounts, as well as certificates of deposit. The company's loan portfolio comprises non-farm/non-residential real estate, construction/land development, residential mortgage, consumer, agricultural, and commercial and industrial loans. It also provides internet banking, mobile banking and voice response information, cash management, overdraft protection, direct deposit, and automatic account transfer services, as well as safe deposit boxes and the United States savings bonds. In addition, the company writes policies for commercial and personal lines of business, including insurance for property, casualty, life, health, and employee benefits. As of December 31, 2021, it operated through 160 branch locations that included 76 branches in Arkansas, 78 branches in Florida, 5 branches in Alabama, and 1 branch in New York City. Home Bancshares, Inc. (Conway, AR) was founded in 1998 and is headquartered in Conway, Arkansas.",Mr. John W. Allison,Banks - Regional,26.69,USD,5299326190,https://images.financialmodelingprep.com/symbol/HOMB.png,1166501,13.28,1.64,1656726,0,402241000,"[{'period': '2024', 'revenue': 969.02, 'unit': 'M', 'net_profit': 402.24}, {'period': '2023', 'revenue': 978.26, 'unit': 'M', 'net_profit': 392.93}, {'period': '2022', 'revenue': 918.88, 'unit': 'M', 'net_profit': 305.26}, {'period': '2021', 'revenue': 699.78, 'unit': 'M', 'net_profit': 319.02}]","[{'period': ""Q4 '24"", 'revenue': 241.57, 'unit': 'M', 'net_profit': 100.56}, {'period': ""Q3 '24"", 'revenue': 254.43, 'unit': 'M', 'net_profit': 100.04}, {'period': ""Q2 '24"", 'revenue': 368.3, 'unit': 'M', 'net_profit': 101.53}, {'period': ""Q1 '24"", 'revenue': 357.72, 'unit': 'M', 'net_profit': 100.11}, {'period': ""Q4 '23"", 'revenue': 343.46, 'unit': 'M', 'net_profit': 86.24}, {'period': ""Q3 '23"", 'revenue': 241.36, 'unit': 'M', 'net_profit': 98.45}]",2.01,2.01,22490748000,17962451000,3353702000,18529723000,14608749000,0,20186000,281063000,422115000,-1,0.023698937976072015,0.036082474226804044,"[0.195, 0.05]","['2025-02-12', '2006-08-31']",__nan__,0.8238820247330146
78,HON,Honeywell International Inc. Common Stock,"Honeywell International Inc. operates as a diversified technology and manufacturing company worldwide. Its Aerospace segment offers auxiliary power units, propulsion engines, integrated avionics, environmental control and electric power systems, engine controls, flight safety, communications, navigation hardware, data and software applications, radar and surveillance systems, aircraft lighting, advanced systems and instruments, satellite and space components, and aircraft wheels and brakes; spare parts; repair, overhaul, and maintenance services; thermal systems, as well as wireless connectivity and management services. The company's Honeywell Building Technologies segment offers software applications for building control and optimization; sensors, switches, control systems, and instruments for energy management; access control; video surveillance; fire products; and installation, maintenance, and upgrades of systems. Its Performance Materials and Technologies segment offers automation control, instrumentation, and software and related services; catalysts and adsorbents, equipment, and consulting; and materials to manufacture end products, such as bullet-resistant armor, nylon, computer chips, and pharmaceutical packaging, as well as provides reduced and low global-warming-potential materials based on hydrofluoro-olefin technology. The company's Safety and Productivity Solutions segment provides personal protection equipment, apparel, gear, and footwear; gas detection technology; cloud-based notification and emergency messaging; mobile devices and software; supply chain and warehouse automation equipment, and software solutions; custom-engineered sensors, switches, and controls; and data and asset management productivity software solutions. The company was founded in 1906 and is headquartered in Charlotte, North Carolina.",Mr. Vimal M. Kapur,Conglomerates,199.1,USD,129169708800,https://images.financialmodelingprep.com/symbol/HON.png,4727578,22.89,16.24,8744497,9605000000,5705000000,"[{'period': '2024', 'revenue': 38.5, 'unit': 'B', 'net_profit': 5.71}, {'period': '2023', 'revenue': 36.66, 'unit': 'B', 'net_profit': 5.66}, {'period': '2022', 'revenue': 35.47, 'unit': 'B', 'net_profit': 4.97}, {'period': '2021', 'revenue': 34.39, 'unit': 'B', 'net_profit': 5.54}]","[{'period': ""Q4 '24"", 'revenue': 10.09, 'unit': 'B', 'net_profit': 1.28}, {'period': ""Q3 '24"", 'revenue': 9.73, 'unit': 'B', 'net_profit': 1.41}, {'period': ""Q2 '24"", 'revenue': 9.57, 'unit': 'B', 'net_profit': 1.54}, {'period': ""Q1 '24"", 'revenue': 9.1, 'unit': 'B', 'net_profit': 1.46}, {'period': ""Q4 '23"", 'revenue': 9.43, 'unit': 'B', 'net_profit': 1.26}, {'period': ""Q3 '23"", 'revenue': 9.21, 'unit': 'B', 'net_profit': 1.51}]",8.76,8.71,1365000000,371000000,10953000000,408000000,174000000,4000000,152000000,10567000000,4933000000,0.1002290950744559,0.00830682219865677,0.026963657678780825,"[1.13, 0.2952]","['2025-02-28', '1970-02-04']",__nan__,0.2989010989010989
79,HONE,HarborOne Bancorp Inc. Common Stock,"HarborOne Bancorp, Inc. operates as the holding company for HarborOne Bank that provides financial services to individuals, families, small and mid-size businesses, and municipalities. The company operates in two segments, HarborOne Bank and HarborOne Mortgage. Its primary deposit products include checking, money market, savings, and term certificate of deposit accounts; and lending products comprise commercial real estate, commercial, residential mortgages, and consumer loans, including indirect automobile lease loans. The company also originates, sells, and services residential mortgage loans. In addition, it provides a range of educational services, such as classes on small business, financial literacy, and personal enrichment. As of December 31, 2021, the company operated through a network of 30 full-service branches located in Massachusetts and Rhode Island, as well as commercial lending offices in each of Boston, Massachusetts, and Providence, Rhode Island. It also had administrative offices in Brockton, Massachusetts, as well as 5 ATM locations in Massachusetts. The company was founded in 1917 and is based in Brockton, Massachusetts.",Mr. Joseph F. Casey,Banks - Regional,9.63,USD,417074337,https://images.financialmodelingprep.com/symbol/HONE.png,196031,14.59,0.4,258453,0,27407000,"[{'period': '2024', 'revenue': 271.41, 'unit': 'M', 'net_profit': 27.41}, {'period': '2023', 'revenue': 163.44, 'unit': 'M', 'net_profit': 16.08}, {'period': '2022', 'revenue': 204.91, 'unit': 'M', 'net_profit': 45.59}, {'period': '2021', 'revenue': 226.32, 'unit': 'M', 'net_profit': 58.52}]","[{'period': ""Q4 '24"", 'revenue': 44.33, 'unit': 'M', 'net_profit': 8.89}, {'period': ""Q3 '24"", 'revenue': 41.28, 'unit': 'M', 'net_profit': 3.92}, {'period': ""Q2 '24"", 'revenue': 77.51, 'unit': 'M', 'net_profit': 7.3}, {'period': ""Q1 '24"", 'revenue': 75.37, 'unit': 'M', 'net_profit': 7.3}, {'period': ""Q4 '23"", 'revenue': 70.99, 'unit': 'M', 'net_profit': -7.11}, {'period': ""Q3 '23"", 'revenue': 42.29, 'unit': 'M', 'net_profit': 8.41}]",0.66,0.66,5753133000,249464000,231071000,5178122000,18393000,0,6575000,44090000,13537000,-1,0.7047334701747838,0.7837837837837839,"[0.09, 0.03]","['2025-04-09', '2020-07-13']",__nan__,0.9000525452827182
80,HOOK,HOOKIPA Pharma Inc. Common Stock,"HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in Phase I/II clinical trial for the treatment of human papillomavirus 16-positive cancers. The company's preclinical stage products include HB-300 program for prostate cancer; and HB-700 for targeting mutated KRAS in pancreatic, colorectal, and lung cancer. HOOKIPA Pharma Inc. has a collaboration with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products using or incorporating its replicating and non-replicating technology platforms for the treatment, cure, diagnosis, or prevention of Hepatitis B Virus. The company was incorporated in 2011 and is headquartered in New York, New York.",Dr. Malte  Peters M.D.,Biotechnology,0.786,USD,9478404,https://images.financialmodelingprep.com/symbol/HOOK.png,64368,-0.23,0.034,36714,-51455000,-43503000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -43.5}, {'period': '2023', 'revenue': 20.13, 'unit': 'M', 'net_profit': -81.58}, {'period': '2022', 'revenue': 14.25, 'unit': 'M', 'net_profit': -64.92}, {'period': '2021', 'revenue': 18.45, 'unit': 'M', 'net_profit': -75.67}]","[{'period': ""Q4 '24"", 'revenue': 1.35, 'unit': 'M', 'net_profit': -24.95}, {'period': ""Q3 '24"", 'revenue': 4.7, 'unit': 'M', 'net_profit': -13.84}, {'period': ""Q2 '24"", 'revenue': 1.29, 'unit': 'M', 'net_profit': -19.09}, {'period': ""Q1 '24"", 'revenue': 36.6, 'unit': 'M', 'net_profit': 14.38}, {'period': ""Q4 '23"", 'revenue': 7.41, 'unit': 'M', 'net_profit': -24.82}, {'period': ""Q3 '23"", 'revenue': 6.87, 'unit': 'M', 'net_profit': -19.07}]",-3.47,-3.47,82545000,80665000,39684000,31331000,23670000,0,24653000,39684000,-76978000,0.3347167810920187,0.46674430007354745,0.5979142526071842,__nan__,__nan__,__nan__,0.37956266278999334
81,HOPE,Hope Bancorp Inc. Common Stock,"Hope Bancorp, Inc. operates as the bank holding company for Bank of Hope that provides banking services for small and medium-sized businesses, and individuals in the United States. The company accepts personal and business checking, money market, savings, time deposit, and individual retirement accounts. Its loan products include commercial loans to businesses for various purposes, such as working capital, purchasing inventory, debt refinancing, business acquisitions, and other business related financing needs; real estate loans; small business administration loans; and consumer loans, such as single-family mortgage, home equity, auto, credit card, and personal loans. The company also offers trade finance services, including the issuance and negotiation of letters of credit, as well as handles documentary collections; warehouse lines of credit to mortgage loan originators; and commercial equipment lease financing. In addition, it provides cash management services, such as remote deposit capture, lock box, and ACH origination services; investment and wealth management services; mobile banking services; debit card services; foreign exchanges services, safe deposit boxes, and other customary bank services; internet banking services; and automated teller machine services. As of December 31, 2021, the company operated 47 full-service branches in California, Washington, Texas, Illinois, New York, New Jersey, Virginia, and Alabama; SBA loan production offices in Atlanta, Houston, Dallas, Denver, Portland, Seattle, Fremont, and Southern California; and a representative office in Seoul, Korea. Hope Bancorp, Inc. was incorporated in 2000 and is headquartered in Los Angeles, California.",Mr. Kevin Sung Kim J.D.,Banks - Regional,9.73,USD,1244252940,https://images.financialmodelingprep.com/symbol/HOPE.png,925008,11.87,0.59,1704956,0,99630000,"[{'period': '2024', 'revenue': 953.98, 'unit': 'M', 'net_profit': 99.63}, {'period': '2023', 'revenue': 571.44, 'unit': 'M', 'net_profit': 133.67}, {'period': '2022', 'revenue': 623.92, 'unit': 'M', 'net_profit': 218.28}, {'period': '2021', 'revenue': 551.96, 'unit': 'M', 'net_profit': 204.57}]","[{'period': ""Q4 '24"", 'revenue': 117.01, 'unit': 'M', 'net_profit': 24.34}, {'period': ""Q3 '24"", 'revenue': 116.65, 'unit': 'M', 'net_profit': 24.16}, {'period': ""Q2 '24"", 'revenue': 246.44, 'unit': 'M', 'net_profit': 25.27}, {'period': ""Q1 '24"", 'revenue': 276.19, 'unit': 'M', 'net_profit': 25.86}, {'period': ""Q4 '23"", 'revenue': 278.5, 'unit': 'M', 'net_profit': 26.48}, {'period': ""Q3 '23"", 'revenue': 143.68, 'unit': 'M', 'net_profit': 30.05}]",0.82,0.82,17054008000,20798000,20798000,14919503000,0,2147928000,93784000,458199000,116722000,-1,-0.25467371870160765,-0.26126126126126137,"[0.14, 0.15]","['2025-02-06', '2001-04-20']",__nan__,0.8748385130345899
82,HOTH,Hoth Therapeutics Inc. Common Stock,"Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-ALZ for the treatment and/or prevention of Alzheimer's or other neuroinflammatory diseases; HT-003 to treat inflammatory bowel diseases, as well as acne and psoriasis; HT-004 for treatment of asthma and allergies using inhalational administration; HT-006 to treat lung diseases resulting from bacterial infections; and HT-002, a novel peptide for treating COVID-19. The company is also developing BioLexa Platform, a proprietary, patented, drug compound platform which is in phase I clinical trial for the treatment of eczema; and HT-005 for treating patients with lupus. The company has license agreements with the George Washington University; the University of Maryland; Isoprene Pharmaceuticals, Inc.; the North Carolina State University; Chelexa BioSciences, Inc.; Zylö Therapeutics, Inc., and the University of Cincinnati. It also has a research collaboration agreement with Weill Cornell Medicine to develop HT-003. Hoth Therapeutics, Inc. was incorporated in 2017 and is headquartered in New York, New York.",Mr. Robb  Knie,Biotechnology,0.8038,USD,10586609,https://images.financialmodelingprep.com/symbol/HOTH.png,977050,-0.63,0.1113,522902,-8215432,-8188300,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.19}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.85}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.68}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.31}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.38}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.13}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.63}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.04}, {'period': ""Q4 '23"", 'revenue': 0.05954, 'unit': 'M', 'net_profit': -1.7}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.09}]",-1.28,-1.28,7712765,7644871,7038923,833906,46769,36819,831197,7038923,-6978251,-52.643393035540555,-0.04370847083446457,0.44347826086956516,__nan__,__nan__,__nan__,0.1081202396287194
83,HOVNP,Hovnanian Enterprises Inc Dep Shr Srs A Pfd,"Hovnanian Enterprises, Inc. is a homebuilding company, which engages in the design, construction, and marketing of single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It operates through the following segments: Northeast, Southeast, and West. The Northeast segment consists of Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia, and West Virginia. The Southeast segment focuses on Florida, Georgia, and South Carolina. The West segment includes Arizona, California, and Texas. The company was founded by Kevork S. Hovnanian in 1959 and is headquartered in Matawan, NJ.",None,Residential Construction,16.55,USD,545085918,https://images.financialmodelingprep.com/symbol/HOVNP.png,13401,-6.69,-0.35,13234,313335998,242008000,"[{'period': '2024', 'revenue': 3000.0, 'unit': 'M', 'net_profit': 242.01}, {'period': '2023', 'revenue': 2760.0, 'unit': 'M', 'net_profit': 205.89}, {'period': '2022', 'revenue': 2920.0, 'unit': 'M', 'net_profit': 225.49}, {'period': '2021', 'revenue': 2780.0, 'unit': 'M', 'net_profit': 607.82}]","[{'period': ""Q1 '25"", 'revenue': 673.62, 'unit': 'M', 'net_profit': 28.19}, {'period': ""Q4 '24"", 'revenue': 979.64, 'unit': 'M', 'net_profit': 94.35}, {'period': ""Q3 '24"", 'revenue': 722.7, 'unit': 'M', 'net_profit': 72.92}, {'period': ""Q2 '24"", 'revenue': 708.38, 'unit': 'M', 'net_profit': 50.84}, {'period': ""Q1 '24"", 'revenue': 593.39, 'unit': 'M', 'net_profit': 23.9}, {'period': ""Q4 '23"", 'revenue': 887.03, 'unit': 'M', 'net_profit': 97.27}]",34.4,31.79,2605574000,1892055000,209976000,1805225000,29400000,142910000,5479000,209976000,5781000,0.10428729316816156,0.17541806101286603,0.19610570236439487,"[0.47656, 0.477]","['2025-04-01', '2005-12-28']",__nan__,0.6928319825113392
84,HOWL,Werewolf Therapeutics Inc. Common Stock,"Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma. The company is also developing WTX-613, a conditionally activated interferon alpha INDUKINE molecule for the treatment of solid tumors and hematologic malignancies. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.",Dr. Daniel J. Hicklin Ph.D.,Biotechnology,0.7197,USD,32262136,https://images.financialmodelingprep.com/symbol/HOWL.png,269365,-0.44,0.0896,186937,-64045000,-70515000,"[{'period': '2024', 'revenue': 1.89, 'unit': 'M', 'net_profit': -70.52}, {'period': '2023', 'revenue': 19.94, 'unit': 'M', 'net_profit': -37.37}, {'period': '2022', 'revenue': 16.4, 'unit': 'M', 'net_profit': -51.56}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -49.77}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -20.4}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -16.67}, {'period': ""Q2 '24"", 'revenue': 1.14, 'unit': 'M', 'net_profit': -17.25}, {'period': ""Q1 '24"", 'revenue': 0.742, 'unit': 'M', 'net_profit': -16.19}, {'period': ""Q4 '23"", 'revenue': 1.5, 'unit': 'M', 'net_profit': -12.0}, {'period': ""Q3 '23"", 'revenue': 5.9, 'unit': 'M', 'net_profit': -8.29}]",-1.63,-1.61,126929000,113066000,112215000,53539000,0,0,15180000,112215000,-56442000,-0.9727398737101494,-0.8870423892100193,-0.5523809523809522,__nan__,__nan__,__nan__,0.4218027401145522
85,HPK,HighPeak Energy Inc. Common Stock,"HighPeak Energy, Inc., an independent oil and natural gas company, engages in the acquisition, exploration, development, and production of oil, natural gas, and natural gas liquids reserves in the Midland Basin in West Texas. As of December 31, 2021, the company had approximately 64,213 MBoe of proved reserves. HighPeak Energy, Inc. was incorporated in 2019 and is headquartered in Fort Worth, Texas.",Mr. Jack Dana Hightower,Oil & Gas Exploration & Production,9.8,USD,1235456600,https://images.financialmodelingprep.com/symbol/HPK.png,290381,14.63,1.61,722603,792106000,95069000,"[{'period': '2024', 'revenue': 1070.0, 'unit': 'M', 'net_profit': 95.07}, {'period': '2023', 'revenue': 1110.0, 'unit': 'M', 'net_profit': 215.87}, {'period': '2022', 'revenue': 755.69, 'unit': 'M', 'net_profit': 236.85}, {'period': '2021', 'revenue': 220.12, 'unit': 'M', 'net_profit': 55.56}]","[{'period': ""Q4 '24"", 'revenue': 234.81, 'unit': 'M', 'net_profit': 8.98}, {'period': ""Q3 '24"", 'revenue': 271.58, 'unit': 'M', 'net_profit': 49.93}, {'period': ""Q2 '24"", 'revenue': 275.27, 'unit': 'M', 'net_profit': 29.72}, {'period': ""Q1 '24"", 'revenue': 287.76, 'unit': 'M', 'net_profit': 6.44}, {'period': ""Q4 '23"", 'revenue': 301.15, 'unit': 'M', 'net_profit': 95.0}, {'period': ""Q3 '23"", 'revenue': 345.59, 'unit': 'M', 'net_profit': 38.78}]",0.69,0.67,3063288000,195012000,86649000,1460832000,85242000,0,284630000,86649000,69209000,-0.07314613078591839,-0.5595925249923563,-0.5818181818181818,"[0.04, 0.1]","['2025-03-03', '2021-07-14']",__nan__,0.47688366226094314
86,HPKEW,HighPeak Energy Inc. Warrant,"HighPeak Energy, Inc., an independent oil and natural gas company, engages in the exploration, development, and production of crude oil, natural gas, and natural gas liquids reserves in the Permian Basin in West Texas and Eastern New Mexico. The company was incorporated in 2019 and is headquartered in Fort Worth, Texas.",Mr. Jack Dana Hightower,Oil & Gas Exploration & Production,0.9,USD,113460300,https://images.financialmodelingprep.com/symbol/HPKEW.png,3439,,0.49,5955,792106000,95069000,"[{'period': '2024', 'revenue': 1070.0, 'unit': 'M', 'net_profit': 95.07}, {'period': '2023', 'revenue': 1110.0, 'unit': 'M', 'net_profit': 215.87}, {'period': '2022', 'revenue': 755.69, 'unit': 'M', 'net_profit': 236.85}, {'period': '2021', 'revenue': 220.12, 'unit': 'M', 'net_profit': 55.56}]","[{'period': ""Q4 '24"", 'revenue': 234.81, 'unit': 'M', 'net_profit': 8.98}, {'period': ""Q3 '24"", 'revenue': 271.58, 'unit': 'M', 'net_profit': 49.93}, {'period': ""Q2 '24"", 'revenue': 275.27, 'unit': 'M', 'net_profit': 29.72}, {'period': ""Q1 '24"", 'revenue': 287.76, 'unit': 'M', 'net_profit': 6.44}, {'period': ""Q4 '23"", 'revenue': 301.15, 'unit': 'M', 'net_profit': 95.0}, {'period': ""Q3 '23"", 'revenue': 345.59, 'unit': 'M', 'net_profit': 38.78}]",0.69,0.67,3063288000,195012000,86649000,1460832000,85242000,0,284630000,86649000,69209000,-0.07314613078591839,-0.5595925249923563,-0.5818181818181818,__nan__,__nan__,__nan__,0.47688366226094314
87,HQI,HireQuest Inc. Common Stock (DE),"HireQuest, Inc. provides temporary staffing solutions in the United States. The company provides temporary staffing services, including skilled and semi-skilled labor and industrial personnel, clerical and administrative personnel, and construction personnel. As of December 31, 2021, the company had a network of approximately 216 franchisee-owned offices in 36 states and the District of Columbia. In addition, the company specializes in commercial drivers. It serves customers primarily in the construction, industrial/manufacturing, warehousing, hospitality, recycling/waste management, disaster recovery, logistics, auctioneering, construction, landscaping, and retail industries. The company was formerly known as Command Center, Inc. and changed its name to HireQuest, Inc. in September 2019.HireQuest, Inc. was founded in 2002 and is headquartered in Goose Creek, South Carolina.",Mr. Richard F. Hermanns,Staffing & Employment Services,10.88,USD,152320000,https://images.financialmodelingprep.com/symbol/HQI.png,16372,38.86,0.29,15787,7858000,3672000,"[{'period': '2024', 'revenue': 34.6, 'unit': 'M', 'net_profit': 3.67}, {'period': '2023', 'revenue': 37.88, 'unit': 'M', 'net_profit': 6.13}, {'period': '2022', 'revenue': 30.95, 'unit': 'M', 'net_profit': 12.46}, {'period': '2021', 'revenue': 22.76, 'unit': 'M', 'net_profit': 11.85}]","[{'period': ""Q4 '24"", 'revenue': 8.08, 'unit': 'M', 'net_profit': 2.22}, {'period': ""Q3 '24"", 'revenue': 9.42, 'unit': 'M', 'net_profit': -2.21}, {'period': ""Q2 '24"", 'revenue': 8.68, 'unit': 'M', 'net_profit': 2.04}, {'period': ""Q1 '24"", 'revenue': 8.42, 'unit': 'M', 'net_profit': 1.62}, {'period': ""Q4 '23"", 'revenue': 9760.0, 'unit': 'K', 'net_profit': 15.0}, {'period': ""Q3 '23"", 'revenue': 9.27, 'unit': 'M', 'net_profit': 1.48}]",0.27,0.26,94013000,49240000,2219000,29209000,43514000,0,24096000,2219000,12224000,-0.3254356597132801,-0.40146699266503666,-0.39999999999999997,"[0.06, 0.05]","['2025-03-03', '2020-08-31']",__nan__,0.3106910746386138
88,HQY,HealthEquity Inc. Common Stock,"HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. The company was incorporated in 2002 and is headquartered in Draper, Utah.",Mr. Scott R. Cutler J.D.,Medical - Healthcare Information Services,83.13,USD,7190454045,https://images.financialmodelingprep.com/symbol/HQY.png,1076383,76.27,6.36,1971042,339119000,96703000,"[{'period': '2025', 'revenue': 1200.0, 'unit': 'M', 'net_profit': 96.7}, {'period': '2024', 'revenue': 999.59, 'unit': 'M', 'net_profit': 55.71}, {'period': '2023', 'revenue': 861.75, 'unit': 'M', 'net_profit': -26.14}, {'period': '2022', 'revenue': 756.56, 'unit': 'M', 'net_profit': -44.29}]","[{'period': ""Q4 '25"", 'revenue': 311.82, 'unit': 'M', 'net_profit': 26.36}, {'period': ""Q3 '25"", 'revenue': 300.43, 'unit': 'M', 'net_profit': 5.7}, {'period': ""Q2 '25"", 'revenue': 299.93, 'unit': 'M', 'net_profit': 35.82}, {'period': ""Q1 '25"", 'revenue': 287.6, 'unit': 'M', 'net_profit': 28.81}, {'period': ""Q4 '24"", 'revenue': 262.39, 'unit': 'M', 'net_profit': 26.36}, {'period': ""Q3 '24"", 'revenue': 249.22, 'unit': 'M', 'net_profit': 14.67}]",1.11,1.09,3448550000,477749000,295948000,1333639000,118006000,0,156323000,295948000,337772000,0.200778284516458,0.7357660827110856,0.7076923076923077,__nan__,__nan__,__nan__,0.3867245653970509
89,HRMY,Harmony Biosciences Holdings Inc. Common Stock,"Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is based in Plymouth Meeting, Pennsylvania.",Dr. Jeffrey M. Dayno M.D.,Biotechnology,29.07,USD,1668231369,https://images.financialmodelingprep.com/symbol/HRMY.png,700134,11.58,0.94,1144528,233412000,145493000,"[{'period': '2024', 'revenue': 714.73, 'unit': 'M', 'net_profit': 145.49}, {'period': '2023', 'revenue': 582.02, 'unit': 'M', 'net_profit': 128.85}, {'period': '2022', 'revenue': 437.86, 'unit': 'M', 'net_profit': 181.47}, {'period': '2021', 'revenue': 305.44, 'unit': 'M', 'net_profit': 34.6}]","[{'period': ""Q4 '24"", 'revenue': 201.27, 'unit': 'M', 'net_profit': 49.48}, {'period': ""Q3 '24"", 'revenue': 186.04, 'unit': 'M', 'net_profit': 46.09}, {'period': ""Q2 '24"", 'revenue': 172.81, 'unit': 'M', 'net_profit': 11.59}, {'period': ""Q1 '24"", 'revenue': 154.62, 'unit': 'M', 'net_profit': 38.33}, {'period': ""Q4 '23"", 'revenue': 168.41, 'unit': 'M', 'net_profit': 26.61}, {'period': ""Q3 '23"", 'revenue': 160.27, 'unit': 'M', 'net_profit': 38.46}]",2.56,2.51,999200000,579252000,467186000,340045000,83033000,108874000,175082000,453001000,218668000,0.05372169453573621,0.1291394069210651,0.17972350230414752,__nan__,__nan__,__nan__,0.34031725380304245
90,HROW,Harrow Health Inc. Common Stock,"Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases; Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company that focused on the development and commercialization of proprietary non-intravenous, sedation, and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings; and Eton Pharmaceuticals, Inc., a commercial-stage pharmaceutical company that engages in developing and commercializing drug products. Harrow Health, Inc. owns royalty rights in four clinical stage drug candidates being developed by Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was incorporated in 2006 and is headquartered in San Diego, California.",Mr. Mark L. Baum J.D.,Drug Manufacturers - Specialty & Generic,24.91,USD,888146122,https://images.financialmodelingprep.com/symbol/HROW.png,501875,-50.84,2.71,966356,8822000000000,-17481000,"[{'period': '2024', 'revenue': 199610000.0, 'unit': 'M', 'net_profit': -17.48}, {'period': '2023', 'revenue': 130.19, 'unit': 'M', 'net_profit': -24.41}, {'period': '2022', 'revenue': 88.59, 'unit': 'M', 'net_profit': -14.09}, {'period': '2021', 'revenue': 72.48, 'unit': 'M', 'net_profit': -18.01}]","[{'period': ""Q4 '24"", 'revenue': 66.83, 'unit': 'M', 'net_profit': 6.78}, {'period': ""Q3 '24"", 'revenue': 49.26, 'unit': 'M', 'net_profit': -4.22}, {'period': ""Q2 '24"", 'revenue': 48.94, 'unit': 'M', 'net_profit': -6.47}, {'period': ""Q1 '24"", 'revenue': 34.59, 'unit': 'M', 'net_profit': -13.56}, {'period': ""Q4 '23"", 'revenue': 36.35, 'unit': 'M', 'net_profit': -9.15}, {'period': ""Q3 '23"", 'revenue': 34.27, 'unit': 'M', 'net_profit': -4.39}]",-0.49,-0.49,388971000000000,189651000000000,47247000000000,319674000000000,116373000000000,0,91343000000000,47247000,-60876000,907332.1276355034,0.28388841096227113,0.3466666666666667,__nan__,__nan__,__nan__,0.821845330371673
91,HROWL,Harrow Health Inc. 8.625% Senior Notes due 2026,"Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.",Mark L. Baum,Medical - Pharmaceuticals,25.3,USD,794348350,https://images.financialmodelingprep.com/symbol/HROWL.png,4636,,-0.01,7811,8822000000000,-17481000,"[{'period': '2024', 'revenue': 199610000.0, 'unit': 'M', 'net_profit': -17.48}, {'period': '2023', 'revenue': 130.19, 'unit': 'M', 'net_profit': -24.41}, {'period': '2022', 'revenue': 88.59, 'unit': 'M', 'net_profit': -14.09}, {'period': '2021', 'revenue': 72.48, 'unit': 'M', 'net_profit': -18.01}]","[{'period': ""Q4 '24"", 'revenue': 66.83, 'unit': 'M', 'net_profit': 6.78}, {'period': ""Q3 '24"", 'revenue': 49.26, 'unit': 'M', 'net_profit': -4.22}, {'period': ""Q2 '24"", 'revenue': 48.94, 'unit': 'M', 'net_profit': -6.47}, {'period': ""Q1 '24"", 'revenue': 34.59, 'unit': 'M', 'net_profit': -13.56}, {'period': ""Q4 '23"", 'revenue': 36.35, 'unit': 'M', 'net_profit': -9.15}, {'period': ""Q3 '23"", 'revenue': 34.27, 'unit': 'M', 'net_profit': -4.39}]",-0.49,-0.49,388971000000000,189651000000000,47247000000000,319674000000000,116373000000000,0,91343000000000,47247000,-60876000,907332.1276355034,0.28388841096227113,0.3466666666666667,"[0.53906, 0.539]","['2025-04-15', '2021-10-14']",__nan__,0.821845330371673
92,HRTX,Heron Therapeutics Inc. Common Stock,"Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; HTX-019, an investigational agent for the prevention of postoperative nausea and vomiting; and HTX-034 for postoperative pain management, as well as is in Phase Ib/II clinical study in patients undergoing bunionectomy. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in San Diego, California.",Mr. Craig Alexander Collard,Biotechnology,1.88,USD,286380400,https://images.financialmodelingprep.com/symbol/HRTX.png,1738798,-20.89,0.11,2161261,-5056000,-13580000,"[{'period': '2024', 'revenue': 144.28, 'unit': 'M', 'net_profit': -13.58}, {'period': '2023', 'revenue': 127.04, 'unit': 'M', 'net_profit': -110.56}, {'period': '2022', 'revenue': 107.67, 'unit': 'M', 'net_profit': -134.52}, {'period': '2021', 'revenue': 86.35, 'unit': 'M', 'net_profit': -217.66}]","[{'period': ""Q4 '24"", 'revenue': 40.78, 'unit': 'M', 'net_profit': 3.66}, {'period': ""Q3 '24"", 'revenue': 42.27, 'unit': 'M', 'net_profit': -4.85}, {'period': ""Q2 '24"", 'revenue': 36.02, 'unit': 'M', 'net_profit': -9.23}, {'period': ""Q1 '24"", 'revenue': 34.67, 'unit': 'M', 'net_profit': -3.16}, {'period': ""Q4 '23"", 'revenue': 34.23, 'unit': 'M', 'net_profit': -10.72}, {'period': ""Q3 '23"", 'revenue': 31.43, 'unit': 'M', 'net_profit': -25.01}]",-0.0891,-0.0891,233147000,209014000,59283000,266798000,78881000,0,91457000,25802000,-24235000,0.9512871897641437,0.8771696560207672,0.8886250000000001,__nan__,__nan__,__nan__,1.144333832303225
93,HRZN,Horizon Technology Finance Corporation Common Stock,"Horizon Technology Finance Corporation is a business development company specializing in lending and and investing in development-stage investments. It focuses on making secured debt and venture lending investments to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries. It seeks to invest in companies in the United States.",Mr. Robert D. Pomeroy Jr.,Asset Management,8.35,USD,336630250,https://images.financialmodelingprep.com/symbol/HRZN.png,381273,-52.19,0.43,779159,0,-5633000,"[{'period': '2024', 'revenue': 99.92, 'unit': 'M', 'net_profit': -5.63}, {'period': '2023', 'revenue': -9.87, 'unit': 'M', 'net_profit': -17.18}, {'period': '2022', 'revenue': 26.64, 'unit': 'M', 'net_profit': 21.15}, {'period': '2021', 'revenue': 33.27, 'unit': 'M', 'net_profit': 27.78}]","[{'period': ""Q4 '24"", 'revenue': -10.61, 'unit': 'M', 'net_profit': -12.43}, {'period': ""Q3 '24"", 'revenue': 24.56, 'unit': 'M', 'net_profit': 7.28}, {'period': ""Q2 '24"", 'revenue': 28.14, 'unit': 'M', 'net_profit': -9.13}, {'period': ""Q1 '24"", 'revenue': 26.14, 'unit': 'M', 'net_profit': 8.65}, {'period': ""Q4 '23"", 'revenue': 26.99, 'unit': 'M', 'net_profit': -10.66}, {'period': ""Q3 '23"", 'revenue': 29.14, 'unit': 'M', 'net_profit': 17.53}]",-0.16,-0.16,821833000,86823000,70264000,485650000,16559000,725157000,14204000,70264000,3937000,-1,0.6722141402385802,0.7142857142857143,"[0.11, 0.22]","['2025-05-16', '2010-12-23']",__nan__,0.5909351413243323
94,HSAQ,Health Sciences Acquisitions Corporation 2 Ordinary Shares,"Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.",Dr. Roderick Tze Ian Wong M.D.,Shell Companies,13.31,USD,149233051,https://images.financialmodelingprep.com/symbol/HSAQ.png,71375,-532.4,2.59,119605,-2735123,-2389982,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.39}, {'period': '2021', 'revenue': 0.0, 'unit': 'K', 'net_profit': -362.75}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -173.54}]","[{'period': ""Q3 '23"", 'revenue': 0.419, 'unit': 'M', 'net_profit': -13.32}, {'period': ""Q2 '23"", 'revenue': 0.915, 'unit': 'M', 'net_profit': -12.05}, {'period': ""Q1 '23"", 'revenue': 1.16, 'unit': 'M', 'net_profit': -9.45}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.36}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -430.54}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -531.67}]",-0.15,-0.15,68075577,299079,175161,7343755,0,67776498,1743755,175161,-1579299,-6.221389665560404,-5.588509993108201,-7.379888268156424,__nan__,__nan__,__nan__,0.10787650026087917
95,HSDT,Helius Medical Technologies Inc. Class A Common Stock (DE),"Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.",Mr. Dane Carl Andreeff,Medical - Devices,0.3249,USD,1990591,https://images.financialmodelingprep.com/symbol/HSDT.png,2573263,-0.08,0.0129,134176,-13803000,-11742000,"[{'period': '2024', 'revenue': 0.52, 'unit': 'M', 'net_profit': -11.74}, {'period': '2023', 'revenue': 0.644, 'unit': 'M', 'net_profit': -8.85}, {'period': '2022', 'revenue': 0.787, 'unit': 'M', 'net_profit': -12.56}, {'period': '2021', 'revenue': 0.522, 'unit': 'M', 'net_profit': -18.12}]","[{'period': ""Q4 '24"", 'revenue': 0.152, 'unit': 'M', 'net_profit': -3.93}, {'period': ""Q3 '24"", 'revenue': 0.051000000000000004, 'unit': 'M', 'net_profit': -3.69}, {'period': ""Q2 '24"", 'revenue': 0.182, 'unit': 'M', 'net_profit': -1.61}, {'period': ""Q1 '24"", 'revenue': 0.135, 'unit': 'M', 'net_profit': -2.52}, {'period': ""Q4 '23"", 'revenue': 0.134, 'unit': 'M', 'net_profit': -1.04}, {'period': ""Q3 '23"", 'revenue': 0.14300000000000002, 'unit': 'M', 'net_profit': -3.66}]",-0.43,-0.43,3542000,3424000,1088000,2483000,635000,0,2163000,1088000,-11046000,-0.14008424878169654,-0.32677966101694916,0.970467032967033,__nan__,__nan__,__nan__,0.7010163749294184
96,HSIC,Henry Schein Inc. Common Stock,"Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.",Mr. Stanley M. Bergman CPA,Medical - Distribution,66.16,USD,8215550320,https://images.financialmodelingprep.com/symbol/HSIC.png,1978003,21.69,3.46,2789496,941000000,390000000,"[{'period': '2024', 'revenue': 12670.0, 'unit': 'M', 'net_profit': 390.0}, {'period': '2023', 'revenue': 12340.0, 'unit': 'M', 'net_profit': 416.0}, {'period': '2022', 'revenue': 12650.0, 'unit': 'M', 'net_profit': 538.0}, {'period': '2021', 'revenue': 12400.0, 'unit': 'M', 'net_profit': 631.0}]","[{'period': ""Q4 '24"", 'revenue': 3190.0, 'unit': 'M', 'net_profit': 94.0}, {'period': ""Q3 '24"", 'revenue': 3170.0, 'unit': 'M', 'net_profit': 99.0}, {'period': ""Q2 '24"", 'revenue': 3140.0, 'unit': 'M', 'net_profit': 104.0}, {'period': ""Q1 '24"", 'revenue': 3170.0, 'unit': 'M', 'net_profit': 93.0}, {'period': ""Q4 '23"", 'revenue': 3020.0, 'unit': 'M', 'net_profit': 18.0}, {'period': ""Q3 '23"", 'revenue': 3160.0, 'unit': 'M', 'net_profit': 137.0}]",3.08,3.05,10218000000,3983000000,122000000,5381000000,1482000000,170000000,2803000000,122000000,661000000,0.07297605473204105,-0.0625,-0.03144654088050317,__nan__,__nan__,__nan__,0.5266196907418281
97,HSII,Heidrick & Struggles International Inc. Common Stock,"Heidrick & Struggles International, Inc., together with its subsidiaries, provides executive search, consulting, and on-demand talent services to businesses and business leaders worldwide. The company enables its clients to build leadership teams by facilitating the recruitment, management, and development of senior executives. It also offers on-demand services to provide clients with independent talent, including professionals with industry and functional expertise for interim leadership roles and critical project-based initiatives; and consulting services, including leadership assessment and development, team and organization acceleration, digital acceleration and innovation, diversity and inclusion advisory services, and culture shaping services. The company provides its services to Fortune 1000 companies; Major U.S. and non-U.S. companies; middle market and emerging growth companies; private equity firms; governmental, higher education, and not-for-profit organizations; and other private and public entities. Heidrick & Struggles International, Inc. was founded in 1953 and is headquartered in Chicago, Illinois.",Ms. Tracey  Heaton J.D.,Staffing & Employment Services,41.28,USD,842516544,https://images.financialmodelingprep.com/symbol/HSII.png,146606,100.68,2.12,149499,92802000,8728000,"[{'period': '2024', 'revenue': 1120.0, 'unit': 'M', 'net_profit': 8.73}, {'period': '2023', 'revenue': 1040.0, 'unit': 'M', 'net_profit': 54.41}, {'period': '2022', 'revenue': 1080.0, 'unit': 'M', 'net_profit': 79.49}, {'period': '2021', 'revenue': 1010.0, 'unit': 'M', 'net_profit': 72.57}]","[{'period': ""Q4 '24"", 'revenue': 280.89, 'unit': 'M', 'net_profit': -14.98}, {'period': ""Q3 '24"", 'revenue': 282.81, 'unit': 'M', 'net_profit': 14.83}, {'period': ""Q2 '24"", 'revenue': 282.88, 'unit': 'M', 'net_profit': -5.16}, {'period': ""Q1 '24"", 'revenue': 269.1, 'unit': 'M', 'net_profit': 14.03}, {'period': ""Q4 '23"", 'revenue': 257.39, 'unit': 'M', 'net_profit': 14.86}, {'period': ""Q3 '23"", 'revenue': 267.9, 'unit': 'M', 'net_profit': 14.99}]",0.43,0.41,1194188000,772977000,563523000,741371000,140801000,58290000,483013000,515627000,124116000,-0.08217701338133339,-0.8395883109722477,-0.8419117647058824,"[0.15, 0.13]","['2025-03-13', '2007-10-31']",__nan__,0.6208159854227308
98,HSKA,Heska Corporation Common Stock,"Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; and turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force, and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was founded in 1988 and is based in Loveland, Colorado.",Mr. Kevin S. Wilson,Medical - Devices,119.99,USD,1309546862,https://images.financialmodelingprep.com/symbol/HSKA.png,336670,-62.494791666666664,0,330887,-20298000,-18424000,"[{'period': '2022', 'revenue': 257.31, 'unit': 'M', 'net_profit': -18.42}, {'period': '2021', 'revenue': 253740.0, 'unit': 'K', 'net_profit': 132.0}, {'period': '2020', 'revenue': 197.32, 'unit': 'M', 'net_profit': -14.03}, {'period': '2019', 'revenue': 122.66, 'unit': 'M', 'net_profit': -1.14}]","[{'period': ""Q1 '23"", 'revenue': 62.38, 'unit': 'M', 'net_profit': -9.78}, {'period': ""Q4 '22"", 'revenue': 66.34, 'unit': 'M', 'net_profit': -3.85}, {'period': ""Q3 '22"", 'revenue': 61490.0, 'unit': 'K', 'net_profit': -78.0}, {'period': ""Q2 '22"", 'revenue': 64.68, 'unit': 'M', 'net_profit': -4.89}, {'period': ""Q1 '22"", 'revenue': 64.8, 'unit': 'M', 'net_profit': -9.61}, {'period': ""Q4 '21"", 'revenue': 68070.0, 'unit': 'K', 'net_profit': -554.0}]",-1.78,-1.78,585816000,265034000,156618000,163608000,36926000,3959000,39577000,156618000,-23927000,-19.44108761329305,-140.57575757575756,-135.84848484848487,"[0.1, 0.1]","['2012-09-26', '2012-03-28']",__nan__,0.27928223196361995
99,HSON,Hudson Global Inc. Common Stock,"Hudson Global, Inc. provides talent solutions for mid-to-large-cap multinational companies and government agencies under the Hudson RPO brand in the Americas, the Asia Pacific, and Europe. It offers recruitment process outsourcing (RPO) services, such as complete recruitment outsourcing, project-based outsourcing, contingent workforce solutions, and recruitment consulting for clients' permanent staff hires; and RPO contracting services, including outsourced professional contract staffing and managed services. The company was formerly known as Hudson Highland Group, Inc. and changed its name to Hudson Global, Inc. in April 2012. Hudson Global, Inc. was founded in 1999 and is headquartered in Old Greenwich, Connecticut.",Mr. Jeffrey E. Eberwein,Staffing & Employment Services,9.62,USD,26462119,https://images.financialmodelingprep.com/symbol/HSON.png,3268,-6.05,0.23,12951,-2448000,-4770000,"[{'period': '2024', 'revenue': 140.06, 'unit': 'M', 'net_profit': -4.77}, {'period': '2023', 'revenue': 161.34, 'unit': 'M', 'net_profit': 2.2}, {'period': '2022', 'revenue': 200.92, 'unit': 'M', 'net_profit': 7.13}, {'period': '2021', 'revenue': 169.21, 'unit': 'M', 'net_profit': 3.23}]","[{'period': ""Q4 '24"", 'revenue': 33600.0, 'unit': 'K', 'net_profit': -585.0}, {'period': ""Q3 '24"", 'revenue': 36850.0, 'unit': 'K', 'net_profit': -846.0}, {'period': ""Q2 '24"", 'revenue': 35710.0, 'unit': 'K', 'net_profit': -441.0}, {'period': ""Q1 '24"", 'revenue': 33.89, 'unit': 'M', 'net_profit': -2.9}, {'period': ""Q4 '23"", 'revenue': 33970.0, 'unit': 'K', 'net_profit': 733.0}, {'period': ""Q3 '23"", 'revenue': 39400.0, 'unit': 'K', 'net_profit': 533.0}]",-1.59,-1.59,52583000,40140000,17011000,12155000,20093000,0,11222000,17011000,-2805000,-1.8589473684210527,-3.170154686078253,-3.2083333333333335,"[0.05, 0.05]","['2016-06-10', '2016-03-11']",__nan__,0.23115835916550975
100,HST,Host Hotels & Resorts Inc. Common Stock,"Host Hotels & Resorts, Inc. is an S&P 500 company and is the largest lodging real estate investment trust and one of the largest owners of luxury and upper-upscale hotels. The Company currently owns 74 properties in the United States and five properties internationally totaling approximately 46,100 rooms. The Company also holds non-controlling interests in six domestic and one international joint ventures. Guided by a disciplined approach to capital allocation and aggressive asset management, the Company partners with premium brands such as Marriott®, Ritz-Carlton®, Westin®, Sheraton®, W®, St. Regis®, The Luxury Collection®, Hyatt®, Fairmont®, Hilton®, Swissôtel®, ibis® and Novotel®, as well as independent brands. For additional information, please visit the Company's website at www.hosthotels.com.",Mr. James F. Risoleo,REIT - Hotel & Motel,14.22,USD,9941301540,https://images.financialmodelingprep.com/symbol/HST.png,10150604,14.36,1.52,20127436,1698000000,697000000,"[{'period': '2024', 'revenue': 5680.0, 'unit': 'M', 'net_profit': 697.0}, {'period': '2023', 'revenue': 5310.0, 'unit': 'M', 'net_profit': 740.0}, {'period': '2022', 'revenue': 4910.0, 'unit': 'M', 'net_profit': 633.0}, {'period': '2021', 'revenue': 2890.0, 'unit': 'M', 'net_profit': -11.0}]","[{'period': ""Q4 '24"", 'revenue': 1430.0, 'unit': 'M', 'net_profit': 108.0}, {'period': ""Q3 '24"", 'revenue': 1320.0, 'unit': 'M', 'net_profit': 82.0}, {'period': ""Q2 '24"", 'revenue': 1470.0, 'unit': 'M', 'net_profit': 239.0}, {'period': ""Q1 '24"", 'revenue': 1470.0, 'unit': 'M', 'net_profit': 268.0}, {'period': ""Q4 '23"", 'revenue': 1320.0, 'unit': 'M', 'net_profit': 132.0}, {'period': ""Q3 '23"", 'revenue': 1210.0, 'unit': 'M', 'net_profit': 111.0}]",0.99,0.99,13048000000,911000000,554000000,6271000000,115000000,166000000,1397000000,554000000,950000000,0.01555023923444976,-0.05810810810810811,-0.04807692307692312,"[0.2, 0.09]","['2025-03-31', '1983-06-20']",__nan__,0.48061005518087063
101,HSTM,HealthStream Inc. Common Stock,"HealthStream, Inc. provides workforce and provider solutions for healthcare organizations in the United States. It operates through two segments, Workforce Solutions and Provider Solutions. The company offers workforce solutions, including software-as-a-service (SaaS) based services and subscription-based solutions to meet the range of its clinical development, talent management, training, education, certification, scheduling, competency assessment, performance appraisal, and other needs, as well as implementation and account management services. It also provides applications for learning, performance appraisal, competency management, disclosure management, clinical assessment and development, simulation-based education, quality management, and industry training. In addition, the company offers VerityStream that delivers enterprise-class solutions to transform the healthcare provider experience for ambulatory surgery centers, urgent care facilities, clinics, medical groups, and other healthcare organizations; EchoCredentialing and MSOW platforms that manage medical staff credentialing, enrollment, and privileging processes for hospitals; and EchoOneApp, a provider enrollment platform for medical groups. Further, it provides CredentialMyDoc, a credentialing and enrollment SaaS solution for medical groups and surgery centers; CredentialStream, a SaaS-based provider credentialing, privileging, and enrollment solution; and NurseGrid Mobile for nurse managers. The company offers its solutions in healthcare industry companies that include private, not-for-profit, and government entities, as well as pharmaceutical and medical device companies through direct sales teams. HealthStream, Inc. was incorporated in 1990 and is headquartered in Nashville, Tennessee.",Mr. Robert A. Frist Jr.,Medical - Healthcare Information Services,31.79,USD,967506397,https://images.financialmodelingprep.com/symbol/HSTM.png,156924,48.17,0.89,203883,62530000,20007000,"[{'period': '2024', 'revenue': 291.65, 'unit': 'M', 'net_profit': 20.01}, {'period': '2023', 'revenue': 279.06, 'unit': 'M', 'net_profit': 15.21}, {'period': '2022', 'revenue': 266.83, 'unit': 'M', 'net_profit': 12.09}, {'period': '2021', 'revenue': 256.71, 'unit': 'M', 'net_profit': 5.84}]","[{'period': ""Q4 '24"", 'revenue': 74.23, 'unit': 'M', 'net_profit': 4.89}, {'period': ""Q3 '24"", 'revenue': 73.09, 'unit': 'M', 'net_profit': 5.72}, {'period': ""Q2 '24"", 'revenue': 71.56, 'unit': 'M', 'net_profit': 4.17}, {'period': ""Q1 '24"", 'revenue': 72.76, 'unit': 'M', 'net_profit': 5.23}, {'period': ""Q4 '23"", 'revenue': 70.58, 'unit': 'M', 'net_profit': 4.59}, {'period': ""Q3 '23"", 'revenue': 70.34, 'unit': 'M', 'net_profit': 3.87}]",0.66,0.66,510766000,153122000,97217000,151411000,35322000,0,115693000,59469000,29518000,0.04938996761038481,0.3151252218497338,0.32000000000000006,"[0.031, 1]","['2025-03-10', '2018-03-05']",__nan__,0.2964390738616118
102,HSTO,Histogen Inc. Common Stock,"Histogen Inc., a clinical-stage therapeutics company, focuses on developing proprietary hypoxia-generated growth factor technology platform and stem cell-free biologic products. It offers HST-003, a human extracellular matrix, which is in Phase 1/2 clinical trial to treat articular cartilage defects in the knee; HST-004, a cell conditioned media solution to treat spinal disc repair; and Emricasan, an orally active pan-caspase inhibitor for the treatment of COVID-19. The company's preclinical product candidates include CTS-2090 and CTS-2096, which are selective caspase-1 inhibitors targeting inflammasome activation, as well as intervenes in a various inflammation mediated disease. Histogen Inc. was founded in 2007 and is headquartered in San Diego, California.",Ms. Susan A. Knudson,Biotechnology,0.02,USD,85435,https://images.financialmodelingprep.com/symbol/HSTO.png,0,-0.0071174377224199285,,0,-10503000,-10621000,"[{'period': '2022', 'revenue': 3.77, 'unit': 'M', 'net_profit': -10.62}, {'period': '2021', 'revenue': 0.919, 'unit': 'M', 'net_profit': -14.4}, {'period': '2020', 'revenue': 2.06, 'unit': 'M', 'net_profit': -25.77}, {'period': '2019', 'revenue': 11.3, 'unit': 'M', 'net_profit': -4.9}]","[{'period': ""Q3 '23"", 'revenue': 0.005, 'unit': 'M', 'net_profit': -3.85}, {'period': ""Q2 '23"", 'revenue': 0.005, 'unit': 'M', 'net_profit': -2.09}, {'period': ""Q1 '23"", 'revenue': 0.005, 'unit': 'M', 'net_profit': -3.47}, {'period': ""Q4 '22"", 'revenue': 0.004, 'unit': 'M', 'net_profit': -2.99}, {'period': ""Q3 '22"", 'revenue': 0.005, 'unit': 'M', 'net_profit': -3.6}, {'period': ""Q2 '22"", 'revenue': 0.005, 'unit': 'M', 'net_profit': -3.39}]",-3.46,-3.46,19073000,13456000,12509000,5697000,99000,0,1234000,12109000,-9899000,0.2951952758019058,0.2626865671641791,0.5392809587217043,__nan__,__nan__,__nan__,0.29869448959261785
103,HTBI,HomeTrust Bancshares Inc. Common Stock,"HomeTrust Bancshares, Inc. operates as the bank holding company for HomeTrust Bank that provides a range of retail and commercial banking products and services. Its deposit products include savings, money market, and demand accounts, as well as certificates of deposit for individuals, businesses, and nonprofit organizations. The company's loan portfolio comprises retail consumer loans, such as one-to-four-family real estate lending, home equity lines of credit, construction and land/lots, indirect auto finance, and consumer lending; and commercial loans that include commercial real estate, construction and development, and commercial and industrial loans. It also provides small business administration loans, equipment finance leases, indirect automobile loans, and municipal leases; and cash management and online/mobile banking services. As of June 30, 2021, the company operated 41 offices in North Carolina, Upstate South Carolina, East Tennessee, and Southwest Virginia. HomeTrust Bancshares, Inc. was founded in 1926 and is headquartered in Asheville, North Carolina.",Mr. C. Hunter Westbrook,Banks - Regional,36.55,USD,634508000,https://images.financialmodelingprep.com/symbol/HTBI.png,38091,11.421875,0,93478,0,0,"[{'period': '2024', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': '2023', 'revenue': 186.37, 'unit': 'M', 'net_profit': 49.64}, {'period': '2022', 'revenue': 149.97, 'unit': 'M', 'net_profit': 35.65}, {'period': '2021', 'revenue': 143.21, 'unit': 'M', 'net_profit': 15.68}]","[{'period': ""Q1 '25"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q4 '24"", 'revenue': 66.65, 'unit': 'M', 'net_profit': 13.11}, {'period': ""Q3 '24"", 'revenue': 73.53, 'unit': 'M', 'net_profit': 12.42}, {'period': ""Q2 '24"", 'revenue': 72.17, 'unit': 'M', 'net_profit': 15.07}, {'period': ""Q1 '24"", 'revenue': 71.31, 'unit': 'M', 'net_profit': 13.46}, {'period': ""Q4 '23"", 'revenue': 50.79, 'unit': 'M', 'net_profit': 14.83}]",3.21,3.2,4607487000,656107000,499066000,4136301000,157041000,166853000,200263000,347140000,-57149000,1,-1,0.08080808080808073,"[0.12, 0.06]","['2025-02-13', '2018-11-20']",__nan__,0.8977347087468722
104,HTBK,Heritage Commerce Corp Common Stock,"Heritage Commerce Corp operates as the bank holding company for Heritage Bank of Commerce that provides various commercial and personal banking services to residents and the business/professional community in California. Its deposit products for business banking and retail markets include interest and non-interest bearing demand, savings, and money market accounts, as well as certificates of deposit and time deposits. The company's loan portfolio comprises commercial loans, such as operating secured and unsecured loans advanced for working capital, equipment purchases, and other business purposes; commercial real estate loans; commercial construction loans for rental properties, commercial buildings, and homes; small business administration loans; home equity lines of credit; multifamily loans on residential properties; residential mortgage loans; and consumer loans consisting of loans for financing automobiles, various consumer goods, and other personal purposes. In addition, it offers other banking services, including cashier's checks, bank by mail, night depositories, safe deposit boxes, direct deposit, automated payroll, electronic funds transfer, online bill pay, homeowner association, remote deposit capture, automated clearing house origination, electronic data interchange, and check imaging services, as well as other customary banking, factoring financing, and electronic banking services. The company operates through 17 full-service branch offices located in the general San Francisco Bay Area of California. Heritage Commerce Corp was founded in 1994 and is headquartered in San Jose, California.",Mr. Robertson  Jones,Banks - Regional,8.81,USD,540082954,https://images.financialmodelingprep.com/symbol/HTBK.png,387022,13.35,0.42,434183,0,40528000,"[{'period': '2024', 'revenue': 170.26, 'unit': 'M', 'net_profit': 40.53}, {'period': '2023', 'revenue': 191.47, 'unit': 'M', 'net_profit': 64.44}, {'period': '2022', 'revenue': 189.99, 'unit': 'M', 'net_profit': 66.56}, {'period': '2021', 'revenue': 155.81, 'unit': 'M', 'net_profit': 47.7}]","[{'period': ""Q4 '24"", 'revenue': 45.04, 'unit': 'M', 'net_profit': 10.62}, {'period': ""Q3 '24"", 'revenue': 42.0, 'unit': 'M', 'net_profit': 10.51}, {'period': ""Q2 '24"", 'revenue': 41.26, 'unit': 'M', 'net_profit': 9.23}, {'period': ""Q1 '24"", 'revenue': 41.96, 'unit': 'M', 'net_profit': 10.17}, {'period': ""Q4 '23"", 'revenue': 60.81, 'unit': 'M', 'net_profit': 13.33}, {'period': ""Q3 '23"", 'revenue': 47.59, 'unit': 'M', 'net_profit': 15.79}]",0.66,0.66,5645006000,29864000,29864000,4955279000,0,0,95595000,29864000,37347000,-1,-0.3711031454153283,-0.37735849056603776,"[0.13, 0.001]","['2025-02-06', '2005-03-04']",__nan__,0.8778164274758964
105,HTBX,Heat Biologics Inc. Common Stock,"Heat Biologics, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating platform that functions as an immune activator to stimulate and expand T-cells; and ComPACT, which delivers antigen driven T-cell activation and specific co-stimulation in a single product. The company develops HS-110, which has completed enrollment in a Phase II clinical trial to treat patients with advanced non-small cell lung cancer; and HS-130 that is in Phase I clinical trial for the treatment of advanced solid tumors. Its products also include PTX-35, a novel T-cell co-stimulator agonist antibody targeting DR3/TNFRSF25 that is in Phase I clinical trial; DR3/TNFRSF25 for various immunotherapy approaches; and COVID-19 vaccine, which is in preclinical stage. Heat Biologics, Inc. has a collaboration with Dr. James Shapiro at University of Alberta to manufacture surrogate mouse version of PTX-35. The company was incorporated in 2008 and is headquartered in Morrisville, North Carolina.",Mr. Jeffrey Wolf,Biotechnology,2.38,USD,61074370,https://images.financialmodelingprep.com/symbol/HTBX.png,155104,-2.0659722222222223,0.0100002,43610,-35546781,-35400807,"[{'period': '2021', 'revenue': 2.11, 'unit': 'M', 'net_profit': -35.4}, {'period': '2020', 'revenue': 2.95, 'unit': 'M', 'net_profit': -26.05}, {'period': '2019', 'revenue': 3.05, 'unit': 'M', 'net_profit': -20.02}, {'period': '2018', 'revenue': 5.79, 'unit': 'M', 'net_profit': -15.73}]","[{'period': ""Q1 '22"", 'revenue': 0.21242, 'unit': 'M', 'net_profit': -8.31}, {'period': ""Q4 '21"", 'revenue': -0.34796, 'unit': 'M', 'net_profit': -13.61}, {'period': ""Q3 '21"", 'revenue': 0.50157, 'unit': 'M', 'net_profit': -7.43}, {'period': ""Q2 '21"", 'revenue': 0.45949, 'unit': 'M', 'net_profit': -6.54}, {'period': ""Q1 '21"", 'revenue': 0.53864, 'unit': 'M', 'net_profit': -7.53}, {'period': ""Q4 '20"", 'revenue': 0.6031900000000001, 'unit': 'M', 'net_profit': -6.45}]",-1.41,-1.41,120961233,99331370,8053879,8927662,66049,88324922,4720745,8053879,0,-0.3822512203700452,-0.35896984295849127,0.13496932515337423,__nan__,__nan__,__nan__,0.07380597715964089
106,HTGM,HTG Molecular Diagnostics Inc. Common Stock,"HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq DLBCL cell of origin assay; HTG EdgeSeq Oncology Biomarker Panel; HTG EdgeSeq ALKPlus assay EU; HTG EdgeSeq Pan B-Cell Lymphoma Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. HTG Molecular Diagnostics, Inc. has a governing agreement with QIAGEN Manchester Limited. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.",Mr. John L. Lubniewski,Medical - Diagnostics & Research,0.48,USD,1062830,https://images.financialmodelingprep.com/symbol/HTGM.png,253915,-0.028070175438596492,0,725429,-20139770,-21594476,"[{'period': '2022', 'revenue': 6.37, 'unit': 'M', 'net_profit': -21.59}, {'period': '2021', 'revenue': 8.91, 'unit': 'M', 'net_profit': -17.15}, {'period': '2020', 'revenue': 8.55, 'unit': 'M', 'net_profit': -20.87}, {'period': '2019', 'revenue': 19.2, 'unit': 'M', 'net_profit': -19.3}]","[{'period': ""Q1 '23"", 'revenue': 1.03, 'unit': 'M', 'net_profit': -5.05}, {'period': ""Q4 '22"", 'revenue': 2.44, 'unit': 'M', 'net_profit': -4.69}, {'period': ""Q3 '22"", 'revenue': 1.25, 'unit': 'M', 'net_profit': -4.52}, {'period': ""Q2 '22"", 'revenue': 1.49, 'unit': 'M', 'net_profit': -5.89}, {'period': ""Q1 '22"", 'revenue': 1.18, 'unit': 'M', 'net_profit': -6.5}, {'period': ""Q4 '21"", 'revenue': 2.88, 'unit': 'M', 'net_profit': -5.15}]",-24.28,-24.28,17777655,15651451,12210857,12385958,1421695,0,8270757,12210857,-18430835,-0.02966070196258434,-0.25950783806751404,0.18138907619689815,__nan__,__nan__,__nan__,0.6967149491876178
107,HTHT,Huazhu Group Limited American Depositary Shares,"H World Group Limited, together with its subsidiaries, develops leased and owned, manachised, and franchised hotels primarily in the People's Republic of China. The company operates hotels under its own brands, such as HanTing Hotel, Ni Hao Hotel, Hi Inn, Elan Hotel, Zleep Hotels, Ibis Hotel, JI Hotel, Orange Hotel, Starway Hotel, Ibis Styles Hotel, CitiGO Hotel, Crystal Orange Hotel, IntercityHotel, Manxin Hotel, Mercure Hotel, Madison Hotel, Novotel Hotel, Joya Hotel, Blossom House, Steigenberger Hotels & Resorts, MAXX by Steigenberger, Jaz in the City, Grand Mercure, Steigenberger Icon, and Song Hotels. As of June 30, 2022, it operated 8,176 hotels with 773,898 rooms. The company was formerly known as Huazhu Group Limited and changed its name to H World Group Limited in June 2022. H World Group Limited was founded in 2005 and is headquartered in Shanghai, the People's Republic of China.",Mr. Hui  Jin,Travel Lodging,32.53,USD,1019275535,https://images.financialmodelingprep.com/symbol/HTHT.png,2071801,24.64,2.68,4778235,6537000000,3048000000,"[{'period': '2024', 'revenue': 23.89, 'unit': 'B', 'net_profit': 3.05}, {'period': '2023', 'revenue': 21.88, 'unit': 'B', 'net_profit': 4.08}, {'period': '2022', 'revenue': 13.86, 'unit': 'B', 'net_profit': -1.81}, {'period': '2021', 'revenue': 12790.0, 'unit': 'M', 'net_profit': -420.0}]","[{'period': ""Q4 '24"", 'revenue': 6020.0, 'unit': 'M', 'net_profit': 49.0}, {'period': ""Q3 '24"", 'revenue': 6.44, 'unit': 'B', 'net_profit': 1.27}, {'period': ""Q2 '24"", 'revenue': 6.15, 'unit': 'B', 'net_profit': 1.07}, {'period': ""Q1 '24"", 'revenue': 5280.0, 'unit': 'M', 'net_profit': 659.0}, {'period': ""Q4 '23"", 'revenue': 5580.0, 'unit': 'M', 'net_profit': 743.0}, {'period': ""Q3 '23"", 'revenue': 6.29, 'unit': 'B', 'net_profit': 1.34}]",9.6,9.3,62552000000,13215000000,11077000000,50281000000,817000000,2316000000,13321000000,7474000000,6620000000,-0.08547845551203134,-0.25385556915544677,6.6494023904382455,"[0.95, 0.68]","['2025-04-09', '2015-12-28']",__nan__,0.8038272157564906
108,HTIA,Healthcare Trust Inc. 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock,"Healthcare Trust, Inc. is a publicly registered real estate investment trust focused on acquiring a diversified portfolio of healthcare real estate, with an emphasis on seniors housing and medical office buildings, located in the United States.",Mr. Michael R. Anderson,REIT - Healthcare Facilities,14.7803,USD,418161765,https://images.financialmodelingprep.com/symbol/HTIA.png,12200,-13.826286248830684,0.2803,28292,,,[],[],,,,,,,,,,,,,,,"[0.46094, 0.083]","['2025-01-03', '2020-01-02']",__nan__,__nan__
109,HTLD,Heartland Express Inc. Common Stock,"Heartland Express, Inc., together with its subsidiaries, operates as a short-to-medium haul truckload carrier in the United States and Canada. It primarily provides nationwide asset-based dry van truckload service for shippers from Washington to Florida and New England to California; and temperature-controlled truckload services. The company offers its services under the Heartland Express and Millis Transfer brand names. It primarily serves retailers and manufacturers in consumer goods, appliances, food products, and automotive industries. The company was founded in 1978 and is headquartered in North Liberty, Iowa.",Mr. David Paul Millis,Trucking,8.75,USD,687134000,https://images.financialmodelingprep.com/symbol/HTLD.png,508006,-23.03,0.54,660791,162430000,-29722000,"[{'period': '2024', 'revenue': 1050.0, 'unit': 'M', 'net_profit': -29.72}, {'period': '2023', 'revenue': 1210.0, 'unit': 'M', 'net_profit': 14.78}, {'period': '2022', 'revenue': 968.0, 'unit': 'M', 'net_profit': 133.58}, {'period': '2021', 'revenue': 607.28, 'unit': 'M', 'net_profit': 79.28}]","[{'period': ""Q4 '24"", 'revenue': 242.58, 'unit': 'M', 'net_profit': -1.85}, {'period': ""Q3 '24"", 'revenue': 259.86, 'unit': 'M', 'net_profit': -9.28}, {'period': ""Q2 '24"", 'revenue': 274.75, 'unit': 'M', 'net_profit': -3.48}, {'period': ""Q1 '24"", 'revenue': 270.32, 'unit': 'M', 'net_profit': -15.11}, {'period': ""Q4 '23"", 'revenue': 275.35, 'unit': 'M', 'net_profit': 5.09}, {'period': ""Q3 '23"", 'revenue': 295.03, 'unit': 'M', 'net_profit': -10.7}]",-0.38,-0.38,1334192000,129448000,12812000,511593000,91620000,0,119559000,12812000,34812000,-0.33178102592161396,-3.011641285956007,-3.0000000000000004,"[0.02, 0.02]","['2025-03-25', '2003-09-15']",__nan__,0.38344780961061076
110,HTLF,Heartland Financial USA Inc. Common Stock,"Heartland Financial USA, Inc., a multi-bank holding company, provides commercial, small business, and consumer banking services to individuals and businesses in the United States. It accepts various deposit products, including checking and other demand deposit accounts; NOW, savings, money market, individual retirement, and health savings accounts; certificates of deposit; and other time deposits. The company also offers commercial and industrial loans; commercial real estate loans; real estate mortgage loans; small business loans; agricultural loans; consumer loans comprising motor vehicle and home improvement loans, home equity line of credit, and fixed rate home equity and personal lines of credit; and credit cards for commercial, business, and personal use. In addition, it provides online banking, mobile banking, telephone banking, bill payment, automated clearing house, wire transfer, zero balance account, transaction reporting, lock box, remote deposit capture, accounts receivable, investment sweep account, reconciliation, treasury management, wealth management, trust, foreign exchange, and various fraud prevention services, such as check and electronic positive pay, as well as commercial purchasing and merchant credit cards, debit cards, and automated teller machines. Further, the company offers investment services, such as mutual funds, annuities, retirement products, education savings products, and brokerage services, as well as vehicle, property and casualty, and life and disability insurance products. Additionally, it is involved in the community development, consumer finance, multi-line insurance agency, and property management businesses. The company operates through 129 banking locations in Iowa, Illinois, Wisconsin, New Mexico, Arizona, Montana, Colorado, Minnesota, Kansas, Missouri, Texas, and California. Heartland Financial USA, Inc. was founded in 1981 and is headquartered in Dubuque, Iowa.",Mr. Bruce K. Lee,Banks - Regional,64.67,USD,2774427071,https://images.financialmodelingprep.com/symbol/HTLF.png,281606,36.331460674157306,-1.43,3034803,0,79920000,"[{'period': '2023', 'revenue': 553.28, 'unit': 'M', 'net_profit': 79.92}, {'period': '2022', 'revenue': 727.55, 'unit': 'M', 'net_profit': 212.18}, {'period': '2021', 'revenue': 688.91, 'unit': 'M', 'net_profit': 219.92}, {'period': '2020', 'revenue': 606.92, 'unit': 'M', 'net_profit': 137.94}]","[{'period': ""Q3 '24"", 'revenue': 196.81, 'unit': 'M', 'net_profit': 64.15}, {'period': ""Q2 '24"", 'revenue': 273.5, 'unit': 'M', 'net_profit': 39.74}, {'period': ""Q1 '24"", 'revenue': 279.29, 'unit': 'M', 'net_profit': 51.71}, {'period': ""Q4 '23"", 'revenue': 144.01, 'unit': 'M', 'net_profit': -70.36}, {'period': ""Q3 '23"", 'revenue': 174.03, 'unit': 'M', 'net_profit': 48.09}, {'period': ""Q2 '23"", 'revenue': 183.0, 'unit': 'M', 'net_profit': 49.42}]",1.51,1.68,19411707000,323013000,323013000,17478590000,0,0,152175000,323013000,273252000,-1,-0.6233386747101518,-0.6854166666666667,"[0.3, 0.1199]","['2025-01-14', '1999-03-24']",__nan__,0.9004148888091088
111,HTLFP,Heartland Financial USA Inc. Depositary Shares each representing a 1/400th ownership interest in a share of 7.00% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series E,"Heartland Financial USA, Inc., a multi-bank holding company, provides commercial, small business, and consumer banking services to individuals and businesses in the United States. It accepts various deposit products, including checking and other demand deposit accounts; NOW, savings, money market, individual retirement, and health savings accounts; certificates of deposit; and other time deposits. The company also offers commercial and industrial loans; commercial real estate loans; real estate mortgage loans; small business loans; agricultural loans; consumer loans comprising motor vehicle and home improvement loans, home equity line of credit, and fixed rate home equity and personal lines of credit; and credit cards for commercial, business, and personal use. In addition, it provides online banking, mobile banking, telephone banking, bill payment, automated clearing house, wire transfer, zero balance account, transaction reporting, lock box, remote deposit capture, accounts receivable, investment sweep account, reconciliation, treasury management, wealth management, trust, foreign exchange, and various fraud prevention services, such as check and electronic positive pay, as well as commercial purchasing and merchant credit cards, debit cards, and automated teller machines. Further, the company offers investment services, such as mutual funds, annuities, retirement products, education savings products, and brokerage services, as well as vehicle, property and casualty, and life and disability insurance products. Additionally, it is involved in the community development, consumer finance, multi-line insurance agency, and property management businesses. The company operates through 129 banking locations in Iowa, Illinois, Wisconsin, New Mexico, Arizona, Montana, Colorado, Minnesota, Kansas, Missouri, Texas, and California. Heartland Financial USA, Inc. was founded in 1981 and is headquartered in Dubuque, Iowa.",Mr. Bruce K. Lee,Banks - Regional,25.05,USD,1074101290,https://images.financialmodelingprep.com/symbol/HTLFP.png,5088,5.252673516460474,-0.31,23656,0,79920000,"[{'period': '2023', 'revenue': 553.28, 'unit': 'M', 'net_profit': 79.92}, {'period': '2022', 'revenue': 727.55, 'unit': 'M', 'net_profit': 212.18}, {'period': '2021', 'revenue': 688.91, 'unit': 'M', 'net_profit': 219.92}, {'period': '2020', 'revenue': 606.92, 'unit': 'M', 'net_profit': 137.94}]","[{'period': ""Q3 '24"", 'revenue': 196.81, 'unit': 'M', 'net_profit': 64.15}, {'period': ""Q2 '24"", 'revenue': 273.5, 'unit': 'M', 'net_profit': 39.74}, {'period': ""Q1 '24"", 'revenue': 279.29, 'unit': 'M', 'net_profit': 51.71}, {'period': ""Q4 '23"", 'revenue': 144.01, 'unit': 'M', 'net_profit': -70.36}, {'period': ""Q3 '23"", 'revenue': 174.03, 'unit': 'M', 'net_profit': 48.09}, {'period': ""Q2 '23"", 'revenue': 183.0, 'unit': 'M', 'net_profit': 49.42}]",1.51,1.68,19411707000,323013000,323013000,17478590000,0,0,152175000,323013000,273252000,-1,-0.6233386747101518,-0.6854166666666667,"[0.4375, 0.53]","['2024-12-31', '2020-09-29']",__nan__,0.9004148888091088
112,HTOO,Fusion Fuel Green PLC Class A Ordinary Shares,"Fusion Fuel Green PLC focuses on the production of hydrogen in Portugal, Southern Europe, and Morocco. The company intends to provide hydrogen generators to clients that operate their own green hydrogen plants; green hydrogen as an output from green hydrogen plants; and operational and monitoring services of green hydrogen plants using fusion fuel hydrogen generators. It serves natural gas networks and grids, ammonia producers, oil refineries, regulators, and related government departments. The company was founded in 2018 and is based in Dublin, Ireland.",Mr. John-Paul  Backwell,Renewable Utilities,0.2288,USD,5356094,https://images.financialmodelingprep.com/symbol/HTOO.png,234177,-0.13,-0.0012,2306933,-27771000,-31016000,"[{'period': '2023', 'revenue': 4.14, 'unit': 'M', 'net_profit': -31.02}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -27.35}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 23.56}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -360.28}]","[{'period': ""Q2 '24"", 'revenue': 0.251, 'unit': 'M', 'net_profit': -2.8}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.14}, {'period': ""Q4 '23"", 'revenue': 2.07, 'unit': 'M', 'net_profit': -8.59}, {'period': ""Q3 '23"", 'revenue': 2.58, 'unit': 'M', 'net_profit': -8.59}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.92}, {'period': ""Q1 '23"", 'revenue': 0.57616, 'unit': 'M', 'net_profit': -6.92}]",-2.12,-2.12,42351000,11323000,860000,39620000,5086000,0,20364000,860000,-18129602,0.10494085796241982,-0.13416462500457088,-0.034146341463414775,__nan__,__nan__,__nan__,0.9355150999976388
113,HTOOW,Fusion Fuel Green PLC Warrant,"Fusion Fuel Green PLC focuses on the production of hydrogen in Portugal, Southern Europe, and Morocco. The company intends to provide hydrogen generators to clients that operate their own green hydrogen plants; green hydrogen as an output from green hydrogen plants; and operational and monitoring services of green hydrogen plants using fusion fuel hydrogen generators. It serves natural gas networks and grids, ammonia producers, oil refineries, regulators, and related government departments. The company was founded in 2018 and is based in Dublin, Ireland.",Mr. John-Paul  Backwell,Renewable Utilities,0.0065,USD,6209578,https://images.financialmodelingprep.com/symbol/HTOOW.png,42206,,0.001,7793,-27771000,-31016000,"[{'period': '2023', 'revenue': 4.14, 'unit': 'M', 'net_profit': -31.02}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -27.35}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 23.56}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -360.28}]","[{'period': ""Q2 '24"", 'revenue': 0.251, 'unit': 'M', 'net_profit': -2.8}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.14}, {'period': ""Q4 '23"", 'revenue': 2.07, 'unit': 'M', 'net_profit': -8.59}, {'period': ""Q3 '23"", 'revenue': 2.58, 'unit': 'M', 'net_profit': -8.59}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.92}, {'period': ""Q1 '23"", 'revenue': 0.57616, 'unit': 'M', 'net_profit': -6.92}]",-2.12,-2.12,42351000,11323000,860000,39620000,5086000,0,20364000,860000,-18129602,0.10494085796241982,-0.13416462500457088,-0.034146341463414775,__nan__,__nan__,__nan__,0.9355150999976388
114,HUBG,Hub Group Inc. Class A Common Stock,"Hub Group, Inc., a supply chain solutions provider, offers transportation and logistics management services in North America. The company's transportation services include intermodal, truckload, less-than-truckload, flatbed, temperature-controlled, and dedicated and regional trucking, as well as final mile, railcar, small parcel, and international transportation. Its logistics services comprise full outsource logistics solution, transportation management, freight consolidation, warehousing and fulfillment, final mile delivery, and parcel and international services. The company also provides dry van, expedited, less-than-truckload, refrigerated, and flatbed truck brokerage services. It offers a fleet of approximately 1,000 tractors and 4,600 trailers to its customers, as well as the driver staffing, management, and infrastructure. The company serves a range of industries, including retail, consumer products, and durable goods. As of December 31, 2021, it owned approximately 43,750 dry, 53-foot containers, as well as 450 refrigerated, 53-foot containers; and leased approximately 250 dry, 53-foot containers. The company was founded in 1971 and is headquartered in Oak Brook, Illinois.",Mr. Phillip D. Yeager,Integrated Freight & Logistics,35.31,USD,2151364149,https://images.financialmodelingprep.com/symbol/HUBG.png,660565,20.77,3.41,836117,266387000,103993000,"[{'period': '2024', 'revenue': 3950.0, 'unit': 'M', 'net_profit': 103.99}, {'period': '2023', 'revenue': 4200.0, 'unit': 'M', 'net_profit': 167.53}, {'period': '2022', 'revenue': 5340.0, 'unit': 'M', 'net_profit': 356.95}, {'period': '2021', 'revenue': 4230.0, 'unit': 'M', 'net_profit': 171.47}]","[{'period': ""Q4 '24"", 'revenue': 973.51, 'unit': 'M', 'net_profit': 24.32}, {'period': ""Q3 '24"", 'revenue': 986.89, 'unit': 'M', 'net_profit': 23.6}, {'period': ""Q2 '24"", 'revenue': 986.5, 'unit': 'M', 'net_profit': 29.02}, {'period': ""Q1 '24"", 'revenue': 999.49, 'unit': 'M', 'net_profit': 27.05}, {'period': ""Q4 '23"", 'revenue': 985.02, 'unit': 'M', 'net_profit': 28.79}, {'period': ""Q3 '23"", 'revenue': 1020.0, 'unit': 'M', 'net_profit': 30.46}]",1.72,1.7,2868343000,768329000,98248000,1176392000,581516000,0,579481000,98248000,143572000,-0.32019333583424564,-0.37925003581490857,-0.35094339622641507,"[0.125, 0.125]","['2025-03-18', '2024-03-07']",__nan__,0.41012947196342975
115,HUDI,Huadi International Group Co. Ltd. Ordinary Shares,"Huadi International Group Co., Ltd. develops, manufactures, markets, and sells industrial stainless steel seamless pipes, tubes, bars, and plates in the People's Republic of China. The company's products are used in oil and gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, electricity, automobile, naval architecture, paper mill, and mechanical industries. It also exports its products to 20 countries, including the United States, Mexico, Thailand, Australia, Argentina, India, the Philippines, the United Arab Emirates, Taiwan, Canada, and internationally. The company was founded in 1992 and is based in Wenzhou, the People's Republic of China. Huadi International Group Co., Ltd. is a subsidiary of Yongqiang Donghai Limited.",Mr. Huisen  Wang,Steel,1.54,USD,21989968,https://images.financialmodelingprep.com/symbol/HUDI.png,21736,154,0.04,3992,-43121,137422,"[{'period': '2024', 'revenue': 74270.0, 'unit': 'K', 'net_profit': 137.42}, {'period': '2023', 'revenue': 84.33, 'unit': 'M', 'net_profit': 3.26}, {'period': '2022', 'revenue': 76.37, 'unit': 'M', 'net_profit': 1.92}, {'period': '2021', 'revenue': 70.25, 'unit': 'M', 'net_profit': 2.53}]","[{'period': ""Q4 '24"", 'revenue': 18590.0, 'unit': 'K', 'net_profit': -333.55}, {'period': ""Q3 '24"", 'revenue': 18590.0, 'unit': 'K', 'net_profit': -333.55}, {'period': ""Q2 '24"", 'revenue': 18540.0, 'unit': 'K', 'net_profit': 402.26}, {'period': ""Q1 '24"", 'revenue': 18540.0, 'unit': 'K', 'net_profit': 402.26}, {'period': ""Q4 '23"", 'revenue': 46.38, 'unit': 'M', 'net_profit': 1.82}, {'period': ""Q3 '23"", 'revenue': 23190.0, 'unit': 'K', 'net_profit': 910.57}]",0.0096,0.0096,103594531,77472209,18118456,25277092,27315639,13012340,23828193,18118456,9925948,-1.0121282299945098,-0.9578165356037133,-0.9582608695652174,__nan__,__nan__,__nan__,0.2440002551872164
116,HUGE,FSD Pharma Inc. Class B Subordinate Voting Shares,"FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such as depressive disorder; and Lucid-MS, a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. FSD Pharma Inc. was founded in 1998 and is headquartered in Toronto, Canada.",Mr. Zeeshan  Saeed,Drug Manufacturers - Specialty & Generic,0.0899,USD,66671,https://images.financialmodelingprep.com/symbol/HUGE.png,196163,-0.005532307692307692,-0.0101,22015006,-17376731,-18564915,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -18.56}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -23.32}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -35.41}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -32.72}]","[{'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.89}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.7}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.13}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.42}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.89}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.94}]",-0.47,-0.47,17385421,11028589,3495165,4542207,7416752,908741,4542207,2742934,-11057604,0.22442647643776784,0.20397667034244038,0.21666666666666667,__nan__,__nan__,__nan__,0.26126528658696274
117,HUIZ,Huize Holding Limited American Depositary Shares,"Huize Holding Limited, together with its subsidiaries, offers insurance brokerage services in the People's Republic of China. The company provides life and health insurance products, such as critical illness, illness and disease, and term and whole life insurance products; and property and casualty insurance products, including travel, individual casualty, and corporate liability insurance products. It offers its products through internet and mobile internet channels. The company also provides digital and technology development, and Internet information consulting services; and management, marketing, investment, and financial consulting services. Huize Holding Limited was founded in 2006 and is headquartered in Shenzhen, the People's Republic of China.",Mr. Cunjun  Ma,Insurance - Brokers,2,USD,991904,https://images.financialmodelingprep.com/symbol/HUIZ.png,21544,7.14,0.2,10407,64679000,70188000,"[{'period': '2023', 'revenue': 1200.0, 'unit': 'M', 'net_profit': 70.19}, {'period': '2022', 'revenue': 1160.0, 'unit': 'M', 'net_profit': -13.99}, {'period': '2021', 'revenue': 2250.0, 'unit': 'M', 'net_profit': -83.13}, {'period': '2020', 'revenue': 1220.0, 'unit': 'M', 'net_profit': -18.53}]","[{'period': ""Q3 '24"", 'revenue': 369.7, 'unit': 'M', 'net_profit': 18.65}, {'period': ""Q2 '24"", 'revenue': 282.95, 'unit': 'M', 'net_profit': -23.35}, {'period': ""Q1 '24"", 'revenue': 310.31, 'unit': 'M', 'net_profit': 6.91}, {'period': ""Q4 '23"", 'revenue': 236.01, 'unit': 'M', 'net_profit': 17.99}, {'period': ""Q3 '23"", 'revenue': 292.44, 'unit': 'M', 'net_profit': 20.17}, {'period': ""Q2 '23"", 'revenue': 368.19, 'unit': 'M', 'net_profit': 14.12}]",7.01,7.01,947006000,606460000,258137000,536591000,299869000,76688000,395044000,249258000,106827000,3.674564776909399,6.016295025728988,26.96296296296296,__nan__,__nan__,__nan__,0.5666183741180099
118,HURC,Hurco Companies Inc. Common Stock,"Hurco Companies, Inc., an industrial technology company, designs, manufactures, and sells computerized machine tools to companies in the metal cutting industry worldwide. The company's principal products include general-purpose computerized machine tools, including vertical and horizontal machining centers, turning centers, and toolroom machines. It also provides computer control systems and related software for press brake applications. In addition, the company offers machine tool components, automation integration equipment, and solutions for job shops; and software options, control upgrades, and accessories and replacement parts for its products, as well as customer service, training, and applications support services. It serves independent job shops and specialized short-run production applications within large manufacturing operations, as well as precision tool, die, and mold manufacturers in aerospace, defense, medical equipment, energy, automotive/transportation, electronics, and computer industries. The company sells its products under the Hurco, Milltronics, and Takumi brands through independent agents and distributors, as well as through its direct sales and service organizations. Hurco Companies, Inc. was incorporated in 1968 and is headquartered in Indianapolis, Indiana.",Mr. Gregory S. Volovic,Industrial - Machinery,14.49,USD,93953015,https://images.financialmodelingprep.com/symbol/HURC.png,19655,-4.86,0.68,29063,-5740000,-16608000,"[{'period': '2024', 'revenue': 37.74, 'unit': 'M', 'net_profit': -16.61}, {'period': '2023', 'revenue': 227.81, 'unit': 'M', 'net_profit': 4.39}, {'period': '2022', 'revenue': 250.81, 'unit': 'M', 'net_profit': 8.23}, {'period': '2021', 'revenue': 235.19, 'unit': 'M', 'net_profit': 6.76}]","[{'period': ""Q1 '25"", 'revenue': 8.29, 'unit': 'M', 'net_profit': -4.32}, {'period': ""Q4 '24"", 'revenue': 53.7, 'unit': 'M', 'net_profit': -1.44}, {'period': ""Q3 '24"", 'revenue': 42.65, 'unit': 'M', 'net_profit': -9.6}, {'period': ""Q2 '24"", 'revenue': 45.17, 'unit': 'M', 'net_profit': -3.92}, {'period': ""Q1 '24"", 'revenue': 45.06, 'unit': 'M', 'net_profit': -1.65}, {'period': ""Q4 '23"", 'revenue': 66.11, 'unit': 'M', 'net_profit': 2.42}]",-2.56,-2.56,268643000,228577000,33330000,61471000,36678000,0,47789000,33330000,-3760000,-1.5157696109264085,-4.7840054682159945,-4.820895522388059,"[0.16, 0.05]","['2024-03-27', '1989-10-26']",__nan__,0.22882040477511045
119,HURN,Huron Consulting Group Inc. Common Stock,"Huron Consulting Group Inc., a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Business Advisory, and Education. The Healthcare segment provides advisory services in the areas of financial and operational improvement, care transformation, and revenue cycle managed services; organizational transformation; and digital, technology and analytic solutions to national and regional hospitals, integrated health systems, academic medical centers, community hospitals, medical groups, and health plans. The Business Advisory segment offers cloud-based technology, analytics, restructuring, and capital advisory solutions to life science, financial, healthcare, education, energy and utilities, and industrials and manufacturing industries, as well as to public sectors. The Education segment provides research enterprise and student lifecycle; digital, technology and analytic solutions; and organizational transformation services to public and private colleges and universities, academic medical centers, research institutes, and other not-for-profit organizations. Huron Consulting Group Inc. was incorporated in 2002 and is headquartered in Chicago, Illinois.","Mr. C. Mark Hussey C.F.A., C.M.A., C.P.A., M.B.A.",Consulting Services,144.11,USD,2582624132,https://images.financialmodelingprep.com/symbol/HURN.png,208704,22.98,8.57,380366,204032000,116626000,"[{'period': '2024', 'revenue': 1520.0, 'unit': 'M', 'net_profit': 116.63}, {'period': '2023', 'revenue': 1400.0, 'unit': 'M', 'net_profit': 62.48}, {'period': '2022', 'revenue': 1160.0, 'unit': 'M', 'net_profit': 75.55}, {'period': '2021', 'revenue': 926.96, 'unit': 'M', 'net_profit': 62.99}]","[{'period': ""Q4 '24"", 'revenue': 399.31, 'unit': 'M', 'net_profit': 33.99}, {'period': ""Q3 '24"", 'revenue': 378.09, 'unit': 'M', 'net_profit': 27.15}, {'period': ""Q2 '24"", 'revenue': 381.02, 'unit': 'M', 'net_profit': 37.48}, {'period': ""Q1 '24"", 'revenue': 363.38, 'unit': 'M', 'net_profit': 18.01}, {'period': ""Q4 '23"", 'revenue': 350.0, 'unit': 'M', 'net_profit': 2.83}, {'period': ""Q3 '23"", 'revenue': 367.47, 'unit': 'M', 'net_profit': 21.52}]",6.52,6.27,1343617000,409117000,21911000,782290000,359143000,69712000,338820000,21911000,192668000,0.26073308781729654,0.8666431921125498,0.963855421686747,__nan__,__nan__,__nan__,0.5822269292514162
120,HUSN,Hudson Capital Inc. Ordinary Shares,"Hudson Capital Inc., through its subsidiary, Freight App, Inc., operates a transportation logistics technology platform in North American. The company offers Fr8App focuses on truckload freight for domestic and cross-border markets in Mexico, the United States, and Canada. Its Fr8App uses its proprietary technology platform to connect carriers and shippers, and enhance matching and operation efficiency through technologies, such as live pricing and real-time tracking, digital freight marketplace, broker, transportation management, fleet management, and committed capacity solutions. The company is based in New York, New York.",Mr. Jianxin Lin,Software - Application,1.68,USD,0,https://images.financialmodelingprep.com/symbol/HUSN.png,1776070,-1.3849958779884584,-0.1400001,5060,-2142329,-2145530,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.15}, {'period': '2020', 'revenue': 0.000618, 'unit': 'M', 'net_profit': -9.08}, {'period': '2019', 'revenue': 1.37, 'unit': 'M', 'net_profit': -62.0}, {'period': '2018', 'revenue': 14.4, 'unit': 'M', 'net_profit': -3.82}]","[{'period': ""Q2 '20"", 'revenue': 0.303, 'unit': 'K', 'net_profit': -320.12}, {'period': ""Q4 '19"", 'revenue': 0.13644, 'unit': 'M', 'net_profit': -6.11}, {'period': ""Q2 '19"", 'revenue': 1.23, 'unit': 'M', 'net_profit': -55.88}, {'period': ""Q4 '18"", 'revenue': 2.98, 'unit': 'M', 'net_profit': -10.67}, {'period': ""Q2 '18"", 'revenue': 11.42, 'unit': 'M', 'net_profit': 6.85}, {'period': ""Q4 '17"", 'revenue': 12.01, 'unit': 'M', 'net_profit': 10.79}]",-0.74,-0.74,2765455,2754381,221312,122352,2505740,0,122352,221312,-4859893,0.763909199889709,0.7635871574361901,0.7628205128205128,__nan__,__nan__,__nan__,0.04424299075558995
121,HVBC,HV Bancorp Inc. Common Stock,"HV Bancorp, Inc. operates as the bank holding company for Huntingdon Valley Bank that provides various financial products and services to individuals and businesses. Its deposit products include money market, savings, and checking accounts, as well as demand deposits and certificates of deposit; and loan portfolio comprises one-to-four family residential real estate, commercial real estate, home equity, commercial business, construction, and consumer loans, as well as home equity lines of credit. The company also invests in various investment securities. It serves communities located in Montgomery, Bucks, and Philadelphia counties in Pennsylvania, as well as Burlington County in New Jersey and New Castle County in Delaware; and from its seven full-service banking offices and one limited service branch. The company was founded in 1871 and is headquartered in Doylestown, Pennsylvania.",Mr. Travis J. Thompson,Banks - Regional,34.6,USD,77407466,https://images.financialmodelingprep.com/symbol/HVBC.png,5368,32.64150943396226,0.7,28754,8340000,2230000,"[{'period': '2022', 'revenue': 25.74, 'unit': 'M', 'net_profit': 2.23}, {'period': '2021', 'revenue': 27.92, 'unit': 'M', 'net_profit': 4.05}, {'period': '2020', 'revenue': 27.55, 'unit': 'M', 'net_profit': 5.77}, {'period': '2019', 'revenue': 12420.0, 'unit': 'K', 'net_profit': 879.0}]","[{'period': ""Q1 '23"", 'revenue': 6580.0, 'unit': 'K', 'net_profit': 608.0}, {'period': ""Q4 '22"", 'revenue': 6330.0, 'unit': 'K', 'net_profit': 284.0}, {'period': ""Q3 '22"", 'revenue': 7090.0, 'unit': 'K', 'net_profit': 705.0}, {'period': ""Q2 '22"", 'revenue': 6580.0, 'unit': 'K', 'net_profit': 640.0}, {'period': ""Q1 '22"", 'revenue': 5750.0, 'unit': 'K', 'net_profit': 601.0}, {'period': ""Q4 '21"", 'revenue': 5850.0, 'unit': 'K', 'net_profit': 351.0}]",1.1,1.1,615757000,49532000,49532000,573664000,2473000,85935000,8234000,12369000,30374000,0.17779974579861602,-0.44965449160908194,-0.46078431372549017,"[0.5, 0.5]","['2018-03-07', '2018-03-07']",__nan__,0.9316402411990444
122,HWBK,Hawthorn Bancshares Inc. Common Stock,"Hawthorn Bancshares, Inc. operates as the bank holding company for Hawthorn Bank that provides commercial and personal banking services. It accepts checking, savings, money market, individual retirement, and other time deposit accounts; and certificates of deposit. The company also offers commercial and industrial, single payment personal, installment, commercial and residential real estate, and consumer loans, as well as equipment, operating, and small business administration loans; and debit and credit cards. In addition, it provides trust services that include estate planning, investment, and asset management services; and cash management, safety deposit box, brokerage, and Internet banking services. The company operates through 23 banking offices in Missouri communities, Jefferson City, Columbia, Clinton, Warsaw, Springfield, St. Louis, and the greater Kansas City metropolitan area. Hawthorn Bancshares, Inc. was founded in 1865 and is headquartered in Jefferson City, Missouri.",Mr. Brent M. Giles,Banks - Regional,27.5,USD,191998675,https://images.financialmodelingprep.com/symbol/HWBK.png,14970,10.54,1,22994,0,18256000,"[{'period': '2024', 'revenue': 72.91, 'unit': 'M', 'net_profit': 18.26}, {'period': '2023', 'revenue': 52790.0, 'unit': 'K', 'net_profit': 956.0}, {'period': '2022', 'revenue': 72.73, 'unit': 'M', 'net_profit': 20.75}, {'period': '2021', 'revenue': 75.08, 'unit': 'M', 'net_profit': 22.52}]","[{'period': ""Q4 '24"", 'revenue': 18.87, 'unit': 'M', 'net_profit': 4.6}, {'period': ""Q3 '24"", 'revenue': 18.12, 'unit': 'M', 'net_profit': 4.57}, {'period': ""Q2 '24"", 'revenue': 27.55, 'unit': 'M', 'net_profit': 4.63}, {'period': ""Q1 '24"", 'revenue': 27.07, 'unit': 'M', 'net_profit': 4.46}, {'period': ""Q4 '23"", 'revenue': 15.81, 'unit': 'M', 'net_profit': -7.44}, {'period': ""Q3 '23"", 'revenue': 15.76, 'unit': 'M', 'net_profit': 2.58}]",2.61,2.61,1825185000,50994000,50994000,1675638000,0,218877000,0,50994000,22589000,-1,18.09623430962343,17.64285714285714,"[0.19, 0.7527]","['2025-03-14', '1999-09-13']",__nan__,0.9180647441218287
123,HWC,Hancock Whitney Corporation Common Stock,"Hancock Whitney Corporation operates as the financial holding company for Hancock Whitney Bank that provides traditional and online banking services to commercial, small business, and retail customers. It accepts various deposit products, including noninterest-bearing demand deposits, interest-bearing transaction accounts, savings accounts, money market deposit accounts, and time deposit accounts. The company also offers loans products comprising commercial and industrial loans; commercial real estate loans; construction and land development loans; residential mortgages; consumer loans comprising second lien mortgage home loans, home equity lines of credit, and nonresidential consumer purpose loans; revolving credit facilities; and letters of credit and financial guarantees. In addition, it offers investment brokerage and treasury management services, and annuity and life insurance products; and trust and investment management services to retirement plans, corporations, and individuals. Further, the company facilitates investments in new market tax credit activities; and holds various foreclosed assets. The company operates 177 banking locations and 239 automated teller machines primarily in the Gulf south corridor, including southern and central Mississippi; southern and central Alabama; southern, central, and northwest Louisiana; the northern, central, and panhandle regions of Florida; and certain areas of east Texas, including Houston, Beaumont, Dallas, and San Antonio. It also operates a loan production office in Tennessee; and a trust and asset management office in Texas. The company was formerly known as Hancock Holding Company and changed its name to Hancock Whitney Corporation in May 2018. Hancock Whitney Corporation was founded in 1899 and is headquartered in Gulfport, Mississippi.",Mr. John M. Hairston,Banks - Regional,49.99,USD,4305488730,https://images.financialmodelingprep.com/symbol/HWC.png,756722,9.47,3.79,1517886,0,460815000,"[{'period': '2024', 'revenue': 1440.0, 'unit': 'M', 'net_profit': 460.81}, {'period': '2023', 'revenue': 1320.0, 'unit': 'M', 'net_profit': 392.6}, {'period': '2022', 'revenue': 1380.0, 'unit': 'M', 'net_profit': 524.09}, {'period': '2021', 'revenue': 1300.0, 'unit': 'M', 'net_profit': 463.21}]","[{'period': ""Q4 '24"", 'revenue': 363.71, 'unit': 'M', 'net_profit': 122.07}, {'period': ""Q3 '24"", 'revenue': 367.66, 'unit': 'M', 'net_profit': 115.57}, {'period': ""Q2 '24"", 'revenue': 359.6, 'unit': 'M', 'net_profit': 114.56}, {'period': ""Q1 '24"", 'revenue': 529.1, 'unit': 'M', 'net_profit': 108.61}, {'period': ""Q4 '23"", 'revenue': 308.41, 'unit': 'M', 'net_profit': 50.6}, {'period': ""Q3 '23"", 'revenue': 355.21, 'unit': 'M', 'net_profit': 97.74}]",5.3,5.28,35081785000,5879638000,5736401000,30954149000,162444000,0,659163000,574910000,227125000,-1,0.173745930993729,0.17516629711751663,"[0.45, 0.2001]","['2025-03-05', '1987-03-02']",__nan__,0.8823424748769197
124,HWCC,Houston Wire & Cable Company Common Stock,"Houston Wire & Cable Company, through its subsidiaries, sells electrical and mechanical wire and cable, industrial fasteners, hardware, and related services in the United States. The company offers wire and cable products, including continuous and interlocked armor cables; control and power cables; electronic wires and cables; flexible and portable cords; instrumentation and thermocouple cables; lead and high temperature cables; medium voltage cables; and premise and category wires and cables, primary and secondary aluminum distribution cables, and steel wire ropes and wire rope slings, as well as synthetic fiber rope slings, chains, shackles, and other related hardware and corrosion resistant products. It also provides private branded products comprising its proprietary brand LifeGuard, a low-smoke zero-halogen cable. The company's products are used in maintenance, repair, and operations activities, and related projects; larger-scale projects in the utility, industrial, and infrastructure markets; and a range of industrial applications, such as communications, energy, engineering and construction, general manufacturing, marine construction and marine transportation, mining, infrastructure, oilfield services, petrochemical, transportation, utility, wastewater treatment, and food and beverage. Houston Wire & Cable Company was founded in 1975 and is headquartered in Houston, Texas.",Mr. James Pokluda,Industrial - Distribution,5.3,USD,0,https://images.financialmodelingprep.com/symbol/HWCC.png,249433,0,0.01000023,10357,-7954000,-12582000,"[{'period': '2020', 'revenue': 286.02, 'unit': 'M', 'net_profit': -12.58}, {'period': '2019', 'revenue': 338.29, 'unit': 'M', 'net_profit': 2.55}, {'period': '2018', 'revenue': 356.86, 'unit': 'M', 'net_profit': 8.64}, {'period': '2017', 'revenue': 317700.0, 'unit': 'K', 'net_profit': -222.0}]","[{'period': ""Q1 '21"", 'revenue': 67030.0, 'unit': 'K', 'net_profit': 159.0}, {'period': ""Q4 '20"", 'revenue': 65.46, 'unit': 'M', 'net_profit': -10.23}, {'period': ""Q3 '20"", 'revenue': 70250.0, 'unit': 'K', 'net_profit': -735.0}, {'period': ""Q2 '20"", 'revenue': 66.78, 'unit': 'M', 'net_profit': -2.16}, {'period': ""Q1 '20"", 'revenue': 83530.0, 'unit': 'K', 'net_profit': 545.0}, {'period': ""Q4 '19"", 'revenue': 82290.0, 'unit': 'K', 'net_profit': -656.0}]",-0.77,-0.77,157712000,118233000,0,65818000,41279000,0,26347000,0,34010000,-1.847612958226769,-5.934117647058824,-6.133333333333334,"[0.03, 0.075]","['2016-08-17', '2007-08-13']",__nan__,0.41733032362787864
125,HWCPL,Hancock Whitney Corporation 5.95% Subordinated Notes due 2045,,,,,,,,,,,,,,[],[],,,,,,,,,,,,,,,__nan__,__nan__,__nan__,__nan__
126,HWCPZ,Hancock Whitney Corporation 6.25% Subordinated Notes due 2060,"Hancock Whitney Corp. operates as a bank holding company, which engages in the provision of financial services. It also offers trust and investment management services to retirement plans, corporations, individuals, brokerage services, annuity products, life insurance, general insurance and agency services, including life, title insurance and consumer financing service. The company was founded in 1984 and is headquartered in Gulfport, MS.",,Banks - Regional,23.825,USD,3979107240,https://images.financialmodelingprep.com/symbol/HWCPZ.png,15078,,0.275,5012,0,460815000,"[{'period': '2024', 'revenue': 1440.0, 'unit': 'M', 'net_profit': 460.81}, {'period': '2023', 'revenue': 1320.0, 'unit': 'M', 'net_profit': 392.6}, {'period': '2022', 'revenue': 1380.0, 'unit': 'M', 'net_profit': 524.09}, {'period': '2021', 'revenue': 1300.0, 'unit': 'M', 'net_profit': 463.21}]","[{'period': ""Q4 '24"", 'revenue': 363.71, 'unit': 'M', 'net_profit': 122.07}, {'period': ""Q3 '24"", 'revenue': 367.66, 'unit': 'M', 'net_profit': 115.57}, {'period': ""Q2 '24"", 'revenue': 359.6, 'unit': 'M', 'net_profit': 114.56}, {'period': ""Q1 '24"", 'revenue': 529.1, 'unit': 'M', 'net_profit': 108.61}, {'period': ""Q4 '23"", 'revenue': 308.41, 'unit': 'M', 'net_profit': 50.6}, {'period': ""Q3 '23"", 'revenue': 355.21, 'unit': 'M', 'net_profit': 97.74}]",5.3,5.28,35081785000,5879638000,5736401000,30954149000,162444000,0,659163000,574910000,227125000,-1,0.173745930993729,0.17516629711751663,"[0.39063, 0.447]","['2025-02-28', '2020-08-31']",__nan__,0.8823424748769197
127,HWKN,Hawkins Inc. Common Stock,"Hawkins, Inc. blends, manufactures, and distributes chemicals and other specialty ingredients in the United States and internationally. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries. This segment primarily provides acids, alkalis, and food-grade and pharmaceutical salts and ingredients. It also receives, stores, and distributes various chemicals, such as liquid caustic soda, sulfuric acid, hydrochloric acid, urea, phosphoric acid, aqua ammonia, and potassium hydroxide. In addition, this segment manufactures sodium hypochlorite and agricultural products, as well as various food-grade and pharmaceutical products that include liquid phosphates, lactates, and other blended products; repackages water treatment chemicals and bulk industrial chemicals; and performs custom blending of chemicals, and contract and private label bleach packaging. The Water Treatment segment offers chemicals, equipment, and solutions for potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool and agriculture water. The Health and Nutrition segment offers ingredient distribution, processing, and formulation solutions to manufacturers of nutraceutical, functional food and beverage, personal care, dietary supplement and other nutritional food, and health and wellness products. Its products portfolio includes minerals, botanicals and herbs, vitamins and amino acids, excipients, joint products, sweeteners, and enzymes. The company was founded in 1938 and is headquartered in Roseville, Minnesota.",Mr. Patrick H. Hawkins,Chemicals - Specialty,112.33,USD,2350954570,https://images.financialmodelingprep.com/symbol/HWKN.png,135777,28.73,9.01,138257,137230000,75363000,"[{'period': '2024', 'revenue': 919.16, 'unit': 'M', 'net_profit': 75.36}, {'period': '2023', 'revenue': 935.1, 'unit': 'M', 'net_profit': 60.04}, {'period': '2022', 'revenue': 774.54, 'unit': 'M', 'net_profit': 51.54}, {'period': '2021', 'revenue': 596.87, 'unit': 'M', 'net_profit': 40.98}]","[{'period': ""Q3 '25"", 'revenue': 226.21, 'unit': 'M', 'net_profit': 15.02}, {'period': ""Q2 '25"", 'revenue': 247.03, 'unit': 'M', 'net_profit': 24.12}, {'period': ""Q1 '25"", 'revenue': 255.88, 'unit': 'M', 'net_profit': 28.88}, {'period': ""Q4 '24"", 'revenue': 223.02, 'unit': 'M', 'net_profit': 13.83}, {'period': ""Q3 '24"", 'revenue': 208.5, 'unit': 'M', 'net_profit': 14.88}, {'period': ""Q2 '24"", 'revenue': 236.53, 'unit': 'M', 'net_profit': 23.22}]",3.61,3.59,657934000,202826000,7153000,251908000,114477000,4268000,103307000,7153000,119348000,0.17063475137980158,0.255192285271731,0.2534722222222222,"[0.18, 0.1404]","['2025-02-14', '1987-04-06']",__nan__,0.38287730988214624
128,HX,Xiaobai Maimai Inc. ADR,"Hexindai Inc. is a holding company, which engages in the operation of online marketplace connecting borrowers and investors. The company is headquartered in Beijing, Beijing and currently employs 552 full-time employees. The firm is focused on offering borrowers a range of products designed-based on customer segmentation data and tailored to the specific needs of the emerging middle class in China. The firm also offers five tailored loan products such as Provident Fund Loans, Property-Owner Loans, Car-Owner Loans, Insurance-Holder Loans, and Premier Customer Loans. The firm offers products and services to Borrowers, and Investors.",Mr. Xiaobo An,Medical - Distribution,2.24,USD,53370688,https://images.financialmodelingprep.com/symbol/HX.png,2959035,-1.8421052631578947,-0.09999991,224821,-8499800,-9458784,"[{'period': '2024', 'revenue': 2.41, 'unit': 'M', 'net_profit': -9.46}, {'period': '2023', 'revenue': 13.18, 'unit': 'M', 'net_profit': -13.08}, {'period': '2022', 'revenue': 6.31, 'unit': 'M', 'net_profit': -16.85}, {'period': '2021', 'revenue': 1.75, 'unit': 'M', 'net_profit': -31.55}]","[{'period': ""Q4 '24"", 'revenue': 0.7603800000000001, 'unit': 'M', 'net_profit': -3.0}, {'period': ""Q3 '24"", 'revenue': 0.7603800000000001, 'unit': 'M', 'net_profit': -3.0}, {'period': ""Q2 '24"", 'revenue': 0.44679, 'unit': 'M', 'net_profit': -1.53}, {'period': ""Q1 '24"", 'revenue': 0.44679, 'unit': 'M', 'net_profit': -1.53}, {'period': ""Q4 '23"", 'revenue': 0.66224, 'unit': 'M', 'net_profit': -7.41}, {'period': ""Q3 '23"", 'revenue': 0.66224, 'unit': 'M', 'net_profit': -7.41}]",-0.21,-0.2,142018117,142018117,85174017,3593923,0,0,3593923,85174017,1351240,0.4034584642568114,0.27707455450679674,0.6315789473684211,"[0.1267, 0.1267]","['2018-08-01', '2018-08-01']",__nan__,0.025306088236615613
129,HYAC,Haymaker Acquisition Corp. III Class A common stock,"Haymaker Acquisition Corp. III does not have any significant operations. It intends to acquire and operate a business in the consumer and consumer-related products. The company was incorporated in 2020 and is based in New York, New York.",Mr. Christopher  Bradley,Shell Companies,11,USD,325023600,https://images.financialmodelingprep.com/symbol/HYAC.png,33365,28.95,-0.03,1739,-940259,3157000,"[{'period': '2024', 'revenue': 139.06, 'unit': 'M', 'net_profit': 3.16}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.7}, {'period': '2021', 'revenue': 0.0, 'unit': '', 'net_profit': -744.0}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.0}]","[{'period': ""Q4 '24"", 'revenue': 148.02, 'unit': 'M', 'net_profit': 2.64}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.88}, {'period': ""Q2 '24"", 'revenue': 49.17, 'unit': 'M', 'net_profit': 2.94}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.87}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.85}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 864.29}]",0.14,0.14,250043147,282493,101126,9442388,0,0,792388,101126,-419849,-1.2000111464863148,-0.3284454714527637,-0.12499999999999993,__nan__,__nan__,__nan__,0.0377630345533925
130,HYACU,Haymaker Acquisition Corp. III Unit,"Haymaker Acquisition Corp. III does not have any significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of consumer and consumer-related products and services. The company was incorporated in 2020 and is based in New York, New York. As of May 26, 2022, biote Corp. operates as a subsidiary of BioTe Holdings, LLC.",Mr. Steven J. Heyer,Shell Companies,10.1,USD,1213696800,https://images.financialmodelingprep.com/symbol/HYACU.png,8265,0,0,477,-940259,3157000,"[{'period': '2024', 'revenue': 139.06, 'unit': 'M', 'net_profit': 3.16}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.7}, {'period': '2021', 'revenue': 0.0, 'unit': '', 'net_profit': -744.0}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.0}]","[{'period': ""Q4 '24"", 'revenue': 148.02, 'unit': 'M', 'net_profit': 2.64}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.88}, {'period': ""Q2 '24"", 'revenue': 49.17, 'unit': 'M', 'net_profit': 2.94}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.87}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.85}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 864.29}]",0.14,0.14,250043147,282493,101126,9442388,0,0,792388,101126,-419849,-1.2000111464863148,-0.3284454714527637,-0.12499999999999993,__nan__,__nan__,__nan__,0.0377630345533925
131,HYACW,Haymaker Acquisition Corp. III Warrant,"Haymaker Acquisition Corp. III is a blank check company. The company was incorporated in 2020 and is based in New York, New York.",Mr. Steven J. Heyer,Shell Companies,0.6784,USD,0,https://images.financialmodelingprep.com/symbol/HYACW.png,0,0,0.05140001,200,-940259,3157000,"[{'period': '2024', 'revenue': 139.06, 'unit': 'M', 'net_profit': 3.16}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.7}, {'period': '2021', 'revenue': 0.0, 'unit': '', 'net_profit': -744.0}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.0}]","[{'period': ""Q4 '24"", 'revenue': 148.02, 'unit': 'M', 'net_profit': 2.64}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.88}, {'period': ""Q2 '24"", 'revenue': 49.17, 'unit': 'M', 'net_profit': 2.94}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.87}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.85}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 864.29}]",0.14,0.14,250043147,282493,101126,9442388,0,0,792388,101126,-419849,-1.2000111464863148,-0.3284454714527637,-0.12499999999999993,__nan__,__nan__,__nan__,0.0377630345533925
132,HYFM,Hydrofarm Holdings Group Inc. Common Stock,"Hydrofarm Holdings Group, Inc., together with its subsidiaries, engages in the manufacture and distribution of controlled environment agriculture (CEA) equipment and supplies in the United States and Canada. The company offers agricultural lighting devices, indoor climate control equipment, hydroponics and nutrients, and plant additives used to grow, farm, and cultivate cannabis, flowers, fruits, plants, vegetables, grains, and herbs in controlled environment; and distributes CEA equipment and supplies, which include grow light systems; heating, ventilation, and air conditioning systems; humidity and carbon dioxide monitors and controllers; water pumps, heaters, chillers, and filters; nutrient and fertilizer delivery systems; and various growing media made from soil, rock wool or coconut fiber. It also provides hydroponics systems, such as hydro systems, hydro trays and components, meters and solutions, pumps and irrigation systems, water filtration systems, pots and containers, and tents and tarps; atmospheric control equipment comprising controllers, monitors and timers, ventilation/air conditioning equipment, air purification equipment, and CO2 equipment; and nutrients and additives. The company offers its products under the Phantom, PhotoBio, Active Aqua, Active Air, HEAVY 16, House & Garden, Mad Farmer, Roots Organics, Soul, Procision, Grotek, Gaia Green, Innovative Growers Equipment, Quantum, Xtrasun, Digilux, Agrobrite, SunBlaster, Jump Start, Active Eye, Autopilot, Phat, oxyClone, and GROW!T brands. Hydrofarm Holdings Group, Inc. was founded in 1977 and is based in Shoemakersville, Pennsylvania.",Mr. B. John  Lindeman,Agricultural - Machinery,1.68,USD,7751990,https://images.financialmodelingprep.com/symbol/HYFM.png,22693,-0.12,0.08,29371,-19920000,-66717000,"[{'period': '2024', 'revenue': 190.29, 'unit': 'M', 'net_profit': -66.72}, {'period': '2023', 'revenue': 226.58, 'unit': 'M', 'net_profit': -64.81}, {'period': '2022', 'revenue': 344.5, 'unit': 'M', 'net_profit': -285.42}, {'period': '2021', 'revenue': 479.42, 'unit': 'M', 'net_profit': 13.42}]","[{'period': ""Q4 '24"", 'revenue': 37.31, 'unit': 'M', 'net_profit': -17.51}, {'period': ""Q3 '24"", 'revenue': 44.01, 'unit': 'M', 'net_profit': -13.15}, {'period': ""Q2 '24"", 'revenue': 54.79, 'unit': 'M', 'net_profit': -23.45}, {'period': ""Q1 '24"", 'revenue': 54.17, 'unit': 'M', 'net_profit': -12.61}, {'period': ""Q4 '23"", 'revenue': 47.18, 'unit': 'M', 'net_profit': -15.21}, {'period': ""Q3 '23"", 'revenue': 54.17, 'unit': 'M', 'net_profit': -19.88}]",-1.45,-1.45,426104000,95212000,26111000,202382000,14756000,0,34987000,26111000,-324000,-0.137700676092334,-0.02937682255103143,-0.021126760563380302,__nan__,__nan__,__nan__,0.47495916489871015
133,HYMC,Hycroft Mining Holding Corporation Class A Common Stock,"Hycroft Mining Holding Corporation, together with its subsidiaries, operates as a gold and silver development company in the United States. The company holds interests in the Hycroft mine that covers an area of approximately 70,671 acres located in the state of Nevada. As of December 31, 2021, its Hycroft mine had measured and indicated mineral resources of 9.6 million ounces of gold, and 446.0 million ounces of silver. Hycroft Mining Holding Corporation is headquartered in Winnemucca, Nevada.","Dr. Diane Renee Garrett Eng., M.A., M.S., Mineral Eco, Ph.D.",Gold,2.76,USD,68954184,https://images.financialmodelingprep.com/symbol/HYMC.png,212365,-1.05,0.3,241447,-41059000,-60896000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -60.9}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -55.02}, {'period': '2022', 'revenue': 33.23, 'unit': 'M', 'net_profit': -68.17}, {'period': '2021', 'revenue': 110.73, 'unit': 'M', 'net_profit': -88.56}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.74}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.23}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -13.18}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -20.75}, {'period': ""Q4 '23"", 'revenue': -3.83, 'unit': 'M', 'net_profit': -11.51}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.71}]",-2.63,-2.63,140135000,54600000,50014000,173550000,369000,151000,5794000,49560000,-37150000,-0.2573187163155316,-0.10671706891538238,-0.007662835249042153,__nan__,__nan__,__nan__,1.2384486388125735
134,HYMCL,Hycroft Mining Holding Corporation Warrants,"Hycroft Mining Holding Corporation, together with its subsidiaries, operates as a gold and silver development company in the United States. The company holds interests in the Hycroft mine that covers an area of approximately 70,671 acres located in the state of Nevada. As of December 31, 2021, its Hycroft mine had measured and indicated mineral resources of 9.6 million ounces of gold, and 446.0 million ounces of silver. Hycroft Mining Holding Corporation is headquartered in Winnemucca, Nevada.","Dr. Diane Renee Garrett Eng., M.A., M.S., Mineral Eco, Ph.D.",Gold,0.0299,USD,747004,https://images.financialmodelingprep.com/symbol/HYMCL.png,42695,-0.02,0.003,33296,-41059000,-60896000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -60.9}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -55.02}, {'period': '2022', 'revenue': 33.23, 'unit': 'M', 'net_profit': -68.17}, {'period': '2021', 'revenue': 110.73, 'unit': 'M', 'net_profit': -88.56}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.74}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.23}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -13.18}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -20.75}, {'period': ""Q4 '23"", 'revenue': -3.83, 'unit': 'M', 'net_profit': -11.51}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.71}]",-2.63,-2.63,140135000,54600000,50014000,173550000,369000,151000,5794000,49560000,-37150000,-0.2573187163155316,-0.10671706891538238,-0.007662835249042153,__nan__,__nan__,__nan__,1.2384486388125735
135,HYMCW,Hycroft Mining Holding Corporation  Warrant,"Hycroft Mining Holding Corporation, together with its subsidiaries, operates as a gold and silver development company in the United States. The company holds interests in the Hycroft mine that covers an area of approximately 70,671 acres located in the state of Nevada. As of December 31, 2021, its Hycroft mine had measured and indicated mineral resources of 9.6 million ounces of gold, and 446.0 million ounces of silver. Hycroft Mining Holding Corporation is headquartered in Winnemucca, Nevada.","Dr. Diane Renee Garrett Eng., M.A., M.S., Mineral Eco, Ph.D.",Gold,0.0015,USD,37475,https://images.financialmodelingprep.com/symbol/HYMCW.png,73891.5875,,0.0003,85280,-41059000,-60896000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -60.9}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -55.02}, {'period': '2022', 'revenue': 33.23, 'unit': 'M', 'net_profit': -68.17}, {'period': '2021', 'revenue': 110.73, 'unit': 'M', 'net_profit': -88.56}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.74}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.23}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -13.18}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -20.75}, {'period': ""Q4 '23"", 'revenue': -3.83, 'unit': 'M', 'net_profit': -11.51}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.71}]",-2.63,-2.63,140135000,54600000,50014000,173550000,369000,151000,5794000,49560000,-37150000,-0.2573187163155316,-0.10671706891538238,-0.007662835249042153,__nan__,__nan__,__nan__,1.2384486388125735
136,HYMCZ,Hycroft Mining Holding Corporation Warrant,,,Gold,0.035,USD,0,https://images.financialmodelingprep.com/symbol/HYMCZ.png,0,0,-0.026,347106,-41059000,-60896000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -60.9}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -55.02}, {'period': '2022', 'revenue': 33.23, 'unit': 'M', 'net_profit': -68.17}, {'period': '2021', 'revenue': 110.73, 'unit': 'M', 'net_profit': -88.56}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.74}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.23}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -13.18}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -20.75}, {'period': ""Q4 '23"", 'revenue': -3.83, 'unit': 'M', 'net_profit': -11.51}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -15.71}]",-2.63,-2.63,140135000,54600000,50014000,173550000,369000,151000,5794000,49560000,-37150000,-0.2573187163155316,-0.10671706891538238,-0.007662835249042153,__nan__,__nan__,__nan__,1.2384486388125735
137,HYRE,HyreCar Inc. Common Stock,"HyreCar Inc., together with subsidiaries, operates a web-based car-sharing marketplace in the United States. Its marketplace allows car and fleet owners to rent their idle cars to ride-sharing service drivers, such as Uber and Lyft drivers. HyreCar Inc. was incorporated in 2014 and is headquartered in Los Angeles, California.",Mr. Eduardo  Iniguez,Rental & Leasing Services,0.0185,USD,486786,https://images.financialmodelingprep.com/symbol/HYRE.png,722704,-0.022839506172839506,0,6487497,-27900205,-25953717,"[{'period': '2021', 'revenue': 35.72, 'unit': 'M', 'net_profit': -25.95}, {'period': '2020', 'revenue': 25.23, 'unit': 'M', 'net_profit': -15.22}, {'period': '2019', 'revenue': 15.85, 'unit': 'M', 'net_profit': -12.52}, {'period': '2018', 'revenue': 9.78, 'unit': 'M', 'net_profit': -11.24}]","[{'period': ""Q3 '22"", 'revenue': 10.27, 'unit': 'M', 'net_profit': -5.38}, {'period': ""Q2 '22"", 'revenue': 10.51, 'unit': 'M', 'net_profit': -4.38}, {'period': ""Q1 '22"", 'revenue': 9.55, 'unit': 'M', 'net_profit': -5.32}, {'period': ""Q4 '21"", 'revenue': 9.56, 'unit': 'M', 'net_profit': -3.26}, {'period': ""Q3 '21"", 'revenue': 9.65, 'unit': 'M', 'net_profit': -6.15}, {'period': ""Q2 '21"", 'revenue': 9.06, 'unit': 'M', 'net_profit': -9.34}]",-1.26,-1.26,16444370,16066513,11499136,10827053,162586,0,10827053,11499136,-18075614,-0.8453776077838117,-0.705136706427563,-0.4482758620689655,__nan__,__nan__,__nan__,0.6584048522381825
138,HYW,Hywin Holdings Ltd. American Depositary Shares,"Hywin Holdings Ltd., through its subsidiaries, provides wealth management, insurance brokerage, and asset management service in China. It distributes private market investment products comprising asset-backed products, such as real estate securitization products, and equity investments in real estate projects or private project companies; venture capital, private equity, and hedge funds; and supply chain financing products, cash management products, and funds managed by its subsidiaries. The company also offers public market investment products, including money market funds, such as government bonds, central bank bills, term deposits, certificates of deposits, and corporate commercial papers; government bonds, corporate bonds, convertible bonds, and other traded debt instruments; and equities and multi-strategy funds. In addition, it provides individual whole life insurance, individual term life insurance, universal life insurance, individual health insurance, and annuity insurance products, as well as critical illness insurance comprising personal accident insurance products; discretionary and advisory mandates to ultra-high-net-worth clients; and overseas property investment services for residential properties, as well as client referrals to overseas property developers. Further, the company manages and distributes a range of private funds to professional investors; and offers information technology services, including transaction process management, data analysis, and system maintenance services to asset management service and financial product providers. The company was founded in 2006 and is headquartered in Shanghai, China. Hywin Holdings Ltd. is a subsidiary of Grand Lead Group Limited.",Ms. Dian  Wang,Asset Management,0.3689,USD,10329200,https://images.financialmodelingprep.com/symbol/HYW.png,298676,-0.07422535211267606,-0.0001,12056,272629000,120270000,"[{'period': '2023', 'revenue': 2090.0, 'unit': 'M', 'net_profit': 120.27}, {'period': '2022', 'revenue': 1940.0, 'unit': 'M', 'net_profit': 235.87}, {'period': '2021', 'revenue': 1830.0, 'unit': 'M', 'net_profit': 207.66}, {'period': '2020', 'revenue': 1280.0, 'unit': 'M', 'net_profit': 106.15}]","[{'period': ""Q2 '24"", 'revenue': 0.77442, 'unit': 'B', 'net_profit': -1.04}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q4 '23"", 'revenue': 1100.0, 'unit': 'M', 'net_profit': 59.84}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q2 '23"", 'revenue': 1020.0, 'unit': 'M', 'net_profit': 67.27}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]",4.15,4.15,2373492000,1469803000,897811000,1130270000,448625000,1000000,1009195000,868908000,503836000,-0.23206776013543012,-0.4900983172862903,-0.507125890736342,__nan__,__nan__,__nan__,0.47620552333860827
139,HZNP,Horizon Therapeutics Public Limited Company Ordinary Shares,"Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-trbw) for intravenous infusion; KRYSTEXXA (pegloticase injection) for intravenous infusion; RAVICTI (glycerol phenylbutyrate) oral liquid; PROCYSBI (cysteamine bitartrate) delayed-release capsules and granules for oral use; ACTIMMUNE (interferon gamma-1b) injection for subcutaneous use; BUPHENYL (sodium phenylbutyrate) tablets and powder for oral use; QUINSAIR (levofloxacin) solution for inhalation; and UPLIZNA (inebilizumab-cdon) injection for intravenous use. The company also markets PENNSAID (diclofenac sodium topical solution) for topical use; DUEXIS (ibuprofen/famotidine) tablets for oral use; RAYOS (prednisone) delayed-release tablets for oral use; and VIMOVO (naproxen/esomeprazole magnesium) delayed-release tablets for oral use. It has collaboration agreements with HemoShear Therapeutics, LLC.; Alpine Immune Sciences, Inc.; Halozyme Therapeutics, Inc.; and Arrowhead Pharmaceuticals, Inc. The company was formerly known as Horizon Pharma Public Limited Company and changed its name to Horizon Therapeutics Public Limited Company in May 2019. Horizon Therapeutics Public Limited Company was founded in 2005 and is headquartered in Dublin, Ireland with additional offices in Deerfield, Illinois; Chicago, Illinois; Lake Forest, Illinois; South San Francisco, California; Washington, D.C.; Gaithersburg, Maryland; Rockville, Maryland; and Mannheim, Germany.",Mr. Timothy P. Walbert,Drug Manufacturers - General,116.3,USD,26602827531,https://images.financialmodelingprep.com/symbol/HZNP.png,23917757,61.861702127659576,0,23917757,1114659000,521482000,"[{'period': '2022', 'revenue': 3630.0, 'unit': 'M', 'net_profit': 521.48}, {'period': '2021', 'revenue': 3230.0, 'unit': 'M', 'net_profit': 534.49}, {'period': '2020', 'revenue': 2200.0, 'unit': 'M', 'net_profit': 389.8}, {'period': '2019', 'revenue': 1300.0, 'unit': 'M', 'net_profit': 573.02}]","[{'period': ""Q2 '23"", 'revenue': 944.96, 'unit': 'M', 'net_profit': 127.07}, {'period': ""Q1 '23"", 'revenue': 832.06, 'unit': 'M', 'net_profit': 54.68}, {'period': ""Q4 '22"", 'revenue': 942.03, 'unit': 'M', 'net_profit': 120.41}, {'period': ""Q3 '22"", 'revenue': 925.36, 'unit': 'M', 'net_profit': 135.84}, {'period': ""Q2 '22"", 'revenue': 876.41, 'unit': 'M', 'net_profit': 60.97}, {'period': ""Q1 '22"", 'revenue': 885.25, 'unit': 'M', 'net_profit': 204.26}]",2.28,2.22,9114616000,3652843000,2352833000,4042442000,676347000,0,949137000,2352833000,1131566000,0.22619356683974304,-0.024339044062481874,-0.037974683544303924,__nan__,__nan__,__nan__,0.443512047024252
140,IAC,IAC/InterActiveCorp Common Stock,"IAC/InterActiveCorp operates as a media and internet company worldwide. The company publishes original and engaging digital content in the form of articles, illustrations, and videos and images across entertainment, food, home, beauty, travel, health, family, luxury, and fashion areas; and magazines related to women and lifestyle. It also operates a digital marketplace that connects home service professionals with consumers for repairing, remodeling, cleaning, landscaping, maintenance, and enhancement services under the Angi Ads, Angi Leads, and Angi Services brands. In addition, the company operates websites that offer general search services and information, including Ask.com, a search site with a variety of fresh and contemporary content; Reference.com that offers content across select vertical categories; Consumersearch.com, which offers content designed to simplify the product research process; and Shopping.net, a vertical shopping search site that contains a mix of search services and/or content targeted to various user or segment demographics, as well as offers direct-to-consumer downloadable desktop applications. Further, it offers Care.com, an online destination for families to connect with caregivers for their children, aging parents, pets, and homes; develops and provides subscription mobile applications across the communication, language, weather, business, health, and lifestyle verticals; a technology driven staffing platform for flexible W-2 work under the Bluecrew name; a platform to connect healthcare professionals with job opportunities under the Vivian Health name; The Daily Beast, a website dedicated to news, commentary, culture, and entertainment that publishes original reporting and opinion; and production and producer services for feature films for sale and distribution through theatrical releases and video-on-demand services. The company was formerly known as IAC HOLDINGS, INC. IAC/InterActiveCorp is headquartered in New York, New York.",Mr. Barry  Diller,Internet Content & Information,35.56,USD,2849674280,https://images.financialmodelingprep.com/symbol/IAC.png,1338254,-5.48,2.88,2343001,-4230000,-539897000,"[{'period': '2024', 'revenue': 3810.0, 'unit': 'M', 'net_profit': -539.9}, {'period': '2023', 'revenue': 4370.0, 'unit': 'M', 'net_profit': 265.94}, {'period': '2022', 'revenue': 5.24, 'unit': 'B', 'net_profit': -1.2}, {'period': '2021', 'revenue': 3700.0, 'unit': 'M', 'net_profit': 597.55}]","[{'period': ""Q4 '24"", 'revenue': 989.31, 'unit': 'M', 'net_profit': -198.98}, {'period': ""Q3 '24"", 'revenue': 938.72, 'unit': 'M', 'net_profit': -243.72}, {'period': ""Q2 '24"", 'revenue': 949.53, 'unit': 'M', 'net_profit': -142.23}, {'period': ""Q1 '24"", 'revenue': 929.68, 'unit': 'M', 'net_profit': 45.03}, {'period': ""Q4 '23"", 'revenue': 1060.0, 'unit': 'M', 'net_profit': 327.75}, {'period': ""Q3 '23"", 'revenue': 1110.0, 'unit': 'M', 'net_profit': -390.54}]",-6.5,-6.5,9547160000,2485035000,1798170000,3969262000,519690000,438534000,886192000,1798170000,289012000,-1.0038541157947678,-3.0301306299869895,-3.1103896103896105,"[0.34, 0.12]","['2015-11-10', '2011-11-10']",__nan__,0.4157531663866532
141,IART,Integra LifeSciences Holdings Corporation Common Stock,"Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.",Ms. Mojdeh  Poul,Medical - Devices,19.19,USD,1481830691,https://images.financialmodelingprep.com/symbol/IART.png,679362,-213.22,1.12,996830,193288000,-6944000,"[{'period': '2024', 'revenue': 1610.0, 'unit': 'M', 'net_profit': -6.94}, {'period': '2023', 'revenue': 1540.0, 'unit': 'M', 'net_profit': 67.74}, {'period': '2022', 'revenue': 1560.0, 'unit': 'M', 'net_profit': 180.55}, {'period': '2021', 'revenue': 1540.0, 'unit': 'M', 'net_profit': 169.07}]","[{'period': ""Q4 '24"", 'revenue': 442.65, 'unit': 'M', 'net_profit': 19.43}, {'period': ""Q3 '24"", 'revenue': 380.83, 'unit': 'M', 'net_profit': -10.7}, {'period': ""Q2 '24"", 'revenue': 418.18, 'unit': 'M', 'net_profit': -12.4}, {'period': ""Q1 '24"", 'revenue': 368.87, 'unit': 'M', 'net_profit': -3.28}, {'period': ""Q4 '23"", 'revenue': 397.04, 'unit': 'M', 'net_profit': 19.83}, {'period': ""Q3 '23"", 'revenue': 382.42, 'unit': 'M', 'net_profit': 19.5}]",-0.09,-0.09,4037424000,1081681000,273567000,2492144000,272370000,0,922126000,246375000,24964000,-0.29460281081554524,-1.1025080822544693,-1.103448275862069,__nan__,__nan__,__nan__,0.6172609069545334
142,IBCP,Independent Bank Corporation Common Stock,"Independent Bank Corporation operates as the bank holding company for Independent Bank that provides various banking services to individuals and businesses. The company offers checking and savings accounts, commercial lending, direct and indirect consumer financing, mortgage lending, and safe deposit box services, as well as automatic teller machine, and Internet and mobile banking services. It also provides title insurance, insurance brokerage, and investment services. The company offers its services through approximately 59 branches, two drive-thru facilities, and seven loan production offices in Michigan; and two loan production offices in Ohio. Independent Bank Corporation was founded in 1864 and is based in Grand Rapids, Michigan.",Mr. William Bradford Kessel CPA,Banks - Regional,29.835,USD,623375474,https://images.financialmodelingprep.com/symbol/IBCP.png,122416,9.44,1.275,135170,0,66790000,"[{'period': '2024', 'revenue': 215.8, 'unit': 'M', 'net_profit': 66.79}, {'period': '2023', 'revenue': 200.5, 'unit': 'M', 'net_profit': 59.07}, {'period': '2022', 'revenue': 204.57, 'unit': 'M', 'net_profit': 63.35}, {'period': '2021', 'revenue': 199.03, 'unit': 'M', 'net_profit': 62.9}]","[{'period': ""Q4 '24"", 'revenue': 60.41, 'unit': 'M', 'net_profit': 18.46}, {'period': ""Q3 '24"", 'revenue': 77.85, 'unit': 'M', 'net_profit': 13.81}, {'period': ""Q2 '24"", 'revenue': 78.85, 'unit': 'M', 'net_profit': 18.53}, {'period': ""Q1 '24"", 'revenue': 77.44, 'unit': 'M', 'net_profit': 15.99}, {'period': ""Q4 '23"", 'revenue': 79.12, 'unit': 'M', 'net_profit': 13.74}, {'period': ""Q3 '23"", 'revenue': 53.4, 'unit': 'M', 'net_profit': 17.54}]",3.2,3.16,5338104000,145268000,145268000,4883418000,0,898618000,0,119882000,55201000,-1,0.13074982646824793,0.13475177304964553,"[0.26, 0.0117]","['2025-02-04', '1985-10-04']",__nan__,0.9148225662145211
143,IBEX,IBEX Limited Common Shares,"IBEX Limited provides end-to-end technology-enabled customer lifecycle experience solutions in the United States and internationally. The company provides ibex Connect, a customer engagement solution that comprises customer service, technical support, revenue generation, and other value-added outsourced back-office services through the CX model, which integrates voice, email, chat, SMS, social media, and other communication applications; ibex Digital, a customer acquisition solution that includes digital marketing, e-commerce technology, and platform solutions; and ibex CX, a customer experience solution, which provides a suite of proprietary software tools to measure, monitor, and manage its clients' customer experience. As of October 1, 2021, the company operated 33 customer engagement and three customer acquisition delivery centers. It serves banking and financial services, delivery and logistics, health tech and wellness, high tech, retail and e-commerce, streaming and entertainment, travel and hospitality, and utility industries. The company was formerly known as IBEX Holdings Limited and changed its name to IBEX Limited in September 2019. The company was incorporated in 2017 and is headquartered in Washington, District of Columbia. IBEX Limited is a subsidiary of The Resource Group International Limited.",Mr. Robert T. Dechant,Information Technology Services,23.26,USD,306843594,https://images.financialmodelingprep.com/symbol/IBEX.png,211385,10.97,0.76,299170,60961000,33655000,"[{'period': '2024', 'revenue': 508.57, 'unit': 'M', 'net_profit': 33.66}, {'period': '2023', 'revenue': 523.12, 'unit': 'M', 'net_profit': 31.58}, {'period': '2022', 'revenue': 493.57, 'unit': 'M', 'net_profit': 21.46}, {'period': '2021', 'revenue': 443.66, 'unit': 'M', 'net_profit': 2.85}]","[{'period': ""Q2 '25"", 'revenue': 140.68, 'unit': 'M', 'net_profit': 9.27}, {'period': ""Q1 '25"", 'revenue': 129.72, 'unit': 'M', 'net_profit': 7.53}, {'period': ""Q4 '24"", 'revenue': 124.53, 'unit': 'M', 'net_profit': 9.85}, {'period': ""Q3 '24"", 'revenue': 126.8, 'unit': 'M', 'net_profit': 10.31}, {'period': ""Q2 '24"", 'revenue': 132.63, 'unit': 'M', 'net_profit': 6.08}, {'period': ""Q1 '24"", 'revenue': 124.61, 'unit': 'M', 'net_profit': 7.42}]",1.9,1.84,293904000,179958000,62720000,128105000,107638000,615000,70996000,62720000,27045000,-0.17580174138770213,0.06563865493002344,0.0919540229885057,__nan__,__nan__,__nan__,0.43587361859654855
144,IBKR,Interactive Brokers Group Inc. Class A Common Stock,"Interactive Brokers Group, Inc. operates as an automated electronic broker worldwide. The company specializes in executing, clearing, and settling trades in stocks, options, futures, foreign exchange instruments, bonds, mutual funds, exchange traded funds (ETFs), metals, and cryptocurrencies. It also custodies and services accounts for hedge and mutual funds, ETFs, registered investment advisors, proprietary trading groups, introducing brokers, and individual investors. In addition, it offers custody, prime brokerage, securities, and margin lending services. The company serves institutional and individual customers through approximately 150 electronic exchanges and market centers. Interactive Brokers Group, Inc. was founded in 1977 and is headquartered in Greenwich, Connecticut.",Mr. Milan  Galik,Financial - Capital Markets,170.72,USD,72142270835,https://images.financialmodelingprep.com/symbol/IBKR.png,2341959,23.78,23.7,4359949,4277000000,755000000,"[{'period': '2024', 'revenue': 5180.0, 'unit': 'M', 'net_profit': 755.0}, {'period': '2023', 'revenue': 4420.0, 'unit': 'M', 'net_profit': 600.0}, {'period': '2022', 'revenue': 3170.0, 'unit': 'M', 'net_profit': 380.0}, {'period': '2021', 'revenue': 2750.0, 'unit': 'M', 'net_profit': 308.0}]","[{'period': ""Q4 '24"", 'revenue': 1410.0, 'unit': 'M', 'net_profit': 217.0}, {'period': ""Q3 '24"", 'revenue': 1340.0, 'unit': 'M', 'net_profit': 184.0}, {'period': ""Q2 '24"", 'revenue': 1250.0, 'unit': 'M', 'net_profit': 179.0}, {'period': ""Q1 '24"", 'revenue': 1210.0, 'unit': 'M', 'net_profit': 175.0}, {'period': ""Q4 '23"", 'revenue': 1150.0, 'unit': 'M', 'net_profit': 160.0}, {'period': ""Q3 '23"", 'revenue': 1160.0, 'unit': 'M', 'net_profit': 167.0}]",6.98,6.93,150142000000,135230000000,3633000000,133545000000,67074000000,13791000000,117004000000,3633000000,8675000000,0.1653950953678474,0.25833333333333336,0.2202797202797204,"[0.25, 1.79]","['2025-02-28', '2010-12-07']",__nan__,0.8894579797791424
145,IBOC,International Bancshares Corporation Common Stock,"International Bancshares Corporation, a financial holding company, provides commercial and retail banking services. It accepts checking and saving deposits; and offers commercial, real estate, personal, home improvement, automobile, and other installment and term loans. The company also provides international banking services, including letters of credit, commercial and industrial loans, and foreign exchange services. In addition, it offers other banking related services, such as credit cards, safety deposit boxes, collection, notary public, escrow, drive up and walk up facilities, and other customary banking services; and Internet banking services, as well as securities products through third party providers. As of February 28, 2022, the company had 170 branch facilities and 263 ATMs serving 76 communities in Texas and Oklahoma. International Bancshares Corporation was founded in 1966 and is headquartered in Laredo, Texas.",Mr. Mike K. Sohn,Banks - Regional,60.29,USD,3750990582,https://images.financialmodelingprep.com/symbol/IBOC.png,334559,9.18,3.89,462262,0,409167000,"[{'period': '2024', 'revenue': 833.64, 'unit': 'M', 'net_profit': 409.17}, {'period': '2023', 'revenue': 974.09, 'unit': 'M', 'net_profit': 411.77}, {'period': '2022', 'revenue': 674.76, 'unit': 'M', 'net_profit': 300.23}, {'period': '2021', 'revenue': 593.6, 'unit': 'M', 'net_profit': 253.92}]","[{'period': ""Q4 '24"", 'revenue': 208.26, 'unit': 'M', 'net_profit': 115.08}, {'period': ""Q3 '24"", 'revenue': 211.78, 'unit': 'M', 'net_profit': 99.77}, {'period': ""Q2 '24"", 'revenue': 259.19, 'unit': 'M', 'net_profit': 96.98}, {'period': ""Q1 '24"", 'revenue': 254.33, 'unit': 'M', 'net_profit': 97.33}, {'period': ""Q4 '23"", 'revenue': 256.91, 'unit': 'M', 'net_profit': 106.38}, {'period': ""Q3 '23"", 'revenue': 212.71, 'unit': 'M', 'net_profit': 103.26}]",6.58,6.57,15738852000,5340568000,5340568000,12942145000,72175000,5354445000,0,352652000,459801000,-1,-0.006316663752404267,-0.007541478129713397,"[0.7, 0.5]","['2025-02-14', '1996-04-01']",__nan__,0.822305527747513
146,IBRX,ImmunityBio Inc. Common Stock,"ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The company also develops therapeutic agents, which are in Phase II or III clinical trial for the treatment of liquid and solid tumors, including bladder, pancreatic, and lung cancers, as well as pathogens as SARS-CoV-2 and HIV. It has collaboration agreements with National Cancer Institute, National Institute of Deafness and Communication Disorders, and Amyris, Inc.; and license agreements with CytRx Corporation, EnGeneIC Pty Limited, GlobeImmune, Inc., and Infectious Disease Research Institute, Sanford Health, Shenzhen Beike Biotechnology Co. Ltd., Sorrento Therapeutics, Inc., and Viracta Therapeutics, Inc. The company was founded in 2014 and is based in San Diego, California.",Mr. Richard Gerald Adcock,Biotechnology,2.6,USD,2218949200,https://images.financialmodelingprep.com/symbol/IBRX.png,6555063,-4.19,0.18,10013196,-264433000,-413564000,"[{'period': '2024', 'revenue': 14.74, 'unit': 'M', 'net_profit': -413.56}, {'period': '2023', 'revenue': 0.622, 'unit': 'M', 'net_profit': -583.2}, {'period': '2022', 'revenue': 0.24, 'unit': 'M', 'net_profit': -417.32}, {'period': '2021', 'revenue': 0.934, 'unit': 'M', 'net_profit': -349.85}]","[{'period': ""Q4 '24"", 'revenue': 7.55, 'unit': 'M', 'net_profit': -59.16}, {'period': ""Q3 '24"", 'revenue': 6.11, 'unit': 'M', 'net_profit': -85.73}, {'period': ""Q2 '24"", 'revenue': 1.05, 'unit': 'M', 'net_profit': -134.56}, {'period': ""Q1 '24"", 'revenue': 0.04, 'unit': 'M', 'net_profit': -134.11}, {'period': ""Q4 '23"", 'revenue': 0.139, 'unit': 'M', 'net_profit': -233.39}, {'period': ""Q3 '23"", 'revenue': 0.082, 'unit': 'M', 'net_profit': -95.58}]",-0.59,-0.59,382933000,184586000,149809000,871062000,2653000,0,54944000,143428000,-398124000,0.3937553590015177,0.2908661924978909,0.4869565217391304,__nan__,__nan__,__nan__,2.274711241914382
147,IBTX,Independent Bank Group Inc Common Stock,"Independent Bank Group, Inc. operates as the bank holding company for Independent Bank that provides various commercial banking products and services to businesses, professionals, and individuals in the United States. It accepts various deposit products, including checking and savings accounts, demand deposits, money market accounts, and certificates of deposit. The company also provides commercial real estate loans; commercial construction, land, and land development loans; residential real estate loans; single-family interim construction loans; commercial loans comprising SBA guaranteed loans, business term loans, equipment lease financing, lines of credit, and energy related loans; agricultural loans for farmers and ranchers; consumer installment loans comprising loans to purchase cars, boats, and other recreational vehicles; and residential mortgages, as well as mortgage warehouse purchase loans. In addition, it offers debit cards, online and mobile banking, eStatement, bank-by-mail, and direct deposit services; and business accounts and management services, including analyzed business checking, business savings, and treasury management services. As of December 31, 2021, the company operated 93 full-service branches. Independent Bank Group, Inc. was founded in 2002 and is headquartered in McKinney, Texas.",Mr. David R. Brooks,Banks - Regional,60.67,USD,2513928187,https://images.financialmodelingprep.com/symbol/IBTX.png,279376,-5.778095238095238,0.28,1536709,0,43201000,"[{'period': '2023', 'revenue': 503.86, 'unit': 'M', 'net_profit': 43.2}, {'period': '2022', 'revenue': 610.17, 'unit': 'M', 'net_profit': 196.29}, {'period': '2021', 'revenue': 587.14, 'unit': 'M', 'net_profit': 224.75}, {'period': '2020', 'revenue': 601.14, 'unit': 'M', 'net_profit': 201.21}]","[{'period': ""Q3 '24"", 'revenue': 120.31, 'unit': 'M', 'net_profit': 20.44}, {'period': ""Q2 '24"", 'revenue': 254.82, 'unit': 'M', 'net_profit': -491.27}, {'period': ""Q1 '24"", 'revenue': 250.24, 'unit': 'M', 'net_profit': 24.15}, {'period': ""Q4 '23"", 'revenue': 243.19, 'unit': 'M', 'net_profit': 14.86}, {'period': ""Q3 '23"", 'revenue': 122.75, 'unit': 'M', 'net_profit': 32.77}, {'period': ""Q2 '23"", 'revenue': 127.35, 'unit': 'M', 'net_profit': 33.08}]",1.04,1.04,19035102000,711747000,711747000,16669008999,0,1798983000,0,722237000,144290000,-1,-0.7799134957792258,-0.7791932059447982,"[0.38, 0.06]","['2024-10-31', '2013-08-20']",__nan__,0.8756984332944473
148,ICAD,iCAD Inc. Common Stock,"iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, and image storage and review systems; SecondLook, a machine learning-based cancer detection algorithm that analyzes 2D full-field digital mammography images to identify and mark suspicious masses and calcifications; and automated density assessment solutions, which provides automated, consistent, and standardized density assessment. It also offers ProFound AI, a deep-learning algorithm designed to detect malignant soft-tissue densities and calcifications in digital breast tomosynthesis; ProFound AI Risk, a tool that provides breast cancer risk estimation based on a screening mammogram; and magnetic resonance imaging applications, a tool to detect breast and prostate cancer. In addition, the company offers VeraLook, a solution designed to support the detection of colonic polyps in conjunction with CT Colonography. Further, it provides Xoft Axxent electronic brachytherapy systems for the treatment of early stage breast, non-melanoma skin, and gynecological cancers to university research and community hospitals, cancer care clinics, veterinary facilities, and dermatology offices. The company sells its products through direct sales organizations, as well as through various original equipment manufacturer partners, distributors, technology platform partners, and resellers. It also exports its products in Europe, Taiwan, Canada, China, and internationally. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.",Ms. Dana R. Brown,Medical - Devices,1.76,USD,48163632,https://images.financialmodelingprep.com/symbol/ICAD.png,478450,-8.38,0.1,221735,-5149000,-5420000,"[{'period': '2024', 'revenue': 19.61, 'unit': 'M', 'net_profit': -5.42}, {'period': '2023', 'revenue': 17.32, 'unit': 'M', 'net_profit': -4.85}, {'period': '2022', 'revenue': 27.94, 'unit': 'M', 'net_profit': -13.66}, {'period': '2021', 'revenue': 33.64, 'unit': 'M', 'net_profit': -11.24}]","[{'period': ""Q4 '24"", 'revenue': 5410.0, 'unit': 'K', 'net_profit': -854.0}, {'period': ""Q3 '24"", 'revenue': 4.22, 'unit': 'M', 'net_profit': -1.8}, {'period': ""Q2 '24"", 'revenue': 5.03, 'unit': 'M', 'net_profit': -1.74}, {'period': ""Q1 '24"", 'revenue': 4.95, 'unit': 'M', 'net_profit': -1.22}, {'period': ""Q4 '23"", 'revenue': 4.74, 'unit': 'M', 'net_profit': 1.36}, {'period': ""Q3 '23"", 'revenue': 4.07, 'unit': 'M', 'net_profit': -1.37}]",-0.21,-0.21,37540000,26427000,17206000,8856000,7207000,0,7561000,17206000,-4113000,0.21568926123381568,-0.11821745409531668,0.2222222222222223,__nan__,__nan__,__nan__,0.23590836441129462
149,ICBK,County Bancorp Inc. Common Stock,"County Bancorp, Inc. is a bank holding company, which engages in the provision of banking and financial services. The company is headquartered in Manitowoc, Wisconsin and currently employs 142 full-time employees. The firm's primary activities consist of holding the stock of its subsidiary bank, Investors Community Bank (the Bank), and providing banking and related business activities through the Bank and its other subsidiaries. The company operates in the community banking segment. The Bank is an independent community bank offering financial services focusing on the needs of agricultural businesses, with a primary focus on dairy-related lending with lending relationships in over 60 Wisconsin counties. The company also serves business and retail customers throughout Wisconsin, but is focused on northeastern and central Wisconsin. Its customers are served from its service branches in Manitowoc and Stevens Point, and its loan production offices located in Darlington, Eau Claire, Fond du Lac, and Sheboygan. Its subsidiaries include Investors Insurance Services, LLC, County Bancorp Statutory Trust II, County Bancorp Statutory Trust III and County Acquisition LLC.",Mr. Timothy Schneider,Banks - Regional,35.25,USD,0,https://images.financialmodelingprep.com/symbol/ICBK.png,0,11.568756153593698,0.66,9587,28602000,5479000,"[{'period': '2020', 'revenue': 51.23, 'unit': 'M', 'net_profit': 5.48}, {'period': '2019', 'revenue': 54.17, 'unit': 'M', 'net_profit': 16.45}, {'period': '2018', 'revenue': 50.79, 'unit': 'M', 'net_profit': 14.25}, {'period': '2017', 'revenue': 46.54, 'unit': 'M', 'net_profit': 10.43}]","[{'period': ""Q3 '21"", 'revenue': 13.94, 'unit': 'M', 'net_profit': 4.11}, {'period': ""Q2 '21"", 'revenue': 13.69, 'unit': 'M', 'net_profit': 6.74}, {'period': ""Q1 '21"", 'revenue': 13.93, 'unit': 'M', 'net_profit': 3.93}, {'period': ""Q4 '20"", 'revenue': 15.13, 'unit': 'M', 'net_profit': 4.52}, {'period': ""Q3 '20"", 'revenue': 12.33, 'unit': 'M', 'net_profit': 3.42}, {'period': ""Q2 '20"", 'revenue': 12.27, 'unit': 'M', 'net_profit': 2.73}]",0.86,0.86,19138000,19084000,372354000,1300582000,11093000,352854000,12337000,19500000,-27363000,-0.4077893036834586,-0.6669705810843667,-0.6460905349794239,"[0.1, 0.04]","['2021-11-04', '2015-02-26']",__nan__,67.95809384470687
150,ICCC,ImmuCell Corporation Common Stock,"ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.",Mr. Michael F. Brigham,Biotechnology,4.935,USD,44329230,https://images.financialmodelingprep.com/symbol/ICCC.png,10408,-18.98,0.125,20584,1044443,-2157000,"[{'period': '2024', 'revenue': 26.49, 'unit': 'M', 'net_profit': -2.16}, {'period': '2023', 'revenue': 17.47, 'unit': 'M', 'net_profit': -5.77}, {'period': '2022', 'revenue': 18.57, 'unit': 'M', 'net_profit': -2.49}, {'period': '2021', 'revenue': 19240.0, 'unit': 'K', 'net_profit': -78.0}]","[{'period': ""Q4 '24"", 'revenue': 7750.0, 'unit': 'K', 'net_profit': 515.0}, {'period': ""Q3 '24"", 'revenue': 6010.0, 'unit': 'K', 'net_profit': -701.69}, {'period': ""Q2 '24"", 'revenue': 5.47, 'unit': 'M', 'net_profit': -1.53}, {'period': ""Q1 '24"", 'revenue': 7260.0, 'unit': 'K', 'net_profit': -437.87}, {'period': ""Q4 '23"", 'revenue': 5.1, 'unit': 'M', 'net_profit': -1.14}, {'period': ""Q3 '23"", 'revenue': 5400.0, 'unit': 'K', 'net_profit': -940.0}]",-0.26,-0.26,45100477,15042750,3758232,17582290,3811688,0,4412213000,3758232,-107822,1.4170969982153105,0.6264675047509801,0.6533333333333333,__nan__,__nan__,__nan__,0.38984709629567776
151,ICCH,ICC Holdings Inc. Common Stock,"ICC Holdings, Inc., together with its subsidiaries, provides property and casualty insurance products to the food and beverage industry in the United States. The company offers commercial multi-peril, liquor liability, workers' compensation, and umbrella liability insurance products. It markets its products through a network of 186 independent agents in Arizona, Colorado, Illinois, Indiana, Iowa, Kansas, Minnesota, Michigan, Missouri, Ohio, Oregon, Pennsylvania, Tennessee, Utah, and Wisconsin. ICC Holdings, Inc. was founded in 1950 and is headquartered in Rock Island, Illinois.",Mr. Arron Keath Sutherland,Insurance - Specialty,23.49,USD,69594763,https://images.financialmodelingprep.com/symbol/ICCH.png,5038,13.578034682080926,0.01,32742,6470031,4256895,"[{'period': '2023', 'revenue': 82.94, 'unit': 'M', 'net_profit': 4.26}, {'period': '2022', 'revenue': 69680.0, 'unit': 'K', 'net_profit': -471.34}, {'period': '2021', 'revenue': 61.44, 'unit': 'M', 'net_profit': 4.14}, {'period': '2020', 'revenue': 54.88, 'unit': 'M', 'net_profit': 3.53}]","[{'period': ""Q4 '24"", 'revenue': 1.67, 'unit': 'M', 'net_profit': 1.61}, {'period': ""Q3 '24"", 'revenue': 24.38, 'unit': 'M', 'net_profit': 2.05}, {'period': ""Q2 '24"", 'revenue': 22180.0, 'unit': 'K', 'net_profit': -731.88}, {'period': ""Q1 '24"", 'revenue': 23.08, 'unit': 'M', 'net_profit': 2.24}, {'period': ""Q4 '23"", 'revenue': 23.12, 'unit': 'M', 'net_profit': 2.86}, {'period': ""Q3 '23"", 'revenue': 19760.0, 'unit': 'K', 'net_profit': -768.96}]",1.44,1.43,211017013,1478135,1478135,144013464,0,29897190,67757924,1478135,7902941,37.67114739792839,10.031397450694184,9.999999999999998,__nan__,__nan__,__nan__,0.6824732373593024
152,ICFI,ICF International Inc. Common Stock,"ICF International, Inc. provides management, marketing, technology, and policy consulting and implementation services to government and commercial clients in the United States and internationally. It researches critical policy, industry, stakeholder issues, trends, and behaviors; measures and evaluates results and their impact; and provides strategic planning and advisory services to its clients on how to navigate societal, market, business, communication, and technology challenges. The company also identifies, defines, and implements policies, plans, programs, and business tools through a range of standard and customized methodologies for its clients; conducts survey research; collects and analyzes various data to understand critical issues and options for its clients; and provides actionable business intelligence, as well as information and data management solutions that allow integrated and purpose-driven data usage. In addition, it provides solutions to optimize the customer and citizen experience; modernizes IT systems; and cyber security solutions that support the range of cyber security missions and protect IT infrastructures in the face of relentless threats, as well as designs, develops, and implements technology systems and business tools that are principal to its clients' mission or business performance. Further, the company informs and engages its clients' constituents, customers, and employees through public relations, branding and marketing, multichannel and strategic communications, and reputation issues management. It serves energy, environment, and infrastructure; health, education, and social programs; safety and security; and consumer and financial markets. The company was formerly known as ICF Consulting Group Holdings, LLC and changed its name to ICF International, Inc. in 2006. ICF International, Inc. was founded in 1969 and is headquartered in Fairfax, Virginia.",Mr. John M. Wasson,Consulting Services,83.24,USD,1534620964,https://images.financialmodelingprep.com/symbol/ICFI.png,329504,14.3,4.62,337954,221124000,110170000,"[{'period': '2024', 'revenue': 2020.0, 'unit': 'M', 'net_profit': 110.17}, {'period': '2023', 'revenue': 1960.0, 'unit': 'M', 'net_profit': 82.61}, {'period': '2022', 'revenue': 1780.0, 'unit': 'M', 'net_profit': 64.24}, {'period': '2021', 'revenue': 1550.0, 'unit': 'M', 'net_profit': 71.13}]","[{'period': ""Q4 '24"", 'revenue': 496.32, 'unit': 'M', 'net_profit': 24.56}, {'period': ""Q3 '24"", 'revenue': 517.0, 'unit': 'M', 'net_profit': 32.68}, {'period': ""Q2 '24"", 'revenue': 512.03, 'unit': 'M', 'net_profit': 25.61}, {'period': ""Q1 '24"", 'revenue': 494.44, 'unit': 'M', 'net_profit': 27.32}, {'period': ""Q4 '23"", 'revenue': 478.35, 'unit': 'M', 'net_profit': 22.16}, {'period': ""Q3 '23"", 'revenue': 501.52, 'unit': 'M', 'net_profit': 23.74}]",5.88,5.82,2066353000,492074000,4960000,1083894000,452124000,0,449180000,4960000,150114000,0.12265060974990608,0.33358349876531257,0.3394077448747153,"[0.14, 0.14]","['2025-03-28', '2018-03-28']",__nan__,0.5245444510207113
153,ICHR,Ichor Holdings Ordinary Shares,"Ichor Holdings, Ltd. engages in the design, engineering, and manufacture of fluid delivery subsystems and components for semiconductor capital equipment. It primarily offers gas and chemical delivery systems and subsystems that are used in the manufacturing of semiconductor devices. The company's gas delivery subsystems deliver, monitor, and control gases used in semiconductor manufacturing processes, such as etch and deposition; and chemical delivery subsystems blend and dispense the reactive liquid chemistries used in semiconductor manufacturing processes comprising chemical-mechanical planarization, electroplating, and cleaning. It also manufactures precision machined components, weldments, electron beam, laser-welded components, precision vacuum and hydrogen brazing, surface treatment technologies, and other proprietary products for use in fluid delivery systems. The company primarily markets its products directly and through resellers to equipment OEMs in the semiconductor equipment market in the United States, the United Kingdom, Singapore, Malaysia, Korea, Mexico, and internationally. Ichor Holdings, Ltd. was incorporated in 1999 and is headquartered in Fremont, California.",Mr. Jeffrey S. Andreson,Semiconductors,20.9,USD,712961700,https://images.financialmodelingprep.com/symbol/ICHR.png,357604,-32.66,4.23,625369,-7640000,-20820000,"[{'period': '2024', 'revenue': 849.04, 'unit': 'M', 'net_profit': -20.82}, {'period': '2023', 'revenue': 811.12, 'unit': 'M', 'net_profit': -42.98}, {'period': '2022', 'revenue': 1280.0, 'unit': 'M', 'net_profit': 72.8}, {'period': '2021', 'revenue': 1100.0, 'unit': 'M', 'net_profit': 70.9}]","[{'period': ""Q4 '24"", 'revenue': 233.29, 'unit': 'M', 'net_profit': -3.94}, {'period': ""Q3 '24"", 'revenue': 211.14, 'unit': 'M', 'net_profit': -2.78}, {'period': ""Q2 '24"", 'revenue': 203.23, 'unit': 'M', 'net_profit': -5.11}, {'period': ""Q1 '24"", 'revenue': 201.38, 'unit': 'M', 'net_profit': -8.99}, {'period': ""Q4 '23"", 'revenue': 203.48, 'unit': 'M', 'net_profit': -11.9}, {'period': ""Q3 '23"", 'revenue': 196.76, 'unit': 'M', 'net_profit': -10.43}]",-0.64,-0.64,995564000,452620000,108669000,297228000,86619000,0,135670000,108669000,10244000,-1.3339452749366203,0.515644992439223,0.564625850340136,__nan__,__nan__,__nan__,0.2985523783503622
154,ICLK,iClick Interactive Asia Group Limited American Depositary Shares,"iClick Interactive Asia Group Limited, together with its subsidiaries, provides online marketing services in the People's Republic of China and internationally. It offers iAudience, an audience identification solution that allows marketers to search, identify, and customize their targeted audience to generate or enhance brand awareness; iAccess and iActivation, an audience engagement and activation solution tailored for brand awareness-driven and performance-driven campaigns; and iNsights, an online campaign results monitoring and measurement solution. The company also provides mobile marketing solutions, which identify, engage, and activate audience on mobile apps, as well as monitor and measure the results of online marketing activities on such channels. In addition, it offers enterprise solutions that help clients collate information from various consumer touchpoints and integrate them into a single data management platform to drive sales and marketing decisions. The company sells its solutions by entering into sales contracts with entities or marketing agencies, including marketing campaign contracts. The company was formerly known as Optimix Media Asia Limited and changed its name to iClick Interactive Asia Group Limited in March 2017. iClick Interactive Asia Group Limited was founded in 2009 and is headquartered in Quarry Bay, Hong Kong.",Dr. Jian  Tang,Advertising Agencies,9.24,USD,82012290,https://images.financialmodelingprep.com/symbol/ICLK.png,87546,-3.230769230769231,0.84,147971,-35553000,-38690000,"[{'period': '2023', 'revenue': 133.22, 'unit': 'M', 'net_profit': -38.69}, {'period': '2022', 'revenue': 169.08, 'unit': 'M', 'net_profit': -202.73}, {'period': '2021', 'revenue': 307.7, 'unit': 'M', 'net_profit': -16.49}, {'period': '2020', 'revenue': 254.75, 'unit': 'M', 'net_profit': -14.79}]","[{'period': ""Q4 '23"", 'revenue': 33.04, 'unit': 'M', 'net_profit': -5.09}, {'period': ""Q3 '23"", 'revenue': 33.04, 'unit': 'M', 'net_profit': -5.09}, {'period': ""Q2 '23"", 'revenue': 33.57, 'unit': 'M', 'net_profit': -14.26}, {'period': ""Q1 '23"", 'revenue': 33.57, 'unit': 'M', 'net_profit': -14.26}, {'period': ""Q4 '22"", 'revenue': 42.6, 'unit': 'M', 'net_profit': -128.33}, {'period': ""Q3 '22"", 'revenue': 41.03, 'unit': 'M', 'net_profit': -19.38}]",-0.756,-0.756,163704000,159803000,58040000,122452000,60930000,3397000,120072000,50766000,-19523000,0.8268865581816588,0.8091559751592011,0.8119402985074626,__nan__,__nan__,__nan__,0.7480086008894101
155,ICLR,ICON plc Ordinary Shares,"ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services. The company's clinical development services also comprise medical imaging, clinical research and laboratory services, project management, site monitoring and management services, data management, biostatistics and programming, medical writing and publishing, medical affair, endpoint adjudication/data monitoring committees, pharmacovigilance, interactive response technologies, clinical supplies management, strategic regulatory, medical communication, and consulting and advisory services. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company was incorporated in 1990 and is headquartered in Dublin, Ireland.","Dr. Steven A. Cutler MBA, Ph.D.",Medical - Diagnostics & Research,155.49,USD,12556890381,https://images.financialmodelingprep.com/symbol/ICLR.png,1039036,16.32,12.99,1748833,1594921000,791474000,"[{'period': '2024', 'revenue': 8280.0, 'unit': 'M', 'net_profit': 791.47}, {'period': '2023', 'revenue': 8119.999999999999, 'unit': 'M', 'net_profit': 612.34}, {'period': '2022', 'revenue': 7740.0, 'unit': 'M', 'net_profit': 505.3}, {'period': '2021', 'revenue': 5480.0, 'unit': 'M', 'net_profit': 153.19}]","[{'period': ""Q4 '24"", 'revenue': 2040.0, 'unit': 'M', 'net_profit': 260.0}, {'period': ""Q3 '24"", 'revenue': 2029.9999999999998, 'unit': 'M', 'net_profit': 197.13}, {'period': ""Q2 '24"", 'revenue': 2120.0, 'unit': 'M', 'net_profit': 146.91}, {'period': ""Q1 '24"", 'revenue': 2090.0, 'unit': 'M', 'net_profit': 187.44}, {'period': ""Q4 '23"", 'revenue': 2070.0, 'unit': 'M', 'net_profit': 216.42}, {'period': ""Q3 '23"", 'revenue': 2060.0, 'unit': 'M', 'net_profit': 163.66}]",9.6,9.53,16877678000,3530493000,538785000,7354679000,2688263000,57948000,2796406000,538785000,1118592000,0.04829976417016556,0.29255064629655336,0.28686327077747986,__nan__,__nan__,__nan__,0.4357636755482597
156,ICMB,Investcorp Credit Management BDC Inc. Common Stock,"Investcorp Credit Management BDC, Inc. is a business development company specializing in loan, mezzanine, middle market, growth capital, acquisitions, market/product expansion, organic growth, refinancings and recapitalization investments. It also selectively invests in mezzanine loans/structured equity and in the equity of portfolio companies through warrants and other instruments, in most cases taking such upside participation interests as part of a broader investment relationship. The fund typically invests in United States and Europe. Within United States, the fund seeks to invest in Midatlantic, Midwest, Northeast, Southeast, and West Coast regions. The fund primarily invests in cable and satellites; consumer services; healthcare equipment and services; industrials; information technology; telecommunication services; and utilities sectors. The fund seeks to invest between $5 million to $25 million in companies that have annual revenues of at least $50 million with EBITDA at least $15 million.",Mr. Suhail Ahmad Shaikh,Asset Management,2.66,USD,38341240,https://images.financialmodelingprep.com/symbol/ICMB.png,32204,5.78,0.04,61445,0,-4092469,"[{'period': '2024', 'revenue': 0.86068, 'unit': 'M', 'net_profit': -4.09}, {'period': '2023', 'revenue': 7.47, 'unit': 'M', 'net_profit': 3.23}, {'period': '2022', 'revenue': 0.07111, 'unit': 'M', 'net_profit': 2.59}, {'period': '2021', 'revenue': 3.18, 'unit': 'M', 'net_profit': -2.31}]","[{'period': ""Q2 '25"", 'revenue': 664.77, 'unit': 'K', 'net_profit': -564.54}, {'period': ""Q1 '25"", 'revenue': 4.67, 'unit': 'M', 'net_profit': 6.61}, {'period': ""Q4 '24"", 'revenue': 3.29, 'unit': 'M', 'net_profit': -1.95}, {'period': ""Q3 '24"", 'revenue': 0.34612000000000004, 'unit': 'M', 'net_profit': 2.41}, {'period': ""Q2 '24"", 'revenue': 0.37215, 'unit': 'M', 'net_profit': -2.87}, {'period': ""Q1 '24"", 'revenue': -0.60842, 'unit': 'M', 'net_profit': -1.68}]",-0.28,-0.28,192237745,7668215,158768,117227536,2147590,184569530,10321578,158768,37056525,1,-2.265254352832568,-2.272727272727273,"[0.12, 0.1812]","['2025-04-25', '2014-03-20']",__nan__,0.6098049891294761
157,ICON,Iconix Brand Group Inc. Common Stock,"Icon Energy Corp. operates as an international shipping company. The Company focuses on acquiring, owning, chartering, and operating dry bulk vessels, as well as offers sea-borne transportation services for dry bulk cargo, including iron ore, coal, grains and bauxite, steel, sugar, fertilizers, cement, and scrap metal.",Ms. Ismini Evangelia Panagiotidi,Industrials,2.27,USD,4960540,https://images.financialmodelingprep.com/symbol/ICON.png,377185,0.19,0.19,423203,2195000,1155000,"[{'period': '2023', 'revenue': 4.48, 'unit': 'M', 'net_profit': 1.16}, {'period': '2022', 'revenue': 7.24, 'unit': 'M', 'net_profit': 4.24}, {'period': '2021', 'revenue': 5.96, 'unit': 'M', 'net_profit': 3.32}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -101.92}]","[{'period': ""Q3 '24"", 'revenue': 863.0, 'unit': 'K', 'net_profit': -425.0}, {'period': ""Q4 '23"", 'revenue': 1230.0, 'unit': 'K', 'net_profit': 403.0}, {'period': ""Q3 '23"", 'revenue': 939.0, 'unit': 'K', 'net_profit': 64.0}, {'period': ""Q4 '22"", 'revenue': 1300.0, 'unit': 'K', 'net_profit': 453.0}, {'period': ""Q1 '21"", 'revenue': 23.63, 'unit': 'M', 'net_profit': 4.19}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -101.92}]",0.94,0.94,12882000,3022000,2702000,3713000,207000,0,3713000,2702000,2483000,-0.5846736045411542,-0.7277227722772277,-0.727536231884058,"[0.0021, 0.08]","['2024-12-16', '2024-09-13']",__nan__,0.2882316410495265
158,ICPT,Intercept Pharmaceuticals Inc. Common Stock,"Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid in adults. It is also developing Ocaliva for various indications, including nonalcoholic steatohepatitis; and other product candidates in various stages of clinical and preclinical development. The company has a license agreement with Aralez Pharmaceuticals Canada Inc. to develop and commercialize bezafibrate in the United States. It markets its products through an internal commercial organization and third-party distributors. The company was incorporated in 2002 and is headquartered in New York, New York.",Mr. Jerome B. Durso,Biotechnology,19,USD,794694000,https://images.financialmodelingprep.com/symbol/ICPT.png,2054565,-17.431192660550458,0.04,3906002,-61695000,115174000,"[{'period': '2022', 'revenue': 285.71, 'unit': 'M', 'net_profit': 115.17}, {'period': '2021', 'revenue': 363.47, 'unit': 'M', 'net_profit': -145.02}, {'period': '2020', 'revenue': 312.69, 'unit': 'M', 'net_profit': -324.23}, {'period': '2019', 'revenue': 252.0, 'unit': 'M', 'net_profit': -391.05}]","[{'period': ""Q3 '23"", 'revenue': 88.79, 'unit': 'M', 'net_profit': -2.79}, {'period': ""Q2 '23"", 'revenue': 83.72, 'unit': 'M', 'net_profit': -5.86}, {'period': ""Q1 '23"", 'revenue': 67.96, 'unit': 'M', 'net_profit': -29.57}, {'period': ""Q4 '22"", 'revenue': 77.22, 'unit': 'M', 'net_profit': -20.38}, {'period': ""Q3 '22"", 'revenue': 77.59, 'unit': 'M', 'net_profit': 173.51}, {'period': ""Q2 '22"", 'revenue': 71.76, 'unit': 'M', 'net_profit': -7.53}]",3.41,3.4,553711000,540127000,490909000,460634000,26862000,0,230077000,50517000,-27348000,-0.15094022834116858,1.7941829515521783,1.7494505494505495,__nan__,__nan__,__nan__,0.8319032852878125
159,ICUI,ICU Medical Inc. Common Stock,"ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. The company offers infusion pumps under the Plum 360 and LifeCare PCA brands; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; and related professional services. It also provides critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.",Mr. Vivek  Jain,Medical - Instruments & Supplies,151.04,USD,3717124608,https://images.financialmodelingprep.com/symbol/ICUI.png,269004,-31.27,17.07,426448,42964000,-117688000,"[{'period': '2024', 'revenue': 2380.0, 'unit': 'M', 'net_profit': -117.69}, {'period': '2023', 'revenue': 2260.0, 'unit': 'M', 'net_profit': -29.66}, {'period': '2022', 'revenue': 2280.0, 'unit': 'M', 'net_profit': -74.29}, {'period': '2021', 'revenue': 1320.0, 'unit': 'M', 'net_profit': 103.14}]","[{'period': ""Q4 '24"", 'revenue': 629.8, 'unit': 'M', 'net_profit': -23.83}, {'period': ""Q3 '24"", 'revenue': 589.13, 'unit': 'M', 'net_profit': -32.98}, {'period': ""Q2 '24"", 'revenue': 596.46, 'unit': 'M', 'net_profit': -21.41}, {'period': ""Q1 '24"", 'revenue': 565.96, 'unit': 'M', 'net_profit': -39.47}, {'period': ""Q4 '23"", 'revenue': 587.99, 'unit': 'M', 'net_profit': -17.15}, {'period': ""Q3 '23"", 'revenue': 553.31, 'unit': 'M', 'net_profit': 7.24}]",-4.83,-4.83,4203931000,1441983000,308566000,2238696000,202696000,0,556182000,308566000,124660000,-0.830317296071911,-2.968571910301804,-2.926829268292683,__nan__,__nan__,__nan__,0.5325244396256742
160,IDBA,IDEX Biometrics ASA American Depositary Shares,"IDEX Biometrics ASA engages in the design, development, and sale of fingerprint authentication solutions in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific regions. The company's fingerprint authentication solutions are used primarily in contactless financial payment, access control, and smart cards, as well as card-based devices for the storage of digital currencies. It primarily serves manufacturers of smart cards for financial payment applications and biometric payment card markets. IDEX Biometrics ASA was incorporated in 1996 and is headquartered in Oslo, Norway.",Mr. Vincent  Graziani,Software - Application,4.88,USD,90786544,https://images.financialmodelingprep.com/symbol/IDBA.png,1419,-2.0082304526748973,0.08,4535,-25901571,-26713127,"[{'period': '2023', 'revenue': 4.15, 'unit': 'M', 'net_profit': -26.71}, {'period': '2022', 'revenue': 4.09, 'unit': 'M', 'net_profit': -32.66}, {'period': '2021', 'revenue': 2.84, 'unit': 'M', 'net_profit': -32.55}, {'period': '2020', 'revenue': 1.09, 'unit': 'M', 'net_profit': -26.75}]","[{'period': ""Q3 '24"", 'revenue': 0.06126, 'unit': 'M', 'net_profit': 1.39}, {'period': ""Q2 '24"", 'revenue': 0.38629, 'unit': 'M', 'net_profit': -6.69}, {'period': ""Q1 '24"", 'revenue': 0.35631, 'unit': 'M', 'net_profit': -5.19}, {'period': ""Q4 '23"", 'revenue': 0.51034, 'unit': 'M', 'net_profit': -5.26}, {'period': ""Q3 '23"", 'revenue': 0.92331, 'unit': 'M', 'net_profit': -6.83}, {'period': ""Q2 '23"", 'revenue': 1.46, 'unit': 'M', 'net_profit': -7.44}]",-1.07,-1.07,25040861,20376170,11387863,13671054,982092,81225,12429143,11387863,-27334083,0.1343347147488386,0.18208429271279844,-6.133333333333334,__nan__,__nan__,__nan__,0.5459498377471925
161,IDCC,InterDigital Inc. Common Stock,"InterDigital, Inc., together with its subsidiaries, designs and develops technologies that enable and enhance wireless communications in the United States, China, South Korea, Japan, Taiwan, and Europe. It provides technology solutions for use in digital cellular and wireless products and networks, including 2G, 3G, 4G, 5G, and IEEE 802-related products and networks. The company develops cellular technologies, such as technologies related to CDMA, TDMA, OFDM/OFDMA, and MIMO for use in 2G, 3G, 4G, and 5G wireless networks, as well as mobile terminal devices; and 3GPP technology portfolio in 5G NR, beyond 5G (B5G), extended reality over wireless, and cellular Internet of Things (IoT) areas, as well as technologies for automobiles, wearables, smart homes, drones, and other connected consumer electronic products. It also provides video coding and transmission technologies; and engages in the research and development of artificial intelligence. The company's patented technologies are used in various products that include cellular phones, tablets, notebook computers, and wireless personal digital assistants; wireless infrastructure equipment, which comprise base stations; components, dongles, and modules for wireless devices; and IoT devices and software platforms. As of December 31, 2021, it had a portfolio of approximately 27,500 patents and patent applications related to wireless communications, video coding, display technology, and other areas. InterDigital, Inc. was incorporated in 1972 and is headquartered in Wilmington, Delaware.",Mr. Lawrence  Chen J.D.,Software - Application,207.07,USD,5318385880,https://images.financialmodelingprep.com/symbol/IDCC.png,398800,17.14,16.58,514275,544750000,358614000,"[{'period': '2024', 'revenue': 868.52, 'unit': 'M', 'net_profit': 358.61}, {'period': '2023', 'revenue': 549.59, 'unit': 'M', 'net_profit': 214.07}, {'period': '2022', 'revenue': 457.79, 'unit': 'M', 'net_profit': 93.69}, {'period': '2021', 'revenue': 425.41, 'unit': 'M', 'net_profit': 55.3}]","[{'period': ""Q4 '24"", 'revenue': 252.8, 'unit': 'M', 'net_profit': 133.11}, {'period': ""Q3 '24"", 'revenue': 128.68, 'unit': 'M', 'net_profit': 34.19}, {'period': ""Q2 '24"", 'revenue': 223.49, 'unit': 'M', 'net_profit': 109.66}, {'period': ""Q1 '24"", 'revenue': 263.54, 'unit': 'M', 'net_profit': 81.65}, {'period': ""Q4 '23"", 'revenue': 105.52, 'unit': 'M', 'net_profit': 39.09}, {'period': ""Q3 '23"", 'revenue': 140.11, 'unit': 'M', 'net_profit': 47.94}]",14.16,12.07,1835529000,1230822000,958208000,978314000,188302000,19851000,725810000,527360000,265679000,0.524974875356574,0.6752262121091798,0.7766624843161858,"[0.6, 0.1]","['2025-04-09', '2011-01-10']",__nan__,0.5329874929788633
162,IDEX,Ideanomics Inc. Common Stock,"Ideanomics, Inc. focuses on driving the adoption of commercial electric vehicles, associated energy consumption, and developing financial services and fintech products. Its Ideanomics Mobility division facilitates the adoption of electric vehicles by commercial fleet operators. This division also offers solutions for the procurement, financing, charging, and energy management needs for fleet operators of commercial electric vehicles. The company's Ideanomics Capital division provides fintech services, which focuses on the enhancement of efficiency, transparency, and profitability for the financial services industry. Ideanomics, Inc. was incorporated in 2004 and is headquartered in New York, New York.",Mr. Alfred P. Poor,Agricultural - Machinery,0.0021,USD,42143,https://images.financialmodelingprep.com/symbol/IDEX.png,57046,-0.00010199125789218067,-0.0029,15339,-188040000,-223829000,"[{'period': '2023', 'revenue': 15.46, 'unit': 'M', 'net_profit': -223.83}, {'period': '2022', 'revenue': 100.94, 'unit': 'M', 'net_profit': -267.1}, {'period': '2021', 'revenue': 114.08, 'unit': 'M', 'net_profit': -245.2}, {'period': '2020', 'revenue': 26.76, 'unit': 'M', 'net_profit': -118.52}]","[{'period': ""Q4 '23"", 'revenue': 3.82, 'unit': 'M', 'net_profit': -41.01}, {'period': ""Q3 '23"", 'revenue': 0.665, 'unit': 'M', 'net_profit': -63.01}, {'period': ""Q2 '23"", 'revenue': 8.18, 'unit': 'M', 'net_profit': -35.5}, {'period': ""Q1 '23"", 'revenue': 10.56, 'unit': 'M', 'net_profit': -84.32}, {'period': ""Q4 '22"", 'revenue': 17.07, 'unit': 'M', 'net_profit': -162.24}, {'period': ""Q3 '22"", 'revenue': 8.22, 'unit': 'M', 'net_profit': -37.41}]",-22.45,-22.45,116884000,32598999,1249000,137155000,1113000,0,117633000,1249000,-52657000,-0.24193409902978028,0.1619967203049068,0.6552518427518428,__nan__,__nan__,__nan__,1.1734283563190855
163,IDN,Intellicheck Inc. Common Stock,"Intellicheck, Inc., a technology company, develops, integrates, and markets threat identification and identity authentication solutions for bank and retail fraud prevention, law enforcement threat identification, and mobile and handheld access control and security systems primarily in the United States. It provides identity systems products, including commercial identification products, such as Intellicheck Platform, an identity solution that checks whether an ID is valid, matches the ID to the person presenting it, and provides a risk score to determine the risk of doing business with that person; IDN-Portal that provides the ability to scan an ID using a mobile phone; IDN-Portal+ that uses a retail scanner to validate an ID, and get additional data for analytics and analysis; IDN-Direct that provides access to additional data and the ability to use the platform's Risk Score capability to help with decision-making; and Intellicheck mobile app, which provides the ability to login and scan an ID. The company also offers State Aware Software solution, which provides or restricts information that is electronically scanned from an ID based on the electronic reading laws according to the state in which the ID is scanned; data collection devices that enable its software applications to be used on a variety of commercially available credit card terminals, PDAs, tablets, laptops, desktops, mobile phones, and point-of-sale terminals; and instant credit application kiosk software applications. It serves government, military, and commercial markets. The company was formerly known as Intellicheck Mobilisa, Inc. and changed its name to Intellicheck, Inc. in May 2017. Intellicheck, Inc. was incorporated in 1994 and is headquartered in Melville, New York.",Mr. Bryan  Lewis,Software - Application,2.55,USD,50530800,https://images.financialmodelingprep.com/symbol/IDN.png,69601,-51,0.28,121967,-732000,-918000,"[{'period': '2024', 'revenue': 20000.0, 'unit': 'K', 'net_profit': -918.0}, {'period': '2023', 'revenue': 18.91, 'unit': 'M', 'net_profit': -1.98}, {'period': '2022', 'revenue': 15.97, 'unit': 'M', 'net_profit': -3.85}, {'period': '2021', 'revenue': 16.39, 'unit': 'M', 'net_profit': -4.13}]","[{'period': ""Q4 '24"", 'revenue': 5940.0, 'unit': 'K', 'net_profit': 488.0}, {'period': ""Q3 '24"", 'revenue': 4710.0, 'unit': 'K', 'net_profit': -837.0}, {'period': ""Q2 '24"", 'revenue': 4670.0, 'unit': 'K', 'net_profit': -127.0}, {'period': ""Q1 '24"", 'revenue': 4680.0, 'unit': 'K', 'net_profit': -442.0}, {'period': ""Q4 '23"", 'revenue': 5180.0, 'unit': 'K', 'net_profit': 757.0}, {'period': ""Q3 '23"", 'revenue': 4760.0, 'unit': 'K', 'net_profit': -644.0}]",-0.0475,-0.0475,20933000,9912000,4666000,3186000,4675000,0,3186000,4666000,-2751000,0.6328986960882648,0.5363636363636364,0.525,__nan__,__nan__,__nan__,0.15219987579420055
164,IDRA,Idera Pharmaceuticals Inc. Common Stock,"Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating solid tumors, squamous cell carcinoma of the head and neck, and colorectal cancer. The company has a collaboration agreement with Bristol-Meyers Squibb. Idera Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Exton, Pennsylvania.",Mr. Vincent J. Milano,Biotechnology,0.425,USD,0,https://images.financialmodelingprep.com/symbol/IDRA.png,34017,0,-0.1272,371878,-27818000,-23360000,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -23.36}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 98.08}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -112.66}, {'period': '2019', 'revenue': 1.45, 'unit': 'M', 'net_profit': -56.52}]","[{'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.87}, {'period': ""Q4 '22"", 'revenue': -0.049, 'unit': 'M', 'net_profit': -10.73}, {'period': ""Q3 '22"", 'revenue': 0.049, 'unit': 'M', 'net_profit': -3.1}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.35}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.18}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.12}]",-7.18,-7.18,101107000,17863000,12044000,62173000,4208000,0,21423000,12044000,-24495000,-1.2835099877700775,-1.238163207047021,-1.1456389452332658,__nan__,__nan__,__nan__,0.6149228045535917
165,IDXX,IDEXX Laboratories Inc. Common Stock,"IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.",Mr. Jonathan J. Mazelsky,Medical - Diagnostics & Research,397.1,USD,32180586900,https://images.financialmodelingprep.com/symbol/IDXX.png,808452,37.15,36.06,2186898,1270972000,887867000,"[{'period': '2024', 'revenue': 3900.0, 'unit': 'M', 'net_profit': 887.87}, {'period': '2023', 'revenue': 3660.0, 'unit': 'M', 'net_profit': 845.04}, {'period': '2022', 'revenue': 3370.0, 'unit': 'M', 'net_profit': 679.09}, {'period': '2021', 'revenue': 3220.0, 'unit': 'M', 'net_profit': 744.85}]","[{'period': ""Q4 '24"", 'revenue': 954.29, 'unit': 'M', 'net_profit': 216.15}, {'period': ""Q3 '24"", 'revenue': 975.54, 'unit': 'M', 'net_profit': 232.84}, {'period': ""Q2 '24"", 'revenue': 1000.0, 'unit': 'M', 'net_profit': 203.3}, {'period': ""Q1 '24"", 'revenue': 964.1, 'unit': 'M', 'net_profit': 235.58}, {'period': ""Q4 '23"", 'revenue': 901.6, 'unit': 'M', 'net_profit': 194.52}, {'period': ""Q3 '23"", 'revenue': 915.53, 'unit': 'M', 'net_profit': 212.23}]",10.77,10.67,3293443000,1399897000,288266000,1698130000,561316000,57718000,1067916000,288266000,798079000,0.04377805061326391,0.05067795446853529,0.05899705014749259,__nan__,__nan__,__nan__,0.5156093486360627
166,IDYA,IDEAYA Biosciences Inc. Common Stock,"IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinical trial for patients with solid tumors having methylthioadenosine phosphorylase deletions; and IDE196, a protein kinase C inhibitor that is in Phase I/II clinical trial for genetically defined cancers having GNAQ or GNA11 gene mutations. Its preclinical pipeline includes various synthetic lethality programs targeting PARG inhibitor in tumors for patients having tumors with a defined biomarker based on genetic mutations and/or molecular signatures; Pol Theta inhibitors in tumors with BRCA or other homologous recombination deficiency mutations; and WRN inhibitors in tumors with high microsatellite instability. The company has a research collaboration agreement with Cancer Research UK and the University of Manchester to develop small molecule inhibitors of Poly (ADP-ribose) glycohydrolase; and a clinical trial collaboration and supply agreement with Pfizer Inc. for Phase I/II study in metastatic uveal melanoma, skin melanoma, and other solid tumors, as well as a strategic partnership with GlaxoSmithKline plc. IDEAYA Biosciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.",Mr. Yujiro S. Hata,Biotechnology,15.78,USD,1381340172,https://images.financialmodelingprep.com/symbol/IDYA.png,1073588,-4.7,1.28,3276548,-326975000,-274477000,"[{'period': '2024', 'revenue': 7.0, 'unit': 'M', 'net_profit': -274.48}, {'period': '2023', 'revenue': 23.39, 'unit': 'M', 'net_profit': -112.96}, {'period': '2022', 'revenue': 50.93, 'unit': 'M', 'net_profit': -54.81}, {'period': '2021', 'revenue': 27.94, 'unit': 'M', 'net_profit': -47.53}]","[{'period': ""Q4 '24"", 'revenue': 7.0, 'unit': 'M', 'net_profit': -130.31}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -51.82}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -52.77}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -39.57}, {'period': ""Q4 '23"", 'revenue': 3.92, 'unit': 'M', 'net_profit': -33.95}, {'period': ""Q3 '23"", 'revenue': 8.04, 'unit': 'M', 'net_profit': -27.44}]",-3.36,-3.36,1124091000,689713000,676319000,64944000,3000,0,46071000,84378000,-251441000,-1.5070732474064759,-1.4298386168677686,-0.7142857142857143,__nan__,__nan__,__nan__,0.05777468194300995
167,IEA,Infrastructure and Energy Alternatives Inc. Common Stock,"Infrastructure and Energy Alternatives, Inc., through its subsidiaries, operates as a diversified infrastructure construction company in the United States. The company engages in providing engineering, procurement, and construction (EPC) services for the renewable energy, traditional power, and civil infrastructure industries. It operates in two segments, Renewables and Specialty Civil. The Renewables segment provides a range of services, including full EPC project delivery, design, site development, construction, installation, and maintenance of infrastructure services for the wind and solar industries. The Specialty Civil segment offers a range of services that comprise environmental remediation services, such as site development, environmental site closure, and outsourced contract mining and coal ash management services; rail infrastructure services, including planning, design, procurement, construction, and maintenance of infrastructure projects for railway and intermodal facilities; and heavy civil construction services consisting of road and bridge construction, specialty paving, and industrial maintenance, as well as other local, state, and government projects. The company was founded in 1947 and is headquartered in Indianapolis, Indiana. As of October 7, 2022, Infrastructure and Energy Alternatives, Inc. operates as a subsidiary of MasTec, Inc..",Mr. John Roehm,Engineering & Construction,13.72,USD,0,https://images.financialmodelingprep.com/symbol/IEA.png,0,-5.973008271658685,-0.06,5101286,19246000,-83729000,"[{'period': '2021', 'revenue': 2080.0, 'unit': 'M', 'net_profit': -83.73}, {'period': '2020', 'revenue': 1750000.0, 'unit': 'K', 'net_profit': 728.0}, {'period': '2019', 'revenue': 1460.0, 'unit': 'M', 'net_profit': 6.23}, {'period': '2018', 'revenue': 779.34, 'unit': 'M', 'net_profit': 4.24}]","[{'period': ""Q2 '22"", 'revenue': 680.6, 'unit': 'M', 'net_profit': 16.97}, {'period': ""Q1 '22"", 'revenue': 360.1, 'unit': 'M', 'net_profit': -27.07}, {'period': ""Q4 '21"", 'revenue': 544.1, 'unit': 'M', 'net_profit': 31.66}, {'period': ""Q3 '21"", 'revenue': 697.76, 'unit': 'M', 'net_profit': -99.65}, {'period': ""Q2 '21"", 'revenue': 560.15, 'unit': 'M', 'net_profit': 4.7}, {'period': ""Q1 '21"", 'revenue': 276.41, 'unit': 'M', 'net_profit': -20.43}]",-2.2,-2.2,899753000,661799000,124027000,862496000,494998000,-8199000,490976000,124027000,-41032000,-0.8431190342275369,-116.01236263736264,-63.85714285714286,__nan__,__nan__,__nan__,0.9585919691293054
168,IEAWW,Infrastructure and Energy Alternatives Inc. Warrant,,None,,1.65,USD,0,https://images.financialmodelingprep.com/symbol/IEAWW.png,0,0,-0.13,149995,19246000,-83729000,"[{'period': '2021', 'revenue': 2080.0, 'unit': 'M', 'net_profit': -83.73}, {'period': '2020', 'revenue': 1750000.0, 'unit': 'K', 'net_profit': 728.0}, {'period': '2019', 'revenue': 1460.0, 'unit': 'M', 'net_profit': 6.23}, {'period': '2018', 'revenue': 779.34, 'unit': 'M', 'net_profit': 4.24}]","[{'period': ""Q2 '22"", 'revenue': 680.6, 'unit': 'M', 'net_profit': 16.97}, {'period': ""Q1 '22"", 'revenue': 360.1, 'unit': 'M', 'net_profit': -27.07}, {'period': ""Q4 '21"", 'revenue': 544.1, 'unit': 'M', 'net_profit': 31.66}, {'period': ""Q3 '21"", 'revenue': 697.76, 'unit': 'M', 'net_profit': -99.65}, {'period': ""Q2 '21"", 'revenue': 560.15, 'unit': 'M', 'net_profit': 4.7}, {'period': ""Q1 '21"", 'revenue': 276.41, 'unit': 'M', 'net_profit': -20.43}]",-2.2,-2.2,899753000,661799000,124027000,862496000,494998000,-8199000,490976000,124027000,-41032000,-0.8431190342275369,-116.01236263736264,-63.85714285714286,__nan__,__nan__,__nan__,0.9585919691293054
169,IEC,IEC Electronics Corp. Common Stock,,,,,,,,,,,,13466000,6753000,"[{'period': '2020', 'revenue': 182.71, 'unit': 'M', 'net_profit': 6.75}, {'period': '2019', 'revenue': 156.98, 'unit': 'M', 'net_profit': 4.75}, {'period': '2018', 'revenue': 116.92, 'unit': 'M', 'net_profit': 10.41}, {'period': '2017', 'revenue': 96450.0, 'unit': 'K', 'net_profit': 81.0}]","[{'period': ""Q2 '21"", 'revenue': 49.37, 'unit': 'M', 'net_profit': 1.03}, {'period': ""Q1 '21"", 'revenue': 45360.0, 'unit': 'K', 'net_profit': -348.0}, {'period': ""Q4 '20"", 'revenue': 47.48, 'unit': 'M', 'net_profit': 1.54}, {'period': ""Q3 '20"", 'revenue': 46.45, 'unit': 'M', 'net_profit': 1.93}, {'period': ""Q2 '20"", 'revenue': 47.36, 'unit': 'M', 'net_profit': 2.11}, {'period': ""Q1 '20"", 'revenue': 44.17, 'unit': 'M', 'net_profit': 1.52}]",0.63,0.63,122964000,92577000,312000,83809000,39134000,0,54129000,312000,8752000,0.2948076923076923,0.4225826838002949,0.39999999999999997,__nan__,__nan__,__nan__,0.6815734686574932
170,IEP,Icahn Enterprises L.P. Common Stock,"Icahn Enterprises L.P., through its subsidiaries, operates in investment, energy, automotive, food packaging, real estate, home fashion, and pharma businesses in the United States and Internationally. Its Investment segment invests its proprietary capital through various private investment funds. The company's Energy segment refines and markets transportation fuels; and produces and markets nitrogen fertilizers in the form of urea ammonium nitrate and ammonia. Its Automotive segment is involved in the retail and wholesale distribution of automotive parts; and offers automotive repair and maintenance services. The company's Food Packaging segment produces and sells cellulosic, fibrous, and plastic casings that are used for preparing processed meat products. Its Real Estate segment is involved in the rental of retail, office, and industrial properties; construction and sale of single-family homes and residential units; and golf and club operations. This segment also engages in hotel and timeshare resort operations. The company's Home Fashion segment manufactures, sources, markets, distributes, and sells home fashion consumer products. Its Pharma segment offers pharmaceutical products and services. The company was incorporated in 1987 and is headquartered in Sunny Isles Beach, Florida.",Mr. Andrew  Teno,Conglomerates,8.43,USD,4406664480,https://images.financialmodelingprep.com/symbol/IEP.png,762968,-8.97,0.625,1078929,467000000,-445000000,"[{'period': '2024', 'revenue': 9900.0, 'unit': 'M', 'net_profit': -445.0}, {'period': '2023', 'revenue': 11850.0, 'unit': 'M', 'net_profit': -684.0}, {'period': '2022', 'revenue': 14130.0, 'unit': 'M', 'net_profit': -25.0}, {'period': '2021', 'revenue': 10940.0, 'unit': 'M', 'net_profit': -500.0}]","[{'period': ""Q4 '24"", 'revenue': 2510.0, 'unit': 'M', 'net_profit': -98.0}, {'period': ""Q3 '24"", 'revenue': 2220.0, 'unit': 'M', 'net_profit': 54.0}, {'period': ""Q2 '24"", 'revenue': 2640.0, 'unit': 'M', 'net_profit': -325.0}, {'period': ""Q1 '24"", 'revenue': 2240.0, 'unit': 'M', 'net_profit': -37.0}, {'period': ""Q4 '23"", 'revenue': 2960.0, 'unit': 'M', 'net_profit': -136.0}, {'period': ""Q3 '23"", 'revenue': 2990.0, 'unit': 'M', 'net_profit': 162.0}]",-0.95,-0.95,16279000000,10581000000,4913000000,11658000000,2110000000,-998000000,2420000000,2603000000,552000000,2.1133333333333333,0.34941520467836257,0.4571428571428572,"[0.5, 0.48623]","['2025-03-10', '1988-03-25']",__nan__,0.716137354874378
171,IESC,IES Holdings Inc. Common Stock,"IES Holdings, Inc. designs and installs integrated electrical and technology systems, and provides infrastructure products and services in the United States. Its Commercial & Industrial segment offers electrical and mechanical design, construction, and maintenance services for office buildings, manufacturing facilities, data centers, chemical plants, refineries, wind farms, solar facilities, municipal infrastructures, and health care facilities. Its Communications segment designs, installs, and maintains network infrastructure within data centers for co-location and managed hosting customers; corporate, educational, financial, hospitality, and healthcare buildings; e-commerce distribution centers; and high-tech manufacturing facilities. This segment also provides design and installation services for audio/visual, telephone, fire, and wireless access and intrusion alarm systems; and engages in designing/building, servicing, and maintaining data network systems. Its Infrastructure Solutions segment maintains and repairs alternating and direct current electric motors and generators, and power generating and distribution equipment; manufactures custom-engineered metal enclosed bus duct solutions used in power distribution; manufactures custom commercial and industrial generator enclosures; manufactures, re-manufactures, and repairs industrial lifting magnets; and maintains and repairs railroad main and auxiliary generators, main alternators, and traction motors. Its Residential segment offers electrical installations to single-family housing and multi-family apartments; and cable television installations to residential and light commercial applications, as well as installs residential solar power for new construction and existing residences. The company was formerly known as Integrated Electrical Services, Inc. and changed its name to IES Holdings, Inc. in May 2016. The company was incorporated in 1997 and is headquartered in Houston, Texas.",Mr. Jeffrey Lund Gendell,Engineering & Construction,189.67,USD,3794651822,https://images.financialmodelingprep.com/symbol/IESC.png,231680,17.68,24.55,323446,337009000,219116000,"[{'period': '2024', 'revenue': 2880.0, 'unit': 'M', 'net_profit': 219.12}, {'period': '2023', 'revenue': 2380.0, 'unit': 'M', 'net_profit': 108.29}, {'period': '2022', 'revenue': 2170.0, 'unit': 'M', 'net_profit': 34.76}, {'period': '2021', 'revenue': 1540.0, 'unit': 'M', 'net_profit': 66.66}]","[{'period': ""Q1 '25"", 'revenue': 749.55, 'unit': 'M', 'net_profit': 57.68}, {'period': ""Q4 '24"", 'revenue': 775.77, 'unit': 'M', 'net_profit': 63.15}, {'period': ""Q3 '24"", 'revenue': 768.41, 'unit': 'M', 'net_profit': 62.1}, {'period': ""Q2 '24"", 'revenue': 705.73, 'unit': 'M', 'net_profit': 52.91}, {'period': ""Q1 '24"", 'revenue': 634.44, 'unit': 'M', 'net_profit': 40.96}, {'period': ""Q4 '23"", 'revenue': 649.02, 'unit': 'M', 'net_profit': 37.79}]",10.02,9.89,1244026000,871694000,135835000,591917000,619765000,0,522554000,100832000,189245000,0.8835631368033937,1.0234559692671394,1.187772925764192,__nan__,__nan__,__nan__,0.47580757958434955
172,IFBD,Infobird Co. Ltd Ordinary Shares,"Infobird Co., Ltd, through its subsidiaries, operates as a software-as-a-service (SaaS) provider of artificial intelligence (AI) enabled customer engagement solutions in the People's Republic of China. It offers customer relationship management cloud-based services, such as SaaS and business process outsourcing services to its clients. The company also provides AI-powered cloud-based sales force management software, including intelligent quality inspection and intelligent training software to enable its clients to monitor, benchmark, and enhance the performances of agents; consumer product and retail store digitalization solutions; and other services, including software license selling, data analysis, and other professional services. It serves corporate clients in the finance, education, public services, healthcare, and consumer products industries. The company was incorporated in 2020 and is based in Beijing, the People's Republic of China.",Ms. Cheuk Yee  Li,Software - Application,1.43,USD,2841367,https://images.financialmodelingprep.com/symbol/IFBD.png,21116,-0.06,0.03,13549,-20701841,-2576531,"[{'period': '2023', 'revenue': 0.28, 'unit': 'M', 'net_profit': -2.58}, {'period': '2022', 'revenue': 5.51, 'unit': 'M', 'net_profit': -15.27}, {'period': '2021', 'revenue': 9.64, 'unit': 'M', 'net_profit': -13.87}, {'period': '2020', 'revenue': 14.53, 'unit': 'M', 'net_profit': 4.0}]","[{'period': ""Q2 '24"", 'revenue': 20.0, 'unit': 'K', 'net_profit': -811.95}, {'period': ""Q4 '23"", 'revenue': 0.28, 'unit': 'M', 'net_profit': 2.01}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.58}, {'period': ""Q4 '22"", 'revenue': 2.93, 'unit': 'M', 'net_profit': -7.52}, {'period': ""Q2 '22"", 'revenue': 2.58, 'unit': 'M', 'net_profit': -7.75}, {'period': ""Q4 '21"", 'revenue': 5.16, 'unit': 'M', 'net_profit': -7.95}]",-6.55,-6.55,57655499,5467737,52659,62997,5404514,0,62997,52659,-2719961,-65.8484902303323,0.8312350465668421,0.506405425772419,__nan__,__nan__,__nan__,0.0010926451265299082
173,IFMK,iFresh Inc. Common Stock,"iFresh Inc., through its subsidiaries, operates a network of grocery supermarket chains in the north-eastern United States. It operates through Wholesale and Retail segments. The company provides vegetables, seafood, meat, fruits, snacks, seasonings, and spices, such as peanut oil, cooking wine, vinegar, dark soy sauce, black bean sauce, pepper oil, and chilly oil; tea, condiments, canned goods, flour products, marine food products, candies groceries, traditional Chinese medicine, health products, and dried food; rice and rice products; assortment of noodles, frozen vegetables, frozen dumplings, frozen seafood products, and aquatic products; and cooking utensils. Its brand portfolio includes Family Elephant, Feiyan, Green Acre, Golden Smell, Redolent, and I FRESH. The company also distributes its products to wholesale stores, retail supermarkets, and restaurants. As of August 10, 2020, it operated nine retail supermarkets and two in-house wholesale businesses. The company offers its products through online sales channels and delivery network in suburban areas. iFresh Inc. was founded in 1995 and is headquartered in Long Island City, New York.",Ms. Ping  Zhou,Grocery Stores,0.0001,USD,9627,https://images.financialmodelingprep.com/symbol/IFMK.png,375,,3.0000000015651188e-12,100,-5771218,-8286854,"[{'period': '2020', 'revenue': 89.45, 'unit': 'M', 'net_profit': -8.29}, {'period': '2019', 'revenue': 125.43, 'unit': 'M', 'net_profit': -12.0}, {'period': '2018', 'revenue': 136690.0, 'unit': 'K', 'net_profit': -791.29}, {'period': '2017', 'revenue': 130.88, 'unit': 'M', 'net_profit': 1.55}]","[{'period': ""Q3 '21"", 'revenue': 25.63, 'unit': 'M', 'net_profit': 2.31}, {'period': ""Q2 '21"", 'revenue': 24.22, 'unit': 'M', 'net_profit': -3.19}, {'period': ""Q1 '21"", 'revenue': 21530.0, 'unit': 'K', 'net_profit': 912.96}, {'period': ""Q4 '20"", 'revenue': 22.87, 'unit': 'M', 'net_profit': -1.96}, {'period': ""Q3 '20"", 'revenue': 20.89, 'unit': 'M', 'net_profit': -2.07}, {'period': ""Q2 '20"", 'revenue': 21860.0, 'unit': 'K', 'net_profit': -886.72}]",-0.45,-0.45,99259161,14034375,751942,101809308,3405341,5060370,42672307,751942,-3690284,0.2775804026019642,0.3096269128782467,0.43037974683544306,__nan__,__nan__,__nan__,1.0256918049105814
174,IFRX,InflaRx N.V. Common Stock,"InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody, which completed the Phase III clinical trial for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; for the treatment of anti-neutrophil cytoplasm antibody associated vasculitis, a rare and life-threatening autoimmune disease that is in Phase II trial; to treat pyoderma gangraenosum, a chronic inflammatory skin disorder that is in Phase IIa exploratory study; and for the treatment of PD-1/PD-L1 inhibitor resistant/refractory locally advanced or metastatic cutaneous squamous cell carcinoma that is in Phase II clinical development stage. The company also develops INF904, an oral, small molecule drug candidate for the undisclosed chronic inflammatory and autoimmune diseases; and IFX002 that is in pre-clinical development stage for the treatment of chronic inflammation and autoimmune diseases. It has co-development agreement with Beijing Defengrei Biotechnology Co. Ltd.; and clinical trial collaboration and supply agreement with Merck & Co. Inc. The company was formerly known as Fireman B.V. and changed its name to InflaRx N.V. in 2017. InflaRx N.V. was founded in 2007 and is headquartered in Jena, Germany.","Dr. Niels C. Riedemann M.D., Ph.D.",Biotechnology,0.9289,USD,62360122,https://images.financialmodelingprep.com/symbol/IFRX.png,403360,-1.08,-0.007,839968,-45553417,-46064402,"[{'period': '2024', 'revenue': 0.16579, 'unit': 'M', 'net_profit': -46.06}, {'period': '2023', 'revenue': 0.06309000000000001, 'unit': 'M', 'net_profit': -42.67}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -27.04}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -45.65}]","[{'period': ""Q4 '24"", 'revenue': -0.000423, 'unit': 'M', 'net_profit': -5.11}, {'period': ""Q3 '24"", 'revenue': 0.12382, 'unit': 'M', 'net_profit': -17.45}, {'period': ""Q2 '24"", 'revenue': 0.00636, 'unit': 'M', 'net_profit': -13.85}, {'period': ""Q1 '24"", 'revenue': 0.03625, 'unit': 'M', 'net_profit': -9.71}, {'period': ""Q4 '23"", 'revenue': 0.00223, 'unit': 'M', 'net_profit': -15.52}, {'period': ""Q3 '23"", 'revenue': 0.0608, 'unit': 'M', 'net_profit': -7.45}]",-0.78,-0.78,76018457,71656505,52838332,14602418,1735335,3092290,14166475,18375980,-48603561,-0.08295183441489244,-0.07961260189217895,0,__nan__,__nan__,__nan__,0.19209042877573798
175,IGAC,IG Acquisition Corp. Class A Common Stock,"IG Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.",Mr. Christian  Goode,Shell Companies,10.12,USD,101562296,https://images.financialmodelingprep.com/symbol/IGAC.png,10035,-140.55555555555554,0.005,5100,17388275,37601337,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 37.6}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -297.33}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 981.78}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.55}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 21.77}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -765.08}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.73}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.1}]",1,1,300153160,128145,88770,30647835,0,0,1747835,88770,-1284501,59.481991208332914,127.46458949237709,127.58227848101265,__nan__,__nan__,__nan__,0.10210732080914957
176,IGACU,IG Acquisition Corp. Unit,"IG Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.",Mr. Christian  Goode,Shell Companies,10.1104,USD,0,https://images.financialmodelingprep.com/symbol/IGACU.png,1106,0,-0.0196,1172,17388275,37601337,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 37.6}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -297.33}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 981.78}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.55}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 21.77}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -765.08}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.73}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.1}]",1,1,300153160,128145,88770,30647835,0,0,1747835,88770,-1284501,59.481991208332914,127.46458949237709,127.58227848101265,__nan__,__nan__,__nan__,0.10210732080914957
177,IGACW,IG Acquisition Corp. Warrant,,,Shell Companies,0.0018,USD,0,https://images.financialmodelingprep.com/symbol/IGACW.png,0,0,0,390448,17388275,37601337,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 37.6}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -297.33}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 981.78}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.55}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 21.77}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -765.08}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.73}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.1}]",1,1,300153160,128145,88770,30647835,0,0,1747835,88770,-1284501,59.481991208332914,127.46458949237709,127.58227848101265,__nan__,__nan__,__nan__,0.10210732080914957
178,IGIC,International General Insurance Holdings Ltd. Ordinary Share,"International General Insurance Holdings Ltd. provides specialty insurance and reinsurance solutions worldwide. The company operates through three segments: Specialty Long-tail, Specialty Short-tail, and Reinsurance. It underwrites a diversified portfolio of specialty risks, including energy, property, construction and engineering, ports and terminals, general aviation, political violence, casualty, financial institutions, marine, contingency, and treaty reinsurance. The company was founded in 2001 and is based in Amman, Jordan.",Mr. Waleed Wasef Jabsheh,Insurance - Diversified,23.5,USD,1060059150,https://images.financialmodelingprep.com/symbol/IGIC.png,99595,7.89,1.07,183756,0,135200000,"[{'period': '2024', 'revenue': 539.0, 'unit': 'M', 'net_profit': 135.2}, {'period': '2023', 'revenue': 471.96, 'unit': 'M', 'net_profit': 118.19}, {'period': '2022', 'revenue': 386.6, 'unit': 'M', 'net_profit': 89.23}, {'period': '2021', 'revenue': 357.1, 'unit': 'M', 'net_profit': 46.81}]","[{'period': ""Q4 '24"", 'revenue': 135.2, 'unit': 'M', 'net_profit': 30.1}, {'period': ""Q3 '24"", 'revenue': 136.3, 'unit': 'M', 'net_profit': 34.5}, {'period': ""Q2 '24"", 'revenue': 134.8, 'unit': 'M', 'net_profit': 32.8}, {'period': ""Q1 '24"", 'revenue': 127.9, 'unit': 'M', 'net_profit': 37.9}, {'period': ""Q4 '23"", 'revenue': 122.5, 'unit': 'M', 'net_profit': 32.99}, {'period': ""Q3 '23"", 'revenue': 95.3, 'unit': 'M', 'net_profit': 10.9}]",2.94,2.98,2037600000,380580000,380580000,1382800000,0,911457000,90049000,155245000,202842000,0,0.14388209215357803,0.13953488372093018,"[0.875, 0.09]","['2025-04-04', '2020-08-21']",__nan__,0.6786415390655673
179,IGICW,International General Insurance Holdings Ltd. Warrants expiring 03/17/2025,,None,Insurance - Diversified,1.05,USD,0,https://images.financialmodelingprep.com/symbol/IGICW.png,0,0,-0.07,12303,0,135200000,"[{'period': '2024', 'revenue': 539.0, 'unit': 'M', 'net_profit': 135.2}, {'period': '2023', 'revenue': 471.96, 'unit': 'M', 'net_profit': 118.19}, {'period': '2022', 'revenue': 386.6, 'unit': 'M', 'net_profit': 89.23}, {'period': '2021', 'revenue': 357.1, 'unit': 'M', 'net_profit': 46.81}]","[{'period': ""Q4 '24"", 'revenue': 135.2, 'unit': 'M', 'net_profit': 30.1}, {'period': ""Q3 '24"", 'revenue': 136.3, 'unit': 'M', 'net_profit': 34.5}, {'period': ""Q2 '24"", 'revenue': 134.8, 'unit': 'M', 'net_profit': 32.8}, {'period': ""Q1 '24"", 'revenue': 127.9, 'unit': 'M', 'net_profit': 37.9}, {'period': ""Q4 '23"", 'revenue': 122.5, 'unit': 'M', 'net_profit': 32.99}, {'period': ""Q3 '23"", 'revenue': 95.3, 'unit': 'M', 'net_profit': 10.9}]",2.94,2.98,2037600000,380580000,380580000,1382800000,0,911457000,90049000,155245000,202842000,0,0.14388209215357803,0.13953488372093018,__nan__,__nan__,__nan__,0.6786415390655673
180,IGMS,IGM Biosciences Inc. Common Stock,"IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non-Hodgkin's lymphoma (NHL). It is also developing IGM-8444, an IgM antibody, which is in Phase 1 clinical trials for the treatment of patients with solid cancers; and IGM-7354, an anti-PD-L1 IgM antibody for the treatment of patients with solid and hematologic malignancies; IGM-2644, a bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins for the treatment of patients with multiple myeloma; and IGM-2537, a bispecific T cell engaging IgM antibody targeting CD123 and CD3 proteins for the treatment of patients with acute myeloid leukemia, myelodysplastic syndromes, and acute lymphoblastic leukemia. It has a collaboration and license agreement with Genzyme Corporation to generate, develop, manufacture, and commercialize IgM antibodies. The company was formerly known as Palingen, Inc. and changed its name to IGM Biosciences, Inc. in 2010. IGM Biosciences, Inc. was incorporated in 1993 and is headquartered in Mountain View, California.",Ms. Mary Beth Harler M.D.,Biotechnology,1.06,USD,63361921,https://images.financialmodelingprep.com/symbol/IGMS.png,355234,-0.33,0.04,255752,-208580000,-195795000,"[{'period': '2024', 'revenue': 2.68, 'unit': 'M', 'net_profit': -195.79}, {'period': '2023', 'revenue': 2.13, 'unit': 'M', 'net_profit': -246.42}, {'period': '2022', 'revenue': 1.07, 'unit': 'M', 'net_profit': -214.25}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -160.68}]","[{'period': ""Q4 '24"", 'revenue': 0.41200000000000003, 'unit': 'M', 'net_profit': -36.65}, {'period': ""Q3 '24"", 'revenue': 0.516, 'unit': 'M', 'net_profit': -61.43}, {'period': ""Q2 '24"", 'revenue': 1.25, 'unit': 'M', 'net_profit': -47.9}, {'period': ""Q1 '24"", 'revenue': 0.497, 'unit': 'M', 'net_profit': -49.82}, {'period': ""Q4 '23"", 'revenue': 0.651, 'unit': 'M', 'net_profit': -60.7}, {'period': ""Q3 '23"", 'revenue': 0.509, 'unit': 'M', 'net_profit': -61.99}]",-3.24,-3.24,265712000,193620000,183787000,217540000,0,0,37638000,26495000,-158848000,0.17673805445259277,0.2054290305824297,0.3121019108280254,__nan__,__nan__,__nan__,0.8187059673631601
181,IGNY,Ignyte Acquisition Corp. Common Stock,"Ignyte Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company intends to focus on target businesses in the life sciences, biotechnology, and healthcare sectors. Ignyte Acquisition Corp. was incorporated in 2020 and is based in New York, New York.",Mr. David Ira Rosenberg,Shell Companies,13.05,USD,261763425,https://images.financialmodelingprep.com/symbol/IGNY.png,23970,52.2,1.66,164801,-11847848,-13236717,"[{'period': '2022', 'revenue': 0.60768, 'unit': 'M', 'net_profit': -13.24}, {'period': '2021', 'revenue': 0.0, 'unit': 'K', 'net_profit': -6.69}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.94}, {'period': ""Q1 '23"", 'revenue': 0.01385, 'unit': 'M', 'net_profit': -6.38}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -154.84}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 154.29}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.63}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.2}]",-0.75,-0.75,7529712,3230793,654892,15624189,0,0,10801121,654892,-7627874,-24278923.32001541,-1978582510.2107623,-832.3333333333334,__nan__,__nan__,__nan__,2.075004860743678
182,IGNYU,Ignyte Acquisition Corp. Unit,"As of November 1, 2022, Ignyte Acquisition Corp. was acquired by Peak Bio Co., Ltd., in a reverse merger transaction. Ignyte Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company intends to focus on target businesses in the life sciences, biotechnology, and healthcare sectors. Ignyte Acquisition Corp. was incorporated in 2020 and is based in New York, New York.",,Shell Companies,12.96,USD,0,https://images.financialmodelingprep.com/symbol/IGNYU.png,1111,209.03225806451613,1.46,6697,-11847848,-13236717,"[{'period': '2022', 'revenue': 0.60768, 'unit': 'M', 'net_profit': -13.24}, {'period': '2021', 'revenue': 0.0, 'unit': 'K', 'net_profit': -6.69}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.94}, {'period': ""Q1 '23"", 'revenue': 0.01385, 'unit': 'M', 'net_profit': -6.38}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -154.84}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 154.29}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.63}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.2}]",-0.75,-0.75,7529712,3230793,654892,15624189,0,0,10801121,654892,-7627874,-24278923.32001541,-1978582510.2107623,-832.3333333333334,__nan__,__nan__,__nan__,2.075004860743678
183,IGNYW,Ignyte Acquisition Corp. Warrant,"Ignyte Acquisition Corp. intends enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. The company was founded in 2020 and is based in New York, New York.",Mr. David Ira Rosenberg,Shell Companies,0.1706,USD,0,https://images.financialmodelingprep.com/symbol/IGNYW.png,0,0,-0.1354,165417,-11847848,-13236717,"[{'period': '2022', 'revenue': 0.60768, 'unit': 'M', 'net_profit': -13.24}, {'period': '2021', 'revenue': 0.0, 'unit': 'K', 'net_profit': -6.69}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.94}, {'period': ""Q1 '23"", 'revenue': 0.01385, 'unit': 'M', 'net_profit': -6.38}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -154.84}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 154.29}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.63}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.2}]",-0.75,-0.75,7529712,3230793,654892,15624189,0,0,10801121,654892,-7627874,-24278923.32001541,-1978582510.2107623,-832.3333333333334,__nan__,__nan__,__nan__,2.075004860743678
184,IHRT,iHeartMedia Inc. Class A Common Stock,"iHeartMedia, Inc. operates as a media and entertainment company worldwide. It operates through three segments: Multiplatform Group, Digital Audio Group, and Audio & Media Services Group. The Multiplatform Group segment offers broadcast radio stations, sponsorship, and live and virtual events; and operates Premiere Networks, a national radio network that produces, distributes, or represents approximately 120 syndicated radio programs and services to approximately 6,400 radio station affiliates. It also delivers real-time traffic flow and incident information, and weather updates, sports, and news through approximately 2,100 radio stations and 170 television affiliates, and Internet and mobile partnerships. As of December 31, 2021, this segment owned 863 radio stations, which included 249 AM and 614 FM radio stations. The Digital Audio Group segment provides podcasting, digital sites, newsletters, digital services, and programs; and iHeartRadio, a mobile app and web-based service for radio stations, digital-only stations, custom artist stations, and podcasts. The Audio and Media Services Group segment engages in the media representation business. This segment also provides cloud and on-premises broadcast software, such as radio and television automation, music scheduling, newsroom automation, advertising sales management, disaster recovery solutions; and real-time audio recognition technology to approximately 10,000 radio and television stations, cable channels, record labels, advertisers, and agencies, as well as media streaming and research services. The company was formerly known as CC Media Holdings, Inc. and changed its name to iHeartMedia, Inc. in September 2014. iHeartMedia, Inc. is headquartered in San Antonio, Texas.",Mr. Robert W. Pittman,Broadcasting,1.22,USD,176881197,https://images.financialmodelingprep.com/symbol/IHRT.png,833277,-0.18,0.07,837316,-378880000,-1009941000,"[{'period': '2024', 'revenue': 3.85, 'unit': 'B', 'net_profit': -1.01}, {'period': '2023', 'revenue': 3.75, 'unit': 'B', 'net_profit': -1.1}, {'period': '2022', 'revenue': 3910.0, 'unit': 'M', 'net_profit': -262.67}, {'period': '2021', 'revenue': 3560.0, 'unit': 'M', 'net_profit': -158.39}]","[{'period': ""Q4 '24"", 'revenue': 1120.0, 'unit': 'M', 'net_profit': 31.49}, {'period': ""Q3 '24"", 'revenue': 1010.0, 'unit': 'M', 'net_profit': -41.27}, {'period': ""Q2 '24"", 'revenue': 929.09, 'unit': 'M', 'net_profit': -981.66}, {'period': ""Q1 '24"", 'revenue': 799.04, 'unit': 'M', 'net_profit': -18.51}, {'period': ""Q4 '23"", 'revenue': 1070.0, 'unit': 'M', 'net_profit': 13.12}, {'period': ""Q3 '23"", 'revenue': 952.99, 'unit': 'M', 'net_profit': -27.49}]",-6.68,151188,5571696000,1361842000,259580000,6943476000,993328000,0,870280000,259580000,-26165000,-1.6296312914520839,0.08408666315999493,0.09607577807848444,__nan__,__nan__,__nan__,1.246205105231872
185,III,Information Services Group Inc. Information Services Group Inc. Common Stock,"Information Services Group, Inc., together with its subsidiaries, operates as a technology research and advisory company in the Americas, Europe, and the Asia Pacific. The company offers digital transformation services, including automation, cloud, and data analytics; sourcing advisory; managed governance and risk; network carrier; technology strategy and operations design; change management; and market intelligence and technology research and analysis services. It supports private and public sector organizations to transform and optimize their operational environments. The company also provides ISG Digital, a client solution platform that helps clients developing technology, transformation, sourcing, and digital solutions; and ISG Enterprise, a client solution platform that helps clients manage change and optimize operations in areas comprising finance, human resource, and Procure2Pay. In addition, it offers ISG GovernX, a software platform, which provides insights from market and performance data, and automates the management of third-party supplier relationships that comprise contract and project lifecycles, and risk management. The company serves private sector clients operating in the manufacturing, banking and financial services, insurance, health sciences, energy and utilities, and consumer services industries; and public sector clients, including state and local governments, airport and transit authorities, and national and provincial government units. Information Services Group, Inc. was founded in 2006 and is based in Stamford, Connecticut.",Mr. Michael P. Connors,Information Technology Services,3.61,USD,174201272,https://images.financialmodelingprep.com/symbol/III.png,108814,60.17,0,134106,16952000,2839000,"[{'period': '2024', 'revenue': 247.59, 'unit': 'M', 'net_profit': 2.84}, {'period': '2023', 'revenue': 291.05, 'unit': 'M', 'net_profit': 6.15}, {'period': '2022', 'revenue': 286.27, 'unit': 'M', 'net_profit': 19.73}, {'period': '2021', 'revenue': 277.83, 'unit': 'M', 'net_profit': 15.53}]","[{'period': ""Q4 '24"", 'revenue': 57.78, 'unit': 'M', 'net_profit': 3.04}, {'period': ""Q3 '24"", 'revenue': 61.28, 'unit': 'M', 'net_profit': 1.15}, {'period': ""Q2 '24"", 'revenue': 64.26, 'unit': 'M', 'net_profit': 2.04}, {'period': ""Q1 '24"", 'revenue': 64.27, 'unit': 'M', 'net_profit': -3.39}, {'period': ""Q4 '23"", 'revenue': 66.19, 'unit': 'M', 'net_profit': -2.87}, {'period': ""Q3 '23"", 'revenue': 71.77, 'unit': 'M', 'net_profit': 3.2}]",0.0582,0.0567,204515000,91281000,23075000,108229000,58822000,0,38420000,23075000,17035000,-0.20071667688245556,-0.5386740331491713,-0.5523076923076923,"[0.045, 0.14]","['2025-03-21', '2015-01-13']",__nan__,0.5291983473094883
186,IIII,INSU Acquisition Corp. III Class A Common Stock,"INSU Acquisition Corp. III does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or assets. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.",,Shell Companies,10.08,USD,0,https://images.financialmodelingprep.com/symbol/IIII.png,92810,42,0,167785,4105266,9937264,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 9.94}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -72.43}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.12}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 956.34}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'T', 'net_profit': 6.39}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.47}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.28}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.17}]",0.29,0.29,250424168,415811,223949,16987859,0,250008357,1230942,223949,-837671,57.67595328160809,138.19060109893144,139.0952380952381,__nan__,__nan__,__nan__,0.06783633998137113
187,IIIIU,INSU Acquisition Corp. III Unit,"INSU Acquisition Corp. III does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or assets. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.",,Shell Companies,10.08,USD,0,https://images.financialmodelingprep.com/symbol/IIIIU.png,2181,72.5179856115108,0,6084,4105266,9937264,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 9.94}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -72.43}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.12}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 956.34}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'T', 'net_profit': 6.39}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.47}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.28}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.17}]",0.29,0.29,250424168,415811,223949,16987859,0,250008357,1230942,223949,-837671,57.67595328160809,138.19060109893144,139.0952380952381,__nan__,__nan__,__nan__,0.06783633998137113
188,IIIIW,INSU Acquisition Corp. III Warrant,,,Shell Companies,0.0055,USD,0,https://images.financialmodelingprep.com/symbol/IIIIW.png,36224,0,0.0003,29608,4105266,9937264,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 9.94}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -72.43}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.12}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 956.34}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'T', 'net_profit': 6.39}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.47}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.28}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.17}]",0.29,0.29,250424168,415811,223949,16987859,0,250008357,1230942,223949,-837671,57.67595328160809,138.19060109893144,139.0952380952381,__nan__,__nan__,__nan__,0.06783633998137113
189,IIIV,i3 Verticals Inc. Class A Common Stock,"i3 Verticals, Inc. provides integrated payment and software solutions to small- and medium-sized businesses and organizations in education, non-profit, public sector, and healthcare markets in the United States. It operates in two segments, Merchant Services, and Proprietary Software and Payments. The company offers payment processing services that enables clients to accept electronic payments, facilitating the exchange of funds and transaction data between clients, financial institutions, and payment networks. The company also licenses software; and provides ongoing support, and other point of sale-related solutions. It offers its solutions to clients through direct sales force; distribution partners, including independent software vendors, value-added resellers, and independent sales organizations; and referral partners, such as financial institutions, trade associations, chambers of commerce, and card issuers. The company was founded in 2012 and is headquartered in Nashville, Tennessee.",Mr. Gregory S. Daily,Software - Infrastructure,24.18,USD,566496294,https://images.financialmodelingprep.com/symbol/IIIV.png,236698,-142.24,1.42,805955,33225000,113341000,"[{'period': '2024', 'revenue': 229.92, 'unit': 'M', 'net_profit': 113.34}, {'period': '2023', 'revenue': 370240.0, 'unit': 'K', 'net_profit': -811.0}, {'period': '2022', 'revenue': 317.86, 'unit': 'M', 'net_profit': -23.22}, {'period': '2021', 'revenue': 224.12, 'unit': 'M', 'net_profit': -7.84}]","[{'period': ""Q1 '25"", 'revenue': 61.69, 'unit': 'M', 'net_profit': 2.06}, {'period': ""Q4 '24"", 'revenue': 60.86, 'unit': 'M', 'net_profit': 117.91}, {'period': ""Q3 '24"", 'revenue': 56.04, 'unit': 'M', 'net_profit': -7.54}, {'period': ""Q2 '24"", 'revenue': 94.54, 'unit': 'M', 'net_profit': 1.88}, {'period': ""Q1 '24"", 'revenue': 91.99, 'unit': 'M', 'net_profit': 1.1}, {'period': ""Q4 '23"", 'revenue': 96.41, 'unit': 'M', 'net_profit': 4.55}]",-2.13,-3.21,730675000,153393000,86541000,215316000,56183000,0,164731000,86541000,48409000,-0.4245158831884158,140.75462392108508,-59.68376068376068,__nan__,__nan__,__nan__,0.294680945700893
190,IIN,Intricon Corporation Common Stock,"IntriCon Corporation, together with its subsidiaries, designs, develops, engineers, manufactures, and distributes body-worn devices in the United States, Europe, Asia, and internationally. It offers micro-miniature products, microelectronics, micro-mechanical assemblies, high-precision injection-molded plastic components, and assemblies and software solutions for medical devices, hearing healthcare, and professional audio communication devices markets. The company also provides micro coils for surgical navigation clinical applications, such as interventional pulmonology and electrophysiology; joint engineering and manufacturing services for complex medical devices, including catheters covering a range of applications for cardiology, peripheral vascular, neurology, radiology, and pulmonology; bubble sensors and flow restrictors that monitor and control the flow of fluid in an intravenous infusion system; and safety needle products for original equipment manufacturing customers. In addition, it offers professional audio headset products used for emergency response needs in the fire, law enforcement, safety, aviation, and military markets; and a line of miniature ear- and head-worn devices used by performers and support staff in the music and stage performance markets. The company sells its hearing device products, and medical and professional audio communications products directly to hearing instrument manufacturers, distributors, and partnerships; and microphone products to the radio communication and professional audio industries, as well as markets and sells hearing aid devices directly to consumers through direct mail advertising, Internet, and call center. The company was formerly known as Selas Corporation of America and changed its name to IntriCon Corporation. The company was incorporated in 1930 and is headquartered in Arden Hills, Minnesota.",Mr. Mark Gorder,Medical - Instruments & Supplies,24.23,USD,0,https://images.financialmodelingprep.com/symbol/IIN.png,107996,226.44859813084113,0.02999878,198448,5591000,-64000,"[{'period': '2021', 'revenue': 125210.0, 'unit': 'K', 'net_profit': -64.0}, {'period': '2020', 'revenue': 102.77, 'unit': 'M', 'net_profit': -2.52}, {'period': '2019', 'revenue': 113.49, 'unit': 'M', 'net_profit': -3.78}, {'period': '2018', 'revenue': 116.46, 'unit': 'M', 'net_profit': 5.55}]","[{'period': ""Q1 '22"", 'revenue': 33060.0, 'unit': 'K', 'net_profit': -597.0}, {'period': ""Q4 '21"", 'revenue': 32170.0, 'unit': 'K', 'net_profit': 24.0}, {'period': ""Q3 '21"", 'revenue': 31050.0, 'unit': 'K', 'net_profit': 337.0}, {'period': ""Q2 '21"", 'revenue': 30.21, 'unit': 'M', 'net_profit': -1.18}, {'period': ""Q1 '21"", 'revenue': 31770.0, 'unit': 'K', 'net_profit': 714.0}, {'period': ""Q4 '20"", 'revenue': 30.3, 'unit': 'M', 'net_profit': 1.09}]",-0.007,-0.007,122459000,74381000,25004000,28709000,19712000,5031000,20212000,5584000,-2066000,1.5896248263084762,0.9746434231378764,0.975,"[0.045, 0.3]","['2001-09-12', '1981-06-17']",__nan__,0.23443764851909618
191,IIVI,II-VI Incorporated Common Stock,"II-VI Incorporated develops, manufactures, and markets engineered materials, optoelectronic components, and devices worldwide. It operates in two segments, Compound Semiconductors and Photonic Solutions. The Compound Semiconductors segment provides optical and electro-optical components and materials used in high-power CO2 lasers, fiber-lasers, and direct diode lasers for materials processing applications; infrared optical components and high-precision optical assemblies for aerospace and defense, medical, and commercial laser imaging applications; semiconductor lasers and detectors for optical interconnects and sensing applications; engineered materials for thermoelectric, ceramics, and silicon carbide various applications; and compound semiconductor epitaxial wafers for applications in optical and wireless communication. The Photonic Solutions segment manufactures transceivers for data centers and telecom optical networks; pump lasers, optical amplifiers, wavelength selective switches, and advanced components for telecom networks; and crystal materials, optics, lasers, and optoelectronic modules in a range of applications, including optical communications, life sciences, and consumer electronics markets. The company serves original equipment manufacturers, laser end users, system integrators of high-power lasers, U.S. government prime contractors, and various U.S. government agencies, as well as manufacturers of equipment and devices for industrial, optical communications, consumer electronics, and security and monitoring applications. The company was incorporated in 1971 and is headquartered in Saxonburg, Pennsylvania.","Dr. Vincent D. Mattera Jr., Ph.D.","Hardware, Equipment & Parts",227.08,USD,30513807103,https://images.financialmodelingprep.com/symbol/IIVI.png,51552,0,11.82,247144,682936000,-279511000,"[{'period': '2024', 'revenue': 4710.0, 'unit': 'M', 'net_profit': -279.51}, {'period': '2023', 'revenue': 5160.0, 'unit': 'M', 'net_profit': -259.46}, {'period': '2022', 'revenue': 3320.0, 'unit': 'M', 'net_profit': 234.76}, {'period': '2021', 'revenue': 3110.0, 'unit': 'M', 'net_profit': 297.55}]","[{'period': ""Q2 '25"", 'revenue': 1440.0, 'unit': 'M', 'net_profit': 103.39}, {'period': ""Q1 '25"", 'revenue': 1350.0, 'unit': 'M', 'net_profit': 26.0}, {'period': ""Q4 '24"", 'revenue': 1310.0, 'unit': 'M', 'net_profit': -48.44}, {'period': ""Q3 '24"", 'revenue': 1210.0, 'unit': 'M', 'net_profit': -13.19}, {'period': ""Q2 '24"", 'revenue': 1130.0, 'unit': 'M', 'net_profit': -26.99}, {'period': ""Q1 '24"", 'revenue': 1050.0, 'unit': 'M', 'net_profit': -67.0}]",-1.84,-1.84,14488634000,3660099000,926033000,6542355000,848542000,0,1343767000,926033000,198915000,0.11408627392124972,-0.07728803891188554,0.026455026455026363,"[3, 2.8]","['2023-06-14', '2020-09-14']",__nan__,0.4515508501353544
192,IIVIP,II-VI Incorporated 6.00% Series A Mandatory Convertible Preferred Stock,"II-VI Incorporated develops, manufactures, and markets engineered materials, optoelectronic components, and devices worldwide. It operates through two segments, Compound Semiconductors and Photonic Solutions. The Compound Semiconductors segment provides optical and electro-optical components and materials used in high-power CO2 lasers, fiber-lasers, and direct diode lasers for materials processing applications; infrared optical components and high-precision optical assemblies for aerospace and defense, medical, and commercial laser imaging applications; semiconductor lasers and detectors for optical interconnects and sensing applications; engineered materials for thermoelectric, ceramics, and silicon carbide various applications; and compound semiconductor epitaxial wafers for applications in optical and wireless communication. The Photonic Solutions segment manufactures transceivers for data centers and telecom optical networks; pump lasers, optical amplifiers, wavelength selective switches, and advanced components for telecom networks; and crystal materials, optics, lasers, and optoelectronic modules in a range of applications, including optical communications, life sciences, and consumer electronics markets. The company serves original equipment manufacturers, laser end users, system integrators of high-power lasers, U.S. government prime contractors, and various U.S. government agencies, as well as manufacturers of equipment and devices for industrial, optical communications, consumer electronics, and security and monitoring applications. II-VI Incorporated was incorporated in 1971 and is headquartered in Saxonburg, Pennsylvania.","Dr. Vincent D. Mattera Jr., Ph.D.","Hardware, Equipment & Parts",187.51,USD,0,https://images.financialmodelingprep.com/symbol/IIVIP.png,17060,75.97649918962723,-0.42,28885,682936000,-279511000,"[{'period': '2024', 'revenue': 4710.0, 'unit': 'M', 'net_profit': -279.51}, {'period': '2023', 'revenue': 5160.0, 'unit': 'M', 'net_profit': -259.46}, {'period': '2022', 'revenue': 3320.0, 'unit': 'M', 'net_profit': 234.76}, {'period': '2021', 'revenue': 3110.0, 'unit': 'M', 'net_profit': 297.55}]","[{'period': ""Q2 '25"", 'revenue': 1440.0, 'unit': 'M', 'net_profit': 103.39}, {'period': ""Q1 '25"", 'revenue': 1350.0, 'unit': 'M', 'net_profit': 26.0}, {'period': ""Q4 '24"", 'revenue': 1310.0, 'unit': 'M', 'net_profit': -48.44}, {'period': ""Q3 '24"", 'revenue': 1210.0, 'unit': 'M', 'net_profit': -13.19}, {'period': ""Q2 '24"", 'revenue': 1130.0, 'unit': 'M', 'net_profit': -26.99}, {'period': ""Q1 '24"", 'revenue': 1050.0, 'unit': 'M', 'net_profit': -67.0}]",-1.84,-1.84,14488634000,3660099000,926033000,6542355000,875451000,0,1343767000,926033000,198915000,0.11408627392124972,-0.07728803891188554,0.026455026455026363,"[3, 2.8]","['2023-03-14', '2020-09-14']",__nan__,0.4515508501353544
193,IKNA,Ikena Oncology Inc. Common Stock,"Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. It is also developing a small molecule inhibitor program against ERK5 in the RAS signaling pathway; IK-175, an oral inhibitor of aryl hydrocarbon receptor; and IK-007, an oral selective EP4 receptor antagonist for the treatment of microsatellite stable colorectal cancer. The company was incorporated in 2016 and is headquartered in Boston, Massachusetts.",Dr. Mark  Manfredi Ph.D.,Biotechnology,1.1,USD,44284240,https://images.financialmodelingprep.com/symbol/IKNA.png,118924,-1.08,0.02,237341,-58973000,-49234000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -49.23}, {'period': '2023', 'revenue': 9.16, 'unit': 'M', 'net_profit': -68.17}, {'period': '2022', 'revenue': 15.62, 'unit': 'M', 'net_profit': -66.63}, {'period': '2021', 'revenue': 30.98, 'unit': 'M', 'net_profit': -34.12}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.12}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.23}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -13.73}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -16.15}, {'period': ""Q4 '23"", 'revenue': 0.659, 'unit': 'M', 'net_profit': -19.49}, {'period': ""Q3 '23"", 'revenue': 1.19, 'unit': 'M', 'net_profit': -17.34}]",-1.02,-1.02,141510000,127169000,124386000,15576000,0,0,10778000,39393000,-46004000,0.20732018764197482,0.277733767567409,0.3742331288343558,__nan__,__nan__,__nan__,0.11006995972016112
194,IKNX,Ikonics Corporation,"IKONICS Corp. engages in the development, manufacture, and trade of photochemical imaging products. The company is headquartered in Duluth, Minnesota and currently employs 75 full-time employees. The firm has five operating segments: Domestic, Export, IKONICS Imaging, Digital Texturing (DTX) and Advanced Material Solutions (AMS). Domestic segment sells screen printing film, emulsions, and inkjet receptive film to distributors located in the United States and Canada. IKONICS Imaging segment sells photo resistant film, art supplies, glass, metal medium and related abrasive etching equipment. AMS segment provides sound deadening technology to the aerospace industry along with products and services for etched composites, ceramics, glass and silicon wafers. DTX segment includes products and customers related to inkjet technology used for mold texturing and prototyping. Export segment sells primarily the same products as Domestic and the IKONICS Imaging products not related to AMS or DTX.",Mr. Glenn Sandgren,Chemicals - Specialty,33.9,USD,5910193800,https://images.financialmodelingprep.com/symbol/IKNX.png,29877,-153.39366515837105,-0.09999847,55149,135295,-439320,"[{'period': '2020', 'revenue': 13430.0, 'unit': 'K', 'net_profit': -439.32}, {'period': '2019', 'revenue': 17620.0, 'unit': 'K', 'net_profit': -813.56}, {'period': '2018', 'revenue': 18210.0, 'unit': 'K', 'net_profit': 139.47}, {'period': '2017', 'revenue': 17240.0, 'unit': 'K', 'net_profit': -226.15}]","[{'period': ""Q3 '21"", 'revenue': 4740.0, 'unit': 'K', 'net_profit': -851.74}, {'period': ""Q2 '21"", 'revenue': 4250.0, 'unit': 'K', 'net_profit': -722.28}, {'period': ""Q1 '21"", 'revenue': 3070.0, 'unit': 'K', 'net_profit': -321.64}, {'period': ""Q4 '20"", 'revenue': 4.23, 'unit': 'M', 'net_profit': 1.46}, {'period': ""Q3 '20"", 'revenue': 3130.0, 'unit': 'K', 'net_profit': -274.0}, {'period': ""Q2 '20"", 'revenue': 2.57, 'unit': 'M', 'net_profit': -1.04}]",-0.22,-0.22,15435399,7803453,3693845,3596053,2338664,0,3596053,3693845,-563654,1.6367153123220497,0.46000162250263654,0.46341463414634143,"[1, 0.01]","['2012-12-18', '1999-12-29']",__nan__,0.23297441161061014
195,IKT,Inhibikase Therapeutics Inc. Common Stock,"Inhibikase Therapeutics, Inc., a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain. The company's product candidates include IkT-148009, a small molecule Abelson tyrosine kinase inhibitor for use in the treatment of PD, as well as gastrointestinal complications that arise as early symptoms of PD, such as swallowing, dysphagia, neurogenic constipation, and multiple system atrophy; and IkT-001Pro, a prodrug of the anti-cancer agent Imatinib that is in preclinical development to minimize gastrointestinal side effects and for the treatment of blood and stomach cancers. It is also involved in developing various research programs for other neurological diseases. The company has research and development collaborations with The Johns Hopkins University, Arizona State University, and Michigan State University, as well as Louisiana State University. Inhibikase Therapeutics, Inc. was founded in 2008 and is headquartered in Atlanta, Georgia.",Mr. Mark T. Iwicki,Biotechnology,1.89,USD,140505435,https://images.financialmodelingprep.com/symbol/IKT.png,173309,-1.63,0.23,212330,-28589068,-27519886,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -27.52}, {'period': '2023', 'revenue': 0.2605, 'unit': 'M', 'net_profit': -19.03}, {'period': '2022', 'revenue': 0.12344, 'unit': 'M', 'net_profit': -17.91}, {'period': '2021', 'revenue': 3.1, 'unit': 'M', 'net_profit': -14.81}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.13}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.78}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.96}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.65}, {'period': ""Q4 '23"", 'revenue': 1e-06, 'unit': 'M', 'net_profit': -4.18}, {'period': ""Q3 '23"", 'revenue': 0.07956999999999999, 'unit': 'M', 'net_profit': -4.6}]",-1.16,-1.16,98599846,98451309,97543528,3733566,0,0,3733566,56490579,-19148067,-0.4357423823574403,-0.4462165750874605,0.6750700280112045,__nan__,__nan__,__nan__,0.037865840074435816
196,ILMN,Illumina Inc. Common Stock,"Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.",Mr. Jacob  Thaysen Ph.D.,Medical - Diagnostics & Research,76.3,USD,12085920000,https://images.financialmodelingprep.com/symbol/ILMN.png,2713270,-9.92,6,4430711,-725000000,-1223000000,"[{'period': '2024', 'revenue': 4.37, 'unit': 'B', 'net_profit': -1.22}, {'period': '2023', 'revenue': 4.5, 'unit': 'B', 'net_profit': -1.16}, {'period': '2022', 'revenue': 4.58, 'unit': 'B', 'net_profit': -4.4}, {'period': '2021', 'revenue': 4530.0, 'unit': 'M', 'net_profit': 762.0}]","[{'period': ""Q4 '24"", 'revenue': 1100.0, 'unit': 'M', 'net_profit': 187.0}, {'period': ""Q3 '24"", 'revenue': 1080.0, 'unit': 'M', 'net_profit': 705.0}, {'period': ""Q2 '24"", 'revenue': 1.11, 'unit': 'B', 'net_profit': -1.99}, {'period': ""Q1 '24"", 'revenue': 1080.0, 'unit': 'M', 'net_profit': -126.0}, {'period': ""Q4 '23"", 'revenue': 1120.0, 'unit': 'M', 'net_profit': -176.0}, {'period': ""Q3 '23"", 'revenue': 1120.0, 'unit': 'M', 'net_profit': -754.0}]",-7.69,-7.69,6303000000,2746000000,1220000000,3930000000,735000000,0,1547000000,1127000000,709000000,-0.1924342105263158,-0.053402239448751075,-0.046258503401360646,__nan__,__nan__,__nan__,0.6235126130414088
197,ILPT,Industrial Logistics Properties Trust Common Shares of Beneficial Interest,"ILPT is a real estate investment trust, or REIT, that owns and leases industrial and logistics properties throughout the United States. ILPT is managed by the operating subsidiary of The RMR Group Inc. (Nasdaq: RMR), an alternative asset management company that is headquartered in Newton, MA.",Ms. Tiffany R. Sy CPA,REIT - Industrial,2.98,USD,197110014,https://images.financialmodelingprep.com/symbol/ILPT.png,313454,-2.04,0.18,1174406,322185000,-95669000,"[{'period': '2024', 'revenue': 442.32, 'unit': 'M', 'net_profit': -95.67}, {'period': '2023', 'revenue': 437.34, 'unit': 'M', 'net_profit': -107.99}, {'period': '2022', 'revenue': 388.15, 'unit': 'M', 'net_profit': -293.92}, {'period': '2021', 'revenue': 219.87, 'unit': 'M', 'net_profit': 78.76}]","[{'period': ""Q4 '24"", 'revenue': 110.52, 'unit': 'M', 'net_profit': -24.1}, {'period': ""Q3 '24"", 'revenue': 108.94, 'unit': 'M', 'net_profit': -24.99}, {'period': ""Q2 '24"", 'revenue': 110.62, 'unit': 'M', 'net_profit': -23.18}, {'period': ""Q1 '24"", 'revenue': 112.23, 'unit': 'M', 'net_profit': -23.4}, {'period': ""Q4 '23"", 'revenue': 108.89, 'unit': 'M', 'net_profit': -31.24}, {'period': ""Q3 '23"", 'revenue': 110.14, 'unit': 'M', 'net_profit': -26.11}]",-1.46,-1.46,5406331000,371642000,242480000,4397001000,129162000,116732000,81527000,131706000,1963000,0.04629638650468127,0.11408569391326895,0.11515151515151513,"[0.01, 0.27]","['2025-01-27', '2018-04-27']",__nan__,0.8133059185610352
198,IMAB,I-MAB American Depositary Shares,"I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinical trials to treat pediatric growth hormone deficiency; TJ107, a recombinant human IL-7, which is in Phase 2 for cancer treatment-related lymphopenia and cancer immunotherapy; and Lemzoparlimab, a CD47 monoclonal antibody that has completed Phase 2 clinical trial. Its product candidates also includes Enoblituzumab, a humanized B7-H3 antibody that is in Phase 2 to treat head and neck cancer, and other oncology diseases; Efineptakin, a long-acting recombinant human IL-7, which is in Phase 2 clinical trials to treat lymphopenia and cancer immunotherapy; TJ210, a monoclonal antibody against human C5aR1 that is in Phase 1 for the treatment of cancers and autoimmune; Plonmarlimab, a GM-CSF monoclonal antibody for inflammation and CRS-related therapies; Uliledlimab, a CD73 antibody, which is in Phase 2 clinical trials for treating solid tumors and oncology; TJ-L14B, a PD-L1-based tumor-dependent T-cell engager for solid cancers; and TJ-CD4B, a tumor-dependent T cell engager for gastric and other cancers, as well as TJ-L1IF, a PD-L1/IFN-a antibody-cytokine fusion protein for solid tumors and TJ-C64B, a tumor-dependent T-cell engager for ovarian and other cancers. I-Mab has strategic collaboration agreement with AbbVie Ireland Unlimited Company; Sinopharm Group Co. Ltd.; PT Kalbe Genexine Biologics; and Roche Diagnostics. The company was founded in 2014 and is headquartered in Shanghai, the People's Republic of China.",Mr. Skelton  Joseph,Biotechnology,0.6888,USD,24407808,https://images.financialmodelingprep.com/symbol/IMAB.png,258985,-1.11,0.0028,163039,-1212070000,-1465694000,"[{'period': '2023', 'revenue': 0.02764, 'unit': 'B', 'net_profit': -1.47}, {'period': '2022', 'revenue': -0.22156, 'unit': 'B', 'net_profit': -2.51}, {'period': '2021', 'revenue': 0.08803, 'unit': 'B', 'net_profit': -2.33}, {'period': '2020', 'revenue': 1540.0, 'unit': 'M', 'net_profit': 470.92}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.06}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -20.49}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 25.13}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 20.84}, {'period': ""Q4 '23"", 'revenue': 3.99, 'unit': 'M', 'net_profit': -346.45}, {'period': ""Q3 '23"", 'revenue': 3.99, 'unit': 'M', 'net_profit': -346.45}]",-7.6608695651178005,-7.6565217390309,212680000,176693000,173398000,11520000,1172000,30824000,8454000,68263000,-52717000,0.37654793128226705,0.4154333097889098,0.4202040144784469,__nan__,__nan__,__nan__,0.05416588301673876
199,IMAC,IMAC Holdings Inc. Common Stock,"IMAC Holdings, Inc. owns, manages, and subleases a chain of innovative medical advancements and care regeneration centers in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides physical therapy and spinal decompression, and chiropractic manipulation. The company owns or manages 15 outpatient medical clinics in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Brentwood, Tennessee.",Mr. Jeffrey S. Ervin M.B.A.,Medical - Care Facilities,1.01,USD,33082348,https://images.financialmodelingprep.com/symbol/IMAC.png,0,-2.269662921348315,0.019800007,81451,-5946795,-9418585,"[{'period': '2023', 'revenue': 5.2, 'unit': 'M', 'net_profit': -9.42}, {'period': '2022', 'revenue': 16.19, 'unit': 'M', 'net_profit': -26.74}, {'period': '2021', 'revenue': 14.39, 'unit': 'M', 'net_profit': -11.1}, {'period': '2020', 'revenue': 12.84, 'unit': 'M', 'net_profit': -5.57}]","[{'period': ""Q3 '24"", 'revenue': 0.056299999999999996, 'unit': 'M', 'net_profit': -2.2}, {'period': ""Q2 '24"", 'revenue': 0.01575, 'unit': 'M', 'net_profit': -1.38}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -407.22}, {'period': ""Q4 '23"", 'revenue': -5.0, 'unit': 'M', 'net_profit': -1.46}, {'period': ""Q3 '23"", 'revenue': 1.57, 'unit': 'M', 'net_profit': -2.91}, {'period': ""Q2 '23"", 'revenue': 1.34, 'unit': 'M', 'net_profit': -1.4}]",-5.82,-8.47,1144119,1144119,221511,1896766,731067,0,1896766,221511,-2790151,0.41705037909206116,0.6478323911933055,0.7949260042283298,__nan__,__nan__,__nan__,1.657839787644467
200,IMACW,IMAC Holdings Inc. Warrant,,None,Medical - Care Facilities,0.012,USD,1741857,https://images.financialmodelingprep.com/symbol/IMACW.png,0,0,0.0011,45294,-5946795,-9418585,"[{'period': '2023', 'revenue': 5.2, 'unit': 'M', 'net_profit': -9.42}, {'period': '2022', 'revenue': 16.19, 'unit': 'M', 'net_profit': -26.74}, {'period': '2021', 'revenue': 14.39, 'unit': 'M', 'net_profit': -11.1}, {'period': '2020', 'revenue': 12.84, 'unit': 'M', 'net_profit': -5.57}]","[{'period': ""Q3 '24"", 'revenue': 0.056299999999999996, 'unit': 'M', 'net_profit': -2.2}, {'period': ""Q2 '24"", 'revenue': 0.01575, 'unit': 'M', 'net_profit': -1.38}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -407.22}, {'period': ""Q4 '23"", 'revenue': -5.0, 'unit': 'M', 'net_profit': -1.46}, {'period': ""Q3 '23"", 'revenue': 1.57, 'unit': 'M', 'net_profit': -2.91}, {'period': ""Q2 '23"", 'revenue': 1.34, 'unit': 'M', 'net_profit': -1.4}]",-5.82,-8.47,1144119,1144119,221511,1896766,731067,0,1896766,221511,-2790151,0.41705037909206116,0.6478323911933055,0.7949260042283298,__nan__,__nan__,__nan__,1.657839787644467
201,IMBI,iMedia Brands Inc. Class A Common Stock,"iMedia Brands, Inc. operates as an interactive media company in the United States and internationally. It operates through three segments: Entertainment, Consumer Brands, and Media Commerce Services. The company operates television networks, including ShopHQ that offers jewelry and watches, home, beauty and health, and fashion and accessories; ShopBulldogTV, which provides male-oriented products and services; ShopHQHealth that offers women and men products and services focused on health and wellness categories, such as physical, mental and spiritual health, financial and motivational wellness, weight management, and telehealth medical services; ShopJewelryHQ for jewelry products and services; and 1-2-3.tv, a retailing marketplace for live and automated auctions. It also provides women's apparel and accessories under the Christopher & Banks brand; men and women accessories under the J.W. Hulme brand; and Shaq kitchen products and watches. In addition, the company operates online marketplaces for discounted merchandise through OurGalleria.com and TheCloseout.com; and Retail Media Exchange, an advertising auction platform for advertisers, digital publishers, and supply-side and demand-side platforms. Further, it offers a suite of value-added services; Float Left, an OTT software as a service app platform for media and consumer brands; and i3PL, an end-to-end, white label, managed services specializing in ecommerce customer experience and fulfillment services. The company was formerly known as EVINE Live Inc. and changed its name to iMedia Brands, Inc. in July 2019. iMedia Brands, Inc. was incorporated in 1990 and is headquartered in Eden Prairie, Minnesota.",Mr. Timothy A. Peterman CPA,Specialty Retail,0.11,USD,3180848,https://images.financialmodelingprep.com/symbol/IMBI.png,5043644,-0.049107142857142856,-0.025,21733092,-6039000,-70460000,"[{'period': '2022', 'revenue': 544.55, 'unit': 'M', 'net_profit': -70.46}, {'period': '2021', 'revenue': 551.13, 'unit': 'M', 'net_profit': -23.03}, {'period': '2020', 'revenue': 454.17, 'unit': 'M', 'net_profit': -13.23}, {'period': '2019', 'revenue': 501.82, 'unit': 'M', 'net_profit': -56.3}]","[{'period': ""Q4 '22"", 'revenue': 133.51, 'unit': 'M', 'net_profit': -24.16}, {'period': ""Q3 '22"", 'revenue': 123.26, 'unit': 'M', 'net_profit': -21.3}, {'period': ""Q2 '22"", 'revenue': 133.23, 'unit': 'M', 'net_profit': -11.2}, {'period': ""Q1 '22"", 'revenue': 154.54, 'unit': 'M', 'net_profit': -12.21}, {'period': ""Q4 '21"", 'revenue': 193.81, 'unit': 'M', 'net_profit': -5.77}, {'period': ""Q3 '21"", 'revenue': 130.68, 'unit': 'M', 'net_profit': -9.49}]",-2.63,-2.63,443748000,201356000,7187000,426705000,50576000,0,183713000,7187000,-60013000,-1.2348526094734387,-2.0600191088334925,-1.2100840336134453,__nan__,__nan__,__nan__,0.9615930663349469
202,IMCC,IM Cannabis Corp. Common Shares,"IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.",Mr. Uri  Birenberg,Drug Manufacturers - Specialty & Generic,1.405,USD,4335057,https://images.financialmodelingprep.com/symbol/IMCC.png,11240,-0.44,-0.015,47734,-6144000,-10585000,"[{'period': '2024', 'revenue': 54.03, 'unit': 'M', 'net_profit': -10.59}, {'period': '2023', 'revenue': 48.8, 'unit': 'M', 'net_profit': -9.5}, {'period': '2022', 'revenue': 54.34, 'unit': 'M', 'net_profit': -24.92}, {'period': '2021', 'revenue': 54.3, 'unit': 'M', 'net_profit': -18.52}]","[{'period': ""Q4 '24"", 'revenue': 13.34, 'unit': 'M', 'net_profit': -1.01}, {'period': ""Q3 '24"", 'revenue': 13880.0, 'unit': 'K', 'net_profit': -922.0}, {'period': ""Q2 '24"", 'revenue': 14.75, 'unit': 'M', 'net_profit': -3.03}, {'period': ""Q1 '24"", 'revenue': 12.06, 'unit': 'M', 'net_profit': -5.62}, {'period': ""Q4 '23"", 'revenue': 10.7, 'unit': 'M', 'net_profit': -3.29}, {'period': ""Q3 '23"", 'revenue': 38.11, 'unit': 'M', 'net_profit': -6.21}]",-4.51,-4.51,39188000,23364000,863000,36042000,16679000,1631000,34918000,863000,-1233000,-1.2021505376344086,-0.11444514634659929,-0.013483146067415642,__nan__,__nan__,__nan__,0.9197203225477187
203,IMCR,Immunocore Holdings plc American Depositary Shares,"Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in Phase I/II dose escalation trial in patients with solid tumor cancers, including non-small-cell lung (NSCLC), gastric, head and neck, ovarian, and synovial sarcoma cancers; IMC-F106C, which is in a Phase I/II dose escalation trial in patients with multiple solid tumor cancers comprising NSCLC, small-cell lung, endometrial, ovarian, cutaneous melanoma, and breast cancers. In addition, the company's programs for infectious diseases include IMC-I109V, which is in a Phase I/II clinical trial in patients with chronic hepatitis B virus; and IMC-M113V that is in pre-clinical development stage for patients with human immunosuppression virus. Further, it develops product candidates to provide precision targeted immunosuppression for the treatment of autoimmune diseases. Immunocore Holdings plc was founded in 1999 and is headquartered in Abingdon, the United Kingdom.",Dr. Bahija  Jallal Ph.D.,Biotechnology,26.12,USD,1307694143,https://images.financialmodelingprep.com/symbol/IMCR.png,306339,-25.61,1.59,346046,-70461000,-51087000,"[{'period': '2024', 'revenue': 310.2, 'unit': 'M', 'net_profit': -51.09}, {'period': '2023', 'revenue': 249.43, 'unit': 'M', 'net_profit': -55.29}, {'period': '2022', 'revenue': 143.74, 'unit': 'M', 'net_profit': -41.22}, {'period': '2021', 'revenue': 26.52, 'unit': 'M', 'net_profit': -131.52}]","[{'period': ""Q4 '24"", 'revenue': 84.05, 'unit': 'M', 'net_profit': -23.77}, {'period': ""Q3 '24"", 'revenue': 80.25, 'unit': 'M', 'net_profit': 8.74}, {'period': ""Q2 '24"", 'revenue': 75.4, 'unit': 'M', 'net_profit': -11.62}, {'period': ""Q1 '24"", 'revenue': 70.5, 'unit': 'M', 'net_profit': -24.44}, {'period': ""Q4 '23"", 'revenue': 105.64, 'unit': 'M', 'net_profit': -26.42}, {'period': ""Q3 '23"", 'revenue': 62.62, 'unit': 'M', 'net_profit': 2.32}]",-1.02,-1.02,1009506000,929864000,820376000,648790000,63009000,0,212181000,455731000,20888000,-0.36430701312783176,0.07596722556839763,0.09734513274336273,__nan__,__nan__,__nan__,0.6426806774798763
204,IMGN,ImmunoGen Inc. Common Stock,"ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm. Its preclinical programs include IMGC936, an ADC in co-development with MacroGenics, Inc.; and IMGN151, an anti FRa product candidate. The company has collaborations with Roche; Amgen/Oxford BioTherapeutics; Bayer HealthCare AG; Eli Lilly and Company; Novartis Institutes for BioMedical Research, Inc.; CytomX Therapeutics, Inc.; Fusion Pharmaceuticals Inc.; Debiopharm International SA; and MacroGenics, Inc. ImmunoGen, Inc. was founded in 1980 and is headquartered in Waltham, Massachusetts.",Mr. Mark Joseph Enyedy,Biotechnology,31.235,USD,8725621690,https://images.financialmodelingprep.com/symbol/IMGN.png,8287745,-111.55357142857143,0.005,19311442,-217546000,-222929000,"[{'period': '2022', 'revenue': 108.78, 'unit': 'M', 'net_profit': -222.93}, {'period': '2021', 'revenue': 108.78, 'unit': 'M', 'net_profit': -222.93}, {'period': '2020', 'revenue': 132.3, 'unit': 'M', 'net_profit': -66.68}, {'period': '2019', 'revenue': 82.27, 'unit': 'M', 'net_profit': -122.09}]","[{'period': ""Q3 '23"", 'revenue': 113.42, 'unit': 'M', 'net_profit': 30.75}, {'period': ""Q2 '23"", 'revenue': 83.15, 'unit': 'M', 'net_profit': -4.25}, {'period': ""Q1 '23"", 'revenue': 49.87, 'unit': 'M', 'net_profit': -40.57}, {'period': ""Q4 '22"", 'revenue': 41.17, 'unit': 'M', 'net_profit': -59.01}, {'period': ""Q3 '22"", 'revenue': 15.38, 'unit': 'M', 'net_profit': -78.08}, {'period': ""Q2 '22"", 'revenue': 14.16, 'unit': 'M', 'net_profit': -62.99}]",-0.88,-0.88,348936000,275138000,275138000,193110000,17978000,0,121858000,275138000,-231166000,0,0,0,__nan__,__nan__,__nan__,0.5534252699635464
205,IMKTA,Ingles Markets Incorporated Class A Common Stock,"Ingles Markets, Incorporated operates a chain of supermarkets in the southeast United States. It offers food products, including grocery, meat and dairy products, produce, frozen foods, and other perishables; and non-food products, which include fuel centers, pharmacies, health and beauty care products, and general merchandise, as well as private label items. The company also owns and operates a milk processing and packaging plant that supplies organic milk, fruit juices, and bottled water products to other retailers, food service distributors, and grocery warehouses. In addition, it provides home meal replacement items, delicatessens, bakeries, floral departments, and greeting cards, as well as broad selections of local organic, beverage, and health-related items. As of September 25, 2021, the company operated 189 supermarkets under the brand name Ingles, and nine supermarkets under the brand name Sav-Mor in western North Carolina, western South Carolina, northern Georgia, eastern Tennessee, southwestern Virginia, and northeastern Alabama, as well as 111 pharmacies and 107 fuel stations. Ingles Markets, Incorporated was founded in 1963 and is headquartered in Asheville, North Carolina.",Mr. James W. Lanning,Grocery Stores,64.49,USD,1198865940,https://images.financialmodelingprep.com/symbol/IMKTA.png,121195,15.54,1.75,164293,282983680,105541301,"[{'period': '2024', 'revenue': 5640.0, 'unit': 'M', 'net_profit': 105.54}, {'period': '2023', 'revenue': 5890.0, 'unit': 'M', 'net_profit': 210.81}, {'period': '2022', 'revenue': 5680.0, 'unit': 'M', 'net_profit': 272.76}, {'period': '2021', 'revenue': 4990.0, 'unit': 'M', 'net_profit': 249.73}]","[{'period': ""Q1 '25"", 'revenue': 1290000.0, 'unit': 'M', 'net_profit': 16.59}, {'period': ""Q4 '24"", 'revenue': 1400.0, 'unit': 'M', 'net_profit': -1.47}, {'period': ""Q3 '24"", 'revenue': 1390.0, 'unit': 'M', 'net_profit': 31.72}, {'period': ""Q2 '24"", 'revenue': 1370.0, 'unit': 'M', 'net_profit': 31.9}, {'period': ""Q1 '24"", 'revenue': 1480.0, 'unit': 'M', 'net_profit': 43.39}, {'period': ""Q4 '23"", 'revenue': 1580.0, 'unit': 'M', 'net_profit': 52.64}]",5.56,5.56,2527882715,925547755,353687911,982133625,78266383,0,320621944,353687911,51661106000,-0.3206529013516265,-0.49935809381667956,-0.5101321585903084,"[0.165, 0.2]","['2025-04-10', '1987-12-15']",__nan__,0.3885202502363722
206,IMMP,Immutep Limited American Depositary Shares,"Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as a chemoimmunotherapy combination for metastatic breast cancer. The company also develops TACTI-002, which is in a Phase II clinical trial for the treatment of head and neck squamous cell carcinoma (HNSCC) and non-small cell lung cancer; TACTI-003 that is in Phase IIb clinical trial to treat HNSCC; and INSIGHT-004 and INSIGHT-003, which is in a Phase I clinical trial for the treatment of solid tumors, as well as INSIGHT-005 that is in Phase I/IIa clinical trial to treat solid tumors. Its other products include IMP761, an agonist of lymphocyte activation gene 3 for autoimmune disease; IMP701, an antagonist antibody that acts to stimulate T cell proliferation in cancer patients; and IMP731, a depleting antibody that removes T cells involved in autoimmunity. Immutep Limited has collaboration agreements with GlaxoSmithKline, Novartis, CYTLIMIC Inc., Merck & Co., Inc., Institute of Clinical Cancer Research, Merck KGaA, and EOC Pharma. The company was formerly known as Prima BioMed Ltd and changed its name to Immutep Limited in November 2017. Immutep Limited was incorporated in 1987 and is based in Sydney, Australia.",Mr. Marc  Voigt,Biotechnology,1.5,USD,218338512,https://images.financialmodelingprep.com/symbol/IMMP.png,78108,-7.5,0.05,102617,-44544368,-42716625,"[{'period': '2024', 'revenue': 3.84, 'unit': 'M', 'net_profit': -42.72}, {'period': '2023', 'revenue': 3.51, 'unit': 'M', 'net_profit': -39.9}, {'period': '2022', 'revenue': 0.17037000000000002, 'unit': 'M', 'net_profit': -32.21}, {'period': '2021', 'revenue': 3.97, 'unit': 'M', 'net_profit': -29.9}]","[{'period': ""Q2 '25"", 'revenue': 3.15, 'unit': 'M', 'net_profit': -22.38}, {'period': ""Q4 '24"", 'revenue': 1.73, 'unit': 'M', 'net_profit': -21.49}, {'period': ""Q2 '24"", 'revenue': 2.11, 'unit': 'M', 'net_profit': -21.23}, {'period': ""Q4 '23"", 'revenue': 1.82, 'unit': 'M', 'net_profit': -19.27}, {'period': ""Q2 '23"", 'revenue': 1.69, 'unit': 'M', 'net_profit': -20.62}, {'period': ""Q4 '22"", 'revenue': 0.17037000000000002, 'unit': 'M', 'net_profit': -15.94}]",-0.0356,-0.0356,201579281,191350442,181876455,12057539,7558532,0,10486352,161790147,-35753598,-0.12565110597769524,-0.07069010426718757,0.1963882618510158,__nan__,__nan__,__nan__,0.05981536862411966
207,IMMR,Immersion Corporation Common Stock,"Immersion Corporation, together with its subsidiaries, invents, scales, and licenses haptic technologies that allow people to use their sense of touch to engage with and experience various digital products in North America, Europe, and Asia. The company provides technology, patent, and combined licenses. It also provides software development kits (SDKs) comprising tools, integration software, and effect libraries that allow for the design, encoding, and playback of tactile effects in content. In addition, the company offers reference designs and reference technology, engineering and integration services, and software and firmware services. The company offers its products to mobile communications, wearables, and consumer electronics; gaming and virtual reality (VR); automotive; and other markets. Immersion Corporation was incorporated in 1993 and is headquartered in Aventura, Florida.",Mr. Eric Brandon Singer,Software - Application,7.18,USD,232606152,https://images.financialmodelingprep.com/symbol/IMMR.png,455459,3.99,0.55,580489,17994000,33976000,"[{'period': '2023', 'revenue': 33.92, 'unit': 'M', 'net_profit': 33.98}, {'period': '2022', 'revenue': 38.46, 'unit': 'M', 'net_profit': 30.66}, {'period': '2021', 'revenue': 35.09, 'unit': 'M', 'net_profit': 12.48}, {'period': '2020', 'revenue': 30.46, 'unit': 'M', 'net_profit': 5.4}]","[{'period': ""Q4 '24"", 'revenue': 474.76, 'unit': 'M', 'net_profit': 15.47}, {'period': ""Q3 '24"", 'revenue': 616.25, 'unit': 'M', 'net_profit': 27.16}, {'period': ""Q2 '24"", 'revenue': 99.42, 'unit': 'M', 'net_profit': 28.95}, {'period': ""Q1 '24"", 'revenue': 43.85, 'unit': 'M', 'net_profit': 18.66}, {'period': ""Q4 '23"", 'revenue': 10.38, 'unit': 'M', 'net_profit': 15.99}, {'period': ""Q3 '23"", 'revenue': 9.48, 'unit': 'M', 'net_profit': 2.68}]",1.05,1.04,215731000,172450000,160362000,32629000,9981000,33350000,19313000,56071000,20600000,-0.26314496314496316,0.10800939212105401,0.14130434782608695,"[0.045, 0.13]","['2025-04-14', '2023-01-12']",__nan__,0.15124854564248996
208,IMNM,Immunome Inc. Common Stock,"Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.",Dr. Clay B. Siegall Ph.D.,Biotechnology,6.21,USD,539963226,https://images.financialmodelingprep.com/symbol/IMNM.png,1137719,-1.24,0.65,2250453,-151354000,-292963000,"[{'period': '2024', 'revenue': 9.04, 'unit': 'M', 'net_profit': -292.96}, {'period': '2023', 'revenue': 14.02, 'unit': 'M', 'net_profit': -106.81}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -37.51}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -24.47}]","[{'period': ""Q4 '24"", 'revenue': 2.74, 'unit': 'M', 'net_profit': -80.25}, {'period': ""Q3 '24"", 'revenue': 2.91, 'unit': 'M', 'net_profit': -47.1}, {'period': ""Q2 '24"", 'revenue': 2.36, 'unit': 'M', 'net_profit': -36.12}, {'period': ""Q1 '24"", 'revenue': 1.03, 'unit': 'M', 'net_profit': -129.49}, {'period': ""Q4 '23"", 'revenue': 3.83, 'unit': 'M', 'net_profit': -92.63}, {'period': ""Q3 '23"", 'revenue': 3.56, 'unit': 'M', 'net_profit': -4.34}]",-5,-5,240241000,221339000,217303000,59076000,0,0,54307000,143351000,-117967000,-4.353683987124615,-1.742945152894032,0.07063197026022303,__nan__,__nan__,__nan__,0.24590307233153375
209,IMOS,ChipMOS TECHNOLOGIES INC. American Depositary Shares,"ChipMOS TECHNOLOGIES INC. engages in the research, development, manufacture, and sale of high-integration and high-precision integrated circuits, and related assembly and testing services in Taiwan, People's Republic of China, Japan, Singapore, and internationally. It operates through Testing; Assembly; Testing and Assembly for LCD, OLED and other Display Panel Driver Semiconductors; Bumping; and Other segments. The company provides a range of back-end assembly and testing services, including engineering test, wafer probing, and final test of memory and logic/mixed-signal semiconductors, as well as leadframe-based and organic substrate-based package assembly services for memory and logic/mixed-signal semiconductors; and gold bumping, reel to reel assembly, and test services for LCD and other panel display driver semiconductors. Its semiconductors are used in personal computers; graphics applications, such as game consoles; communications equipment; mobile products comprising cellular handsets, tablets, and consumer electronic products; and automotive/industry and display applications, such as display panels. The company was incorporated in 1997 and is headquartered in Hsinchu, Taiwan.",Mr. Shih-Jye  Cheng,Semiconductors,14.45,USD,531140095,https://images.financialmodelingprep.com/symbol/IMOS.png,26490,12.46,0.7,38456,5826829000,1419995000,"[{'period': '2024', 'revenue': 22.7, 'unit': 'B', 'net_profit': 1.42}, {'period': '2023', 'revenue': 21.36, 'unit': 'B', 'net_profit': 1.97}, {'period': '2022', 'revenue': 23.52, 'unit': 'B', 'net_profit': 3.44}, {'period': '2021', 'revenue': 27.4, 'unit': 'B', 'net_profit': 4.94}]","[{'period': ""Q4 '24"", 'revenue': 5400.0, 'unit': 'M', 'net_profit': 232.23}, {'period': ""Q3 '24"", 'revenue': 6070.0, 'unit': 'M', 'net_profit': 299.4}, {'period': ""Q2 '24"", 'revenue': 5810.0, 'unit': 'M', 'net_profit': 450.58}, {'period': ""Q1 '24"", 'revenue': 5420.0, 'unit': 'M', 'net_profit': 437.79}, {'period': ""Q4 '23"", 'revenue': 5730.0, 'unit': 'M', 'net_profit': 481.99}, {'period': ""Q3 '23"", 'revenue': 5580.0, 'unit': 'M', 'net_profit': 580.57}]",1.93,1.93,45379852000,23643516000,15334089000,20305618000,5407901000,423226000,8673445000,15219039000,859427999,-0.1786324555000819,-0.2782983027244335,-0.2878228782287823,"[1.11166, 0.13097]","['2024-06-27', '2012-12-03']",__nan__,0.44745888549834845
210,IMPL,Impel NeuroPharma Inc. Common Stock,"Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. The company is also developing INP105, an upper nasal formulation of olanzapine for the acute treatment of agitation and aggression in autism spectrum disorder; and INP107, an upper nasal formulation of carbidopa/levodopa, which has completed Phase IIa clinical trial for the treatment of OFF episodes in Parkinson's disease. Impel Pharmaceuticals Inc. was formerly known as Impel NeuroPharma, Inc. and changed its name to Impel Pharmaceuticals Inc. in April 2022. Impel Pharmaceuticals Inc. was incorporated in 2008 and is headquartered in Seattle, Washington.",Mr. Leonard S. Paolillo,Biotechnology,0.04,USD,956000,https://images.financialmodelingprep.com/symbol/IMPL.png,1023947,-0.01282051282051282,-0.015,720030,-83184000,-129440000,"[{'period': '2022', 'revenue': 12.65, 'unit': 'M', 'net_profit': -129.44}, {'period': '2021', 'revenue': 0.668, 'unit': 'M', 'net_profit': -76.54}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -45.8}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -41.86}]","[{'period': ""Q3 '23"", 'revenue': 5.02, 'unit': 'M', 'net_profit': -13.81}, {'period': ""Q2 '23"", 'revenue': 6.58, 'unit': 'M', 'net_profit': -7.36}, {'period': ""Q1 '23"", 'revenue': 4.37, 'unit': 'M', 'net_profit': -38.63}, {'period': ""Q4 '22"", 'revenue': 5.01, 'unit': 'M', 'net_profit': -36.31}, {'period': ""Q3 '22"", 'revenue': 3.08, 'unit': 'M', 'net_profit': -40.95}, {'period': ""Q2 '22"", 'revenue': 2.8, 'unit': 'M', 'net_profit': -29.43}]",-5.52,-5.52,88550000,79809000,60654000,132707000,7444000,0,22163000,60654000,-95019000,-0.1816244779681241,-0.6912302707222745,-0.05343511450381667,__nan__,__nan__,__nan__,1.4986674195369847
211,IMRA,IMARA Inc. Common Stock,"IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas. IMARA Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.",Dr. Rahul D. Ballal Ph.D.,Biotechnology,6.32,USD,165797546,https://images.financialmodelingprep.com/symbol/IMRA.png,116259,105.33333333333333,0.87,271721,-68659000,1576000,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.58}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -51.15}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -40.88}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -22.89}]","[{'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -20.77}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -16.72}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 32.27}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.39}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.45}]",0.24,0.24,91959000,89636000,88198000,1830000,0,0,1830000,88198000,-35931000,-0.3372611651052724,1.0308107368379895,1.0253968253968255,__nan__,__nan__,__nan__,0.019900172903141618
212,IMRN,Immuron Limited American Depositary Shares,"Immuron Limited, a biopharmaceutical company, researches, develops, and commercializes polyclonal antibodies in Australia, the United States, and internationally. The company operates through two segments, Research and Development, and Hyperimmune Products. It markets Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and reduce the symptoms of minor gastro-intestinal disorders, as well as for dietary supplement for digestive tract protection; and Protectyn, an immune supplement to maintain a healthy digestive function and liver. The company is also developing Travelan (IMM-124E) that is in Phase III clinical trials to reduce the risk of contracting travelers' diarrhea, as well as acts as an anti-viral activity against SARS-CoV-2; and IMM-529, which is in clinical development stage focuses on treating patients suffering from recurring clostridium difficile infection. It has a research agreement with Naval Medical Research Center to develop and clinically evaluate a therapeutic targeting Campylobacter and ETEC infections; and a collaboration agreement with the Walter Reed Army Institute of Research to develop an oral therapeutic for shigellosis. Immuron Limited was incorporated in 1994 and is based in Carlton, Australia.","Mr. Steven George Lydeamore CPA, M.B.A.",Biotechnology,1.7,USD,9738686,https://images.financialmodelingprep.com/symbol/IMRN.png,12327,-2.21,-0.01,5856,-6192357,-6936957,"[{'period': '2024', 'revenue': 4.9, 'unit': 'M', 'net_profit': -6.94}, {'period': '2023', 'revenue': 1.8, 'unit': 'M', 'net_profit': -3.79}, {'period': '2022', 'revenue': 0.76519, 'unit': 'M', 'net_profit': -2.85}, {'period': '2021', 'revenue': 0.14578, 'unit': 'M', 'net_profit': -8.38}]","[{'period': ""Q2 '25"", 'revenue': 2.0, 'unit': 'M', 'net_profit': -1.24}, {'period': ""Q1 '25"", 'revenue': 2.0, 'unit': 'M', 'net_profit': -1.24}, {'period': ""Q4 '24"", 'revenue': 2.55, 'unit': 'M', 'net_profit': -4.86}, {'period': ""Q3 '24"", 'revenue': 1.27, 'unit': 'M', 'net_profit': -2.43}, {'period': ""Q2 '24"", 'revenue': 2.36, 'unit': 'M', 'net_profit': -2.07}, {'period': ""Q1 '24"", 'revenue': 1.18, 'unit': 'M', 'net_profit': -1.04}]",-0.0304,-0.0304,15549969,14726337,11657315,2840525,1387573,0,2698979,11657315,-5880334,-0.6309689772923315,-0.8320201177496833,-0.8313253012048193,__nan__,__nan__,__nan__,0.1826707821732635
213,IMRNW,Immuron Limited Warrants,"Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, Israel, Canada, the United States, and internationally. The company operates through two segments, Research and Development, and Hyperimmune Products. It offers Travelan, an over-the-counter medicine to reduce the risk of travelers’ diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for support digestive health and gastrointestinal tract protection; and Protectyn, an immune supplement to help maintain a healthy digestive function and liver. The company is also developing Travelan (IMM-124E) to reduce the risk of contracting travelers’ diarrhea in the United States, and Travelers’ Diarrhea; and IMM-529, for treating patients suffering from recurring clostridium difficile infection. It has a research agreement with Naval Medical Research Center to develop and clinically evaluate a therapeutic targeting Campylobacter and enterotoxigenic Escherichia coli infections; and a collaboration agreement with the Walter Reed Army Institute of Research to develop an oral therapeutic for shigellosis. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia.",None,Biotechnology,0.0855,USD,0,https://images.financialmodelingprep.com/symbol/IMRNW.png,0,0,0.0123,96555,-3401562,-3786507,"[{'period': '2023', 'revenue': 1.8, 'unit': 'M', 'net_profit': -3.79}, {'period': '2022', 'revenue': 0.76519, 'unit': 'M', 'net_profit': -2.85}, {'period': '2021', 'revenue': 0.14578, 'unit': 'M', 'net_profit': -8.38}, {'period': '2020', 'revenue': 2.52, 'unit': 'M', 'net_profit': -2.93}]",[],-0.0166,-0.0166,21988182,20409337,17159764,2371346,19029,159066,2219139,17159764,-2602934,-0.15262448981666438,-0.3266187942628792,-0.32799999999999996,__nan__,__nan__,__nan__,0.10784638766406426
214,IMTE,Integrated Media Technology Limited Ordinary Shares,"Integrated Media Technology Limited offers laminated switchable glass, nano-coated plate filter, air filter, and Internet of Things (IoT) products. It also engages in the provision of financial research services; development of Ouction platform, a non-fungible token trading marketplace; and distribution of halal food products. The company was formerly known as China Integrated Media Corporation Limited and changed its name to Integrated Media Technology Limited in October 2016. Integrated Media Technology Limited was incorporated in 2008 and is headquartered in Wan Chai, Hong Kong.",Mr. Con  Unerkov,"Hardware, Equipment & Parts",1.47,USD,5044202,https://images.financialmodelingprep.com/symbol/IMTE.png,2156390,-0.26,-0.03,83456,-17012025,-16733789,"[{'period': '2023', 'revenue': 0.37368, 'unit': 'M', 'net_profit': -16.73}, {'period': '2022', 'revenue': 0.52681, 'unit': 'M', 'net_profit': -15.62}, {'period': '2021', 'revenue': 0.19311, 'unit': 'M', 'net_profit': -8.11}, {'period': '2020', 'revenue': 1.74, 'unit': 'M', 'net_profit': -12.13}]","[{'period': ""Q2 '24"", 'revenue': 32.78, 'unit': 'K', 'net_profit': -954.42}, {'period': ""Q1 '24"", 'revenue': 33.53, 'unit': 'K', 'net_profit': -976.32}, {'period': ""Q4 '23"", 'revenue': 0.1018, 'unit': 'M', 'net_profit': -12.69}, {'period': ""Q3 '23"", 'revenue': 0.06192, 'unit': 'M', 'net_profit': -13.46}, {'period': ""Q2 '23"", 'revenue': 228.93, 'unit': 'K', 'net_profit': 427.26}, {'period': ""Q1 '23"", 'revenue': 226.44, 'unit': 'K', 'net_profit': 422.6}]",-7.52,-7.52,30134828,3690314,675781,13531649,17354,0,2387649,675781,-12160292,-0.9126424445450307,-0.07096839061002191,-6.91578947368421,__nan__,__nan__,__nan__,0.44903687520632274
215,IMTX,Immatics N.V. Ordinary Shares,"Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its ACTengine product candidates are in Phase I clinical trials, which include IMA201 that targets melanoma-associated antigen 4 or 8 in patients with solid tumors; IMA202 that targets melanoma-associated antigen 1 in patients with various solid tumors, including squamous non-small cell lung carcinoma and hepatocellular carcinoma; and IMA203 that targets preferentially expressed antigen in melanoma in adult patients with relapsed and/or refractory solid tumors, as well as IMA204, which is in preclinical studies that targets tumor stroma cell. The company's TCR Bispecifics product candidates, which are in preclinical studies include IMA401, a cancer testis antigen for the treatment of solid tumors; and IMA402 for the treatment of solid tumors. It also develops IMA101 for the treatment of cancer; and IMA301, an allogenic cellular therapy product candidate. The company has a strategic collaboration agreement with GlaxoSmithKline Intellectual Property Development Limited to develop novel adoptive cell therapies targeting multiple cancer indications; MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies; Celgene Switzerland LLC to develop novel adoptive cell therapies targeting multiple cancers; and Genmab A/S to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics N.V. is headquartered in Tübingen, Germany.",Dr. Harpreet  Singh Ph.D.,Biotechnology,4.04,USD,491062000,https://images.financialmodelingprep.com/symbol/IMTX.png,990952,26.93,0.52,919770,34457000,15218000,"[{'period': '2024', 'revenue': 155.84, 'unit': 'M', 'net_profit': 15.22}, {'period': '2023', 'revenue': 54.0, 'unit': 'M', 'net_profit': -96.99}, {'period': '2022', 'revenue': 172.83, 'unit': 'M', 'net_profit': 37.51}, {'period': '2021', 'revenue': 34.76, 'unit': 'M', 'net_profit': -95.06}]","[{'period': ""Q4 '24"", 'revenue': 56.25, 'unit': 'M', 'net_profit': 44.86}, {'period': ""Q3 '24"", 'revenue': 50.56, 'unit': 'M', 'net_profit': -8.57}, {'period': ""Q2 '24"", 'revenue': 18.75, 'unit': 'M', 'net_profit': -18.02}, {'period': ""Q1 '24"", 'revenue': 30.45, 'unit': 'M', 'net_profit': -3.07}, {'period': ""Q4 '23"", 'revenue': 15.92, 'unit': 'M', 'net_profit': -26.15}, {'period': ""Q3 '23"", 'revenue': 5.93, 'unit': 'M', 'net_profit': -26.49}]",0.14,0.14,696146000,629555000,604452000,121304000,6745000,0,67987000,236748000,-174510000,1.3874664057843897,1.1568963028640946,1.1166666666666667,__nan__,__nan__,__nan__,0.17425080371071586
216,IMTXW,Immatics N.V. Warrants,"Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its products pipeline includes IMA203 that targets solid tumors, which is in Phase 1b clinical trial; IMA203CD8, a cell therapy product that is in Phase 1b clinical trial; IMA204 that targets tumor stroma, which is in preclinical stage; and IMA30x, an allogenic cellular therapy product candidate, which is in preclinical stage. The company also develops TCR Bispecifics products, including IMA401, which is in Phase 1b clinical trial; and IMA402 and IMA403, which are in preclinical stages. The company has a strategic collaboration agreement with MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies; Celgene Corporation to develop novel adoptive cell therapies targeting multiple cancers; and Genmab A/S to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics N.V. is headquartered in Tübingen, Germany.",Dr. Harpreet  Singh Ph.D.,Biotechnology,0.0125,USD,491062686,https://images.financialmodelingprep.com/symbol/IMTXW.png,24845.74054,,-0.0029,200,34457000,15218000,"[{'period': '2024', 'revenue': 155.84, 'unit': 'M', 'net_profit': 15.22}, {'period': '2023', 'revenue': 54.0, 'unit': 'M', 'net_profit': -96.99}, {'period': '2022', 'revenue': 172.83, 'unit': 'M', 'net_profit': 37.51}, {'period': '2021', 'revenue': 34.76, 'unit': 'M', 'net_profit': -95.06}]","[{'period': ""Q4 '24"", 'revenue': 56.25, 'unit': 'M', 'net_profit': 44.86}, {'period': ""Q3 '24"", 'revenue': 50.56, 'unit': 'M', 'net_profit': -8.57}, {'period': ""Q2 '24"", 'revenue': 18.75, 'unit': 'M', 'net_profit': -18.02}, {'period': ""Q1 '24"", 'revenue': 30.45, 'unit': 'M', 'net_profit': -3.07}, {'period': ""Q4 '23"", 'revenue': 15.92, 'unit': 'M', 'net_profit': -26.15}, {'period': ""Q3 '23"", 'revenue': 5.93, 'unit': 'M', 'net_profit': -26.49}]",0.14,0.14,696146000,629555000,604452000,121304000,6745000,0,67987000,236748000,-174510000,1.3874664057843897,1.1568963028640946,1.1166666666666667,__nan__,__nan__,__nan__,0.17425080371071586
217,IMUX,Immunic Inc. Common Stock,"Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of ROR?t; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor induced colitis, and other intestinal barrier function diseases. Immunic, Inc. is headquartered in New York, New York.",Dr. Daniel  Vitt Ph.D.,Biotechnology,0.9246,USD,83353522,https://images.financialmodelingprep.com/symbol/IMUX.png,847818,-0.92,0.0296,1039287,-98052000,-100507000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -100.51}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -93.61}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -154.3}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -92.79}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -25.18}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -24.37}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.38}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -29.58}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -21.57}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -22.77}]",-1,-1,40868000,39332000,35668000,22439000,0,0,22175000,35668000,-85030000,0.010694971345548471,-0.07365508695466393,0.5260663507109005,__nan__,__nan__,__nan__,0.5490603895468337
218,IMV,IMV Inc. Common Shares,"IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and microsatellite instability high tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.",Mr. Andrew  Hall M.Sc.,Biotechnology,0.8225,USD,9632791,https://images.financialmodelingprep.com/symbol/IMV.png,152414,-0.18076923076923077,0,44894,-38492000,-38492000,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -38.49}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -37.5}, {'period': '2020', 'revenue': 0.00235, 'unit': 'M', 'net_profit': -27.36}, {'period': '2019', 'revenue': 0.04517, 'unit': 'M', 'net_profit': -21.9}]","[{'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.59}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.44}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.76}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.83}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.21}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.5}]",-4.61,-4.61,31348000,27588000,21223000,37950000,1925000,0,9420000,21223000,-34470000,-0.09535869781736434,-0.02656283336889268,0.08712871287128704,__nan__,__nan__,__nan__,1.2106035472757433
219,IMVT,Immunovant Inc. Common Stock,"Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia. The company was incorporated in 2018 is headquartered in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.","Dr. Peter  Salzmann M.B.A., M.D.",Biotechnology,14.9,USD,2530928900,https://images.financialmodelingprep.com/symbol/IMVT.png,1764868,-5.69,1.59,5250831,-269978000,-259336000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -259.34}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -210.96}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -156.73}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -107.43}]","[{'period': ""Q3 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -111.12}, {'period': ""Q2 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -109.12}, {'period': ""Q1 '25"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -87.15}, {'period': ""Q4 '24"", 'revenue': 1.5, 'unit': 'M', 'net_profit': -75.32}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -51.42}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -58.66}]",-1.88,-1.88,666365000,665770000,635365000,48608000,5503000,0,48608000,635365000,-214587000,-0.2878970743272575,-0.22931361395525218,-0.09941520467836254,__nan__,__nan__,__nan__,0.07294500761594622
220,IMXI,International Money Express Inc. Common Stock,"International Money Express, Inc., through its subsidiary, operates as a money remittance services company in the United States, Latin America, Mexico, Africa, Central and South America, and the Caribbean. The company offers remittance services, which include a suite of ancillary financial processing solutions and payment services; and online payment options, pre-paid debit cards, and direct deposit payroll cards. It provides services through sending and paying agents and company-operated stores, as well as through online and Internet-enabled mobile devices. International Money Express, Inc. is headquartered in Miami, Florida.",Mr. Robert  Lisy,Software - Infrastructure,12.34,USD,378248148,https://images.financialmodelingprep.com/symbol/IMXI.png,322436,6.89,0.88,324766,108661000,58821000,"[{'period': '2024', 'revenue': 658.65, 'unit': 'M', 'net_profit': 58.82}, {'period': '2023', 'revenue': 658.74, 'unit': 'M', 'net_profit': 59.52}, {'period': '2022', 'revenue': 546.8, 'unit': 'M', 'net_profit': 57.33}, {'period': '2021', 'revenue': 459.21, 'unit': 'M', 'net_profit': 46.84}]","[{'period': ""Q4 '24"", 'revenue': 164.76, 'unit': 'M', 'net_profit': 15.38}, {'period': ""Q3 '24"", 'revenue': 171.95, 'unit': 'M', 'net_profit': 17.3}, {'period': ""Q2 '24"", 'revenue': 148.73, 'unit': 'M', 'net_profit': 14.03}, {'period': ""Q1 '24"", 'revenue': 130.07, 'unit': 'M', 'net_profit': 12.11}, {'period': ""Q4 '23"", 'revenue': 148.11, 'unit': 'M', 'net_profit': 17.5}, {'period': ""Q3 '23"", 'revenue': 172.44, 'unit': 'M', 'net_profit': 14.83}]",1.81,1.79,462377000,297783000,130503000,327453000,107077000,0,151998000,130503000,23088000,0.002814795673520617,-0.011660925817020919,0.0838323353293414,__nan__,__nan__,__nan__,0.7081948280299409
221,INBK,First Internet Bancorp Common Stock,"First Internet Bancorp operates as the bank holding company for First Internet Bank of Indiana that provides commercial and retail banking products and services to individuals and commercial customers in the United States. The company accepts non-interest bearing and interest-bearing demand deposit, savings, money market, and brokered deposit accounts, as well as certificates of deposit. It also offers commercial and industrial, owner-occupied and investor commercial real estate, construction, residential mortgage, home equity and improvement, small installment, term, and other consumer loans, as well as single tenant lease financing, and public and healthcare finance; franchise finance; and small business lending. In addition, the company is involved in the purchase, manage, service, and safekeeping of municipal securities; and provision of municipal finance lending and leasing products to government entities. In addition, it offers corporate credit card and treasury management services. The company provides its services through its firstib.com Website. First Internet Bancorp was founded in 1999 and is headquartered in Fishers, Indiana.",Mr. David B. Becker,Banks - Regional,25.48,USD,221601598,https://images.financialmodelingprep.com/symbol/INBK.png,35998,8.85,2.19,98385,0,25276000,"[{'period': '2024', 'revenue': 291.89, 'unit': 'M', 'net_profit': 25.28}, {'period': '2023', 'revenue': 84.38, 'unit': 'M', 'net_profit': 8.42}, {'period': '2022', 'revenue': 113.37, 'unit': 'M', 'net_profit': 35.54}, {'period': '2021', 'revenue': 118.37, 'unit': 'M', 'net_profit': 48.11}]","[{'period': ""Q4 '24"", 'revenue': 77.77, 'unit': 'M', 'net_profit': 7.33}, {'period': ""Q3 '24"", 'revenue': 32.3, 'unit': 'M', 'net_profit': 6.99}, {'period': ""Q2 '24"", 'revenue': 81.99, 'unit': 'M', 'net_profit': 5.78}, {'period': ""Q1 '24"", 'revenue': 26.63, 'unit': 'M', 'net_profit': 5.18}, {'period': ""Q4 '23"", 'revenue': 23.61, 'unit': 'M', 'net_profit': 4.14}, {'period': ""Q3 '23"", 'revenue': 22.84, 'unit': 'M', 'net_profit': 3.41}]",2.91,2.88,5737859000,624784000,596604000,5353796000,28180000,0,2495000,9249000,12992000,0,2.0029701793988357,2.0631578947368423,"[0.06, 0.25]","['2025-03-31', '2012-12-06']",__nan__,0.9330651032031285
222,INBKL,First Internet Bancorp 6.0% Fixed-to-Floating Rate Subordinated Notes due 2026,,None,,25.03,USD,0,https://images.financialmodelingprep.com/symbol/INBKL.png,1000,10.355812991311543,-0.16,341,-38420000,29453000,"[{'period': '2020', 'revenue': 136.86, 'unit': 'M', 'net_profit': 29.45}]","[{'period': ""Q2 '21"", 'revenue': 33.38, 'unit': 'M', 'net_profit': 13.1}, {'period': ""Q4 '20"", 'revenue': 136.86, 'unit': 'M', 'net_profit': 29.45}]",4.52,4.52,12054000,7367000,7367000,3915212000,0,0,79603000,7367000,,0,0,0,"[0.375, 0.375]","['2021-08-12', '2017-08-11']",__nan__,324.8060394889663
223,INBKZ,First Internet Bancorp 6.0% Fixed-to-Floating Rate Subordinated Notes Due 2029,"First Internet Bancorp engages in the provision of online commercial and retail banking products and services. It offers first-lien residential mortgage loans, consumer loans and credit cards & CRE loans in Indiana and other parts of the midwest in the form of office, retail, industrial, and multifamily loans, with credit tenant lease financing. The company was founded on September 15, 2005 and is headquartered in Indianapolis, IN.",None,Banks - Regional,24.4,USD,203556219,https://images.financialmodelingprep.com/symbol/INBKZ.png,2296,,0.14,1155,0,25276000,"[{'period': '2024', 'revenue': 291.89, 'unit': 'M', 'net_profit': 25.28}, {'period': '2023', 'revenue': 84.38, 'unit': 'M', 'net_profit': 8.42}, {'period': '2022', 'revenue': 113.37, 'unit': 'M', 'net_profit': 35.54}, {'period': '2021', 'revenue': 118.37, 'unit': 'M', 'net_profit': 48.11}]","[{'period': ""Q4 '24"", 'revenue': 77.77, 'unit': 'M', 'net_profit': 7.33}, {'period': ""Q3 '24"", 'revenue': 32.3, 'unit': 'M', 'net_profit': 6.99}, {'period': ""Q2 '24"", 'revenue': 81.99, 'unit': 'M', 'net_profit': 5.78}, {'period': ""Q1 '24"", 'revenue': 26.63, 'unit': 'M', 'net_profit': 5.18}, {'period': ""Q4 '23"", 'revenue': 23.61, 'unit': 'M', 'net_profit': 4.14}, {'period': ""Q3 '23"", 'revenue': 22.84, 'unit': 'M', 'net_profit': 3.41}]",2.91,2.88,5737859000,624784000,596604000,5353796000,28180000,0,2495000,9249000,12992000,0,2.0029701793988357,2.0631578947368423,"[0.5438, 0.375]","['2025-02-14', '2019-08-14']",__nan__,0.9330651032031285
224,INBX,Inhibrx Inc. Common Stock,"Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates includes INBRX-109, a tetravalent therapeutic candidate targeting death-receptor 5 that is in phase 2 clinical trial for the treatment of unresectable or metastatic conventional chondrosarcoma; and INBRX-106, a hexavalent sdAb-based therapeutic candidate targeting OX4 that is in phase 2 clinical trial for the treatment of metastatic solid tumor, non-small cell lung cancer, melanoma, head and neck cancer, gastric (GIST) and gastroesophageal adenocarcinoma (GEA) cancer, renal cell carcinoma, and urothelial (transitional) cell carcinoma. The company was incorporated in 2024 and is based in La Jolla, California.",Mr. Mark Paul Lappe,Biotechnology,12.35,USD,178777414,https://images.financialmodelingprep.com/symbol/INBX.png,111257,0.11,0.66,178262,1703350000,1687572000,"[{'period': '2024', 'revenue': 0.00019999999999999998, 'unit': 'B', 'net_profit': 1.69}, {'period': '2023', 'revenue': 1.8, 'unit': 'M', 'net_profit': -241.36}, {'period': '2022', 'revenue': 2.18, 'unit': 'M', 'net_profit': -145.23}, {'period': '2021', 'revenue': 7.12, 'unit': 'M', 'net_profit': -81.77}]","[{'period': ""Q4 '24"", 'revenue': 0.1, 'unit': 'M', 'net_profit': -47.87}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -43.86}, {'period': ""Q2 '24"", 'revenue': 9.999999999999999e-05, 'unit': 'B', 'net_profit': 1.86}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -78.71}, {'period': ""Q4 '23"", 'revenue': 1.63, 'unit': 'M', 'net_profit': -93.6}, {'period': ""Q3 '23"", 'revenue': 0.11900000000000001, 'unit': 'M', 'net_profit': -51.79}]",114.01,112.62,180767000,160398000,152596000,47183000,397000,0,40730000,152596000,-197006000,9.240966070452313,7.991900099850431,23.267578125,"[0.85, 0.85]","['2024-05-30', '2024-05-30']",__nan__,0.26101556146863086
225,INCY,Incyte Corp. Common Stock,"Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia. Its clinical stage products include ruxolitinib, a steroid-refractory chronic graft-versus-host-diseases (GVHD); itacitinib, which is in Phase II/III clinical trial to treat naive chronic GVHD; and pemigatinib for treating bladder cancer, cholangiocarcinoma, myeloproliferative syndrome, and tumor agnostic. In addition, the company engages in developing Parsaclisib, which is in Phase II clinical trial for follicular lymphoma, marginal zone lymphoma, and mantel cell lymphoma. Additionally, it develops Retifanlimab that is in Phase II clinical trials for MSI-high endometrial cancer, merkel cell carcinoma, and anal cancer, as well as in Phase II clinical trials for patients with non-small cell lung cancer. It has collaboration agreements with Novartis International Pharmaceutical Ltd.; Eli Lilly and Company; Agenus Inc.; Calithera Biosciences, Inc; MacroGenics, Inc.; Merus N.V.; Syros Pharmaceuticals, Inc.; Innovent Biologics, Inc.; Zai Lab Limited; Cellenkos, Inc.; and Nimble Therapeutics, as well as clinical collaborations with MorphoSys AG and Xencor, Inc. to investigate the combination of tafasitamab, plamotamab, and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma, and relapsed or refractory follicular lymphoma. The company was incorporated in 1991 and is headquartered in Wilmington, Delaware.",Mr. Herve  Hoppenot,Biotechnology,58.86,USD,11390822640,https://images.financialmodelingprep.com/symbol/INCY.png,1918596,392.4,1.89,3623479,408158000,32615000,"[{'period': '2024', 'revenue': 4240.0, 'unit': 'M', 'net_profit': 32.62}, {'period': '2023', 'revenue': 3700.0, 'unit': 'M', 'net_profit': 597.6}, {'period': '2022', 'revenue': 3390.0, 'unit': 'M', 'net_profit': 340.66}, {'period': '2021', 'revenue': 2990.0, 'unit': 'M', 'net_profit': 948.58}]","[{'period': ""Q4 '24"", 'revenue': 1180.0, 'unit': 'M', 'net_profit': 201.21}, {'period': ""Q3 '24"", 'revenue': 1140.0, 'unit': 'M', 'net_profit': 106.46}, {'period': ""Q2 '24"", 'revenue': 1040.0, 'unit': 'M', 'net_profit': -444.6}, {'period': ""Q1 '24"", 'revenue': 880.89, 'unit': 'M', 'net_profit': 169.55}, {'period': ""Q4 '23"", 'revenue': 1010.0, 'unit': 'M', 'net_profit': 201.08}, {'period': ""Q3 '23"", 'revenue': 919.02, 'unit': 'M', 'net_profit': 171.27}]",0.16,0.15,5444322000,3239030000,2158092000,1996694000,853154000,18814000,1641847000,1687829000,249074000,-0.5560730281719246,-0.9454232687805703,-0.9400749063670412,__nan__,__nan__,__nan__,0.36674796237254154
226,INDB,Independent Bank Corp. Common Stock,"Independent Bank Corp. operates as the bank holding company for Rockland Trust Company that provides commercial banking products and services to individuals and small-to-medium sized businesses primarily in Massachusetts. The company accepts interest checking, money market, and savings accounts, as well as demand deposits and time certificates of deposit. It also offers commercial and industrial, commercial real estate and construction, small business, consumer real estate, and personal loans. In addition, the company provides investment management and trust services to individuals, institutions, small businesses, and charitable institutions; Internet and mobile banking services, as well as estate settlement, financial planning, tax services, and other services; automated teller machine and debit cards; and mutual fund and unit investment trust shares, general securities, fixed and variable annuities, and life insurance products. As of December 31, 2021, it operates one hundred nineteen retail branches, two limited-service retail branches, and one mobile branch located within Barnstable, Bristol, Dukes, Essex, Middlesex, Nantucket, Norfolk, Plymouth, Suffolk, and Worcester counties in Eastern Massachusetts. The company was founded in 1907 and is headquartered in Rockland, Massachusetts.",Mr. Jeffrey J. Tengel,Banks - Regional,58.62,USD,2492945167,https://images.financialmodelingprep.com/symbol/INDB.png,312160,12.97,3.99,543697,0,192081000,"[{'period': '2024', 'revenue': 852.75, 'unit': 'M', 'net_profit': 192.08}, {'period': '2023', 'revenue': 795.73, 'unit': 'M', 'net_profit': 239.5}, {'period': '2022', 'revenue': 727.92, 'unit': 'M', 'net_profit': 263.81}, {'period': '2021', 'revenue': 507.41, 'unit': 'M', 'net_profit': 120.99}]","[{'period': ""Q4 '24"", 'revenue': 174.92, 'unit': 'M', 'net_profit': 50.03}, {'period': ""Q3 '24"", 'revenue': 248.95, 'unit': 'M', 'net_profit': 42.95}, {'period': ""Q2 '24"", 'revenue': 243.45, 'unit': 'M', 'net_profit': 51.33}, {'period': ""Q1 '24"", 'revenue': 237.74, 'unit': 'M', 'net_profit': 47.77}, {'period': ""Q4 '23"", 'revenue': 207.17, 'unit': 'M', 'net_profit': 54.8}, {'period': ""Q3 '23"", 'revenue': 183.42, 'unit': 'M', 'net_profit': 60.81}]",4.52,4.52,19373565000,187849000,187849000,16380445000,0,2711349000,0,187849000,229921000,0,-0.19799834656913096,-0.16605166051660522,"[0.59, 0.0701]","['2025-03-31', '1986-08-05']",__nan__,0.8455049444952439
227,INDT,INDUS Realty Trust Inc. (MD) Common Stock,"INDUS Realty Trust, Inc. is a real estate business principally engaged in developing, acquiring, managing and leasing industrial/warehouse properties. INDUS owns 41 buildings totaling approximately 4.6 million square feet (4.2 million of which is industrial/warehouse space) in Connecticut, Pennsylvania, North Carolina and Florida in addition to over 3,400 acres of undeveloped land.",Mr. Michael S. Gamzon,Real Estate - Services,66.99,USD,683164020,https://images.financialmodelingprep.com/symbol/INDT.png,98346,-209.34375,0.01,254370,25697000,2770000,"[{'period': '2022', 'revenue': 49.2, 'unit': 'M', 'net_profit': 2.77}, {'period': '2021', 'revenue': 42.34, 'unit': 'M', 'net_profit': 14.14}, {'period': '2020', 'revenue': 37.65, 'unit': 'M', 'net_profit': -10.48}, {'period': '2019', 'revenue': 44.05, 'unit': 'M', 'net_profit': 3.67}]","[{'period': ""Q1 '23"", 'revenue': 13.57, 'unit': 'M', 'net_profit': -13.31}, {'period': ""Q4 '22"", 'revenue': 12.9, 'unit': 'M', 'net_profit': -2.28}, {'period': ""Q3 '22"", 'revenue': 13.04, 'unit': 'M', 'net_profit': 1.12}, {'period': ""Q2 '22"", 'revenue': 11.73, 'unit': 'M', 'net_profit': 2.82}, {'period': ""Q1 '22"", 'revenue': 11520.0, 'unit': 'K', 'net_profit': 269.0}, {'period': ""Q4 '21"", 'revenue': 11.66, 'unit': 'M', 'net_profit': 19.61}]",0.27,0.27,596807000,52401000,52014000,199538000,2790000,0,19635000,52014000,-50231000,0.3355334961800322,-0.8041572398190046,-0.8491620111731844,"[0.18, 0.1]","['2023-06-21', '2007-11-19']",__nan__,0.3343425931666351
228,INFI,Infinity Pharmaceuticals Inc. Common Stock,"Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the treatment of solid tumors. The company has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib; and PellePharm, Inc. to develop and commercialize rights to its hedgehog inhibitor program, IPI-926, a clinical-stage product candidate, as well as collaboration agreements with Arcus Biosciences, Inc., F. Hoffmann-La Roche Ltd., and Bristol Myers Squibb Company. Infinity Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Cambridge, Massachusetts.",Mr. Seth A. Tasker J.D.,Biotechnology,0.008,USD,726089,https://images.financialmodelingprep.com/symbol/INFI.png,3984632,-0.01818181818181818,-0.0088,2476982,-44844000,-43256000,"[{'period': '2022', 'revenue': 2.59, 'unit': 'M', 'net_profit': -43.26}, {'period': '2021', 'revenue': 1.86, 'unit': 'M', 'net_profit': -45.44}, {'period': '2020', 'revenue': 1.72, 'unit': 'M', 'net_profit': -42.94}, {'period': '2019', 'revenue': 3.05, 'unit': 'M', 'net_profit': -47.06}]","[{'period': ""Q2 '23"", 'revenue': 0.583, 'unit': 'M', 'net_profit': -9.96}, {'period': ""Q1 '23"", 'revenue': 0.731, 'unit': 'M', 'net_profit': -10.63}, {'period': ""Q4 '22"", 'revenue': 0.543, 'unit': 'M', 'net_profit': -8.77}, {'period': ""Q3 '22"", 'revenue': 0.712, 'unit': 'M', 'net_profit': -10.55}, {'period': ""Q2 '22"", 'revenue': 0.686, 'unit': 'M', 'net_profit': -11.95}, {'period': ""Q1 '22"", 'revenue': 0.652, 'unit': 'M', 'net_profit': -12.44}]",-0.48,-0.48,42151000,40302000,38313000,61202000,0,0,13628000,38313000,-42448000,-0.005403223998385759,0.04810527705646758,0.09433962264150951,__nan__,__nan__,__nan__,1.4519702972645963
229,INFN,Infinera Corporation Common Stock,"Infinera Corporation provides optical transport networking equipment, software, and services worldwide. The company's product portfolio includes Infinera Groove series for modular and sled-based platforms to support a various transport network applications; Infinera 7300 series, an SDN-ready coherent optical transport system; Infinera FlexILS open optical line system that connects various Infinera and third-party terminal equipment platforms over long-distance fiber optic cable providing switching, multiplexing, amplification, and management channels; and Infinera 7090 and 7100 series for transport platforms. It also offers Infinera XTM series, a packet-optical transport platform that enables metro connectivity solutions; Infinera XTC series, a multi-terabit packet optical transport platforms that integrates digital OTN switching and optical WDM transmission; Infinera mTera series, a network transport solution; and Infinera XT series, a platform that is designed to power cloud scale network services over metro, DCI, long-haul, and subsea networks. The company provides Infinera Cloud Xpress Family that is designed to meet the needs of internet content providers (ICPs), communication service providers, internet exchange service providers, enterprises, and other large-scale data center operators; and ICE-XR Coherent Pluggable Optics. It also offers Infinera Transcend software suite; and system software and customer support services. The company also serves telecommunications service providers, ICPs, cable providers, wholesale carriers, research and education institutions, large enterprises, and government entities. It markets and sells its products and related support services primarily through its direct sales force. The company was formerly known as Zepton Networks. The company was incorporated in 2000 and is headquartered in San Jose, California.",Mr. David W. Heard,Communication Equipment,6.64,USD,1572365280,https://images.financialmodelingprep.com/symbol/INFN.png,950297,-10.375,0,8706267,-38391000,-150338000,"[{'period': '2024', 'revenue': 1420.0, 'unit': 'M', 'net_profit': -150.34}, {'period': '2023', 'revenue': 1610.0, 'unit': 'M', 'net_profit': -25.21}, {'period': '2022', 'revenue': 1570.0, 'unit': 'M', 'net_profit': -76.04}, {'period': '2021', 'revenue': 1430.0, 'unit': 'M', 'net_profit': -170.78}]","[{'period': ""Q4 '24"", 'revenue': 414.39, 'unit': 'M', 'net_profit': -26.34}, {'period': ""Q3 '24"", 'revenue': 354.4, 'unit': 'M', 'net_profit': -14.31}, {'period': ""Q2 '24"", 'revenue': 342.74, 'unit': 'M', 'net_profit': -48.29}, {'period': ""Q1 '24"", 'revenue': 306.92, 'unit': 'M', 'net_profit': -61.4}, {'period': ""Q4 '23"", 'revenue': 453.46, 'unit': 'M', 'net_profit': 12.87}, {'period': ""Q3 '23"", 'revenue': 392.37, 'unit': 'M', 'net_profit': -9.41}]",-0.64,-0.64,1533758000,945822000,145808000,1417243000,336552000,0,626771000,145808000,5667000,-1.4173615263358157,-4.962717645658985,-4.818181818181818,__nan__,__nan__,__nan__,0.9240329960789121
230,INGN,Inogen Inc Common Stock,"Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.",Mr. Kevin R. M. Smith,Medical - Devices,7.04,USD,189285888,https://images.financialmodelingprep.com/symbol/INGN.png,346542,-4.63,0.45,346517,-42516000,-35888000,"[{'period': '2024', 'revenue': 335.7, 'unit': 'M', 'net_profit': -35.89}, {'period': '2023', 'revenue': 315.66, 'unit': 'M', 'net_profit': -102.45}, {'period': '2022', 'revenue': 377.24, 'unit': 'M', 'net_profit': -83.77}, {'period': '2021', 'revenue': 358.0, 'unit': 'M', 'net_profit': -6.33}]","[{'period': ""Q4 '24"", 'revenue': 80.08, 'unit': 'M', 'net_profit': -9.76}, {'period': ""Q3 '24"", 'revenue': 88.83, 'unit': 'M', 'net_profit': -5.96}, {'period': ""Q2 '24"", 'revenue': 88.77, 'unit': 'M', 'net_profit': -5.59}, {'period': ""Q1 '24"", 'revenue': 78.03, 'unit': 'M', 'net_profit': -14.58}, {'period': ""Q4 '23"", 'revenue': 75.9, 'unit': 'M', 'net_profit': -26.55}, {'period': ""Q3 '23"", 'revenue': 83.97, 'unit': 'M', 'net_profit': -45.72}]",-1.52,-1.52,296185000,185451000,113795000,122325000,29563000,0,76686000,113795000,5914000,0.2712375728488173,0.6496988745619772,0.6561085972850679,__nan__,__nan__,__nan__,0.4130020088795854
231,INKA,KludeIn I Acquisition Corp. Class A Common Stock,"KludeIn I Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more businesses. It intends to focus on completing a business combination with a software or technology-enabled business serving consumers or enterprises in the United States. The company was incorporated in 2020 and is based in Berkeley, California.",Mr. Narayan  Ramachandran CFA,Shell Companies,10.4235,USD,51391607,https://images.financialmodelingprep.com/symbol/INKA.png,55998,43.43125,0.2785,164617,-11447069,5032569,"[{'period': '2022', 'revenue': 59.75, 'unit': 'M', 'net_profit': 5.03}, {'period': '2021', 'revenue': 0.0, 'unit': 'K', 'net_profit': -850.64}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q2 '23"", 'revenue': 17.71, 'unit': 'M', 'net_profit': -17.74}, {'period': ""Q1 '23"", 'revenue': 15.51, 'unit': 'M', 'net_profit': -19.16}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 216.26}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -97.7}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -866.58}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.78}]",0.36,0.36,107433910,101161,101161,12433892,26011,107332,4796870,101161,-2405764,-2.521727546622537,6.916207894987427,9.91089108910891,__nan__,__nan__,__nan__,0.115735264591971
232,INKAU,KludeIn I Acquisition Corp. Unit,"KludeIn I Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more businesses. It intends to focus on completing a business combination with a software or technology-enabled business serving consumers or enterprises in the United States. The company was incorporated in 2020 and is based in Berkeley, California.",Mr. Narayan  Ramachandran CFA,Shell Companies,10.49,USD,50532323,https://images.financialmodelingprep.com/symbol/INKAU.png,647,57.01086956521739,0,102,-11447069,5032569,"[{'period': '2022', 'revenue': 59.75, 'unit': 'M', 'net_profit': 5.03}, {'period': '2021', 'revenue': 0.0, 'unit': 'K', 'net_profit': -850.64}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q2 '23"", 'revenue': 17.71, 'unit': 'M', 'net_profit': -17.74}, {'period': ""Q1 '23"", 'revenue': 15.51, 'unit': 'M', 'net_profit': -19.16}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 216.26}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -97.7}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -866.58}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.78}]",0.36,0.36,107433910,101161,101161,12433892,26011,107332,4796870,101161,-2405764,-2.521727546622537,6.916207894987427,9.91089108910891,__nan__,__nan__,__nan__,0.115735264591971
233,INKAW,KludeIn I Acquisition Corp. Warrant,"KludeIn I Acquisition Corp. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more businesses. It intends to focus on completing a business combination with a software or technology-enabled business serving consumers or enterprises in the United States. The company was founded in 2020 and is based in Berkeley, California.",Mr. Narayan  Ramachandran CFA,Shell Companies,0.1661,USD,0,https://images.financialmodelingprep.com/symbol/INKAW.png,0,0,0.0161,13300,-11447069,5032569,"[{'period': '2022', 'revenue': 59.75, 'unit': 'M', 'net_profit': 5.03}, {'period': '2021', 'revenue': 0.0, 'unit': 'K', 'net_profit': -850.64}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q2 '23"", 'revenue': 17.71, 'unit': 'M', 'net_profit': -17.74}, {'period': ""Q1 '23"", 'revenue': 15.51, 'unit': 'M', 'net_profit': -19.16}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 216.26}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -97.7}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -866.58}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.78}]",0.36,0.36,107433910,101161,101161,12433892,26011,107332,4796870,101161,-2405764,-2.521727546622537,6.916207894987427,9.91089108910891,__nan__,__nan__,__nan__,0.115735264591971
234,INM,InMed Pharmaceuticals Inc. Common Shares,"InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of pain. In addition, it engages in the development of cannabinoid-based treatments for various diseases, including dermatology and ocular diseases. Further, the company works on IND-enabling pharmacology and preclinical toxicology studies; and IntegraSyn, an integrated biosynthesis-based manufacturing approach, for synthesizing pharmaceutical-grade cannabinoids. It has a research collaboration agreement with BayMedica Inc. for the manufacturing and testing of novel cannabinoid therapeutics. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada.","Mr. Eric A. Adams B.S. Chem., M.I.B.",Biotechnology,2.425,USD,2927424,https://images.financialmodelingprep.com/symbol/INM.png,488185,-0.2,0.245,44664,-7063931,-7675550,"[{'period': '2024', 'revenue': 4.6, 'unit': 'M', 'net_profit': -7.68}, {'period': '2023', 'revenue': 4.14, 'unit': 'M', 'net_profit': -7.95}, {'period': '2022', 'revenue': 1.09, 'unit': 'M', 'net_profit': -18.6}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -10.2}]","[{'period': ""Q2 '25"", 'revenue': 1.11, 'unit': 'B', 'net_profit': -2.58}, {'period': ""Q1 '25"", 'revenue': 0.00126, 'unit': 'B', 'net_profit': -1.68}, {'period': ""Q4 '24"", 'revenue': 1.28, 'unit': 'M', 'net_profit': -1.94}, {'period': ""Q3 '24"", 'revenue': 1.17, 'unit': 'M', 'net_profit': -1.72}, {'period': ""Q2 '24"", 'revenue': 1.24, 'unit': 'M', 'net_profit': -1.48}, {'period': ""Q1 '24"", 'revenue': 1.69, 'unit': 'M', 'net_profit': -2.54}]",-1.0071,-1.0071,11822782,8689585,6614674,2616673,352838,0,1971808,6571610,-6995125,0.34784680712777905,0.03423313287924363,0.7657906976744185,__nan__,__nan__,__nan__,0.2213246425418315
235,INMB,INmune Bio Inc. Common stock,"INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma and patients with high-risk myelodysplastic syndrome; INB03, an immunotherapy that treats patients with hematologic malignancies and solid tumors; and XPro1595 for the treatment of Alzheimer's disease. The company has license agreements with Xencor, Inc.; Immune Ventures, LLC; University of Pittsburg; and University College London. INmune Bio, Inc. was incorporated in 2015 and is headquartered in Boca Raton, Florida.",Dr. Raymond Joseph Tesi M.D.,Biotechnology,7.63,USD,174958189,https://images.financialmodelingprep.com/symbol/INMB.png,378619,-3.62,0.79,376068,-42635000,-42082000,"[{'period': '2024', 'revenue': 0.014, 'unit': 'M', 'net_profit': -42.08}, {'period': '2023', 'revenue': 0.155, 'unit': 'M', 'net_profit': -30.01}, {'period': '2022', 'revenue': 0.374, 'unit': 'M', 'net_profit': -28.65}, {'period': '2021', 'revenue': 0.181, 'unit': 'M', 'net_profit': -30.34}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.22}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -12.09}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.75}, {'period': ""Q1 '24"", 'revenue': 0.014, 'unit': 'M', 'net_profit': -11.03}, {'period': ""Q4 '23"", 'revenue': 0.028, 'unit': 'M', 'net_profit': -8.41}, {'period': ""Q3 '23"", 'revenue': 0.043000000000000003, 'unit': 'M', 'net_profit': -8.56}]",-2.08,-2.08,39562000,22662000,20922000,7465000,0,0,7221000,20922000,-33361000,-0.43354292054739246,-0.4023593708344442,-0.24550898203592825,__nan__,__nan__,__nan__,0.18869116829280622
236,INMD,InMode Ltd. Ordinary Shares,"InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.",Mr. Moshe  Mizrahy,Medical - Devices,15.46,USD,1075377502,https://images.financialmodelingprep.com/symbol/INMD.png,1208563,6.87,0.98,4096906,113259000,181275000,"[{'period': '2024', 'revenue': 394.82, 'unit': 'M', 'net_profit': 181.28}, {'period': '2023', 'revenue': 492.05, 'unit': 'M', 'net_profit': 197.92}, {'period': '2022', 'revenue': 454.27, 'unit': 'M', 'net_profit': 161.52}, {'period': '2021', 'revenue': 357.56, 'unit': 'M', 'net_profit': 164.97}]","[{'period': ""Q4 '24"", 'revenue': 97.85, 'unit': 'M', 'net_profit': 82.77}, {'period': ""Q3 '24"", 'revenue': 130.23, 'unit': 'M', 'net_profit': 50.99}, {'period': ""Q2 '24"", 'revenue': 86.45, 'unit': 'M', 'net_profit': 23.82}, {'period': ""Q1 '24"", 'revenue': 80.28, 'unit': 'M', 'net_profit': 23.7}, {'period': ""Q4 '23"", 'revenue': 126.78, 'unit': 'M', 'net_profit': 55.16}, {'period': ""Q3 '23"", 'revenue': 123.11, 'unit': 'M', 'net_profit': 46.52}]",2.29,2.25,785667000,714452000,596472000,81854000,41051000,700000,69851000,155329000,131995000,-0.42298110381439047,-0.08409500856410956,-0.03375527426160341,__nan__,__nan__,__nan__,0.10418408816966984
237,INNV,InnovAge Holding Corp. Common Stock,"InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. It manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. The company offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. It serves approximately 6,850 PACE participants in the United States; and operates 18 PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.",Mr. Patrick  Blair,Medical - Care Facilities,2.81,USD,380035640,https://images.financialmodelingprep.com/symbol/INNV.png,62975,-14.79,0.185,72621,1154000,-21338000,"[{'period': '2024', 'revenue': 763.86, 'unit': 'M', 'net_profit': -21.34}, {'period': '2023', 'revenue': 688.09, 'unit': 'M', 'net_profit': -40.67}, {'period': '2022', 'revenue': 698.64, 'unit': 'M', 'net_profit': -7.96}, {'period': '2021', 'revenue': 637.8, 'unit': 'M', 'net_profit': -44.74}]","[{'period': ""Q2 '25"", 'revenue': 209.0, 'unit': 'M', 'net_profit': -13.22}, {'period': ""Q1 '25"", 'revenue': 205.14, 'unit': 'M', 'net_profit': -4.93}, {'period': ""Q4 '24"", 'revenue': 199.4, 'unit': 'M', 'net_profit': -1.7}, {'period': ""Q3 '24"", 'revenue': 193.07, 'unit': 'M', 'net_profit': -5.89}, {'period': ""Q2 '24"", 'revenue': 188.9, 'unit': 'M', 'net_profit': -3.45}, {'period': ""Q1 '24"", 'revenue': 182.49, 'unit': 'M', 'net_profit': -10.3}]",-0.16,-0.16,547661000,173142000,102779000,247853000,51430000,2645000,138599000,56946000,-44812000,1.0394556892778994,0.4753767855825732,0.4666666666666666,__nan__,__nan__,__nan__,0.45256645990859307
238,INO,Inovio Pharmaceuticals Inc. Common Stock,"Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers, including cervical, vulvar, and anal dysplasia; HPV-associated cancers, such as head and neck, cervical, anal, penile, vulvar, and vaginal; other HPV-associated disorders, including recurrent respiratory papillomatosis; glioblastoma multiforme; prostate cancer; HIV; Ebola; Middle East Respiratory Syndrome (MERS); and Lassa fever. Its partners and collaborators include ApolloBio Corp., AstraZeneca, Beijing Advaccine Biotechnology Co., Ltd., The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations (CEPI), Defense Advanced Research Projects Agency (DARPA), Department of Defense (DoD), HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, Medical CBRN Defense Consortium (MCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Ology Bioservices, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Thermo Fisher Scientific, University of Pennsylvania, Walter Reed Army Institute of Research, and The Wistar Institute. The company has an agreement with Richter-Helm BioLogics GmbH & Co. KG to support investigational DNA vaccine INO-4800 for COVID-19; and a partnership with International Vaccine Institute and Seoul National University Hospital. The company was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.",Dr. Jacqueline E. Shea Ph.D.,Biotechnology,1.59,USD,58300848,https://images.financialmodelingprep.com/symbol/INO.png,755195,-0.4,0.13,963377,-103946251,-107254126,"[{'period': '2024', 'revenue': 0.21776, 'unit': 'M', 'net_profit': -107.25}, {'period': '2023', 'revenue': 0.83201, 'unit': 'M', 'net_profit': -135.12}, {'period': '2022', 'revenue': 10.26, 'unit': 'M', 'net_profit': -287.66}, {'period': '2021', 'revenue': 1.77, 'unit': 'M', 'net_profit': -305.38}]","[{'period': ""Q4 '24"", 'revenue': 0.11699, 'unit': 'M', 'net_profit': -19.38}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'B', 'net_profit': -25.17}, {'period': ""Q2 '24"", 'revenue': 0.10076, 'unit': 'M', 'net_profit': -32.24}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -30.47}, {'period': ""Q4 '23"", 'revenue': 0.10265, 'unit': 'M', 'net_profit': -25.0}, {'period': ""Q3 '23"", 'revenue': 0.38845, 'unit': 'M', 'net_profit': -33.93}]",-3.95,-3.95,113197206000,97830050000,94113529000,44693411000,1199056,1613844000,35325584000,65813297000,-104076553000,0.20281130545603118,0.20621500930539255,0.3513957307060755,"[0.0057, 0.0057]","['2017-09-28', '2017-06-28']",__nan__,0.3948278635075145
239,INOD,Innodata Inc. Common Stock,"Innodata Inc. operates as a global data engineering company in the United States, the United Kingdom, the Netherlands, Canada, and internationally. The company operates through three segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment offers AI-enabled software platforms and managed services to companies that require data for training AI and machine learning (ML) algorithms, and AI digital transformation solutions to help companies apply AI/ML for problems relating to analyzing and deriving insights from documents. This segment provides a range of data engineering support services, including data annotation, data transformation, data transformation, data curation, data hygiene, data consolidation, data compliance, and master data management. The Synodex segment offers an industry platform that transforms medical records into useable digital data with its proprietary data models or client data models. The Agility segment provides an industry platform that provides marketing communications and public relations professionals to target and distribute content to journalists and social media influencers; and to monitor and analyze global news channels, such as print, web, radio, and TV, as well as social media channels. It serves banking, insurance, financial services, technology, digital retailing, and information/media sectors through its professional staff, senior management, and direct sales personnel. The company was formerly known as Innodata Isogen, Inc. and changed its name to Innodata Inc. in June 2012. Innodata Inc. was incorporated in 1988 and is headquartered in Ridgefield Park, New Jersey.",Mr. Jack S. Abuhoff J.D.,Information Technology Services,37.11,USD,1161531867,https://images.financialmodelingprep.com/symbol/INOD.png,2068140,41.7,5.02,2598514,21227000,21380000,"[{'period': '2024', 'revenue': 141.1, 'unit': 'M', 'net_profit': 21.38}, {'period': '2023', 'revenue': 86780.0, 'unit': 'K', 'net_profit': -908.0}, {'period': '2022', 'revenue': 79.0, 'unit': 'M', 'net_profit': -12.01}, {'period': '2021', 'revenue': 69.75, 'unit': 'M', 'net_profit': -1.8}]","[{'period': ""Q4 '24"", 'revenue': 59.18, 'unit': 'M', 'net_profit': 10.3}, {'period': ""Q3 '24"", 'revenue': 52.22, 'unit': 'M', 'net_profit': 17.39}, {'period': ""Q2 '24"", 'revenue': 32549.999999999996, 'unit': 'K', 'net_profit': -14.0}, {'period': ""Q1 '24"", 'revenue': 26500.0, 'unit': 'K', 'net_profit': 989.0}, {'period': ""Q4 '23"", 'revenue': 26.11, 'unit': 'M', 'net_profit': 1.65}, {'period': ""Q3 '23"", 'revenue': 22170.0, 'unit': 'K', 'net_profit': 371.0}]",0.74,0.63,113449000,81000000,46897000,50060000,28013000,0,39506000,46883000,27274000,3.216726261422328,24.54625550660793,23.910216718266252,__nan__,__nan__,__nan__,0.44125554213787693
240,INOV,Inovalon Holdings Inc. Class A Common Stock,"Inovalon Holdings, Inc. provides cloud-based platforms for data-driven healthcare. It operates Inovalon ONE Platform, a cloud-based platform that interconnect with the healthcare ecosystem to aggregate and analyze data in real-time, as well as empowers the application in resulting insights. The company also operates myABILITY software platform, an integrated set of cloud-based applications for providers that offers connectivity, administrative, clinical and quality analysis, management, and performance improvement capabilities to acute, post-acute, and ambulatory point-of-care provider facilities. In addition, it offers advisory, implementation, and support services. The company serves health plans and provider organizations, as well as pharmaceutical, medical device, and diagnostics companies. Its platforms include information of data pertaining to approximately 988,000 physicians; 522,000 clinical facilities; and approximately 314 million individuals and 53 billion medical events. Inovalon Holdings, Inc. was founded in 1998 and is headquartered in Bowie, Maryland.",DR. Keith Dunleavy,Medical - Healthcare Information Services,29.4167,USD,13302761,https://images.financialmodelingprep.com/symbol/INOV.png,3618,15.64,1.1357,2017,186563000,22579000,"[{'period': '2020', 'revenue': 667.52, 'unit': 'M', 'net_profit': 22.58}, {'period': '2019', 'revenue': 642.41, 'unit': 'M', 'net_profit': 7.78}, {'period': '2018', 'revenue': 527.68, 'unit': 'M', 'net_profit': -39.16}, {'period': '2017', 'revenue': 449.36, 'unit': 'M', 'net_profit': 34.82}]","[{'period': ""Q3 '21"", 'revenue': 192.23, 'unit': 'M', 'net_profit': 11.73}, {'period': ""Q2 '21"", 'revenue': 190.44, 'unit': 'M', 'net_profit': 9.58}, {'period': ""Q1 '21"", 'revenue': 177.18, 'unit': 'M', 'net_profit': 9.16}, {'period': ""Q4 '20"", 'revenue': 189.75, 'unit': 'M', 'net_profit': 21.41}, {'period': ""Q3 '20"", 'revenue': 161380.0, 'unit': 'K', 'net_profit': 824.0}, {'period': ""Q2 '20"", 'revenue': 162.22, 'unit': 'M', 'net_profit': 2.02}]",0.15,0.15,1971398000,323076000,123880000,1262684000,172667000,0,164278000,123880000,59749000,0.03669724770642202,1.9040514469453376,1.8680688336520075,__nan__,__nan__,__nan__,0.640501816477444
241,INPX,Inpixon Common Stock,"Inpixon, together with its subsidiaries, provides solutions and technologies worldwide. The company operated through three segments: Indoor Intelligence, Saves, and Shoom. The Indoor Intelligence segment offers smart office app provide a frictionless work environment; executive briefing centers, an omni-channel software platform provides a virtual briefing platform allowing organizations to offer a personalized experience for in-office, remote, and hybrid meetings; events, offers a mobile first and virtual event platform to connect remote and in person audiences in a fully branded, end to end event experience; inpixon mapping solution which provides users with the tools to add intelligence to complex indoor spaces; augmented reality and 3D allow businesses to scan a space and attach AR content persistently to any position; analytics and insights, a cloud-based analytics platform allows data from multiple sensors and data sources to be visualized for action by the operator; and on-device positioning solution enables a smartphone's precise location to be displayed to a user in a mobile app. This segment also provides Internet of Things (IoT) software-as-a-service platform, IoT devices, sensors and tags, video integration, security, and transceiver/modules. The Shoom segment offers digital solutions or cloud-based applications and analytics for the media and publishing industry, including eTearsheets and eInvoice. The SAVES provides a set of data analytics and statistical visualization software solutions for engineers and scientists, as well as data analytics and statistical visualization tools which comprise SigmaPlot, SigmaStat, SYSTAT, PeakFit, TableCurve 2D, TableCurve 3D, SigmaScan and MYSTAT. The company was formerly known as Sysorex Global and changed its name to Inpixon in March 2017. Inpixon is headquartered in Palo Alto, California.",Mr. Nadir  Ali,Software - Application,0.0527,USD,10239505,https://images.financialmodelingprep.com/symbol/INPX.png,157399,-3.565629228687415e-05,-0.0066,40421259,-8000000,0,"[{'period': '2023', 'revenue': 6460000.0, 'unit': '', 'net_profit': 0.0}, {'period': '2022', 'revenue': 19.42, 'unit': 'M', 'net_profit': -66.3}, {'period': '2021', 'revenue': 15.99, 'unit': 'M', 'net_profit': -70.13}, {'period': '2020', 'revenue': 9.3, 'unit': 'M', 'net_profit': -29.21}]","[{'period': ""Q1 '24"", 'revenue': 0.22, 'unit': 'M', 'net_profit': -2.66}, {'period': ""Q4 '23"", 'revenue': -0.717, 'unit': 'M', 'net_profit': 29.67}, {'period': ""Q3 '23"", 'revenue': 2.02, 'unit': 'M', 'net_profit': -10.38}, {'period': ""Q2 '23"", 'revenue': 2.06, 'unit': 'M', 'net_profit': -6.97}, {'period': ""Q1 '23"", 'revenue': 3.1, 'unit': 'M', 'net_profit': -12.32}, {'period': ""Q4 '22"", 'revenue': 5.29, 'unit': 'M', 'net_profit': -16.42}]",0,0,0,0,0,17040000,0,0,16899000,0,-29213000,0.4799791991679667,1,1,__nan__,__nan__,__nan__,__nan__
242,INSE,Inspired Entertainment Inc. Common Stock,"Inspired Entertainment, Inc., a business-to-business gaming technology company, supplies content, platform, and other products and services to regulated lottery, betting, and gaming operators worldwide. The company operates through four segments: Gaming, Virtual Sports, Interactive, and Leisure. The Gaming segment supplies gaming terminals and software to betting offices, casinos, gaming halls, and high street adult gaming centers; a portfolio of games through its digital terminals under the Centurion and Super Hot Fruits names; and traditional casino games, such as roulette, blackjack, and number games. The Virtual Sports segment designs, develops, markets, and distributes ultra-high-definition sports games that include greyhounds, tennis, motor racing, cycling, cricket, speedway, golf, and dart, and other horse racing games under the V-Play Soccer, V-Play Football, V-Play Basketball, Virtual Grand National, and V-Play NFLA names. The Interactive segment provides a range of premium random number generated casino content from feature-rich bonus games to European-style casino free spins and table games. The Leisure segment supplies gaming terminals and amusement machines in pubs, bingo halls, and adult gaming centers, as well as family entertainment centers, bowling centers, and other entertainment venues. Inspired Entertainment, Inc. is headquartered in New York, New York.",Mr. Brooks H. Pierce,"Gambling, Resorts & Casinos",7.7,USD,207166960,https://images.financialmodelingprep.com/symbol/INSE.png,153596,3.47,1.01,203350,82300000,64800000,"[{'period': '2024', 'revenue': 297.1, 'unit': 'M', 'net_profit': 64.8}, {'period': '2023', 'revenue': 323.0, 'unit': 'M', 'net_profit': 7.6}, {'period': '2022', 'revenue': 285.4, 'unit': 'M', 'net_profit': 20.6}, {'period': '2021', 'revenue': 208.9, 'unit': 'M', 'net_profit': -36.7}]","[{'period': ""Q4 '24"", 'revenue': 80.4, 'unit': 'M', 'net_profit': 65.1}, {'period': ""Q3 '24"", 'revenue': 78.0, 'unit': 'M', 'net_profit': 3.4}, {'period': ""Q2 '24"", 'revenue': 75.6, 'unit': 'M', 'net_profit': 2.0}, {'period': ""Q1 '24"", 'revenue': 63.1, 'unit': 'M', 'net_profit': -5.7}, {'period': ""Q4 '23"", 'revenue': 81.2, 'unit': 'M', 'net_profit': 10.3}, {'period': ""Q3 '23"", 'revenue': 97.5, 'unit': 'M', 'net_profit': 3.4}]",2.27,2.22,438400000,159900000,29300000,441700000,92600000,0,104000000,29300000,2900000,-0.02023809523809524,7.526315789473684,7.4074074074074066,__nan__,__nan__,__nan__,1.0075273722627738
243,INSG,Inseego Corp. Common Stock,"Inseego Corp. engages in the design and development of fixed and mobile wireless solutions, industrial Internet of Things (IIoT), and cloud solutions for large enterprise verticals, service providers, small and medium-sized businesses, governments, and consumers worldwide. The company provides wireless 4G and 5G hardware products, including private LTE/5G networks, First responders network authority/Firstnet, SD-WAN, telematics, remote monitoring and surveillance, and fixed wireless access and mobile broadband devices. Its products include 4G and 5G fixed wireless routers and gateways, mobile hotspots, and wireless gateways and routers for IIoT applications; and Gb speed 4G LTE hotspots and USB modems, integrated telematics, and mobile tracking hardware devices, which are supported by applications software and cloud services designed to enable customers to analyze data insights and configure/manage their hardware remotely. In addition, the company sells software-as-a-service (SaaS), software, and services solutions in various mobile and IIoT vertical markets comprising fleet management, vehicle telematics, stolen vehicle recovery, asset tracking, monitoring, business connectivity, and subscription management. Its SaaS delivery platforms include telematics, asset tracking, and management platforms which provide fleet, vehicle, aviation, asset, and other telematics applications; and Inseego Subscribe, a hosted SaaS platform that helps organizations in managing the selection, deployment, and spend of their customers wireless assets by helping them to save money on personnel and telecom expenses. Inseego Corp. was founded in 1996 and is based in San Diego, California.",Mr. Juho  Sarvikas,Communication Equipment,7.58,USD,113747754,https://images.financialmodelingprep.com/symbol/INSG.png,154790,-5.38,0.72,222863,9755000,-14369000,"[{'period': '2024', 'revenue': 191.24, 'unit': 'M', 'net_profit': -14.37}, {'period': '2023', 'revenue': 195.69, 'unit': 'M', 'net_profit': -46.19}, {'period': '2022', 'revenue': 245.32, 'unit': 'M', 'net_profit': -67.97}, {'period': '2021', 'revenue': 262.4, 'unit': 'M', 'net_profit': -47.91}]","[{'period': ""Q4 '24"", 'revenue': 48090.0, 'unit': 'K', 'net_profit': -566.0}, {'period': ""Q3 '24"", 'revenue': 54.03, 'unit': 'M', 'net_profit': 8.97}, {'period': ""Q2 '24"", 'revenue': 59150.0, 'unit': 'K', 'net_profit': 624.0}, {'period': ""Q1 '24"", 'revenue': 45.01, 'unit': 'M', 'net_profit': -4.46}, {'period': ""Q4 '23"", 'revenue': 42.75, 'unit': 'M', 'net_profit': -14.34}, {'period': ""Q3 '23"", 'revenue': 48.58, 'unit': 'M', 'net_profit': -22.56}]",-1.15,0.1,99999000,72900000,39596000,112857000,17311000,0,63471000,39596000,33419000,1.7117320881365825,0.6888816715383783,0.7337962962962963,__nan__,__nan__,__nan__,1.128581285812858
244,INSM,Insmed Inc. Common Stock,"Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.","Mr. William H. Lewis J.D., M.B.A.",Medical - Pharmaceuticals,67.55,USD,12226482450,https://images.financialmodelingprep.com/symbol/INSM.png,1982427,-12.13,2.58,5053736,-818794000,-913772000,"[{'period': '2024', 'revenue': 363.71, 'unit': 'M', 'net_profit': -913.77}, {'period': '2023', 'revenue': 305.21, 'unit': 'M', 'net_profit': -749.57}, {'period': '2022', 'revenue': 245.36, 'unit': 'M', 'net_profit': -481.53}, {'period': '2021', 'revenue': 188.46, 'unit': 'M', 'net_profit': -434.65}]","[{'period': ""Q4 '24"", 'revenue': 104.44, 'unit': 'M', 'net_profit': -235.55}, {'period': ""Q3 '24"", 'revenue': 93.42, 'unit': 'M', 'net_profit': -220.52}, {'period': ""Q2 '24"", 'revenue': 90.34, 'unit': 'M', 'net_profit': -300.61}, {'period': ""Q1 '24"", 'revenue': 75.5, 'unit': 'M', 'net_profit': -157.09}, {'period': ""Q4 '23"", 'revenue': 83.69, 'unit': 'M', 'net_profit': -186.06}, {'period': ""Q3 '23"", 'revenue': 79.07, 'unit': 'M', 'net_profit': -158.93}]",-5.57,-5.57,2025231000,1621661000,1433826000,1739852000,52012000,0,297528000,555030000,-705805000,-0.24026435334766283,-0.21906647437787416,-0.04307116104868922,__nan__,__nan__,__nan__,0.8590881731516059
245,INTC,Intel Corporation Common Stock,"Intel Corporation engages in the design, manufacture, and sale of computer products and technologies worldwide. The company operates through CCG, DCG, IOTG, Mobileye, NSG, PSG, and All Other segments. It offers platform products, such as central processing units and chipsets, and system-on-chip and multichip packages; and non-platform or adjacent products, including accelerators, boards and systems, connectivity products, graphics, and memory and storage products. The company also provides high-performance compute solutions for targeted verticals and embedded applications for retail, industrial, and healthcare markets; and solutions for assisted and autonomous driving comprising compute platforms, computer vision and machine learning-based sensing, mapping and localization, driving policy, and active sensors. In addition, it offers workload-optimized platforms and related products for cloud service providers, enterprise and government, and communications service providers. The company serves original equipment manufacturers, original design manufacturers, and cloud service providers. Intel Corporation has a strategic partnership with MILA to develop and apply advances in artificial intelligence methods for enhancing the search in the space of drugs. The company was incorporated in 1968 and is headquartered in Santa Clara, California.",Mr. Lip-Bu  Tan,Semiconductors,21.53,USD,93883502700,https://images.financialmodelingprep.com/symbol/INTC.png,109822116,-4.92,3.4,218902404,1203000000,-18756000000,"[{'period': '2024', 'revenue': 53.1, 'unit': 'B', 'net_profit': -18.76}, {'period': '2023', 'revenue': 54.23, 'unit': 'B', 'net_profit': 1.69}, {'period': '2022', 'revenue': 63.05, 'unit': 'B', 'net_profit': 8.01}, {'period': '2021', 'revenue': 79.02, 'unit': 'B', 'net_profit': 19.87}]","[{'period': ""Q4 '24"", 'revenue': 14260.0, 'unit': 'M', 'net_profit': -126.0}, {'period': ""Q3 '24"", 'revenue': 13.28, 'unit': 'B', 'net_profit': -16.64}, {'period': ""Q2 '24"", 'revenue': 12.83, 'unit': 'B', 'net_profit': -1.61}, {'period': ""Q1 '24"", 'revenue': 12720.0, 'unit': 'M', 'net_profit': -381.0}, {'period': ""Q4 '23"", 'revenue': 15.41, 'unit': 'B', 'net_profit': 2.67}, {'period': ""Q3 '23"", 'revenue': 14160.0, 'unit': 'M', 'net_profit': 297.0}]",-4.38,-4.38,196485000000,47324000000,22062000000,91453000000,3478000000,5383000000,35666000000,8249000000,-15656000000,-0.8929905710727628,-12.104795737122558,-11.95,"[0.125, 0.1]","['2024-08-07', '1992-10-26']",__nan__,0.46544519937908746
246,INTG,Intergroup Corporation (The) Common Stock,"The InterGroup Corporation, through its subsidiaries, operates a hotel under the Hilton San Francisco Financial District name located in San Francisco, California. It operates through three segments: Hotel Operations, Real Estate Operations, and Investment Transactions. The company's hotel consists of 544 guest rooms and luxury suites with approximately 22,000 square feet of meeting room space, a grand ballroom, 5 levels underground parking garage, a pedestrian bridge, and a Chinese culture center. As of June 30, 2021, it owned, managed, and invested in 16 apartment complexes, 3 single-family houses as strategic investments, and 1 commercial real estate property located in the United States, as well as approximately 2 acres of unimproved land in Maui, Hawaii. Further, the company invests in income-producing instruments, corporate debt and equity securities, publicly traded investment funds, mortgage-backed securities, securities issued by REITs, and other companies that invest primarily in real estate. The InterGroup Corporation was incorporated in 1965 and is based in Los Angeles, California.",Mr. John V. Winfield,Travel Lodging,13.45,USD,28987575,https://images.financialmodelingprep.com/symbol/INTG.png,2867,-2.94,0.23,4086,7774000,-9797000,"[{'period': '2024', 'revenue': 58.14, 'unit': 'M', 'net_profit': -9.8}, {'period': '2023', 'revenue': 57.61, 'unit': 'M', 'net_profit': -6.72}, {'period': '2022', 'revenue': 47.22, 'unit': 'M', 'net_profit': -10.62}, {'period': '2021', 'revenue': 28.66, 'unit': 'M', 'net_profit': 10.41}]","[{'period': ""Q2 '25"", 'revenue': 14.44, 'unit': 'M', 'net_profit': -2.73}, {'period': ""Q1 '25"", 'revenue': 16910.0, 'unit': 'K', 'net_profit': -398.0}, {'period': ""Q4 '24"", 'revenue': 13.43, 'unit': 'M', 'net_profit': -3.86}, {'period': ""Q3 '24"", 'revenue': 14.88, 'unit': 'M', 'net_profit': -3.16}, {'period': ""Q2 '24"", 'revenue': 14.32, 'unit': 'M', 'net_profit': -1.53}, {'period': ""Q1 '24"", 'revenue': 15.51, 'unit': 'M', 'net_profit': -1.24}]",-4.46,-4.46,107811000,18265000,11787000,214278000,654000,0,127749000,4333000,425000,-0.20673469387755103,-0.458103884506623,-0.47194719471947205,__nan__,__nan__,__nan__,1.9875337395998554
247,INTU,Intuit Inc. Common Stock,"Intuit Inc. provides financial management and compliance products and services for consumers, small businesses, self-employed, and accounting professionals in the United States, Canada, and internationally. The company operates in four segments: Small Business & Self-Employed, Consumer, Credit Karma, and ProConnect. The Small Business & Self-Employed segment provides QuickBooks online services and desktop software solutions comprising QuickBooks Online Advanced, a cloud-based solution; QuickBooks Enterprise, a hosted solution; QuickBooks Self-Employed solution; QuickBooks Commerce, a solution for product-based businesses; QuickBooks Online Accountant and QuickBooks Accountant Desktop Plus solutions; and payroll solutions, such as online payroll processing, direct deposit of employee paychecks, payroll reports, electronic payment of federal and state payroll taxes, and electronic filing of federal and state payroll tax forms. This segment also offers payment-processing solutions, including credit and debit cards, Apple Pay, and ACH payment services; QuickBooks Cash business bank account; and financial supplies and financing for small businesses. The Consumer segment provides TurboTax income tax preparation products and services; and personal finance. The Credit Karma segment offers consumers with a personal finance platform that provides personalized recommendations of home, auto, and personal loans, as well as credit cards and insurance products. The ProConnect segment provides Lacerte, ProSeries, and ProFile desktop tax-preparation software products; and ProConnect Tax Online tax products, electronic tax filing service, and bank products and related services. It sells products and services through various sales and distribution channels, including multi-channel shop-and-buy experiences, websites and call centers, mobile application stores, and retail and other channels. The company was founded in 1983 and is headquartered in Mountain View, California.",Mr. Sasan K. Goodarzi,Software - Application,596.48,USD,166753141760,https://images.financialmodelingprep.com/symbol/INTU.png,2000313,55.95,52.41,2873091,4581000000,2963000000,"[{'period': '2024', 'revenue': 16.29, 'unit': 'B', 'net_profit': 2.96}, {'period': '2023', 'revenue': 14.37, 'unit': 'B', 'net_profit': 2.38}, {'period': '2022', 'revenue': 12.73, 'unit': 'B', 'net_profit': 2.07}, {'period': '2021', 'revenue': 9.63, 'unit': 'B', 'net_profit': 2.06}]","[{'period': ""Q2 '25"", 'revenue': 3960.0, 'unit': 'M', 'net_profit': 471.0}, {'period': ""Q1 '25"", 'revenue': 3280.0, 'unit': 'M', 'net_profit': 197.0}, {'period': ""Q4 '24"", 'revenue': 3180.0, 'unit': 'M', 'net_profit': -20.0}, {'period': ""Q3 '24"", 'revenue': 6.74, 'unit': 'B', 'net_profit': 2.39}, {'period': ""Q2 '24"", 'revenue': 3390.0, 'unit': 'M', 'net_profit': 353.0}, {'period': ""Q1 '24"", 'revenue': 2980.0, 'unit': 'M', 'net_profit': 241.0}]",10.58,10.43,32132000000,9678000000,4074000000,13696000000,1317000000,131000000,7491000000,3609000000,4634000000,0.13306950284442245,0.24286912751677853,0.2476415094339622,"[1.04, 0.15]","['2025-04-10', '2011-10-05']",__nan__,0.42624175276982446
248,INTZ,Intrusion Inc. Common Stock,"Intrusion Inc., together with its subsidiaries, develops, markets, and supports entity identification, data mining, cybercrime, and advanced persistent threat detection products in the United States. It offers INTRUSION Shield, a cybersecurity solution based on security-as-a-service solution to identify and stop Zero-Day and ransomware attacks. The company also provides INTRUSION TraceCop, a big data tool that contains an inventory of network selectors and enrichments to support forensic investigations; and INTRUSION Savant, a network monitoring solution that uses the data available in TraceCop to identify suspicious traffic in real-time. In addition, it engages in the resale of standard commercially available computers and servers from various vendors; and provision of pre-and post-sales support services, such as network security design, system installation, and technical consulting services. It serves US federal government entities, state and local government entities, and companies ranging from mid-market to large enterprises through a direct sales force and value-added resellers. The company was formerly known as Intrusion.com, Inc. and changed its name to Intrusion Inc. in November 2001. Intrusion Inc. was founded in 1983 and is headquartered in Plano, Texas.",Mr. Anthony E. Scott,Software - Infrastructure,1.04,USD,20293728,https://images.financialmodelingprep.com/symbol/INTZ.png,1307580,-0.64,0.11,263560,-5814000,-7790000,"[{'period': '2024', 'revenue': 5.77, 'unit': 'M', 'net_profit': -7.79}, {'period': '2023', 'revenue': 5.61, 'unit': 'M', 'net_profit': -13.89}, {'period': '2022', 'revenue': 7.53, 'unit': 'M', 'net_profit': -14.54}, {'period': '2021', 'revenue': 7.28, 'unit': 'M', 'net_profit': -18.04}]","[{'period': ""Q4 '24"", 'revenue': 1.68, 'unit': 'M', 'net_profit': -1.96}, {'period': ""Q3 '24"", 'revenue': 1.5, 'unit': 'M', 'net_profit': -2.05}, {'period': ""Q2 '24"", 'revenue': 1.46, 'unit': 'M', 'net_profit': -2.07}, {'period': ""Q1 '24"", 'revenue': 1.13, 'unit': 'M', 'net_profit': -1.72}, {'period': ""Q4 '23"", 'revenue': 1.37, 'unit': 'M', 'net_profit': -2.82}, {'period': ""Q3 '23"", 'revenue': 1.47, 'unit': 'M', 'net_profit': -3.21}]",-1.48,-1.48,11509000,5534000,4851000,5258000,192000,0,3672000,4851000,-6826000,0.43793503480278423,0.4392052408033979,-0.2869565217391305,__nan__,__nan__,__nan__,0.4568598488139717
249,INVA,Innoviva Inc. Common Stock,"Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY ELLIPTA, a once-daily combination medicine consisting of an ICS, LAMA, and LABA. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.",Mr. Pavel  Raifeld C.F.A.,Biotechnology,17.32,USD,1085539660,https://images.financialmodelingprep.com/symbol/INVA.png,821614,48.11,0.07,1099775,85499000,23392000,"[{'period': '2024', 'revenue': 358.71, 'unit': 'M', 'net_profit': 23.39}, {'period': '2023', 'revenue': 310.46, 'unit': 'M', 'net_profit': 179.72}, {'period': '2022', 'revenue': 331.34, 'unit': 'M', 'net_profit': 213.92}, {'period': '2021', 'revenue': 391.87, 'unit': 'M', 'net_profit': 368.84}]","[{'period': ""Q4 '24"", 'revenue': 91.81, 'unit': 'M', 'net_profit': 20.33}, {'period': ""Q3 '24"", 'revenue': 89.51, 'unit': 'M', 'net_profit': 1.21}, {'period': ""Q2 '24"", 'revenue': 103.35, 'unit': 'M', 'net_profit': -34.69}, {'period': ""Q1 '24"", 'revenue': 80.95, 'unit': 'M', 'net_profit': 36.53}, {'period': ""Q4 '23"", 'revenue': 89.27, 'unit': 'M', 'net_profit': 61.53}, {'period': ""Q3 '23"", 'revenue': 67.26, 'unit': 'M', 'net_profit': 82.05}]",0.37,0.32,1301060000,554306000,304964000,609901000,20392000,52293000,236083000,304964000,188420000,-0.656575353470437,-0.8698434248450384,-0.8732876712328766,"[0.25, 0.25]","['2015-09-08', '2014-08-26']",__nan__,0.4687723855932855
250,INVE,Identiv Inc. Common Stock,"Identiv, Inc. operates as a security technology company that secures things, data, and physical places in the Americas, Europe, the Middle East, and the Asia-Pacific. The company operates in two segments, Identity and Premises. The Identity segment offers products and solutions that enables secure access to information serving the logical access and cyber security markets, as well as protecting connected objects and information using radio-frequency identification embedded security. The Premises segment provides solutions for premises security market, such as access control, video surveillance, analytics, audio, access readers, and identities to government facilities, schools, utilities, hospitals, stores, apartment buildings, and shops. The company sells its products through dealers, systems integrators, value added resellers, and resellers. The company was formerly known as Identive Group, Inc. and changed its name to Identiv, Inc. in May 2014. Identiv, Inc. was founded in 1990 and is headquartered in Fremont, California.",Ms. Kirsten F. Newquist,Computer Hardware,3.17,USD,74560619,https://images.financialmodelingprep.com/symbol/INVE.png,61475,-2.78,0.19,122513,-24551000,74820000,"[{'period': '2024', 'revenue': 26.63, 'unit': 'M', 'net_profit': 74.82}, {'period': '2023', 'revenue': 116.38, 'unit': 'M', 'net_profit': -5.49}, {'period': '2022', 'revenue': 112920.0, 'unit': 'K', 'net_profit': -392.0}, {'period': '2021', 'revenue': 103.77, 'unit': 'M', 'net_profit': 1.62}]","[{'period': ""Q4 '24"", 'revenue': 6700.0, 'unit': 'K', 'net_profit': -355.0}, {'period': ""Q3 '24"", 'revenue': 6.53, 'unit': 'M', 'net_profit': 85.95}, {'period': ""Q2 '24"", 'revenue': 6.74, 'unit': 'M', 'net_profit': -6.22}, {'period': ""Q1 '24"", 'revenue': 22.49, 'unit': 'M', 'net_profit': -4.56}, {'period': ""Q4 '23"", 'revenue': 28.98, 'unit': 'M', 'net_profit': -1.6}, {'period': ""Q3 '23"", 'revenue': 31850.0, 'unit': 'K', 'net_profit': -22.0}]",3.14,3.14,163225000,152845000,135646000,9156000,4214000,0,7960000,135646000,-16926000,-10.334718374884579,14.630898159956276,11.827586206896553,__nan__,__nan__,__nan__,0.05609434829223465
251,INVO,INVO BioScience Inc. Common Stock,"INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.",Mr. Steven M. Shum,Medical - Devices,0.833,USD,3253756,https://images.financialmodelingprep.com/symbol/INVO.png,1149370,1.2072463768115942,-0.017,124018,-6880023,-8034612,"[{'period': '2023', 'revenue': 3.02, 'unit': 'M', 'net_profit': -8.03}, {'period': '2022', 'revenue': 0.8222, 'unit': 'M', 'net_profit': -10.89}, {'period': '2021', 'revenue': 4.16, 'unit': 'M', 'net_profit': -6.65}, {'period': '2020', 'revenue': 1.04, 'unit': 'M', 'net_profit': -8.35}]","[{'period': ""Q2 '24"", 'revenue': 1.84, 'unit': 'M', 'net_profit': -2.25}, {'period': ""Q1 '24"", 'revenue': 1.58, 'unit': 'M', 'net_profit': -1.6}, {'period': ""Q4 '23"", 'revenue': 1.38, 'unit': 'M', 'net_profit': -1.99}, {'period': ""Q3 '23"", 'revenue': 0.97489, 'unit': 'M', 'net_profit': -1.25}, {'period': ""Q2 '23"", 'revenue': 0.31589999999999996, 'unit': 'M', 'net_profit': -2.24}, {'period': ""Q1 '23"", 'revenue': 0.34802, 'unit': 'M', 'net_profit': -3.01}]",-5.13,-5.13,20887787,1259775,232424,19994962,140550,3088248,8218875,232424,-5199776,0.3462460394805258,0.2623728357951624,0.7145242070116862,__nan__,__nan__,__nan__,0.9572561229200585
252,INVZ,Innoviz Technologies Ltd. Ordinary shares,"Innoviz Technologies Ltd. designs and manufactures solid-state LiDAR sensors and develops perception software that enables the mass production of autonomous vehicles. The company manufactures InnovizOne, a solid-state LiDAR sensor designed for automakers and robotaxi, shuttle, trucking, and delivery companies requiring an automotive-grade and mass-producible solution to achieve autonomy. Its automotive-grade sensor is integrable into Level 3 through 5 autonomous vehicles for the safety of passengers and pedestrians. The company also provides InnovizTwo, an automotive-grade LiDAR sensor that offers a solution for all levels of autonomous driving, as well as an option to integrate the perception application in the LiDAR sensor; Innoviz360, a 360-degree LiDAR for automotive and non-automotive applications; and perception application, a software application that turns the InnovizOne LiDAR's raw point cloud data into perception outputs to provide scene perception and deliver an automotive-grade ASIL B(D) solution. It operates in Europe, Asia Pacific, the Middle East, Africa, and North America. Innoviz Technologies Ltd. was incorporated in 2016 and is headquartered in Rosh HaAyin, Israel.",Mr. Omer David Keilaf,Auto - Parts,0.5633,USD,112075295,https://images.financialmodelingprep.com/symbol/INVZ.png,8486526,-0.99,0.0522,3877065,-94132000,-94757000,"[{'period': '2024', 'revenue': 24.27, 'unit': 'M', 'net_profit': -94.76}, {'period': '2023', 'revenue': 20.88, 'unit': 'M', 'net_profit': -123.45}, {'period': '2022', 'revenue': 6.03, 'unit': 'M', 'net_profit': -126.87}, {'period': '2021', 'revenue': 5.47, 'unit': 'M', 'net_profit': -153.56}]","[{'period': ""Q4 '24"", 'revenue': 6.03, 'unit': 'M', 'net_profit': -18.6}, {'period': ""Q3 '24"", 'revenue': 4.52, 'unit': 'M', 'net_profit': -24.86}, {'period': ""Q2 '24"", 'revenue': 6.66, 'unit': 'M', 'net_profit': -21.17}, {'period': ""Q1 '24"", 'revenue': 7.06, 'unit': 'M', 'net_profit': -30.14}, {'period': ""Q4 '23"", 'revenue': 14.92, 'unit': 'M', 'net_profit': -30.45}, {'period': ""Q3 '23"", 'revenue': 3.48, 'unit': 'M', 'net_profit': -27.03}]",-1.3,-1.3,132049000,82619000,67948000,53120000,6152000,0,27770000,25365000,-81367000,0.23724171460983712,0.23245095339154664,-0.5476190476190478,__nan__,__nan__,__nan__,0.40227491310044
253,INVZW,Innoviz Technologies Ltd. Warrant,"Innoviz Technologies Ltd. designs and manufactures solid state LiDAR sensors and develops perception software that enable the mass-production of autonomous vehicles. The company manufactures InnovizPro, a solid state LiDAR that offers performance and value for automotive and other applications. It also manufactures InnovizOne, an automotive- grade LiDAR sensor that provides 3D sensing for Level 3-Level 5 autonomous driving. It also manufactures object identification and tracking, sensor fusion, and mapping and localization products. The company has strategic alliances with investors, including Magna International, Samsung, Aptiv, Magma Venture Partners, Vertex Ventures, SoftBank Ventures Asia, 360 Capital Partners, Glory Ventures, Naver, China Merchants Capital (SINO-BLR Industrial Investment Fund, L.P.), Shenzhen Capital Group, New Alliance Capital, Harel Insurance Investments and Financial Services, Phoenix Insurance Company, and others. Innoviz Technologies Ltd. was founded in 2016 and is based in Rosh HaAyin, Israel.",Mr. Omer David Keilaf,Auto - Parts,0.04,USD,101689457,https://images.financialmodelingprep.com/symbol/INVZW.png,80356.03256,,0.0025,21105,-94132000,-94757000,"[{'period': '2024', 'revenue': 24.27, 'unit': 'M', 'net_profit': -94.76}, {'period': '2023', 'revenue': 20.88, 'unit': 'M', 'net_profit': -123.45}, {'period': '2022', 'revenue': 6.03, 'unit': 'M', 'net_profit': -126.87}, {'period': '2021', 'revenue': 5.47, 'unit': 'M', 'net_profit': -153.56}]","[{'period': ""Q4 '24"", 'revenue': 6.03, 'unit': 'M', 'net_profit': -18.6}, {'period': ""Q3 '24"", 'revenue': 4.52, 'unit': 'M', 'net_profit': -24.86}, {'period': ""Q2 '24"", 'revenue': 6.66, 'unit': 'M', 'net_profit': -21.17}, {'period': ""Q1 '24"", 'revenue': 7.06, 'unit': 'M', 'net_profit': -30.14}, {'period': ""Q4 '23"", 'revenue': 14.92, 'unit': 'M', 'net_profit': -30.45}, {'period': ""Q3 '23"", 'revenue': 3.48, 'unit': 'M', 'net_profit': -27.03}]",-1.3,-1.3,132049000,82619000,67948000,53120000,6152000,0,27770000,25365000,-81367000,0.23724171460983712,0.23245095339154664,-0.5476190476190478,__nan__,__nan__,__nan__,0.40227491310044
254,INZY,Inozyme Pharma Inc. Common Stock,"Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, as well as for the treatment of calciphylaxis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. Inozyme Pharma, Inc. was incorporated in 2015 and is headquartered in Boston, Massachusetts.",Dr. Douglas A. Treco Ph.D.,Biotechnology,0.9059,USD,58195197,https://images.financialmodelingprep.com/symbol/INZY.png,673793,-0.56,0.0506,346536,-104030000,-102024000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -102.02}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -71.17}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -65.45}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -56.41}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -27.07}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -24.57}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -27.03}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -23.35}, {'period': ""Q4 '23"", 'revenue': 1.98, 'unit': 'M', 'net_profit': -21.54}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -16.64}]",-1.62,-1.62,123182000,120676000,113087000,65356000,0,0,33898000,21081000,-91969000,-0.390552317809977,-0.4335455043628546,-0.18248175182481752,__nan__,__nan__,__nan__,0.5305645305320582
255,IONS,Ionis Pharmaceuticals Inc. Common Stock,"Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial lipodystrophy. It also develops medicines for various indications that are in phase 3 study, including Eplontersen as a monthly self-administered subcutaneous injection to treat all types of TTR amyloidosis; Olezarsen for patients with severe hypertriglyceridemia (SHTG); Donidalorsen for patients with hereditary angioedema; ION363 for patients with amyotrophic lateral sclerosis; Pelacarsen for patients with established cardiovascular disease and elevated lipoprotein(a); and Tofersen to inhibit the production of superoxide dismutase 1. In addition, the company develops medicines for metabolic diseases, infectious diseases, renal diseases, ophthalmic diseases, and cancer. It has a strategic collaboration with Biogen Inc.; and collaboration and license agreement with AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis AG, Roche, Janssen Biotech, Inc., and Flamingo Therapeutics, Inc. Ionis Pharmaceuticals, Inc. was founded in 1989 and is based in Carlsbad, California.",Dr. Brett P. Monia Ph.D.,Biotechnology,27.77,USD,4414458050,https://images.financialmodelingprep.com/symbol/IONS.png,1780742,-9.13,2.26,3425500,-475081000,-453897000,"[{'period': '2024', 'revenue': 705.14, 'unit': 'M', 'net_profit': -453.9}, {'period': '2023', 'revenue': 787.65, 'unit': 'M', 'net_profit': -366.29}, {'period': '2022', 'revenue': 587.0, 'unit': 'M', 'net_profit': -270.0}, {'period': '2021', 'revenue': 810.0, 'unit': 'M', 'net_profit': -29.0}]","[{'period': ""Q4 '24"", 'revenue': 226.58, 'unit': 'M', 'net_profit': -104.35}, {'period': ""Q3 '24"", 'revenue': 134.0, 'unit': 'M', 'net_profit': -140.48}, {'period': ""Q2 '24"", 'revenue': 225.25, 'unit': 'M', 'net_profit': -66.27}, {'period': ""Q1 '24"", 'revenue': 119.5, 'unit': 'M', 'net_profit': -142.8}, {'period': ""Q4 '23"", 'revenue': 324.5, 'unit': 'M', 'net_profit': -9.26}, {'period': ""Q3 '23"", 'revenue': 144.0, 'unit': 'M', 'net_profit': -147.0}]",-3.04,-3.04,3003675000,2620290000,2297656000,2415324000,92188000,0,309318000,242077000,-546227000,-1.065479761749489,-0.2391874109302567,-0.1875,__nan__,__nan__,__nan__,0.8041229493870009
256,IOSP,Innospec Inc. Common Stock,"Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in various fuels. This segment's products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. Its Performance Chemicals segment provides technology-based solutions for its customers' processes or products that focuses on the personal care, home care, agrochemical, and metal extraction markets. The company's Oilfield Services segment develops and markets chemical solutions for fracturing, stimulation, and completion operations; and products for oil and gas production, as well as products to prevent loss of mud in drilling operations. It sells its products primarily to oil and gas exploration and production companies, oil refineries, fuel manufacturers and users, personal care and home care companies, formulators of agrochemical and metal extraction formulations, and other chemical and industrial companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.",Mr. Patrick S. Williams,Chemicals - Specialty,89.88,USD,2257740660,https://images.financialmodelingprep.com/symbol/IOSP.png,226395,63.3,6.49,311132,224600000,35600000,"[{'period': '2024', 'revenue': 1850.0, 'unit': 'M', 'net_profit': 35.6}, {'period': '2023', 'revenue': 1950.0, 'unit': 'M', 'net_profit': 139.1}, {'period': '2022', 'revenue': 1960.0, 'unit': 'M', 'net_profit': 133.0}, {'period': '2021', 'revenue': 1480.0, 'unit': 'M', 'net_profit': 93.1}]","[{'period': ""Q4 '24"", 'revenue': 466.8, 'unit': 'M', 'net_profit': -70.4}, {'period': ""Q3 '24"", 'revenue': 443.4, 'unit': 'M', 'net_profit': 33.4}, {'period': ""Q2 '24"", 'revenue': 435.0, 'unit': 'M', 'net_profit': 31.2}, {'period': ""Q1 '24"", 'revenue': 500.2, 'unit': 'M', 'net_profit': 41.4}, {'period': ""Q4 '23"", 'revenue': 494.7, 'unit': 'M', 'net_profit': 37.8}, {'period': ""Q3 '23"", 'revenue': 464.1, 'unit': 'M', 'net_profit': 39.2}]",1.43,1.42,1734700000,956600000,289200000,518600000,341700000,0,371400000,289200000,143100000,0.11796913887506222,-0.7440690150970525,-0.7446428571428572,"[0.79, 0.05]","['2024-11-18', '2002-08-22']",__nan__,0.29895659191791085
257,IOVA,Iovance Biotherapeutics Inc. Common Stock,"Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment of metastatic melanoma; C-145-04, of its product candidate lifileucel for recurrent, metastatic, or persistent cervical cancer; and C-145-03, of its product candidate LN-145, for recurrent and/or metastatic head and neck squamous cell carcinoma. Iovance Biotherapeutics, Inc. has collaborations and licensing agreements with H. Lee Moffitt Cancer Center; M.D. Anderson Cancer Center; Ohio State University; Centre hospitalier de l'Université de Montreal; Cellectis S.A.; and Novartis Pharma AG. The company was formerly known as Lion Biotechnologies, Inc. and changed its name to Iovance Biotherapeutics, Inc. in June 2017. Iovance Biotherapeutics, Inc. was incorporated in 2007 and is headquartered in San Carlos, California.","Dr. Frederick G. Vogt Esq., J.D., Ph.D.",Biotechnology,3.27,USD,1072157790,https://images.financialmodelingprep.com/symbol/IOVA.png,9937931,-2.55,0.42,17613515,-395278000,-372177000,"[{'period': '2024', 'revenue': 164.07, 'unit': 'M', 'net_profit': -372.18}, {'period': '2023', 'revenue': 1.19, 'unit': 'M', 'net_profit': -444.04}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -389.92}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -327.82}]","[{'period': ""Q4 '24"", 'revenue': 73.69, 'unit': 'M', 'net_profit': -78.56}, {'period': ""Q3 '24"", 'revenue': 58.55, 'unit': 'M', 'net_profit': -83.54}, {'period': ""Q2 '24"", 'revenue': 31.11, 'unit': 'M', 'net_profit': -97.1}, {'period': ""Q1 '24"", 'revenue': 0.715, 'unit': 'M', 'net_profit': -112.98}, {'period': ""Q4 '23"", 'revenue': 0.482, 'unit': 'M', 'net_profit': -116.38}, {'period': ""Q3 '23"", 'revenue': 0.46900000000000003, 'unit': 'M', 'net_profit': -113.76}]",-1.28,-1.28,910426000,457018000,323781000,200021000,69340000,0,122341000,115694000,-364046000,0.07522600086095566,0.1618333607334524,0.3227513227513227,__nan__,__nan__,__nan__,0.2197004479221815
258,IPA,ImmunoPrecise Antibodies Ltd. Common Stock,"ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its contract research organization services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation. The company has research collaboration agreements with Pierre Fabre S.A for antibody discovery; and Elektrofi, Inc. to explore a high-concentration formulation of COVID-19 antibody cocktail, PolyTope TATX-03. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.",Dr. Jennifer Lynne Bath Ph.D.,Biotechnology,0.392,USD,17939926,https://images.financialmodelingprep.com/symbol/IPA.png,7674000,-0.33,0.007,188734,-22949000,-27177000,"[{'period': '2024', 'revenue': 24.52, 'unit': 'M', 'net_profit': -27.18}, {'period': '2023', 'revenue': 20.66, 'unit': 'M', 'net_profit': -26.56}, {'period': '2022', 'revenue': 19.36, 'unit': 'M', 'net_profit': -16.71}, {'period': '2021', 'revenue': 17.91, 'unit': 'M', 'net_profit': -7.34}]","[{'period': ""Q3 '25"", 'revenue': 6.15, 'unit': 'M', 'net_profit': -21.52}, {'period': ""Q2 '25"", 'revenue': 6.12, 'unit': 'M', 'net_profit': -2.55}, {'period': ""Q1 '25"", 'revenue': 5.26, 'unit': 'M', 'net_profit': -4.0}, {'period': ""Q4 '24"", 'revenue': 6.46, 'unit': 'M', 'net_profit': -18.05}, {'period': ""Q3 '24"", 'revenue': 6.22, 'unit': 'M', 'net_profit': -2.94}, {'period': ""Q2 '24"", 'revenue': 6.15, 'unit': 'M', 'net_profit': -2.62}]",-1.06,-1.06,59988000,11487000,3459000,26067000,4067000,0,8124000,3459000,-5643000,-0.09088748395683795,-0.023230421686746987,0.009345794392523372,__nan__,__nan__,__nan__,0.4345369073814763
259,IPAR,Inter Parfums Inc. Common Stock,"Inter Parfums, Inc., together with its subsidiaries, manufactures, markets, and distributes a range of fragrances and fragrance related products in the United States and internationally. The company operates in two segments, European Based Operations and United States Based Operations. It offers its fragrance and cosmetic products under the Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lily Aldridge, Lanvin, Moncler, Montblanc, Rochas, S.T. Dupont, Van Cleef & Arpels, Abercrombie & Fitch, Anna Sui, babe, Dunhill, Ferragamo, Graff, GUESS, Hollister, MCM, Oscar de la Renta, French Connection, and Ungaro brand names, as well as under the Intimate and Aziza names. It sells its products to department stores, specialty stores, duty free shops, beauty retailers, and domestic and international wholesalers, and distributors, as well as through e-commerce. The company was formerly known as Jean Philippe Fragrances, Inc. and changed its name to Inter Parfums, Inc. in July 1999. Inter Parfums, Inc. was founded in 1982 and is headquartered in New York, New York.",Mr. Jean  Madar,Household & Personal Products,108.53,USD,3486406867,https://images.financialmodelingprep.com/symbol/IPAR.png,258086,21.2,8.83,409139,304574000,164358000,"[{'period': '2024', 'revenue': 1450.0, 'unit': 'M', 'net_profit': 164.36}, {'period': '2023', 'revenue': 1320.0, 'unit': 'M', 'net_profit': 152.65}, {'period': '2022', 'revenue': 1090.0, 'unit': 'M', 'net_profit': 120.94}, {'period': '2021', 'revenue': 879.52, 'unit': 'M', 'net_profit': 87.41}]","[{'period': ""Q4 '24"", 'revenue': 361.5, 'unit': 'M', 'net_profit': 24.23}, {'period': ""Q3 '24"", 'revenue': 424.63, 'unit': 'M', 'net_profit': 100.41}, {'period': ""Q2 '24"", 'revenue': 342.23, 'unit': 'M', 'net_profit': 36.82}, {'period': ""Q1 '24"", 'revenue': 323.96, 'unit': 'M', 'net_profit': 41.05}, {'period': ""Q4 '23"", 'revenue': 328.74, 'unit': 'M', 'net_profit': 10.42}, {'period': ""Q3 '23"", 'revenue': 367.97, 'unit': 'M', 'net_profit': 53.21}]",5.13,5.12,1411261000,914832000,234744000,468616000,281133000,0,326340000,125433000,182902000,0.0839819629364681,0.07667011673457623,0.07547169811320763,"[0.8, 0.015]","['2025-03-14', '2002-03-26']",__nan__,0.332054807721605
260,IPDN,Professional Diversity Network Inc. Common Stock,"Professional Diversity Network, Inc. operates online professional networking communities with career resources in the United States. It operates in three segments: Professional Diversity Network (PDN Network), National Association of Professional Women (NAPW Network), and RemoteMore USA (RemoteMore). The company offers online professional job seeking communities that offers recruitment services, such as single and multiple job postings, recruitment media, talent recruitment communities, corporate memberships, hiring campaign marketing and advertising, e-newsletter marketing, and research and outreach services to various cultural groups and employers. It also provides consumer advertising and consumer marketing solutions through advertising and job postings on its websites. In addition, the company operates a women-only professional networking organization; and offers companies with talented engineers to provide solutions to their software needs. Professional Diversity Network, Inc. was incorporated in 2003 and is headquartered in Chicago, Illinois.",Mr. Xin  He CPA,Staffing & Employment Services,1.28,USD,2666662,https://images.financialmodelingprep.com/symbol/IPDN.png,137686,-0.62,0.26,1666418,-2498706000,-2511965,"[{'period': '2024', 'revenue': 6730.0, 'unit': 'M', 'net_profit': -2.51}, {'period': '2023', 'revenue': 7.7, 'unit': 'M', 'net_profit': -4.31}, {'period': '2022', 'revenue': 8.31, 'unit': 'M', 'net_profit': -3.08}, {'period': '2021', 'revenue': 6.1, 'unit': 'M', 'net_profit': -2.86}]","[{'period': ""Q4 '24"", 'revenue': 1620.0, 'unit': 'K', 'net_profit': -761.94}, {'period': ""Q3 '24"", 'revenue': 1690.0, 'unit': 'K', 'net_profit': -405.05}, {'period': ""Q2 '24"", 'revenue': 1690.0, 'unit': 'K', 'net_profit': -553.15}, {'period': ""Q1 '24"", 'revenue': 1730.0, 'unit': 'K', 'net_profit': -791.83}, {'period': ""Q4 '23"", 'revenue': 1890.0, 'unit': 'K', 'net_profit': -513.66}, {'period': ""Q3 '23"", 'revenue': 2.01, 'unit': 'M', 'net_profit': -1.32}]",-2.01,-2.01,7981801000,3226528000,1731155000,3140897000,1231256,0,2955833000,1731155000,-2522323000,-637.5564829925679,0.41735309937909665,-3.902439024390244,__nan__,__nan__,__nan__,0.39350730493030334
261,IPGP,IPG Photonics Corporation Common Stock,"IPG Photonics Corporation develops, manufactures, and sells various high-performance fiber lasers, fiber amplifiers, and diode lasers used in various applications primarily in materials processing worldwide. The company's laser products include hybrid fiber-solid state lasers with green and ultraviolet wavelengths; fiber pigtailed packaged diodes and fiber coupled direct diode laser systems; high-energy pulsed lasers, multi-wavelength and tunable lasers, and single-polarization and single-frequency lasers; and high-power optical fiber delivery cables, fiber couplers, beam switches, chillers, scanners, and other accessories. It also provides erbium-doped fiber and Raman amplifiers, and integrated communications systems, which are deployed in broadband networks; and ytterbium and thulium specialty fiber amplifiers and broadband light sources. In addition, the company offers integrated laser systems; 2D compact flat sheet cutter systems and multi-axis systems; welding seam stepper and picker, a fiber laser welding tool; high precision laser systems; specialized fiber laser systems; and optical transceiver and transponder modules for interconnecting electronic equipment, including Ethernet switches, IP routers and DWDM/SONET/SDH optical transport modules within telecommunications, cable multi-system operators, and data center networking applications. It's lasers and amplifiers are also used in materials processing, communications, and medical and advanced applications. The company markets its products to original equipment manufacturers, system integrators, and end users through direct sales force, as well as through agreements with independent sales representatives and distributors. IPG Photonics Corporation was founded in 1990 and is headquartered in Oxford, Massachusetts.",Dr. Mark Milton Gitin Ph.D.,Semiconductors,57.47,USD,2445268042,https://images.financialmodelingprep.com/symbol/IPGP.png,347993,-14.05,7.79,527343,75920000,-181526000,"[{'period': '2024', 'revenue': 977.13, 'unit': 'M', 'net_profit': -181.53}, {'period': '2023', 'revenue': 1290.0, 'unit': 'M', 'net_profit': 218.88}, {'period': '2022', 'revenue': 1430.0, 'unit': 'M', 'net_profit': 109.91}, {'period': '2021', 'revenue': 1460.0, 'unit': 'M', 'net_profit': 278.42}]","[{'period': ""Q4 '24"", 'revenue': 234.34, 'unit': 'M', 'net_profit': 7.82}, {'period': ""Q3 '24"", 'revenue': 233.14, 'unit': 'M', 'net_profit': -233.59}, {'period': ""Q2 '24"", 'revenue': 257.64, 'unit': 'M', 'net_profit': 20.15}, {'period': ""Q1 '24"", 'revenue': 252.01, 'unit': 'M', 'net_profit': 24.1}, {'period': ""Q4 '23"", 'revenue': 298.89, 'unit': 'M', 'net_profit': 41.43}, {'period': ""Q3 '23"", 'revenue': 301.4, 'unit': 'M', 'net_profit': 54.99}]",-4.09,-4.09,2289264000,1430995000,930192000,264793000,171131000,0,205019000,620040000,149372000,-0.7479306875794772,-1.8293478558831862,-1.8814655172413794,"[0.65, 0.65]","['2012-12-19', '2012-12-19']",__nan__,0.11566730617351254
262,IPHA,Innate Pharma S.A. ADS,"Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and peripheral T-cell lymphoma, as well as in Phase II clinical trials to treat refractory sézary syndrome; Monalizumab, an immune checkpoint inhibitor that is in Phase III clinical trial to treat advanced solid tumors comprising colorectal and lung cancer, as well as head and neck cancer; Avdoralimab (IPH5401), a monoclonal antibody blocking C5a binding to C5aR1 that is in Phase II clinicals trials for the treatment of COVID-19, bullous pemphigoid, chronic spontaneous urticaria, and other inflammatory diseases; IPH5201, a blocking antibody that is in Phase 1 clinical trials targeting the CD39 immunosuppressive pathway; IPH5301, an anti-CD73 antibody targeting the immunosuppressive adenosine pathway to promote antitumor immunity; and IPH6101, a NKp46-based NK cell engager for the generation and evaluation of up to two bispecific NK cell engagers. Its products in preclinical trials are IPH43, an anti-MICA/B antibody drug conjugate; Anti-Siglec-9, an antibody program; IPH65, a tetraspecific proprietary antibody; IPH25, a checkpoint inhibitor; and IPH62 and IPH64 programs. Innate Pharma S.A. has licensing and collaboration agreements with AstraZeneca, Novo Nordisk A/S, Sanofi, and Orega Biotech; and co-development and license agreement with MedImmune Limited. The company was incorporated in 1999 and is headquartered in Marseille, France.",Mr. Jonathan E. Dickinson,Biotechnology,1.8155,USD,152160187,https://images.financialmodelingprep.com/symbol/IPHA.png,239591,-2.71,0.0655,6729,-1839000,-7570000,"[{'period': '2023', 'revenue': 51.9, 'unit': 'M', 'net_profit': -7.57}, {'period': '2022', 'revenue': 49.64, 'unit': 'M', 'net_profit': -99.1}, {'period': '2021', 'revenue': 12.11, 'unit': 'M', 'net_profit': -59.14}, {'period': '2020', 'revenue': 69.77, 'unit': 'M', 'net_profit': -63.98}]","[{'period': ""Q2 '24"", 'revenue': 12.35, 'unit': 'M', 'net_profit': -24.76}, {'period': ""Q4 '23"", 'revenue': 21.44, 'unit': 'M', 'net_profit': -9.29}, {'period': ""Q2 '23"", 'revenue': 35.34, 'unit': 'M', 'net_profit': 1.72}, {'period': ""Q4 '22"", 'revenue': 8.31, 'unit': 'M', 'net_profit': -64.41}, {'period': ""Q2 '22"", 'revenue': 41.27, 'unit': 'M', 'net_profit': 6.3}, {'period': ""Q4 '21"", 'revenue': 2.79, 'unit': 'M', 'net_profit': -29.09}]",-0.09,-0.09,184193000,148012000,92456000,132292000,15233000,9796000,39637000,70605000,-34909000,0.9699975528183375,0.9236148249800712,0.9274193548387096,__nan__,__nan__,__nan__,0.7182249053981422
263,IPLDP,Interstate Power & Light Company Perp Prd Ser D,"Interstate Power and Light Company, a public utility company, generates and distributes electricity, and distributes and transports natural gas to retail customers in Iowa. The company operates through three segments: Electric Operations, Gas Operations, and Other. It generates electricity from coal, natural gas, and wind energy; and purchases electricity from wholesale energy markets. The company also sells electricity to wholesale customers, including municipalities and rural electric cooperatives in Minnesota, Illinois, and Iowa. In addition, it generates and distributes steam for customers in Cedar Rapids, Iowa; and owns overhead electric distribution lines, underground electric distribution cables, and substation distribution transformers, as well as gas mains in Iowa. The company provides utility services to incorporated communities. It offers electric utility services to retail customers in various industries, such as farming, agriculture, industrial manufacturing, chemical, packaging, and food industries, as well as gas utility services for various industries comprising research, education, hospitality, manufacturing, and chemicals. As of December 31, 2020, it supplied electric service to approximately 495,000 retail customers and natural gas service to approximately 225,000 retail customers. The company was formerly known as Iowa Railway and Light Corporation. The company was incorporated in 1925 and is based in Cedar Rapids, Iowa. Interstate Power and Light Company operates as a subsidiary of Alliant Energy Corporation.",Mr. John O. Larsen,Regulated Electric,24.99,USD,0,https://images.financialmodelingprep.com/symbol/IPLDP.png,55999,0.9385915492957746,-0.02000046,2298,782000000,334000000,"[{'period': '2020', 'revenue': 1950.0, 'unit': 'M', 'net_profit': 334.0}, {'period': '2019', 'revenue': 3650.0, 'unit': 'M', 'net_profit': 567.4}, {'period': '2018', 'revenue': 3530.0, 'unit': 'M', 'net_profit': 522.3}, {'period': '2017', 'revenue': 3380.0, 'unit': 'M', 'net_profit': 467.5}]","[{'period': ""Q3 '21"", 'revenue': 599.0, 'unit': 'M', 'net_profit': 160.0}, {'period': ""Q2 '21"", 'revenue': 455.0, 'unit': 'M', 'net_profit': 88.0}, {'period': ""Q1 '21"", 'revenue': 489.0, 'unit': 'M', 'net_profit': 82.0}, {'period': ""Q4 '20"", 'revenue': 443.0, 'unit': 'M', 'net_profit': 36.0}, {'period': ""Q3 '20"", 'revenue': 553.0, 'unit': 'M', 'net_profit': 151.0}, {'period': ""Q2 '20"", 'revenue': 763.1, 'unit': 'M', 'net_profit': 136.9}]",1.4,1.4,9849000000,496000000,50000000,5885000000,48000000,0,447000000,50000000,-693000000,-0.3671603139920693,-0.411350017624251,-0.409282700421941,"[0.319, 0.305]","['2021-11-29', '2013-05-29']",__nan__,0.5975225911260026
264,IPVI,InterPrivate IV InfraTech Partners Inc. Class A Common Stock,"InterPrivate IV InfraTech Partners Inc. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other transaction with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.",Mr. Kevin L. Timmons,Shell Companies,10.12,USD,363687480,https://images.financialmodelingprep.com/symbol/IPVI.png,3451,-77.84615384615384,-0.005,300,-2737188,-3710378,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.71}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 372.14}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.78}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.43}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.32}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.96}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.18}]",-0.12,-0.12,287877496,257262,35,20980026,0,0,2177927,35,-1227472,0,0,0,__nan__,__nan__,__nan__,0.07287831209981067
265,IPVIU,InterPrivate IV InfraTech Partners Inc. Units,"InterPrivate IV InfraTech Partners Inc. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other transaction with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.",Mr. Kevin L. Timmons,Shell Companies,10.12,USD,402381320,https://images.financialmodelingprep.com/symbol/IPVIU.png,292,-1124.4444444444443,0,5400,-2737188,-3710378,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.71}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 372.14}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.78}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.43}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.32}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.96}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.18}]",-0.12,-0.12,287877496,257262,35,20980026,0,0,2177927,35,-1227472,0,0,0,__nan__,__nan__,__nan__,0.07287831209981067
266,IPVIW,InterPrivate IV InfraTech Partners Inc. Warrant,"InterPrivate IV InfraTech Partners Inc., a blank check company, focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.",Mr. Kevin L. Timmons,Shell Companies,0.0025,USD,363687480,https://images.financialmodelingprep.com/symbol/IPVIW.png,0,0,0,20799,-2737188,-3710378,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.71}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 372.14}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.78}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.43}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.32}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.96}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.18}]",-0.12,-0.12,287877496,257262,35,20980026,0,0,2177927,35,-1227472,0,0,0,__nan__,__nan__,__nan__,0.07287831209981067
267,IPW,iPower Inc. Common Stock,"iPower Inc. engages in the online retail of hydroponics equipment in the United States. It offers various products, including advanced indoor and greenhouse grow-light systems, ventilation systems, activated carbon filters, nutrients, growing media, hydroponic water-resistant grow tents, trimming machines, pumps, and accessories for hydroponic gardening, as well as other indoor and outdoor growing products under the iPower and Simple Deluxe brands through its Zenhydro.com website and various third-party e-commerce channels. The company was formerly known as BZRTH Inc. and changed its name to iPower Inc. in September 2020. iPower Inc. was incorporated in 2018 and is based in Duarte, California.",Mr. Chenlong  Tan,Specialty Retail,0.4799,USD,15092423,https://images.financialmodelingprep.com/symbol/IPW.png,63588,-6.86,0.015,68666,1505017,-1528159,"[{'period': '2024', 'revenue': 86.07, 'unit': 'M', 'net_profit': -1.53}, {'period': '2023', 'revenue': 88.9, 'unit': 'M', 'net_profit': -11.97}, {'period': '2022', 'revenue': 79.42, 'unit': 'M', 'net_profit': 1.52}, {'period': '2021', 'revenue': 54080.0, 'unit': 'K', 'net_profit': -775.75}]","[{'period': ""Q2 '25"", 'revenue': 19070.0, 'unit': 'K', 'net_profit': 218.82}, {'period': ""Q1 '25"", 'revenue': 19.01, 'unit': 'M', 'net_profit': -2.03}, {'period': ""Q4 '24"", 'revenue': 19450.0, 'unit': 'K', 'net_profit': 657.1}, {'period': ""Q3 '24"", 'revenue': 23.31, 'unit': 'M', 'net_profit': 1.02}, {'period': ""Q2 '24"", 'revenue': 16.8, 'unit': 'M', 'net_profit': -1.91}, {'period': ""Q1 '24"", 'revenue': 26.51, 'unit': 'M', 'net_profit': -1.29}]",-0.0511,-0.0511,51295857,35010737,7377837,28279824,14740093,0,23770015,7377837,6164076,1.117834398893982,0.8722850655097745,0.8722500000000001,"[0.23, 0.29]","['2017-06-16', '2009-06-19']",__nan__,0.5513081495061093
268,IPWR,Ideal Power Inc. Common Stock,"Ideal Power Inc. focuses on the development and commercialization of its B-TRAN technology. It develops Bi-directional bi-polar junction TRANsistor solid state switch technology. The company was formerly known as Ideal Power Converters Inc. and changed its name to Ideal Power Inc. in July 2013. Ideal Power Inc. was incorporated in 2007 and is headquartered in Austin, Texas.",Mr. R. Daniel Brdar,Electrical Equipment & Parts,4.26,USD,35521201,https://images.financialmodelingprep.com/symbol/IPWR.png,24463,-3.33,0.45,18013,-11071175,-10417813,"[{'period': '2024', 'revenue': 0.08603000000000001, 'unit': 'M', 'net_profit': -10.42}, {'period': '2023', 'revenue': 0.19887000000000002, 'unit': 'M', 'net_profit': -9.95}, {'period': '2022', 'revenue': 0.20327, 'unit': 'M', 'net_profit': -6.88}, {'period': '2021', 'revenue': 0.5764, 'unit': 'M', 'net_profit': -4.78}]","[{'period': ""Q4 '24"", 'revenue': 0.00541, 'unit': 'M', 'net_profit': -2.6}, {'period': ""Q3 '24"", 'revenue': 0.000554, 'unit': 'M', 'net_profit': -2.69}, {'period': ""Q2 '24"", 'revenue': 0.00133, 'unit': 'M', 'net_profit': -2.66}, {'period': ""Q1 '24"", 'revenue': 0.07873999999999999, 'unit': 'M', 'net_profit': -2.47}, {'period': ""Q4 '23"", 'revenue': 0.06148, 'unit': 'M', 'net_profit': -2.41}, {'period': ""Q3 '23"", 'revenue': 0.0015600000000000002, 'unit': 'M', 'net_profit': -2.74}]",-1.28,-1.28,19826684,16296606,15842850,1971520,692,0,560810,15842850,-8939846,-0.09829358964209746,-0.04659353708350998,0.2049689440993789,__nan__,__nan__,__nan__,0.09943770728377978
269,IQ,iQIYI Inc. American Depositary Shares,"iQIYI, Inc., together with its subsidiaries, provides online entertainment services under the iQIYI brand in the People's Republic of China. The company offers various products and services comprising internet video, online games, live broadcasting, online literature, animations, e-commerce, and social media platform. It operates a platform that provides a collection of internet video content, including professionally-produced content licensed from professional content providers and self-produced content. The company also provides membership, content distribution, and online advertising services. In addition, it operates iQIYI Show, a live broadcasting service that enables users to follow their favorite hosts, celebrities, and shows in real time through live broadcasting; and iQIYI Lite, an easy and quick access to the personalized videos based on their user preferences. Further, it is involved in the talent agency and IP licensing activities, as well as engages in developing a video community app. The company was formerly known as Qiyi.com, Inc. and changed its name to iQIYI, Inc. in November 2017. iQIYI, Inc. was incorporated in 2009 and is headquartered in Beijing, China. iQIYI, Inc. is a subsidiary of Baidu Holdings Limited.",Dr. Yu  Gong,Entertainment,1.725,USD,237300600,https://images.financialmodelingprep.com/symbol/IQ.png,35312372,15.68,0.195,95108246,1817335000,764059000,"[{'period': '2024', 'revenue': 29230.0, 'unit': 'M', 'net_profit': 764.06}, {'period': '2023', 'revenue': 31.87, 'unit': 'B', 'net_profit': 1.93}, {'period': '2022', 'revenue': 29000.0, 'unit': 'M', 'net_profit': -117.78}, {'period': '2021', 'revenue': 30.55, 'unit': 'B', 'net_profit': -6.11}]","[{'period': ""Q4 '24"", 'revenue': 6610.0, 'unit': 'M', 'net_profit': -189.35}, {'period': ""Q3 '24"", 'revenue': 7250.0, 'unit': 'M', 'net_profit': 229.41}, {'period': ""Q2 '24"", 'revenue': 7440.0, 'unit': 'M', 'net_profit': 68.69}, {'period': ""Q1 '24"", 'revenue': 7930.0, 'unit': 'M', 'net_profit': 655.32}, {'period': ""Q4 '23"", 'revenue': 7710.0, 'unit': 'M', 'net_profit': 466.23}, {'period': ""Q3 '23"", 'revenue': 8020.0, 'unit': 'M', 'net_profit': 475.92}]",0.79,0.77,45760525000,9527236000,4471289000,32386761001,4129087000,2108477000,21477333000,3529679000,1937019000,-0.8946724639260282,-0.6031829128383785,-0.6089108910891089,__nan__,__nan__,__nan__,0.7077445243689839
270,IRBT,iRobot Corporation Common Stock,"iRobot Corporation designs, builds, and sells robots and home innovation products in the United States, Europe, the Middle East, Africa, Japan, and internationally. The company offers floor care products, including Roomba floor vacuuming robots; Roomba accessories and consumables, such as the Clean Base Automatic Dirt Disposal, replacement dirt disposal bags for the Clean Base, filters, brushes, and batteries; Braava family of automatic floor mopping robots; and Braava accessories and consumables, which include cleaning solution, washable and disposable mopping pads, replacement tanks, and batteries, as well as subscription services. It also provides H1 Handheld Vacuum, a portable vacuum; H1 Handheld Vacuum accessories comprising filters, chargers, batteries, and an extension kit that converts the H1 Handheld Vacuum into a stick vacuum; air purifiers under the Aeris brand; Root robots to help children learn how to code; and Create 2, a mobile robot platform that offers an opportunity for educators, developers, and high-school and college students to program behaviors, sounds, movements, and add additional electronics, as well as sells filters and fabric covers. The company sells its products through chain stores and other national retailers, distributors, and resellers, as well as through its website and app, and e-commerce websites. iRobot Corporation was incorporated in 1990 and is headquartered in Bedford, Massachusetts.",Mr. Gary S. Cohen,"Furnishings, Fixtures & Appliances",2.25,USD,68914350,https://images.financialmodelingprep.com/symbol/IRBT.png,2446719,-0.46,0.22,3487035,-52564000,-145518000,"[{'period': '2024', 'revenue': 681.85, 'unit': 'M', 'net_profit': -145.52}, {'period': '2023', 'revenue': 890.58, 'unit': 'M', 'net_profit': -304.71}, {'period': '2022', 'revenue': 1180.0, 'unit': 'M', 'net_profit': -286.3}, {'period': '2021', 'revenue': 1560.0, 'unit': 'M', 'net_profit': 30.39}]","[{'period': ""Q4 '24"", 'revenue': 172.04, 'unit': 'M', 'net_profit': -77.11}, {'period': ""Q3 '24"", 'revenue': 193.44, 'unit': 'M', 'net_profit': -6.37}, {'period': ""Q2 '24"", 'revenue': 166.36, 'unit': 'M', 'net_profit': -70.65}, {'period': ""Q1 '24"", 'revenue': 150.01, 'unit': 'M', 'net_profit': 8.61}, {'period': ""Q4 '23"", 'revenue': 307.54, 'unit': 'M', 'net_profit': -63.59}, {'period': ""Q3 '23"", 'revenue': 186.18, 'unit': 'M', 'net_profit': -79.2}]",-4.92,-4.92,516137000,288502000,134303000,454898000,49865000,0,218244000,134303000,-33340000,0.7727345442282166,0.5224377276754947,0.553133514986376,__nan__,__nan__,__nan__,0.8813512691397827
271,IRCP,IRSA Propiedades Comerciales S.A. American Depositary Shares,"IRSA Propiedades Comerciales S.A. operates as an investment arm of IRSA Inversiones y Representaciones S.A. Alto Palermo S.A. engages in the ownership, acquisition, development, leasing, management, and operation of shopping centers, as well as residential and commercial complexes in Argentina. As of June 30, 2007, it owned and operated ten shopping centers covering a total of 264,995 square meters in Argentina, including six in the Buenos Aires metropolitan area and four in the provinces of Cordoba, Mendoza, Salta, and Santa Fe; and a condominium called Torres de Abasto located in front of the Abasto Shopping Center in Buenos Aires. The company offers leases to retail tenants in its ten shopping centers; administration and maintenance of common areas; administration of contributions made by tenants to finance promotional efforts for the shopping centers; and parking lot services for visitors. The company also offers credit card consumer finance service, through the issuance of its Tarjeta Shopping and Tarjeta Shopping Metroshop credit cards, for consumers at shopping centers, hypermarkets, and street stores. It also engages in the development and sale of residential properties, and acquisition and sale of undeveloped parcels of land for future development. In addition, it engages in the development of condominiums associated with its shopping centers. The company was founded in 1889 and is headquartered in Buenos Aires, Argentina.",Mr. Alejandro Gustavo Elsztain,Real Estate - Services,2.4984,USD,0,https://images.financialmodelingprep.com/symbol/IRCP.png,29122,-0.8196850393700787,0.26839995,7811,-3056000000,-21933000000,"[{'period': '2021', 'revenue': 11.0, 'unit': 'B', 'net_profit': -21.93}, {'period': '2020', 'revenue': 11.67, 'unit': 'B', 'net_profit': 17.09}, {'period': '2019', 'revenue': 10.17, 'unit': 'B', 'net_profit': -18.03}, {'period': '2018', 'revenue': 5.95, 'unit': 'B', 'net_profit': 15.1}]","[{'period': ""Q3 '21"", 'revenue': 3.88, 'unit': 'B', 'net_profit': -1.71}, {'period': ""Q2 '21"", 'revenue': 3.33, 'unit': 'B', 'net_profit': -17.15}, {'period': ""Q1 '21"", 'revenue': 2.91, 'unit': 'B', 'net_profit': -10.16}, {'period': ""Q4 '20"", 'revenue': 2.77, 'unit': 'B', 'net_profit': -8.99}, {'period': ""Q3 '20"", 'revenue': 1.3, 'unit': 'B', 'net_profit': 12.35}, {'period': ""Q2 '20"", 'revenue': 1.84, 'unit': 'B', 'net_profit': 18.85}]",-37.76,-37.76,177404000000,22652000000,8898000000,99391000000,13708000000,4312000000,13122000000,793000000,1060000000,-1.117417674879526,-2.283416864950759,-1.2989707046714174,"[15.4743, 0.8623]","['2020-11-23', '2003-11-25']",__nan__,0.5602523054722555
272,IRDM,Iridium Communications Inc Common Stock,"Iridium Communications Inc. provides mobile voice and data communications services and products to businesses, the United States and international governments, non-governmental organizations, and consumers worldwide. The company offers postpaid mobile voice and data satellite communications; prepaid mobile voice satellite communications; push-to-talk; broadband data; and Internet of Things (IoT) services. It also provides hosted payload and other data services, such as satellite time and location services, and inbound connections from the public switched telephone network, short message, subscriber identity module, activation, customer reactivation, and other peripheral services. In addition, the company offers voice and data solutions comprising personnel tracking devices; asset tracking devices for equipment, vehicles, and aircrafts; beyond-line-of-sight aircraft communications applications; maritime communications applications; specialized communications solutions for high-value individuals; mobile communications and data devices for the military and intelligence agencies, such as secure satellite handsets, as well as netted voice, messaging, and paging services; and maintenance services for the United States government's dedicated gateway. Further, it provides satellite handsets, personal connectivity devices, voice and data modems, broadband data devices, and IoT data devices; various accessories for its devices that include batteries, holsters, earbud headphones, portable auxiliary antennas, antenna adaptors, USB data cables, charging units, and others; and engineering and support services. Iridium Communications Inc. sells its products and services to commercial end users through a wholesale distribution network that include service providers, and value-added resellers and manufacturers. The company was formerly known as Iridium Holdings LLC and changed its name to Iridium Communications Inc. in September 2009. Iridium Communications Inc. was founded in 2000 and is headquartered in McLean, Virginia.",Mr. Matthew J. Desch,Telecommunications Services,24.65,USD,2680268450,https://images.financialmodelingprep.com/symbol/IRDM.png,1346826,26.22,2,1621597,404045000,112776000,"[{'period': '2024', 'revenue': 830.68, 'unit': 'M', 'net_profit': 112.78}, {'period': '2023', 'revenue': 790.72, 'unit': 'M', 'net_profit': 15.41}, {'period': '2022', 'revenue': 721.03, 'unit': 'M', 'net_profit': 8.72}, {'period': '2021', 'revenue': 614.5, 'unit': 'M', 'net_profit': -9.32}]","[{'period': ""Q4 '24"", 'revenue': 212.99, 'unit': 'M', 'net_profit': 36.34}, {'period': ""Q3 '24"", 'revenue': 212.77, 'unit': 'M', 'net_profit': 24.45}, {'period': ""Q2 '24"", 'revenue': 201.07, 'unit': 'M', 'net_profit': 32.34}, {'period': ""Q1 '24"", 'revenue': 203.85, 'unit': 'M', 'net_profit': 19.65}, {'period': ""Q4 '23"", 'revenue': 194.74, 'unit': 'M', 'net_profit': 38.02}, {'period': ""Q3 '23"", 'revenue': 197.6, 'unit': 'M', 'net_profit': -1.64}]",0.95,0.94,2671471000,292730000,93526000,2094834000,98803000,42516000,169214000,93526000,306065000,0.06306929703163068,6.315990917937074,6.3076923076923075,"[0.14, 0.13]","['2025-03-17', '2023-03-14']",__nan__,0.784150005745898
273,IRIX,IRIDEX Corporation Common Stock,"IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation systems, which are used for the treatment of diabetic macular edema and other retinal diseases; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.",Mr. Patrick  Mercer,Medical - Devices,0.9407,USD,15793412,https://images.financialmodelingprep.com/symbol/IRIX.png,74078,-1.74,0.0767,59425,-8302000,-8910000,"[{'period': '2024', 'revenue': 48.67, 'unit': 'M', 'net_profit': -8.91}, {'period': '2023', 'revenue': 51.87, 'unit': 'M', 'net_profit': -9.57}, {'period': '2022', 'revenue': 56.97, 'unit': 'M', 'net_profit': -7.55}, {'period': '2021', 'revenue': 53.9, 'unit': 'M', 'net_profit': -5.22}]","[{'period': ""Q4 '24"", 'revenue': 12700.0, 'unit': 'K', 'net_profit': -834.0}, {'period': ""Q3 '24"", 'revenue': 11.58, 'unit': 'M', 'net_profit': -1.93}, {'period': ""Q2 '24"", 'revenue': 12.63, 'unit': 'M', 'net_profit': -2.68}, {'period': ""Q1 '24"", 'revenue': 11.76, 'unit': 'M', 'net_profit': -3.46}, {'period': ""Q4 '23"", 'revenue': 12.46, 'unit': 'M', 'net_profit': -2.96}, {'period': ""Q3 '23"", 'revenue': 12.85, 'unit': 'M', 'net_profit': -1.75}]",-0.54,-0.54,29135000,23562000,2387000,27038000,5951000,0,16559000,2387000,-7285000,-0.041003134796238246,0.06896551724137931,0.08474576271186429,__nan__,__nan__,__nan__,0.9280247125450489
274,IRMD,iRadimed Corporation Common Stock,"IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.",Mr. Roger E. Susi,Medical - Devices,51.76,USD,658133576,https://images.financialmodelingprep.com/symbol/IRMD.png,39901,34.51,3.09,55588,21964727,19234026,"[{'period': '2024', 'revenue': 73.24, 'unit': 'M', 'net_profit': 19.23}, {'period': '2023', 'revenue': 65.56, 'unit': 'M', 'net_profit': 17.19}, {'period': '2022', 'revenue': 53.3, 'unit': 'M', 'net_profit': 12.83}, {'period': '2021', 'revenue': 41.81, 'unit': 'M', 'net_profit': 9.33}]","[{'period': ""Q4 '24"", 'revenue': 19.39, 'unit': 'M', 'net_profit': 5.15}, {'period': ""Q3 '24"", 'revenue': 18.33, 'unit': 'M', 'net_profit': 5.05}, {'period': ""Q2 '24"", 'revenue': 17.93, 'unit': 'M', 'net_profit': 4.9}, {'period': ""Q1 '24"", 'revenue': 17.6, 'unit': 'M', 'net_profit': 4.14}, {'period': ""Q4 '23"", 'revenue': 17.45, 'unit': 'M', 'net_profit': 4.54}, {'period': ""Q3 '23"", 'revenue': 16.5, 'unit': 'M', 'net_profit': 5.07}]",1.52,1.5,98325775,75242219,52233907,11507019,10556733,0,8512308,52233907,17619430,0.0559641007165261,0.11872719100161602,0.11764705882352934,"[0.17, 1]","['2025-02-24', '2022-02-16']",__nan__,0.11702952760860517
275,IROQ,IF Bancorp Inc. Common Stock,"IF Bancorp, Inc. operates as the savings and loan holding company for Iroquois Federal Savings and Loan Association that provides a range of banking and financial services to individual and corporate clients. The company offers various deposit accounts, including savings accounts, certificates of deposit, money market accounts, commercial and personal checking accounts, individual retirement accounts, and health savings accounts. It also provides loans comprising one- to four-family residential mortgage loans; multi-family mortgage loans; commercial real estate loans, such as farm loans; home equity lines of credit; commercial business loans; and consumer loans primarily consisting of automobile loans, as well as construction loans and land development loans. In addition, the company sells property and casualty insurance, as well as offers annuities; mutual funds; individual and group retirement plans; life, disability, and health insurance; individual securities; managed accounts; and other financial services. Further, it invests in securities; and provides ATM, online banking and bill pay, mobile banking, ACH origination, remote deposit capture, and telephone banking services. As of August 31, 2021, it operated a network of seven full-service banking offices located in Watseka, Danville, Clifton, Hoopeston, Savoy, Bourbonnais, and Champaign, Illinois; and a loan production and wealth management office in Osage Beach, Missouri. IF Bancorp, Inc. was founded in 1883 and is headquartered in Watseka, Illinois.",Mr. Walter H. Hasselbring III,Banks - Regional,23.04,USD,77219251,https://images.financialmodelingprep.com/symbol/IROQ.png,2218,24.51,-0.83,3208,3026000,1790000,"[{'period': '2024', 'revenue': 22.08, 'unit': 'M', 'net_profit': 1.79}, {'period': '2023', 'revenue': 26.07, 'unit': 'M', 'net_profit': 4.66}, {'period': '2022', 'revenue': 27.76, 'unit': 'M', 'net_profit': 5.78}, {'period': '2021', 'revenue': 26.41, 'unit': 'M', 'net_profit': 5.35}]","[{'period': ""Q2 '25"", 'revenue': 11.01, 'unit': 'M', 'net_profit': 1.22}, {'period': ""Q1 '25"", 'revenue': 6230.0, 'unit': 'K', 'net_profit': 633.0}, {'period': ""Q4 '24"", 'revenue': 11870.0, 'unit': 'K', 'net_profit': 431.0}, {'period': ""Q3 '24"", 'revenue': 5400.0, 'unit': 'K', 'net_profit': 708.0}, {'period': ""Q2 '24"", 'revenue': 5300.0, 'unit': 'K', 'net_profit': 185.0}, {'period': ""Q1 '24"", 'revenue': 5710.0, 'unit': 'K', 'net_profit': 466.0}]",0.57,0.57,887745000,6191000,6191000,813829000,0,190475000,0,9571000,2036000,-0.562906254513939,-0.6158798283261803,-0.62,"[0.2, 0.05]","['2025-03-21', '2013-09-19']",__nan__,0.9167373513790559
276,IRTC,iRhythm Technologies Inc. Common Stock,"iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.",Mr. Quentin S. Blackford,Medical - Devices,103.45,USD,3249323120,https://images.financialmodelingprep.com/symbol/IRTC.png,449916,-28.5,6.61,658841,-74126000,-113289000,"[{'period': '2024', 'revenue': 591.84, 'unit': 'M', 'net_profit': -113.29}, {'period': '2023', 'revenue': 492.68, 'unit': 'M', 'net_profit': -123.41}, {'period': '2022', 'revenue': 410.92, 'unit': 'M', 'net_profit': -116.16}, {'period': '2021', 'revenue': 322.82, 'unit': 'M', 'net_profit': -101.36}]","[{'period': ""Q4 '24"", 'revenue': 164.32, 'unit': 'M', 'net_profit': -1.33}, {'period': ""Q3 '24"", 'revenue': 147.54, 'unit': 'M', 'net_profit': -46.18}, {'period': ""Q2 '24"", 'revenue': 148.05, 'unit': 'M', 'net_profit': -20.11}, {'period': ""Q1 '24"", 'revenue': 131.93, 'unit': 'M', 'net_profit': -45.67}, {'period': ""Q4 '23"", 'revenue': 132.51, 'unit': 'M', 'net_profit': -38.7}, {'period': ""Q3 '23"", 'revenue': 124.6, 'unit': 'M', 'net_profit': -27.12}]",-3.63,-3.63,931449000,645819000,535553000,840541000,79941000,61902000,110920000,419597000,3390000,0.23472569222192396,0.08198142715913327,0.10148514851485152,__nan__,__nan__,__nan__,0.9024015270830716
277,IRWD,Ironwood Pharmaceuticals Inc. Class A Common Stock,"Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States and Mexico, as well as under the CONSTELLA name in the Canada and European Union. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; and CNP-104, an immune nanoparticle for the treatment of biliary cholangitis. The company has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.",Mr. Thomas A. McCourt,Drug Manufacturers - Specialty & Generic,1.03,USD,166663270,https://images.financialmodelingprep.com/symbol/IRWD.png,3293913,103,-0.08,6171700,100243000,880000,"[{'period': '2024', 'revenue': 351410.0, 'unit': 'K', 'net_profit': 880.0}, {'period': '2023', 'revenue': 0.44274, 'unit': 'B', 'net_profit': -1.0}, {'period': '2022', 'revenue': 410.6, 'unit': 'M', 'net_profit': 175.06}, {'period': '2021', 'revenue': 413.75, 'unit': 'M', 'net_profit': 528.45}]","[{'period': ""Q4 '24"", 'revenue': 90.55, 'unit': 'M', 'net_profit': 2.26}, {'period': ""Q3 '24"", 'revenue': 91.59, 'unit': 'M', 'net_profit': 31.09}, {'period': ""Q2 '24"", 'revenue': 94400.0, 'unit': 'K', 'net_profit': -860.0}, {'period': ""Q1 '24"", 'revenue': 74.88, 'unit': 'M', 'net_profit': -4.16}, {'period': ""Q4 '23"", 'revenue': 117.55, 'unit': 'M', 'net_profit': -1.09}, {'period': ""Q3 '23"", 'revenue': 113.74, 'unit': 'M', 'net_profit': 15.32}]",0.01,0.01,350908000,182368000,88559000,250138000,81886000,0,38846000,88559000,103407000,1.1083866295171583,1.0008780340816912,1.0015503875968992,__nan__,__nan__,__nan__,0.7128307134633579
278,ISBC,Investors Bancorp Inc. Common Stock,"Investors Bancorp, Inc. operates as the bank holding company for Investors Bank that provides various banking products and services to individuals and businesses in the United States. Its deposit products include savings, checking, and money market accounts. The company's loan portfolio comprises multi-family, commercial real estate, commercial and industrial, and construction loans; one-to four-family residential mortgage loans secured by one-to four-family residential real estate; and consumer and other loans primarily consisting of home equity loans, and home equity lines of credit, as well as various life insurance products. As of December 31, 2021, it operated through a network of 154 branches in New Jersey, New York, and Pennsylvania. Investors Bancorp, Inc. was founded in 1926 and is headquartered in Short Hills, New Jersey.",Mr. Kevin Cummings,Banks - Regional,13.87,USD,3455835385,https://images.financialmodelingprep.com/symbol/ISBC.png,5238648,10.428571428571429,-0.35,133025189,477231000,313333000,"[{'period': '2021', 'revenue': 835.48, 'unit': 'M', 'net_profit': 313.33}, {'period': '2020', 'revenue': 793.08, 'unit': 'M', 'net_profit': 221.58}, {'period': '2019', 'revenue': 708.49, 'unit': 'M', 'net_profit': 195.48}, {'period': '2018', 'revenue': 690.1, 'unit': 'M', 'net_profit': 202.58}]","[{'period': ""Q4 '21"", 'revenue': 216.4, 'unit': 'M', 'net_profit': 94.32}, {'period': ""Q3 '21"", 'revenue': 210.55, 'unit': 'M', 'net_profit': 66.93}, {'period': ""Q2 '21"", 'revenue': 207.78, 'unit': 'M', 'net_profit': 79.81}, {'period': ""Q1 '21"", 'revenue': 200.74, 'unit': 'M', 'net_profit': 72.28}, {'period': ""Q4 '20"", 'revenue': 211.46, 'unit': 'M', 'net_profit': 75.14}, {'period': ""Q3 '20"", 'revenue': 201.55, 'unit': 'M', 'net_profit': 64.31}]",1.33,1.33,27806618000,2760166000,2681530000,3298599000,78636000,3995519000,0,287990000,480525000,0.3998615482542467,0.4140852062460511,0.41489361702127675,"[0.16, 0.05]","['2022-02-09', '2012-10-11']",__nan__,0.11862640037706132
279,ISEE,IVERIC bio Inc. Common Stock,"IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 clinical trial for the treatment of geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). It also develops STAR or OPH2005 that is in Phase 2b clinical trial for the treatment of leber congenital amaurosis type 10 (LCA10) and autosomal recessive stargardt disease (STGD1); IC-500, a high temperature requirement A serine peptidase 1 protein inhibitors for the treatment of GA and other age-related retinal diseases; IC-100 for the treatment of rhodopsin-mediated autosomal dominant retinitis pigmentosa; and IC-200 for the treatment of IRDs associated with mutations in the BEST1 gene. In addition, the company develops OPH2001 that has completed Phase 1/2a clinical trial of various doses of Zimura monotherapy for the treatment of GA; OPH2000, which has completed Phase 1/2a clinical trial of various doses of Zimura administered in combination with Lucentis for the treatment of wet AMD; OPH2007 that has completed Phase 2a clinical trial for the treatment of wet AMD; and OPH2002, which has completed Phase 2a clinical trial for the treatment of idiopathic polypoidal choroidal vasculopathy. Its discovery and research programs include miniCEP290 program for LCA10; miniABCA4 Program for STGD1; and miniUSH2A Program for usher syndrome type 2A-Related IRDs. The company was formerly known as Ophthotech Corporation and changed its name to IVERIC bio, Inc. in April 2019. The company was incorporated in 2007 and is based in Parsippany, New Jersey.",Mr. Glenn P. Sblendorio M.B.A.,Biotechnology,39.95,USD,5512180830,https://images.financialmodelingprep.com/symbol/ISEE.png,4945949,-22.4438202247191,0.15,10801886,-192275000,-175745000,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -175.75}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -114.24}, {'period': '2020', 'revenue': 0.0, 'unit': 'M', 'net_profit': -84.55}, {'period': '2019', 'revenue': 0.0, 'unit': 'M', 'net_profit': -58.86}]","[{'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -70.62}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -51.27}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -41.95}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -48.29}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -34.27}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -33.03}]",-1.45,-1.45,666823000,662826000,646835000,132166000,0,0,35587000,476304000,-164507000,-0.6754969195778907,-0.5384110366077838,-0.294642857142857,__nan__,__nan__,__nan__,0.1982025215087062
280,ISIG,Insignia Systems Inc. Common Stock,"Insignia Systems, Inc. provides in-store advertising solutions to consumer-packaged goods manufacturers, retailers, shopper marketing agencies, and brokerages in the United States. It offers in-store signage solutions, which provides point-of-purchase services; merchandising solutions that include various corrugate displays, side caps, free standing shippers, and customized end-cap solutions; and on-pack solutions, which include BoxTalk, coupons, recipes, and cross-promotions. The company was incorporated in 1990 and is headquartered in Minneapolis, Minnesota.",Ms. Kristine A. Glancy,Advertising Agencies,7.73,USD,13895912,https://images.financialmodelingprep.com/symbol/ISIG.png,4163,1.1910631741140216,0.44,11348,-3021000,2414000,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.41}, {'period': '2022', 'revenue': 18.8, 'unit': 'M', 'net_profit': 10.05}, {'period': '2021', 'revenue': 19.5, 'unit': 'M', 'net_profit': -3.53}, {'period': '2020', 'revenue': 17.67, 'unit': 'M', 'net_profit': -4.3}]","[{'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.13}, {'period': ""Q2 '23"", 'revenue': 6210.0, 'unit': 'K', 'net_profit': -36.0}, {'period': ""Q1 '23"", 'revenue': 12.83, 'unit': 'M', 'net_profit': 1.65}, {'period': ""Q4 '22"", 'revenue': 4530.0, 'unit': 'K', 'net_profit': -733.0}, {'period': ""Q3 '22"", 'revenue': 4.87, 'unit': 'M', 'net_profit': 11.8}, {'period': ""Q2 '22"", 'revenue': 3.25, 'unit': 'M', 'net_profit': -1.08}]",1.35,1.35,0,0,0,0,0,0,0,0,0,0.7901208837015423,-0.7597053553653196,-0.7593582887700534,"[0.7, 2]","['2017-01-09', '2011-05-03']",__nan__,__nan__
281,ISLE,Isleworth Healthcare Acquisition Corporation Common stock,"Isleworth Healthcare Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire a business in the biopharmaceutical or medical technology/device industries. The company was incorporated in 2020 and is based in Saint Petersburg, Florida.",Mr. Robert S. Whitehead,Shell Companies,10.01,USD,0,https://images.financialmodelingprep.com/symbol/ISLE.png,0,24.414634146341463,-0.13000011,301893,4901387,10578759,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 10.58}, {'period': '2015', 'revenue': 978.59, 'unit': 'M', 'net_profit': 48.29}, {'period': '2014', 'revenue': 996.28, 'unit': 'M', 'net_profit': 5.18}, {'period': '2013', 'revenue': 954.6, 'unit': 'M', 'net_profit': -129.67}]","[{'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.13}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 10.74}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.99}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.16}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.2}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 11.62}]",0.47,0.47,207967067,859867,465819,8590355,77345,0,277476,465819,-921334,0,0,0,__nan__,__nan__,__nan__,0.04130632375557809
282,ISLEW,Isleworth Healthcare Acquisition Corporation Warrant,"Isleworth Healthcare Acquisition Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in St. Petersburg, Florida.",Mr. Robert S. Whitehead,Shell Companies,0.0019,USD,0,https://images.financialmodelingprep.com/symbol/ISLEW.png,0,0,0,838083,4901387,10578759,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 10.58}, {'period': '2015', 'revenue': 978.59, 'unit': 'M', 'net_profit': 48.29}, {'period': '2014', 'revenue': 996.28, 'unit': 'M', 'net_profit': 5.18}, {'period': '2013', 'revenue': 954.6, 'unit': 'M', 'net_profit': -129.67}]","[{'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.13}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 10.74}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.99}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.16}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.2}, {'period': ""Q1 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 11.62}]",0.47,0.47,207967067,859867,465819,8590355,77345,0,277476,465819,-921334,0,0,0,__nan__,__nan__,__nan__,0.04130632375557809
283,ISNS,Image Sensing Systems Inc. Common Stock,"Image Sensing Systems, Inc. engages in the development and marketing of video and radar image processing products used in traffic applications such as intersection control, highway, bridge and tunnel traffic management, and traffic data collection. The company is headquartered in St. Paul, Minnesota and currently employs 56 full-time employees. The firm develops and markets video and radar processing products for use in traffic, security, police and parking applications, such as intersection control, highway, bridge and tunnel traffic management, venue security, entry control and traffic data collection. The firm operates through two segments: Intersection and Highway. Video products are sold in the Intersection segment. Radar products are sold in the Highway segment. The firm's family of products, which it markets as Autoscope video or video products (Autoscope) and RTMS radar or radar products (RTMS), provides end users with the tools that manage traffic flow and support driver safety. Its technology analyzes signals from sensors and transmits the information to management systems and controllers or directly to users.",Mr. Chad Stelzig,"Hardware, Equipment & Parts",6.44,USD,34825652,https://images.financialmodelingprep.com/symbol/ISNS.png,1265852,0,0.1500001,19708,5701000,6625000,"[{'period': '2023', 'revenue': 13.13, 'unit': 'M', 'net_profit': 6.62}, {'period': '2022', 'revenue': 12.4, 'unit': 'M', 'net_profit': 1.2}, {'period': '2021', 'revenue': 13.24, 'unit': 'M', 'net_profit': 2.29}, {'period': '2020', 'revenue': 13.17, 'unit': 'M', 'net_profit': 1.06}]","[{'period': ""Q3 '24"", 'revenue': 3.38, 'unit': 'M', 'net_profit': 1.34}, {'period': ""Q2 '24"", 'revenue': 3.77, 'unit': 'M', 'net_profit': 1.55}, {'period': ""Q1 '24"", 'revenue': 3140.0, 'unit': 'K', 'net_profit': 852.0}, {'period': ""Q4 '23"", 'revenue': 2.6, 'unit': 'M', 'net_profit': 1.14}, {'period': ""Q3 '23"", 'revenue': 3.79, 'unit': 'M', 'net_profit': 1.52}, {'period': ""Q2 '23"", 'revenue': 4.02, 'unit': 'M', 'net_profit': 1.14}]",1.22,1.22,25647000,19089000,12429000,3101000,3280000,101000,1545000,6506000,5473000,4.6839481555333995,4.507065669160432,4.545454545454546,"[0.12, 0.12]","['2021-05-07', '2021-05-07']",__nan__,0.12091082777712793
284,ISRG,Intuitive Surgical Inc. Common Stock,"Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.",Dr. Gary S. Guthart Ph.D.,Medical - Instruments & Supplies,522.95,USD,187359911250,https://images.financialmodelingprep.com/symbol/ISRG.png,2272208,81.33,65.32,6003287,2673800000,2322600000,"[{'period': '2024', 'revenue': 8.35, 'unit': 'B', 'net_profit': 2.32}, {'period': '2023', 'revenue': 7.12, 'unit': 'B', 'net_profit': 1.8}, {'period': '2022', 'revenue': 6.22, 'unit': 'B', 'net_profit': 1.32}, {'period': '2021', 'revenue': 5.71, 'unit': 'B', 'net_profit': 1.7}]","[{'period': ""Q4 '24"", 'revenue': 2410.0, 'unit': 'M', 'net_profit': 685.7}, {'period': ""Q3 '24"", 'revenue': 2040.0, 'unit': 'M', 'net_profit': 565.1}, {'period': ""Q2 '24"", 'revenue': 2009.9999999999998, 'unit': 'M', 'net_profit': 526.9}, {'period': ""Q1 '24"", 'revenue': 1890.0, 'unit': 'M', 'net_profit': 544.9}, {'period': ""Q4 '23"", 'revenue': 1930.0, 'unit': 'M', 'net_profit': 606.2}, {'period': ""Q3 '23"", 'revenue': 1740.0, 'unit': 'M', 'net_profit': 415.7}]",6.5388,6.42,18743200000,7111000000,4013300000,2213600000,1356800000,4819100000,1745300000,2027400000,1303800000,0.23273397879207008,0.2917686318131257,0.277109375,__nan__,__nan__,__nan__,0.11810149814332664
285,ISSC,Innovative Solutions and Support Inc. Common Stock,"Innovative Solutions and Support, Inc., a systems integrator, designs, develops, manufactures, sells, and services flight guidance, autothrottle, and cockpit display systems in the United States and internationally. It offers flat panel display systems that replicate the display of analog or digital displays on one screen and replace existing displays in legacy aircraft, as well as used for security monitoring on-board aircraft and as tactical workstations on military aircraft; and flight management systems that complement the flat panel display system upgrade for commercial air transport aircraft. The company also provides integrated standby units, which incorporate the measurement and display of attitude, altitude, airspeed, and navigation data into a single standby/backup navigation instrument for military, commercial air transport, and corporate/general aviation applications. In addition, it offers digital air data computers that calculate various air data parameters, such as altitude, airspeed, vertical speed, angle of attack, and other information; integrated air data computers and display units, which calculate and convey air data information; altitude displays that convey aircraft altitude measurements; airspeed displays that convey various airspeed measurements; and altitude alerters. Further, the company offers the engine and fuel displays that convey information related to fuel and oil levels, and engine activity, including oil and hydraulic pressure and temperature; integrated global navigation systems; ThrustSense, a full regime autothrottle; and utility management systems. It serves commercial air transport carriers and corporate/general aviation companies, the Department of Defense and its commercial contractors, aircraft operators, aircraft modification centers, government agencies, and foreign militaries, as well as original equipment manufacturers. Innovative Solutions and Support, Inc. was incorporated in 1988 and is based in Exton, Pennsylvania.",Dr. Shahram  Askarpour,Aerospace & Defense,6.07,USD,106499971,https://images.financialmodelingprep.com/symbol/ISSC.png,218501,15.97,0.47,114587,11886811,6998380,"[{'period': '2024', 'revenue': 47.2, 'unit': 'M', 'net_profit': 7.0}, {'period': '2023', 'revenue': 34.81, 'unit': 'M', 'net_profit': 6.03}, {'period': '2022', 'revenue': 27.74, 'unit': 'M', 'net_profit': 5.52}, {'period': '2021', 'revenue': 23.04, 'unit': 'M', 'net_profit': 5.06}]","[{'period': ""Q1 '25"", 'revenue': 15970.0, 'unit': 'K', 'net_profit': 736.19}, {'period': ""Q4 '24"", 'revenue': 15.38, 'unit': 'M', 'net_profit': 3.18}, {'period': ""Q3 '24"", 'revenue': 11.77, 'unit': 'M', 'net_profit': 1.55}, {'period': ""Q2 '24"", 'revenue': 10.74, 'unit': 'M', 'net_profit': 1.21}, {'period': ""Q1 '24"", 'revenue': 9.31, 'unit': 'M', 'net_profit': 1.06}, {'period': ""Q4 '23"", 'revenue': 12.99, 'unit': 'M', 'net_profit': 2.63}]",0.4,0.4,82382261,34685698,538977,35743606,14292542,0,7265254,538977,5138432,0.36215119029979836,0.161025954107292,0.142857142857143,"[0.001, 1]","['2022-09-26', '2008-09-16']",__nan__,0.43387503045103365
286,ISTR,Investar Holding Corporation Common Stock,"Investar Holding Corporation operates as the bank holding company for Investar Bank that provides a range of commercial banking products to individuals and small to medium-sized businesses in South Louisiana. The company offers various deposit products and services, such as savings, checking, money market, and individual retirement accounts, as well as various certificates of deposit; debit cards; and mobile banking services. It also provides commercial real estate loans; commercial and industrial loans, including working capital lines of credit and equipment loans; loans for the construction of commercial projects, and single family residential and multifamily properties; one-to-four family residential real estate lending, such as second mortgage loans; consumer loans, such as secured and unsecured installment and term loans, home equity loans and lines of credit, and auto loans, as well as loans for personal, family, and household purposes. In addition, the company offers cash management products, including remote deposit capture, virtual vault, electronic statements, positive pay, ACH origination and wire transfer, investment sweep accounts, and business Internet banking services. Further, it provides various other banking services, such as cashiers' checks, direct deposit of payroll and social security checks, night depository, bank-by-mail, automated teller machine, interactive teller machines, merchant card, and mobile wallet payment services. The company operates through a network of 24 full service branches. Investar Holding Corporation was founded in 2006 and is headquartered in Baton Rouge, Louisiana.",Mr. John Joseph D'Angelo,Banks - Regional,16.94,USD,166446172,https://images.financialmodelingprep.com/symbol/ISTR.png,33221,8.3,1.15,58389,101613000,20252000,"[{'period': '2024', 'revenue': 82.41, 'unit': 'M', 'net_profit': 20.25}, {'period': '2023', 'revenue': 83.06, 'unit': 'M', 'net_profit': 16.68}, {'period': '2022', 'revenue': 108.39, 'unit': 'M', 'net_profit': 35.71}, {'period': '2021', 'revenue': 96.26, 'unit': 'M', 'net_profit': 8.0}]","[{'period': ""Q4 '24"", 'revenue': 22.65, 'unit': 'M', 'net_profit': 6.11}, {'period': ""Q3 '24"", 'revenue': 20.28, 'unit': 'M', 'net_profit': 5.38}, {'period': ""Q2 '24"", 'revenue': 38.54, 'unit': 'M', 'net_profit': 4.06}, {'period': ""Q1 '24"", 'revenue': 38.18, 'unit': 'M', 'net_profit': 4.71}, {'period': ""Q4 '23"", 'revenue': 38.44, 'unit': 'M', 'net_profit': 3.54}, {'period': ""Q3 '23"", 'revenue': 19.47, 'unit': 'M', 'net_profit': 2.78}]",2.06,2.05,2722812000,372167000,357744000,2481516000,14423000,0,0,26623000,32604000,0,0.21429427988967503,0.2189349112426036,"[0.105, 0.0068]","['2025-03-31', '2014-09-25']",__nan__,0.9113798528873827
287,ISUN,iSun Inc. Common Stock,"iSun, Inc. operates as a solar engineering, construction, and procurement contractor for commercial and industrial customers in the Northeastern United States. It also provides electrical contracting services; and data and communication services. The company was formerly known as The Peck Company Holdings, Inc. and changed its name to iSun, Inc. in January 2021. iSun, Inc. was founded in 1972 and is headquartered in South Burlington, Vermont.",Mr. Jeffrey  Peck,Solar,0.04745,USD,2248403,https://images.financialmodelingprep.com/symbol/ISUN.png,3406341,-0.065,-0.0217,2732624,-14610000,-19417000,"[{'period': '2023', 'revenue': 95.68, 'unit': 'M', 'net_profit': -19.42}, {'period': '2022', 'revenue': 76.45, 'unit': 'M', 'net_profit': -16.63}, {'period': '2021', 'revenue': 45.31, 'unit': 'M', 'net_profit': -6.24}, {'period': '2020', 'revenue': 21050.0, 'unit': 'K', 'net_profit': -4.33}]","[{'period': ""Q4 '23"", 'revenue': 25.41, 'unit': 'M', 'net_profit': -11.66}, {'period': ""Q3 '23"", 'revenue': 27.91, 'unit': 'M', 'net_profit': -2.25}, {'period': ""Q2 '23"", 'revenue': 25.01, 'unit': 'M', 'net_profit': -2.51}, {'period': ""Q1 '23"", 'revenue': 17.36, 'unit': 'M', 'net_profit': -3.69}, {'period': ""Q4 '22"", 'revenue': 25.86, 'unit': 'M', 'net_profit': -3.11}, {'period': ""Q3 '22"", 'revenue': 19.03, 'unit': 'M', 'net_profit': -5.01}]",-0.73,-0.73,66700999,31477000,3463000,53581000,25547000,8629000,35354000,3463000,-9556000,-0.3881235154394299,-0.1676589091346443,0.3813559322033898,__nan__,__nan__,__nan__,0.8033013118739046
288,ITAC,Industrial Tech Acquisitions Inc. Class A common stock,"Industrial Tech Acquisitions, Inc. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire North American companies operating in the industrial and energy focused technology areas, including software, mobile, and Internet of Things applications; and cloud communications and ultra-high bandwidth services, including LTE and 5G communications. The company is based in Houston, Texas.",Mr. Eugene Scott Crist,Shell Companies,8.2,USD,0,https://images.financialmodelingprep.com/symbol/ITAC.png,37386,0,-0.17000008,50909,-297645,-297645,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -297.64}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.66}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -297.64}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -50.66}]",-0.15,-0.15,77517635,516847,406381,2779508,0,0,111248,406381,,0,0,0,__nan__,__nan__,__nan__,0.0358564602751361
289,ITACU,Industrial Tech Acquisitions Inc. Unit,"Industrial Tech Acquisitions, Inc. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire North American companies operating in the industrial and energy focused technology areas, including software, mobile, and Internet of Things applications; and cloud communications and ultra-high bandwidth services, including LTE and 5G communications. The company is based in Houston, Texas.",Mr. Eugene Scott Crist,Shell Companies,9.94,USD,0,https://images.financialmodelingprep.com/symbol/ITACU.png,539,-7.826771653543307,0,32,-297645,-297645,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -297.64}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.66}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -297.64}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -50.66}]",-0.15,-0.15,77517635,516847,406381,2779508,0,0,111248,406381,,0,0,0,__nan__,__nan__,__nan__,0.0358564602751361
290,ITACW,Industrial Tech Acquisitions Inc. Warrant,,,,,,,,,,,,-297645,-297645,"[{'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -297.64}]","[{'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.66}, {'period': ""Q4 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -297.64}, {'period': ""Q3 '20"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -50.66}]",-0.12,-0.12,77517635,516847,77407169,2779508,0,77000788,111248,406381,-299291,0,0,0,__nan__,__nan__,__nan__,0.0358564602751361
291,ITCI,Intra-Cellular Therapies Inc. Common Stock,"Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in developing lumateperone, which is in Phase III clinical trial for the treatment of bipolar depression, as well as to treat autism spectrum disorder; and in additional neuropsychiatric indications, such as sleep disorders associated with neuropsychiatric and neurological disorders. In addition, the company is developing Lenrispodun (ITI-214) for the treatment of Parkinson's disease and heart failure; ITI-1284-ODT-SL for the treatment of neuropsychiatric disorders and behavioral disturbances in dementia; and ITI-333 for substance use disorders, pain, and psychiatric comorbidities, including depression and anxiety. Intra-Cellular Therapies, Inc. was founded in 2002 and is headquartered in New York, New York.",Dr. Sharon  Mates Ph.D.,Drug Manufacturers - Specialty & Generic,131.87,USD,14047056140,https://images.financialmodelingprep.com/symbol/ITCI.png,3621742,-180.64,0,16042154,-116721000,-74676000,"[{'period': '2024', 'revenue': 680.85, 'unit': 'M', 'net_profit': -74.68}, {'period': '2023', 'revenue': 464.37, 'unit': 'M', 'net_profit': -139.67}, {'period': '2022', 'revenue': 249.13, 'unit': 'M', 'net_profit': -256.26}, {'period': '2021', 'revenue': 81.71, 'unit': 'M', 'net_profit': -284.13}]","[{'period': ""Q4 '24"", 'revenue': 199.22, 'unit': 'M', 'net_profit': -16.89}, {'period': ""Q3 '24"", 'revenue': 175.16, 'unit': 'M', 'net_profit': -26.32}, {'period': ""Q2 '24"", 'revenue': 161.39, 'unit': 'M', 'net_profit': -16.22}, {'period': ""Q1 '24"", 'revenue': 144.87, 'unit': 'M', 'net_profit': -15.25}, {'period': ""Q4 '23"", 'revenue': 131.51, 'unit': 'M', 'net_profit': -28.58}, {'period': ""Q3 '23"", 'revenue': 125.81, 'unit': 'M', 'net_profit': -24.26}]",-0.72,-0.72,1366912000,1307364000,1001066000,218452000,166500000,0,205704000,306948000,-73499000,0.2652263413344413,0.46535504102409897,0.5068493150684932,__nan__,__nan__,__nan__,0.15981423822455287
292,ITHX,ITHAX Acquisition Corp. Class A Ordinary Shares,"ITHAX Acquisition Corp. does not significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.",Mr. Orestes  Fintiklis,Shell Companies,10.13,USD,850845038,https://images.financialmodelingprep.com/symbol/ITHX.png,0,56.27777777777778,-3.8599997,1489808,3311639,7457036,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.46}]","[{'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'B', 'net_profit': 338.72}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 138.5}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.97}]",0.24,0.24,242149,548.954,525.204,15996,0,241600,211.548,525.204,-678926,0,0,0,__nan__,__nan__,__nan__,0.06605850117076675
293,ITHXU,ITHAX Acquisition Corp. Unit,"ITHAX Acquisition Corp. does not significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.",Mr. Orestes  Fintiklis,Shell Companies,11.48,USD,0,https://images.financialmodelingprep.com/symbol/ITHXU.png,0,98.96551724137932,-3.0200005,8214,3311639,7457036,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.46}]","[{'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'B', 'net_profit': 338.72}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 138.5}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.97}]",0.24,0.24,242149,548.954,525.204,15996,0,241600,211.548,525.204,-678926,0,0,0,__nan__,__nan__,__nan__,0.06605850117076675
294,ITHXW,ITHAX Acquisition Corp. Warrant,"Ithax Acquisition Corp. is a blank check company. The company was incorporated in 2020 and is based in New York, New York.",Mr. Orestes  Fintiklis,Shell Companies,0.3773,USD,0,https://images.financialmodelingprep.com/symbol/ITHXW.png,0,0,-0.07269999,201056,3311639,7457036,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.46}]","[{'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'B', 'net_profit': 338.72}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 138.5}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.97}]",0.24,0.24,242149,548.954,525.204,15996,0,241600,211.548,525.204,-678926,0,0,0,__nan__,__nan__,__nan__,0.06605850117076675
295,ITI,Iteris Inc. Common Stock,"Iteris, Inc. provides intelligent transportation systems technology solutions in North America, Europe, South America, and Asia. The company offers smart mobility infrastructure solutions include traveler information systems, transportation performance measurement software, traffic analytics software, transportation operations software, transportation-related data sets, advanced sensing devices, managed services, traffic engineering services, and mobility consulting services. Its products include ClearGuide, ClearRoute, Commercial Vehicle Operations, BlueArgus, TrafficCarma, Vantage Apex, Vantage Fusion, Vantage Next, VantagePegasus, VantageRadius, Vantage Vector, Velocity, SmartCycle, SmartCycle Bike Indicator, SmartSpan, VersiCam, PedTrax, and P-Series products. The company also sells original equipment manufacturer products for the traffic intersection markets, such as traffic signal controllers and traffic signal equipment cabinets. In addition, it offers traffic management centers design, staffing, and operations services; traffic engineering and mobility consulting services include planning, design, development, and implementation of software and hardware-based ITS systems that integrate sensors, video surveillance, computers, and advanced communications equipment; distributes real-time information about traffic conditions; and surface transportation infrastructure systems implementation, and operation and management. Further, the company provides travel demand forecasting and systems engineering, and identify mitigation measures to reduce traffic congestion; ClearMobility platform; and ClearMobility Cloud that enables mobility data management engine, application programming interface framework, and microservices ecosystem. It serves public transportation agencies, municipalities, commercial entities, government agencies, and other transportation infrastructure providers. The company was founded in 1969 and is headquartered in Austin, Texas.",Mr. J. Joseph Bergera Ph.D.,Communication Equipment,7.19,USD,309474137,https://images.financialmodelingprep.com/symbol/ITI.png,815198,239.66666666666666,-0.01,605382,6663000,3131000,"[{'period': '2024', 'revenue': 171.99, 'unit': 'M', 'net_profit': 3.13}, {'period': '2023', 'revenue': 156.05, 'unit': 'M', 'net_profit': -14.86}, {'period': '2022', 'revenue': 133.57, 'unit': 'M', 'net_profit': -6.9}, {'period': '2021', 'revenue': 117140.0, 'unit': 'K', 'net_profit': 491.0}]","[{'period': ""Q1 '25"", 'revenue': 45780.0, 'unit': 'K', 'net_profit': 392.0}, {'period': ""Q4 '24"", 'revenue': 42750.0, 'unit': 'K', 'net_profit': 100.0}, {'period': ""Q3 '24"", 'revenue': 42130.0, 'unit': 'K', 'net_profit': 355.0}, {'period': ""Q2 '24"", 'revenue': 43560.0, 'unit': 'K', 'net_profit': 551.0}, {'period': ""Q1 '24"", 'revenue': 43.55, 'unit': 'M', 'net_profit': 2.12}, {'period': ""Q4 '23"", 'revenue': 42440.0, 'unit': 'K', 'net_profit': -544.0}]",0.073,0.0713,123445000,75931000,25850000,53538000,32942999,0,43330000,25850000,8343000,1.665368484122229,1.210770784247728,1.2085714285714286,"[10.25, 10.25]","['1997-11-03', '1997-11-03']",__nan__,0.4336992182753453
296,ITIC,Investors Title Company Common Stock,"Investors Title Company, through its subsidiaries, engages in the issuance of residential and commercial title insurance for residential, institutional, commercial, and industrial properties. The company underwrites land title insurance for owners and mortgagees as a primary insurer; and assumes the reinsurance of title insurance risks from other title insurance companies. It also provides services in connection with tax-deferred exchanges of like-kind property; acts as a qualified intermediary in tax-deferred exchanges of property; coordinates the exchange aspects of the real estate transaction, such as drafting standard exchange documents, holding the exchange funds between the sale of the old property and the purchase of the new property, and accepting the formal identification of the replacement property. In addition, it serves as an exchange accommodation titleholder for accomplishing reverse exchanges when the taxpayers decide to acquire replacement property before selling the relinquished property. Further, the company offers investment management and trust services to individuals, companies, banks, and trusts; and consulting and management services to clients to start and operate a title insurance agency. It issues title insurance policies primarily through approved attorneys from underwriting offices, as well as through independent issuing agents in 24 states and the District of Columbia, primarily in the eastern half of the United States. The company was founded in 1972 and is headquartered in Chapel Hill, North Carolina.",Mr. James Allen Fine,Insurance - Specialty,236,USD,445091280,https://images.financialmodelingprep.com/symbol/ITIC.png,9591,14.36,22.11,6522,2957000,31073000,"[{'period': '2024', 'revenue': 258.3, 'unit': 'M', 'net_profit': 31.07}, {'period': '2023', 'revenue': 224.75, 'unit': 'M', 'net_profit': 21.69}, {'period': '2022', 'revenue': 283.39, 'unit': 'M', 'net_profit': 23.9}, {'period': '2021', 'revenue': 329.5, 'unit': 'M', 'net_profit': 67.02}]","[{'period': ""Q4 '24"", 'revenue': 70.63, 'unit': 'M', 'net_profit': 8.36}, {'period': ""Q3 '24"", 'revenue': 68.83, 'unit': 'M', 'net_profit': 9.31}, {'period': ""Q2 '24"", 'revenue': 65.38, 'unit': 'M', 'net_profit': 8.87}, {'period': ""Q1 '24"", 'revenue': 53.46, 'unit': 'M', 'net_profit': 4.53}, {'period': ""Q4 '23"", 'revenue': 53.68, 'unit': 'M', 'net_profit': 5.84}, {'period': ""Q3 '23"", 'revenue': 61.41, 'unit': 'M', 'net_profit': 7.08}]",16.48,16.42,333571000,137626000,137626000,81798000,0,119572000,34287000,24654000,407000,-0.9025732265823202,0.4328599096191091,0.43804537521815,"[0.46, 0.025]","['2025-03-24', '1987-03-02']",__nan__,0.2452191587398185
297,ITMR,Itamar Medical Ltd. American Depository Shares,,Mr. Gilad Glick,Medical - Devices,30.87,USD,0,https://images.financialmodelingprep.com/symbol/ITMR.png,135920,-21,0,1017128,-8432000,-10939000,"[{'period': '2020', 'revenue': 41.03, 'unit': 'M', 'net_profit': -10.94}, {'period': '2019', 'revenue': 31.26, 'unit': 'M', 'net_profit': -5.27}, {'period': '2018', 'revenue': 24.19, 'unit': 'M', 'net_profit': -1.73}, {'period': '2017', 'revenue': 20.7, 'unit': 'M', 'net_profit': -5.3}]","[{'period': ""Q3 '21"", 'revenue': 13.57, 'unit': 'M', 'net_profit': -7.98}, {'period': ""Q2 '21"", 'revenue': 12.56, 'unit': 'M', 'net_profit': -4.75}, {'period': ""Q3 '20"", 'revenue': 11.0, 'unit': 'M', 'net_profit': -2.76}, {'period': ""Q2 '20"", 'revenue': 8.88, 'unit': 'M', 'net_profit': -3.24}, {'period': ""Q3 '19"", 'revenue': 8.08, 'unit': 'M', 'net_profit': -1.15}, {'period': ""Q2 '19"", 'revenue': 7.35, 'unit': 'M', 'net_profit': -1.96}]",-0.79,-0.79,64140000,57439000,39670000,21068000,9598000,0,17992000,9670000,-11048000,-1.303825136612022,-1.0764996203492787,-0.717391304347826,__nan__,__nan__,__nan__,0.3284689741191144
298,ITOS,iTeos Therapeutics Inc. Common Stock,"Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1/2 clinical trial, as well as used to engage the Fc gamma receptor, or Fc?R to activate dendritic cells and macrophages and to promote antibody-dependent cellular cytotoxicity, or ADCC activity. Iteos Therapeutics, Inc. was founded in 2011 and is headquartered in Watertown, Massachusetts.",Dr. Michel  Detheux Ph.D.,Biotechnology,5.39,USD,205867277,https://images.financialmodelingprep.com/symbol/ITOS.png,313072,-1.62,0.35,342778,-153087000,-134414000,"[{'period': '2024', 'revenue': 35.0, 'unit': 'M', 'net_profit': -134.41}, {'period': '2023', 'revenue': 12.6, 'unit': 'M', 'net_profit': -112.64}, {'period': '2022', 'revenue': 267.63, 'unit': 'M', 'net_profit': 96.65}, {'period': '2021', 'revenue': 344.77, 'unit': 'M', 'net_profit': 214.52}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -43.71}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -45.36}, {'period': ""Q2 '24"", 'revenue': 35.0, 'unit': 'M', 'net_profit': -7.13}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -38.22}, {'period': ""Q4 '23"", 'revenue': -11.3, 'unit': 'M', 'net_profit': -30.55}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -32.24}]",-3.32,-3.32,686976000,509539000,494648000,96682000,5906000,160354000,40360000,142131000,-99814000,-0.013143526515377132,-0.19328492036718098,-0.05396825396825395,__nan__,__nan__,__nan__,0.14073562977454818
299,ITQ,Itiquira Acquisition Corp. Class A Ordinary Shares,"Itiquira Acquisition Corp. does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus on companies operating in the healthcare, education, consumer, and technology sectors primarily in Brazil. Itiquira Acquisition Corp. was incorporated in 2020 and is based in New York, New York.",Mr. Paulo Carvalho de Gouvea,Shell Companies,10.17,USD,0,https://images.financialmodelingprep.com/symbol/ITQ.png,50227,39.11538461538461,0.01,66025,6008358,13775547,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 13.78}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.9}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.04}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.48}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.41}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.98}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.7}]",0.52,0.52,231170607,1058848,619236,18600249,0,230068808,1138249,619236,-1266217,0,0,0,__nan__,__nan__,__nan__,0.08046113319242182
300,ITQRU,Itiquira Acquisition Corp. Unit,"Itiquira Acquisition Corp. does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus on companies operating in the healthcare, education, consumer, and technology sectors primarily in Brazil. Itiquira Acquisition Corp. was incorporated in 2020 and is based in New York, New York.",Mr. Paulo Carvalho de Gouvea,Shell Companies,10.16,USD,0,https://images.financialmodelingprep.com/symbol/ITQRU.png,1410,29.794721407624632,0.01,2,6008358,13775547,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 13.78}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.9}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 8.04}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.48}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.41}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.98}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.7}]",0.52,0.52,231170607,1058848,619236,18600249,0,230068808,1138249,619236,-1266217,0,0,0,__nan__,__nan__,__nan__,0.08046113319242182
301,ITRI,Itron Inc. Common Stock,"Itron, Inc., a technology and service company, provides end-to-end solutions that help manage operations in the energy, water, and smart city space worldwide. The company operates through three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing. The Networked Solutions segment provides a combination of communicating devices, such as smart meters, modules, endpoints, and sensors; network infrastructure; and associated application software for acquiring and transporting application-specific data. The Outcomes segment offers value-added, enhanced software and services for managing, organizing, analyzing, and interpreting data to enhance decision making, maximize operational profitability, drive resource efficiency, and deliver results for consumers, utilities, and smart cities. In addition, it offers implementation, project management, installation, consulting, and post-sale maintenance support services, as well as cloud and software-as-a-service; and extended or customer-specific warranties. It offers its products and services under the Itron brand. The company markets its products directly through its sales force, as well as through indirect sales force consisting of distributors, sales representatives, partners, and meter manufacturer representatives to utilities and municipalities. Itron, Inc. was incorporated in 1977 and is headquartered in Liberty Lake, Washington.",Mr. Thomas L. Deitrich,"Hardware, Equipment & Parts",99.53,USD,4535582100,https://images.financialmodelingprep.com/symbol/ITRI.png,632098,19.21,7.49,874663,356187000,239105000,"[{'period': '2024', 'revenue': 2440.0, 'unit': 'M', 'net_profit': 239.1}, {'period': '2023', 'revenue': 2170.0, 'unit': 'M', 'net_profit': 96.92}, {'period': '2022', 'revenue': 1800.0, 'unit': 'M', 'net_profit': -9.55}, {'period': '2021', 'revenue': 1980.0, 'unit': 'M', 'net_profit': -78.3}]","[{'period': ""Q4 '24"", 'revenue': 612.86, 'unit': 'M', 'net_profit': 58.11}, {'period': ""Q3 '24"", 'revenue': 615.46, 'unit': 'M', 'net_profit': 77.96}, {'period': ""Q2 '24"", 'revenue': 609.07, 'unit': 'M', 'net_profit': 51.32}, {'period': ""Q1 '24"", 'revenue': 603.44, 'unit': 'M', 'net_profit': 51.72}, {'period': ""Q4 '23"", 'revenue': 577.17, 'unit': 'M', 'net_profit': 44.39}, {'period': ""Q3 '23"", 'revenue': 560.77, 'unit': 'M', 'net_profit': 40.17}]",5.27,5.18,3407623000,1815892000,1051237000,1996195000,350473000,0,528265000,1051237000,238175000,0.8600037598303899,1.4669583071097676,1.4741784037558685,__nan__,__nan__,__nan__,0.5858027721963375
302,ITRM,Iterum Therapeutics plc Ordinary Share,"Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.",Mr. Corey N. Fishman,Biotechnology,1.12,USD,38731168,https://images.financialmodelingprep.com/symbol/ITRM.png,435713,-0.89,0.01,430079,-18696000,-24774000,"[{'period': '2024', 'revenue': 0.0, 'unit': 'M', 'net_profit': -24.77}, {'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -38.37}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': -44.43}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -91.56}]","[{'period': ""Q4 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.58}, {'period': ""Q3 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -6.09}, {'period': ""Q2 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.0}, {'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -7.1}, {'period': ""Q4 '23"", 'revenue': 2.62, 'unit': 'M', 'net_profit': -12.36}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -3.88}]",-1.26,-1.26,44595000,24787000,24125000,48676000,0,0,17605000,24125000,-26772000,0.4593406593406593,0.354356154387428,0.5743243243243243,__nan__,__nan__,__nan__,1.0915125014015024
303,ITRN,Ituran Location and Control Ltd. Ordinary Shares,"Ituran Location and Control Ltd., together with its subsidiaries, provides location-based telematics services and machine-to-machine telematics products. The company's Telematics services segment provides stolen vehicle recovery and tracking services, which locate, track, and recover stolen vehicles for its subscribers; fleet management services that enable corporate and individual customers to track and manage their vehicles in real time; and locator services that allow customers to protect valuable merchandise and equipment. It also offers on-demand navigation guidance, information, and assistance, including the provision of traffic reports and directions, as well as information on the location of gas stations, car repair shops, post offices, hospitals, and other facilities; and Connected Car, a service platform that includes a back-office application, a telematics device installed in the vehicle, mobile apps for IOS and Android users, and interface using the car infotainment screen, as well as usage based insurance and auto financing. This segment serves insurance companies and agents, car manufacturers, dealers and importers, cooperative sales channels, and private subscribers. Its Telematics Products segment provides Base Site, a radio receiver that includes a processor and a data computation unit to collect and send data to and from transponders, and to control centers; Control Center, a center consisting of software used to collect data from various base sites, conduct location calculations, and transmit location data to various customers and law enforcement agencies; navigation and tracking devices installed in vehicles; and SMART, a portable transmitter installed in vehicles that sends a signal to the base site enabling the location of vehicles, equipment, or an individual. The company was incorporated in 1994 and is headquartered in Azor, Israel.",Mr. Nir  Sheratzky,Communication Equipment,33.86,USD,680873641,https://images.financialmodelingprep.com/symbol/ITRN.png,196424,12.54,2.15,158661,91252000,53654000,"[{'period': '2024', 'revenue': 336.26, 'unit': 'M', 'net_profit': 53.65}, {'period': '2023', 'revenue': 319.98, 'unit': 'M', 'net_profit': 48.14}, {'period': '2022', 'revenue': 293.07, 'unit': 'M', 'net_profit': 37.1}, {'period': '2021', 'revenue': 270.88, 'unit': 'M', 'net_profit': 34.26}]","[{'period': ""Q4 '24"", 'revenue': 82.88, 'unit': 'M', 'net_profit': 13.84}, {'period': ""Q3 '24"", 'revenue': 83.48, 'unit': 'M', 'net_profit': 13.65}, {'period': ""Q2 '24"", 'revenue': 84.87, 'unit': 'M', 'net_profit': 13.13}, {'period': ""Q1 '24"", 'revenue': 85.03, 'unit': 'M', 'net_profit': 13.04}, {'period': ""Q4 '23"", 'revenue': 77.81, 'unit': 'M', 'net_profit': 12.02}, {'period': ""Q3 '23"", 'revenue': 81.05, 'unit': 'M', 'net_profit': 12.51}]",2.7,2.7,326878000,197109000,77367000,135621000,47688000,2009999,87722000,77357000,60635000,0.04444368139729195,0.11461038286557118,0.12033195020746888,"[0.5, 0.16]","['2025-03-20', '2006-03-31']",__nan__,0.4148979129828254
304,IVA,Inventiva S.A. American Depository Shares,"Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of MPS VI subtype disease. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company has strategic collaboration with AbbVie for the treatment of autoimmune diseases; and Boehringer Ingelheim International GmbH for developing new treatments for idiopathic pulmonary fibrosis. Inventiva S.A. was founded in 2011 and is based in Daix, France.",Mr. Frederic  Cren,Biotechnology,3.18,USD,303650555,https://images.financialmodelingprep.com/symbol/IVA.png,12245,-0.95,0.14,11131,-102041000,-110426000,"[{'period': '2023', 'revenue': 17.48, 'unit': 'M', 'net_profit': -110.43}, {'period': '2022', 'revenue': 12.18, 'unit': 'M', 'net_profit': -54.27}, {'period': '2021', 'revenue': 4.19, 'unit': 'M', 'net_profit': -49.64}, {'period': '2020', 'revenue': 0.372, 'unit': 'M', 'net_profit': -31.62}]","[{'period': ""Q2 '24"", 'revenue': 2.73, 'unit': 'M', 'net_profit': -49.03}, {'period': ""Q4 '23"", 'revenue': 16.54, 'unit': 'M', 'net_profit': -55.16}, {'period': ""Q2 '23"", 'revenue': 6.62, 'unit': 'M', 'net_profit': -55.27}, {'period': ""Q4 '22"", 'revenue': 15.42, 'unit': 'M', 'net_profit': -24.81}, {'period': ""Q2 '22"", 'revenue': 0.067, 'unit': 'M', 'net_profit': -29.47}, {'period': ""Q4 '21"", 'revenue': 4.05, 'unit': 'M', 'net_profit': -26.5}]",-2.43,-2.43,69561000,48189000,26988000,101592999,3807000,1425000,50158000,26918000,-82154000,-0.7867448783050254,-1.0346022036334157,-0.8549618320610688,__nan__,__nan__,__nan__,1.4604879027041013
305,IVAC,Intevac Inc. Common Stock,"Intevac, Inc. provides vacuum deposition equipment for various thin-film applications, and digital night-vision technologies and products to the defense industry in the United States, Asia, and Europe. It designs, develops, and markets thin-film processing systems for hard disk drive media, display cover panel, solar photovoltaic cell, and advanced semiconductor packaging industries. The company sells its products through direct sales force and distributors. Intevac, Inc. was incorporated in 1990 and is headquartered in Santa Clara, California.",Mr. Nigel D. Hunton,Aerospace & Defense,3.995,USD,108598083,https://images.financialmodelingprep.com/symbol/IVAC.png,394153,-2.61,0,0,-28512000,-39799000,"[{'period': '2024', 'revenue': 63.98, 'unit': 'M', 'net_profit': -39.8}, {'period': '2023', 'revenue': 52.66, 'unit': 'M', 'net_profit': -12.19}, {'period': '2022', 'revenue': 35.76, 'unit': 'M', 'net_profit': -16.75}, {'period': '2021', 'revenue': 38.52, 'unit': 'M', 'net_profit': -23.06}]","[{'period': ""Q4 '24"", 'revenue': 11.32, 'unit': 'M', 'net_profit': -32.76}, {'period': ""Q3 '24"", 'revenue': 28.5, 'unit': 'M', 'net_profit': -2.17}, {'period': ""Q2 '24"", 'revenue': 14.53, 'unit': 'M', 'net_profit': -3.26}, {'period': ""Q1 '24"", 'revenue': 9.63, 'unit': 'M', 'net_profit': -1.61}, {'period': ""Q4 '23"", 'revenue': 12.91, 'unit': 'M', 'net_profit': -1.84}, {'period': ""Q3 '23"", 'revenue': 17.91, 'unit': 'M', 'net_profit': -1.58}]",-1.49,-1.49,109722000,92036000,67208000,31652000,11153000,11221000,20140000,45111000,5621000,-1.4356740133264991,-2.2648892534864644,-2.170212765957447,"[0.052, 0.05]","['2025-03-24', '2025-02-28']",__nan__,0.28847450830280164
306,IZEA,IZEA Worldwide Inc. Common Stock,"IZEA Worldwide, Inc., together with its subsidiaries, creates and operates online marketplaces that connect marketers and content creators. Its technology solutions enable the management of content workflow, creator search and targeting, bidding, analytics, and payment processing. The company uses its platform to manage influencer marketing campaigns on behalf of the company's marketers. It primarily sells influencer marketing and custom content campaigns through sales team and platforms, as well as IZEA Exchange BrandGraph, and Shake platforms. The company was formerly known as IZEA, Inc. and changed its name to IZEA Worldwide, Inc. in August 2018. IZEA Worldwide, Inc. was founded in 2006 and is headquartered in Orlando, Florida.",Mr. Patrick James Venetucci,Internet Content & Information,1.785,USD,30285560,https://images.financialmodelingprep.com/symbol/IZEA.png,31716,-1.62,0.025,42431,-18079617,-18852261,"[{'period': '2024', 'revenue': 35.88, 'unit': 'M', 'net_profit': -18.85}, {'period': '2023', 'revenue': 36.21, 'unit': 'M', 'net_profit': -7.35}, {'period': '2022', 'revenue': 41.1, 'unit': 'M', 'net_profit': -3.31}, {'period': '2021', 'revenue': 30.02, 'unit': 'M', 'net_profit': -5.41}]","[{'period': ""Q3 '24"", 'revenue': 11.0, 'unit': 'M', 'net_profit': -4.62}, {'period': ""Q2 '24"", 'revenue': 8.83, 'unit': 'M', 'net_profit': -8.77}, {'period': ""Q1 '24"", 'revenue': 9.09, 'unit': 'M', 'net_profit': -2.19}, {'period': ""Q4 '23"", 'revenue': 6.95, 'unit': 'M', 'net_profit': -3.27}, {'period': ""Q3 '23"", 'revenue': 8.89, 'unit': 'M', 'net_profit': -1.53}, {'period': ""Q2 '23"", 'revenue': 7.89, 'unit': 'M', 'net_profit': -1.98}]",-1.1,-1.1,62220274,60030040,51071956,13438555,7781824,0,13434521,44644468,-12321510,-1.7252525471777889,-1.5651568299824747,-1.4444444444444446,__nan__,__nan__,__nan__,0.21598353938460638
307,JACK,Jack In The Box Inc. Common Stock,"Jack in the Box Inc. operates and franchises Jack in the Box quick-service restaurants. As of November 23, 2021, it operated and franchised approximately 2,200 Jack in the Box quick-service restaurants in 21 states and Guam. The company was founded in 1951 and is headquartered in San Diego, California.",Mr. Richard D. Cook,Restaurants,25.69,USD,484469727,https://images.financialmodelingprep.com/symbol/JACK.png,820088,-13.74,2.76,1556392,77640000,-35321000,"[{'period': '2024', 'revenue': 1220.0, 'unit': 'M', 'net_profit': -35.32}, {'period': '2023', 'revenue': 1690.0, 'unit': 'M', 'net_profit': 130.83}, {'period': '2022', 'revenue': 1470.0, 'unit': 'M', 'net_profit': 115.78}, {'period': '2021', 'revenue': 1140.0, 'unit': 'M', 'net_profit': 165.75}]","[{'period': ""Q4 '24"", 'revenue': 349.29, 'unit': 'M', 'net_profit': 21.94}, {'period': ""Q3 '24"", 'revenue': 369.17, 'unit': 'M', 'net_profit': -122.3}, {'period': ""Q2 '24"", 'revenue': 365.35, 'unit': 'M', 'net_profit': 24.98}, {'period': ""Q1 '24"", 'revenue': 487.5, 'unit': 'M', 'net_profit': 38.68}, {'period': ""Q4 '23"", 'revenue': 372.52, 'unit': 'M', 'net_profit': 21.9}, {'period': ""Q3 '23"", 'revenue': 396.94, 'unit': 'M', 'net_profit': 29.17}]",-1.79,-1.78,2735629000,181277000,24745000,3587427000,83567000,0,434259000,24745000,0,-0.7675957051303158,-1.2699845596441075,-1.2818897637795277,"[0.44, 0.2]","['2025-03-20', '2014-05-22']",__nan__,1.3113719002101527
308,JAGX,Jaguar Health Inc. Common Stock,"Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer for multiple possible follow-on indications, including cancer therapy-related diarrhea; orphan-drug indications for symptomatic relief of diarrhea in infants and children with congenital diarrheal disorders and for adult and pediatric patients for short bowel syndrome with intestinal failure with; supportive care for diarrhea relief in inflammatory bowel diseases; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, it develops lechlemer, a second-generation anti-secretory agent for cholera; and Canalevia, an oral plant-based drug candidate to treat chemotherapy-induced diarrhea in dogs and exercise-induced diarrhea in dogs. Jaguar Health, Inc. was founded in 2013 and is headquartered in San Francisco, California.",Ms. Lisa A. Conte,Biotechnology,5.045,USD,3400547,https://images.financialmodelingprep.com/symbol/JAGX.png,24581,-0.04,0.325,27473,-36662000,-38492000,"[{'period': '2024', 'revenue': 11.69, 'unit': 'M', 'net_profit': -38.49}, {'period': '2023', 'revenue': 9.76, 'unit': 'M', 'net_profit': -41.3}, {'period': '2022', 'revenue': 11.96, 'unit': 'M', 'net_profit': -47.45}, {'period': '2021', 'revenue': 4.33, 'unit': 'M', 'net_profit': -60.25}]","[{'period': ""Q4 '24"", 'revenue': 3.51, 'unit': 'M', 'net_profit': -9.92}, {'period': ""Q3 '24"", 'revenue': 3.11, 'unit': 'M', 'net_profit': -9.85}, {'period': ""Q2 '24"", 'revenue': 2.72, 'unit': 'M', 'net_profit': -9.49}, {'period': ""Q1 '24"", 'revenue': 2.35, 'unit': 'M', 'net_profit': -9.23}, {'period': ""Q4 '23"", 'revenue': 2.3, 'unit': 'M', 'net_profit': -9.17}, {'period': ""Q3 '23"", 'revenue': 2.81, 'unit': 'M', 'net_profit': -7.78}]",-0.13,-0.13,53425000,32198000,8002000,46931000,1647000,0,19704000,8002000,-29384000,-0.1065769219160303,0.06799031476997579,0.998789797058276,__nan__,__nan__,__nan__,0.878446420215255
309,JAKK,JAKKS Pacific Inc. Common Stock,"JAKKS Pacific, Inc. develops, produces, markets, sells, and distributes toys, consumables, and electronics and related products worldwide. It operates in two segments, Toys/Consumer Products and Costumes. The company offers action figures and accessories, such as licensed characters; toy vehicles and accessories; dolls and accessories, including small, large, fashion, and baby dolls based on licenses, as well as infant and pre-school products; private label products; and foot-to-floor ride-on products, inflatable environments, tents, and wagons. The company also provides role play, dress-up, pretend play, and novelty products for boys and girls based on brands and entertainment properties, as well as on its own proprietary brands; and indoor and outdoor kids' furniture, activity trays and tables, room décor, kiddie pools, and seasonal and outdoor products. In addition, it offers Halloween and everyday costumes for various ages based on licensed and proprietary non-licensed brands, and related Halloween accessories; outdoor activity toys; and junior sports toys, including hyper-charged balls, sport sets, and toy hoops. The company sells its products through in-house sales staff and independent sales representatives to toy and mass-market retail chain stores, department stores, office supply stores, drug and grocery store chains, club stores, value-oriented dollar stores, toy specialty stores, and wholesalers. JAKKS Pacific, Inc. was incorporated in 1995 and is headquartered in Santa Monica, California.",Mr. Stephen G. Berman,Leisure,20.55,USD,229054410,https://images.financialmodelingprep.com/symbol/JAKK.png,150760,6.54,2.04,216999,50873000,33920000,"[{'period': '2024', 'revenue': 691.04, 'unit': 'M', 'net_profit': 33.92}, {'period': '2023', 'revenue': 711.56, 'unit': 'M', 'net_profit': 38.41}, {'period': '2022', 'revenue': 796.19, 'unit': 'M', 'net_profit': 91.41}, {'period': '2021', 'revenue': 621.12, 'unit': 'M', 'net_profit': -5.89}]","[{'period': ""Q4 '24"", 'revenue': 130.74, 'unit': 'M', 'net_profit': -9.11}, {'period': ""Q3 '24"", 'revenue': 321.61, 'unit': 'M', 'net_profit': 52.27}, {'period': ""Q2 '24"", 'revenue': 148.62, 'unit': 'M', 'net_profit': 5.27}, {'period': ""Q1 '24"", 'revenue': 90.08, 'unit': 'M', 'net_profit': -14.51}, {'period': ""Q4 '23"", 'revenue': 127.4, 'unit': 'M', 'net_profit': -11.25}, {'period': ""Q3 '23"", 'revenue': 309.74, 'unit': 'M', 'net_profit': 48.13}]",3.02,2.89,444869000,268687000,69936000,204036000,131629000,0,149420000,69936000,27701000,-0.15186222533426694,-0.11680466593761392,-0.18378378378378382,"[0.25, 0.1]","['2025-03-03', '2011-09-13']",__nan__,0.45864288138755455
310,JAMF,Jamf Holding Corp. Common Stock,"Jamf Holding Corp. offers a cloud software platform for Apple infrastructure and security platform worldwide. Its products include Jamf Pro, an Apple ecosystem management software solution for IT environments; Jamf Now, a pay-as-you-go Apple device management software solution for small-to-medium-sized businesses; Jamf School, a software solution for educators; Jamf Data Policy, a solution to enforce acceptable usage policies to eliminate shadow IT and block risky content and manage data consumption with real-time analytics and granular reporting; and Jamf Connect that streamlines Mac authentication and identity management; and Jamf Private Access, a ZTNA solution that replaces legacy conditional access and VPN technology. The company also offers Jamf Protect, which provides protection of Mac-targeted malware and creates customized telemetry and detections that give enterprise security teams visibility into their Macs; Jamf Threat Defense, a solution to protect workers from malicious attackers; and Jamf Nation, an online community of IT and security professionals focusing on Apple in the enterprise. It sells its SaaS solutions through a subscription model, direct sales force, and online, as well as indirectly through channel partners, including Apple. The company was founded in 2002 and is headquartered in Minneapolis, Minnesota.",Mr. John R. Strosahl,Software - Application,11.59,USD,1499641678,https://images.financialmodelingprep.com/symbol/JAMF.png,745401,-21.87,1.25,1167257,-69096000,-68455000,"[{'period': '2024', 'revenue': 627.4, 'unit': 'M', 'net_profit': -68.45}, {'period': '2023', 'revenue': 560.57, 'unit': 'M', 'net_profit': -110.09}, {'period': '2022', 'revenue': 478.78, 'unit': 'M', 'net_profit': -141.3}, {'period': '2021', 'revenue': 366.39, 'unit': 'M', 'net_profit': -75.19}]","[{'period': ""Q4 '24"", 'revenue': 162.97, 'unit': 'M', 'net_profit': -16.43}, {'period': ""Q3 '24"", 'revenue': 159.29, 'unit': 'M', 'net_profit': -12.24}, {'period': ""Q2 '24"", 'revenue': 153.02, 'unit': 'M', 'net_profit': -19.26}, {'period': ""Q1 '24"", 'revenue': 152.12, 'unit': 'M', 'net_profit': -20.52}, {'period': ""Q4 '23"", 'revenue': 150.65, 'unit': 'M', 'net_profit': -17.41}, {'period': ""Q3 '23"", 'revenue': 142.62, 'unit': 'M', 'net_profit': -32.28}]",-0.53,-0.53,1580229000,424657000,224680000,864246000,138791000,0,421355000,224680000,22183000,-0.0638173392249542,0.37816797776283995,0.3977272727272727,"[0.1878, 0.13]","['2019-12-23', '2018-12-24']",__nan__,0.5469118716337948
311,JAN,JanOne Inc. Common Stock (NV),"JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segments: Biotechnology, Recycling, and Technology. The company's lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. It also provides turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs; and designs, develops, and sells cellular transceiver modules and associated wireless services. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.",Mr. Tony  Isaac,Waste Management,2.23,USD,27141553,https://images.financialmodelingprep.com/symbol/JAN.png,155280,-0.5068181818181818,0.09,139578,-3246000,-20060000,"[{'period': '2023', 'revenue': 0.0, 'unit': 'M', 'net_profit': -20.06}, {'period': '2022', 'revenue': 39.61, 'unit': 'M', 'net_profit': 3.59}, {'period': '2021', 'revenue': 40.02, 'unit': 'M', 'net_profit': -16.89}, {'period': '2020', 'revenue': 33.87, 'unit': 'M', 'net_profit': -8.5}]","[{'period': ""Q1 '24"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -2.14}, {'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -14.23}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -214.0}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 123.0}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -662.0}, {'period': ""Q4 '22"", 'revenue': 11.16, 'unit': 'M', 'net_profit': -6.24}]",-5.01,-5.01,18487000,346000,5000,7285000,266000,286000,5905000,5000,1463000,-0.4162303664921466,-6.589300640847033,-5.394736842105263,__nan__,__nan__,__nan__,0.3940606912965868
312,JAZZ,Jazz Pharmaceuticals plc Common Stock (Ireland),"Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement disorders; and in oncology, including hematologic and solid tumors. Its lead marketed products include Xyrem, an oral solution for the treatment of cataplexy and excessive daytime sleepiness (EDS) in narcolepsy patients seven years of age and older; Sunosi for the treatment of EDS in patients with narcolepsy and obstructive sleep apnea; Erwinaze to treat acute lymphoblastic leukemia; Defitelio for the treatment of adult and pediatric patients with hepatic veno-occlusive disease; Vyxeos liposome for injection, a product for the treatment of adults with newly-diagnosed therapy-related acute myeloid leukemia; and Zepzelca for the treatment of adult patients with metastatic small cell lung cancer. The company also offers Xywav, an oxybate product candidate, to treat EDS and cataplexy with narcolepsy and idiopathic hypersomnia; JZP-324, a low sodium oxybate formulation with the potential to provide a clinically meaningful option for narcolepsy patients; JZP385, a T-type calcium channel modulator, for the treatment of essential tremor; JZP458, a recombinant Erwinia asparaginase, for use as a component of a multi-agent chemotherapeutic regimen in the treatment of pediatric and adult patients; and JZP150 for treatment of post-traumatic stress disorder. The company has licensing and collaboration agreements with ImmunoGen, Inc.; Codiak BioSciences, Inc.; Pfenex, Inc.; XL-protein GmbH; and Redx Pharma plc. Jazz Pharmaceuticals plc was incorporated in 2003 and is headquartered in Dublin, Ireland.",Mr. Bruce C. Cozadd,Biotechnology,110.12,USD,6687862900,https://images.financialmodelingprep.com/symbol/JAZZ.png,1044531,12.73,7.3,2621000,716630000,560120000,"[{'period': '2024', 'revenue': 4070.0000000000005, 'unit': 'M', 'net_profit': 560.12}, {'period': '2023', 'revenue': 3830.0, 'unit': 'M', 'net_profit': 414.83}, {'period': '2022', 'revenue': 3660.0, 'unit': 'M', 'net_profit': -214.14}, {'period': '2021', 'revenue': 3090.0, 'unit': 'M', 'net_profit': -328.95}]","[{'period': ""Q4 '24"", 'revenue': 1090.0, 'unit': 'M', 'net_profit': 191.12}, {'period': ""Q3 '24"", 'revenue': 1050.0, 'unit': 'M', 'net_profit': 215.06}, {'period': ""Q2 '24"", 'revenue': 1020.0, 'unit': 'M', 'net_profit': 168.57}, {'period': ""Q1 '24"", 'revenue': 901.98, 'unit': 'M', 'net_profit': -14.62}, {'period': ""Q4 '23"", 'revenue': 1010.0, 'unit': 'M', 'net_profit': 94.15}, {'period': ""Q3 '23"", 'revenue': 972.14, 'unit': 'M', 'net_profit': 146.82}]",9.06,8.49,12012257000,4629028000,2992864000,7918501000,716765000,0,1038573000,2412864000,1347838000,-0.41550311851837957,0.3502333474756046,0.3035971223021583,__nan__,__nan__,__nan__,0.6592017636652296
313,JBHT,J.B. Hunt Transport Services Inc. Common Stock,"J.B. Hunt Transport Services, Inc. provides surface transportation, delivery, and logistic services in North America. It operates through five segments: Intermodal (JBI), Dedicated Contract Services (DCS), Integrated Capacity Solutions (ICS), Final Mile Services (FMS), and Truckload (JBT). The JBI segment offers intermodal freight solutions. It operates 104,973 pieces of company-owned trailing equipment; owns and maintains its chassis fleet of 85,649 units; and manages a fleet of 5,612 company-owned tractors, 582 independent contractor trucks, and 6,943 company drivers. The DCS segment designs, develops, and executes supply chain solutions that support various transportation networks. As of December 31, 2021, it operated 11,139 company-owned trucks, 544 customer-owned trucks, and 6 contractor trucks. The company also operates 21,069 owned pieces of trailing equipment and 7,753 customer-owned trailers. The ICS segment provides freight brokerage and transportation logistics solutions; flatbed, refrigerated, expedited, and less-than-truckload, as well as dry-van and intermodal solutions; an online multimodal marketplace; and logistics management for customers to outsource the transportation functions. The FMS segment offers delivery services through 1,272 company-owned trucks, 272 customer-owned trucks, and 19 independent contractor trucks; and 1,036 owned pieces of trailing equipment and 185 customer-owned trailers. The JBT segment provides dry-van freight services by utilizing tractors and trailers operating over roads and highways through 734 company-owned tractors and 11,172 company-owned trailers. It also transports or arranges for the transportation of freight, such as general merchandise, specialty consumer items, appliances, forest and paper products, food and beverages, building materials, soaps and cosmetics, automotive parts, agricultural products, electronics, and chemicals. The company was incorporated in 1961 and is headquartered in Lowell, Arkansas.",Ms. Shelley  Simpson,Integrated Freight & Logistics,141.65,USD,14166133200,https://images.financialmodelingprep.com/symbol/JBHT.png,1111408,25.48,12.19,3029930,1599677000,570886000,"[{'period': '2024', 'revenue': 12090.0, 'unit': 'M', 'net_profit': 570.89}, {'period': '2023', 'revenue': 12830.0, 'unit': 'M', 'net_profit': 728.29}, {'period': '2022', 'revenue': 14810.0, 'unit': 'M', 'net_profit': 969.35}, {'period': '2021', 'revenue': 12170.0, 'unit': 'M', 'net_profit': 760.81}]","[{'period': ""Q4 '24"", 'revenue': 3150.0, 'unit': 'M', 'net_profit': 155.45}, {'period': ""Q3 '24"", 'revenue': 3070.0, 'unit': 'M', 'net_profit': 152.07}, {'period': ""Q2 '24"", 'revenue': 2930.0, 'unit': 'M', 'net_profit': 135.87}, {'period': ""Q1 '24"", 'revenue': 2940.0, 'unit': 'M', 'net_profit': 127.49}, {'period': ""Q4 '23"", 'revenue': 3300.0, 'unit': 'M', 'net_profit': 153.53}, {'period': ""Q3 '23"", 'revenue': 3160.0, 'unit': 'M', 'net_profit': 187.43}]",5.6,5.56,8312270000,1770983000,46983000,4297765000,1481940000,0,1678040000,46983000,617783000,-0.07999717042007759,-0.21612496172525392,-0.2067988668555241,"[0.44, 0.4032]","['2025-02-07', '1985-02-05']",__nan__,0.5170386669345437
314,JBLU,JetBlue Airways Corporation Common Stock,"JetBlue Airways Corporation provides air passenger transportation services. As of December 31, 2021, the company operated a fleet of 63 Airbus A321 aircraft, 8 Airbus A220 aircraft, 21 Airbus A321neo aircraft, 130 Airbus A320 aircraft, and 60 Embraer E190 aircraft. It also served 107 destinations in the 31 states in the United States, the District of Columbia, the Commonwealth of Puerto Rico, the U.S. Virgin Islands, and 24 countries in the Caribbean and Latin America. JetBlue Airways Corporation has a strategic partnership with American Airlines Group Inc. to create connectivity for travelers in the Northeast. The company was incorporated in 1998 and is based in Long Island City, New York.",Ms. Joanna L. Geraghty,"Airlines, Airports & Air Services",4.29,USD,1520118600,https://images.financialmodelingprep.com/symbol/JBLU.png,25963454,-1.87,0.69,54869203,108000000,-795000000,"[{'period': '2024', 'revenue': 9280.0, 'unit': 'M', 'net_profit': -795.0}, {'period': '2023', 'revenue': 9620.0, 'unit': 'M', 'net_profit': -310.0}, {'period': '2022', 'revenue': 9160.0, 'unit': 'M', 'net_profit': -362.0}, {'period': '2021', 'revenue': 6040.0, 'unit': 'M', 'net_profit': -182.0}]","[{'period': ""Q4 '24"", 'revenue': 2280.0, 'unit': 'M', 'net_profit': -44.0}, {'period': ""Q3 '24"", 'revenue': 2370.0, 'unit': 'M', 'net_profit': -60.0}, {'period': ""Q2 '24"", 'revenue': 2430.0, 'unit': 'M', 'net_profit': 25.0}, {'period': ""Q1 '24"", 'revenue': 2210.0, 'unit': 'M', 'net_profit': -716.0}, {'period': ""Q4 '23"", 'revenue': 2330.0, 'unit': 'M', 'net_profit': -103.0}, {'period': ""Q3 '23"", 'revenue': 2350.0, 'unit': 'M', 'net_profit': -153.0}]",-2.3,-2.29,16841000000,4100000000,3610000000,14200000000,348000000,336000000,3881000000,1921000000,-1353000000,-0.7826961770623743,-1.564516129032258,-1.473118279569892,__nan__,__nan__,__nan__,0.8431803337093997
315,JBSS,John B. Sanfilippo & Son Inc. Common Stock,"John B. Sanfilippo & Son, Inc., through its subsidiary, JBSS Ventures, LLC, processes and distributes tree nuts and peanuts in the United States. The company offers raw and processed nuts, including almonds, pecans, peanuts, black walnuts, English walnuts, cashews, macadamia nuts, pistachios, pine nuts, Brazil nuts, and filberts in various styles and seasonings. It also offers peanut butter in various sizes and varieties; snack and trail mixes, salad toppings, snacks, snack bites, dried fruit, and chocolate and yogurt coated products; baking ingredients; bulk food products; sunflower kernels, pepitas, almond and cashew butter, candy and confections, corn snacks, chickpea snacks, sesame sticks, and other sesame snack products; and various toppings for ice cream and yogurt. In addition, the company operates a retail store. The company provides its products under the Fisher, Orchard Valley Harvest, Squirrel Brand, and Southern Style Nuts brands, as well as under various private brands. It serves retailers and wholesalers, and commercial ingredient and contract packaging customers through a network of independent brokers, distributors, and suppliers. John B. Sanfilippo & Son, Inc. was founded in 1922 and is headquartered in Elgin, Illinois.",Mr. Jeffrey T. Sanfilippo,Packaged Foods,67.73,USD,788246210,https://images.financialmodelingprep.com/symbol/JBSS.png,79188,16.28,0.98,69301,109090000,60249000,"[{'period': '2024', 'revenue': 1070.0, 'unit': 'M', 'net_profit': 60.25}, {'period': '2023', 'revenue': 999.69, 'unit': 'M', 'net_profit': 62.86}, {'period': '2022', 'revenue': 955.87, 'unit': 'M', 'net_profit': 61.79}, {'period': '2021', 'revenue': 858.48, 'unit': 'M', 'net_profit': 59.74}]","[{'period': ""Q2 '25"", 'revenue': 301.07, 'unit': 'M', 'net_profit': 13.6}, {'period': ""Q1 '25"", 'revenue': 276.2, 'unit': 'M', 'net_profit': 11.66}, {'period': ""Q4 '24"", 'revenue': 269.57, 'unit': 'M', 'net_profit': 10.01}, {'period': ""Q3 '24"", 'revenue': 271.88, 'unit': 'M', 'net_profit': 13.48}, {'period': ""Q2 '24"", 'revenue': 291.22, 'unit': 'M', 'net_profit': 19.17}, {'period': ""Q1 '24"", 'revenue': 234.1, 'unit': 'M', 'net_profit': 17.59}]",5.19,5.15,515575000,294085000,484000,192962000,84960000,0,125940000,484000,73361000,0.009886874895854549,-0.04149100338864407,-0.04419889502762419,"[2.1, 0.05]","['2024-08-20', '1992-11-02']",__nan__,0.3742656257576492
316,JCIC,Jack Creek Investment Corp. Class A Ordinary Shares,"Jack Creek Investment Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in New York, New York.",Mr. Jeffrey E. Kelter,Shell Companies,10.19,USD,0,https://images.financialmodelingprep.com/symbol/JCIC.png,128885,0,0.57,82165,15113643,32295843,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 32.3}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.33}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.71}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 17.1}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.02}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.92}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.22}]",0.79,0.79,345585366,516795,89920,27215431,0,0,754761,89920,-1752236,0,0,0,__nan__,__nan__,__nan__,0.07875168822976145
317,JCICU,Jack Creek Investment Corp. Units,"Jack Creek Investment Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in New York, New York.",Mr. Jeffrey E. Kelter,Shell Companies,10.02,USD,0,https://images.financialmodelingprep.com/symbol/JCICU.png,6624,0,-0.15,2227,15113643,32295843,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 32.3}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.33}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.71}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 17.1}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.02}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.92}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.22}]",0.79,0.79,345585366,516795,89920,27215431,0,0,754761,89920,-1752236,0,0,0,__nan__,__nan__,__nan__,0.07875168822976145
318,JCICW,Jack Creek Investment Corp. Warrants,"Jack Creek Investment Corp. is a blank check company. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses or entities. The company was founded in 2020 and is based in New York, New York.",Mr. Jeffrey E. Kelter,Shell Companies,0.22,USD,0,https://images.financialmodelingprep.com/symbol/JCICW.png,0,0,0.0599,246935,15113643,32295843,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 32.3}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -9.33}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 5.71}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 17.1}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.02}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 4.92}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -8.22}]",0.79,0.79,345585366,516795,89920,27215431,0,0,754761,89920,-1752236,0,0,0,__nan__,__nan__,__nan__,0.07875168822976145
319,JCOM,j2 Global Inc. Common Stock,"J2 Global, Inc., together with its subsidiaries, provides Internet services worldwide. The company operates through three segments: Fax and Martech; Voice, Backup, Security, and Consumer Privacy and Protection; and Digital Media. It offers cloud services, which includes online fax services under the eFax, sFax, MyFax, eFax Plus, eFax Pro, eFax Secure, eFax Corporate, and eFax Developer brands; on-demand voice, cloud phone, and unified communications services under the eVoice, Line2, and Onebox names; online backup and disaster recovery, sync storage, veeam services, and synchronization and sharing solutions under the KeepItSafe, LiveDrive, LiveVault, OffsiteDataSync, and SugarSync names; email security, web security, and endpoint protection services under the VIPRE and Excel Micro brands; email marketing and delivery services under the Campaigner and SMTP names; virtual private network services under the IPVanish and Encrypt.me; IP licensing services; and customer support services. The company also operates a portfolio of Web properties and applications, including IGN, Mashable, PC Mag, Humble Bundle, Speedtest, Offers, Black Friday, AskMen, MedPageToday, Everyday Health, What to Expect, and others that offer technology products, gaming and lifestyle products and services, news and commentary related products, speed testing for Internet and network connections, online deals and discounts for consumers, interactive tools and mobile applications, and tools and information for healthcare professionals, as well as professional networking tools, targeted emails, and white papers for IT professionals. It serves sole proprietors, small to medium-sized businesses and enterprises, and government organizations. The company was formerly known as j2 Global Communications, Inc. and changed its name to j2 Global, Inc. in December 2011. J2 Global, Inc. was founded in 1995 and is headquartered in Los Angeles, California.",Mr. Vivek Shah,Software - Infrastructure,142.84,USD,6750661252,https://images.financialmodelingprep.com/symbol/JCOM.png,357547,0,4.25,355657,319098000,63047000,"[{'period': '2024', 'revenue': 1400.0, 'unit': 'M', 'net_profit': 63.05}, {'period': '2023', 'revenue': 1360.0, 'unit': 'M', 'net_profit': 41.5}, {'period': '2022', 'revenue': 1390.0, 'unit': 'M', 'net_profit': 63.76}, {'period': '2021', 'revenue': 1420.0, 'unit': 'M', 'net_profit': 351.7}]","[{'period': ""Q4 '24"", 'revenue': 412.82, 'unit': 'M', 'net_profit': 64.09}, {'period': ""Q3 '24"", 'revenue': 353.58, 'unit': 'M', 'net_profit': -48.58}, {'period': ""Q2 '24"", 'revenue': 320.8, 'unit': 'M', 'net_profit': 36.91}, {'period': ""Q1 '24"", 'revenue': 314.49, 'unit': 'M', 'net_profit': 10.63}, {'period': ""Q4 '23"", 'revenue': 389.88, 'unit': 'M', 'net_profit': 63.42}, {'period': ""Q3 '23"", 'revenue': 340.99, 'unit': 'M', 'net_profit': -30.97}]",1.42,1.42,3704334000,1272069000,505880000,1893452000,660223000,158187000,899647000,505880000,283680000,-0.09742037676076257,0.5190950051803485,0.595505617977528,"[0.455, 0.2]","['2019-05-17', '2011-08-31']",__nan__,0.5111450533348235
320,JCS,Communications Systems Inc. Common Stock,"Communications Systems, Inc., through its subsidiaries, provides technology solutions and infrastructure in the commercial, healthcare, financial, and education market segments. The company's technology solutions portfolio includes IT managed service, security products and services, cloud migrations, network virtualization and resiliency, wired and wireless network design and implementation, and converged infrastructure configuration, deployment, and management, as well as software-designed wide-area network. Communications Systems, Inc. was founded in 1969 and is headquartered in Minnetonka, Minnesota.",Mr. Roger Lacey,Communication Equipment,8.18,USD,77019526,https://images.financialmodelingprep.com/symbol/JCS.png,14607,6.596774193548387,-0.71000004,48445,-8161882,2973647,"[{'period': '2021', 'revenue': 7.01, 'unit': 'M', 'net_profit': 2.97}, {'period': '2020', 'revenue': 42.58, 'unit': 'M', 'net_profit': -1.8}, {'period': '2019', 'revenue': 50.91, 'unit': 'M', 'net_profit': 6.47}, {'period': '2018', 'revenue': 65.76, 'unit': 'M', 'net_profit': -6.79}]","[{'period': ""Q4 '21"", 'revenue': -17.8, 'unit': 'M', 'net_profit': 8.88}, {'period': ""Q3 '21"", 'revenue': 1.83, 'unit': 'M', 'net_profit': 8.61}, {'period': ""Q2 '21"", 'revenue': 11.0, 'unit': 'M', 'net_profit': -1.94}, {'period': ""Q1 '21"", 'revenue': 10.16, 'unit': 'M', 'net_profit': -2.16}, {'period': ""Q4 '20"", 'revenue': 11.68, 'unit': 'M', 'net_profit': -1.63}, {'period': ""Q3 '20"", 'revenue': 12110.0, 'unit': 'K', 'net_profit': 262.37}]",1.23,1.23,11380006,6527895,3491160,446530,0,135240,2609967,3491160,0,-9.403782738546687,2.656006045640801,2.5974025974025974,"[3.5, 0.0334]","['2021-10-18', '1985-09-16']",__nan__,0.03923811639466623
321,JCTCF,Jewett-Cameron Trading Company Common Shares,"Jewett-Cameron Trading Company Ltd., through its subsidiaries, engages in the manufacturing and distribution of specialty metal products and wholesale distribution of wood products to home centers and other retailers. The company operates through three segments: Industrial Wood Products; Pet, Fencing and Other; and Seed Processing and Sales. The Industrial Wood Products segment processes and distributes industrial wood products. It offers treated plywood to the transportation industry. The Pet, Fencing and Other segment is involved in the wholesale of pet products, including various enclosures/kennels, beds, bowls, and compostable dog waste bags; fencing and containment products, such as post systems, wood and other fencing infill products, and kitted security fencing solutions; and other products comprising garden, landscaping, and miscellaneous products for the home. The Seed Processing and Sales segment processes and distributes agricultural seeds to distributors, as well as cleaning seeds. The company markets its products under the Lucky Dog, Adjust-A-Gate, Fit-Right, Perimeter Patrol, Lifetime Post, Early Start, Spring Gardner, Greenline, and Weatherguard brands. It operates in the United States, Canada, Mexico, Latin America, the Caribbean, Europe, and the Asia Pacific. The company was founded in 1953 and is headquartered in North Plains, Oregon.",Mr. Chad  Summers,"Paper, Lumber & Forest Products",4.89,USD,17138472,https://images.financialmodelingprep.com/symbol/JCTCF.png,5729,14.382352941176471,-0.06,807,898856,-20626,"[{'period': '2023', 'revenue': 54290.0, 'unit': 'K', 'net_profit': -20.63}, {'period': '2022', 'revenue': 62.9, 'unit': 'M', 'net_profit': 1.16}, {'period': '2021', 'revenue': 57.5, 'unit': 'M', 'net_profit': 3.45}, {'period': '2020', 'revenue': 44.95, 'unit': 'M', 'net_profit': 2.78}]","[{'period': ""Q3 '24"", 'revenue': 15900.0, 'unit': 'K', 'net_profit': 154.86}, {'period': ""Q2 '24"", 'revenue': 8230.0, 'unit': 'K', 'net_profit': -534.14}, {'period': ""Q1 '24"", 'revenue': 9.81, 'unit': 'M', 'net_profit': 1.29}, {'period': ""Q4 '23"", 'revenue': 14620.0, 'unit': 'K', 'net_profit': 290.22}, {'period': ""Q3 '23"", 'revenue': 18950.0, 'unit': 'K', 'net_profit': 734.95}, {'period': ""Q2 '23"", 'revenue': 8140.000000000001, 'unit': 'K', 'net_profit': -972.04}]",-0.0059,-0.0059,29798603,24688456,83696,5701276,5634924,-319875,5701276,83696,5269724,-0.564436424181867,-1.0177180590023562,-1.0178787878787878,__nan__,__nan__,__nan__,0.19132695583078174
322,JD,JD.com Inc. American Depositary Shares,"JD.com, Inc. operates as a supply chain-based technology and service provider in the People's Republic of China. The company offers computers, communication, and consumer electronics products, as well as home appliances; and general merchandise products comprising food, beverage and fresh produce, baby and maternity products, furniture and household goods, cosmetics and other personal care items, pharmaceutical and healthcare products, industrial products, books, automobile accessories, apparel and footwear, bags, and jewelry. It also provides online marketplace services for third-party merchants; marketing services; and omni-channel solutions to customers and offline retailers, as well as online healthcare services. In addition, the company develops, owns, and manages its logistics facilities and other real estate properties to support third parties; offers asset management services and integrated service platform; leasing of storage facilities and related management services; and engages in online retail business. Further, it provides integrated data, technology, business, and user management industry solutions to support the digitization of enterprises and institutions; and technology-driven supply chain solutions and logistics services. The company was formerly known as 360buy Jingdong Inc. and changed its name to JD.com, Inc. in January 2014. JD.com, Inc. was incorporated in 2006 and is headquartered in Beijing, the People's Republic of China.",Mr. Qiangdong  Liu,Specialty Retail,35.075,USD,53842231289,https://images.financialmodelingprep.com/symbol/JD.png,14260918,9.53,2.055,26266067,47356664720,41359000000,"[{'period': '2024', 'revenue': 1160.0, 'unit': 'B', 'net_profit': 41.36}, {'period': '2023', 'revenue': 1080.0, 'unit': 'B', 'net_profit': 24.17}, {'period': '2022', 'revenue': 1050.0, 'unit': 'B', 'net_profit': 10.38}, {'period': '2021', 'revenue': 951.59, 'unit': 'B', 'net_profit': -3.56}]","[{'period': ""Q4 '24"", 'revenue': 346.99, 'unit': 'B', 'net_profit': 9.85}, {'period': ""Q3 '24"", 'revenue': 260.39, 'unit': 'B', 'net_profit': 11.73}, {'period': ""Q2 '24"", 'revenue': 291.4, 'unit': 'B', 'net_profit': 12.64}, {'period': ""Q1 '24"", 'revenue': 260.05, 'unit': 'B', 'net_profit': 7.13}, {'period': ""Q4 '23"", 'revenue': 306.08, 'unit': 'B', 'net_profit': 3.39}, {'period': ""Q3 '23"", 'revenue': 247.7, 'unit': 'B', 'net_profit': 7.94}]",13.43,13.445,698234000000,386698000000,233995000000,384937000000,30401000000,116220000000,299521000000,108350000000,0,0.105869853116316,0.711383291264948,0.7464239271781533,"[0.98, 1.26]","['2025-04-08', '2022-05-19']",__nan__,0.5513008532956001
323,JFIN,Jiayin Group Inc. American Depositary Shares,"Jiayin Group Inc. provides online consumer finance services in the People's Republic of China. The company operates a fintech platform that facilitates transparent, secure, and fast connections between individual borrowers and financial institutions funding partners. It also provides referral services for investment products offered by the financial service providers; and software development, risk control, marketing support, and IT assistance services. The company was founded in 2011 and is headquartered in Shanghai, the People's Republic of China.",Mr. Dinggui  Yan,Internet Content & Information,10.31,USD,67098697,https://images.financialmodelingprep.com/symbol/JFIN.png,173875,3.78,-0.42,292106,1341931000,1297619000,"[{'period': '2023', 'revenue': 5.47, 'unit': 'B', 'net_profit': 1.3}, {'period': '2022', 'revenue': 3.27, 'unit': 'B', 'net_profit': 1.18}, {'period': '2021', 'revenue': 1780.0, 'unit': 'M', 'net_profit': 472.09}, {'period': '2020', 'revenue': 1300.0, 'unit': 'M', 'net_profit': 252.88}]","[{'period': ""Q3 '24"", 'revenue': 1440.0, 'unit': 'M', 'net_profit': 269.61}, {'period': ""Q2 '24"", 'revenue': 1480.0, 'unit': 'M', 'net_profit': 238.27}, {'period': ""Q1 '24"", 'revenue': 1480.0, 'unit': 'M', 'net_profit': 273.07}, {'period': ""Q4 '23"", 'revenue': 1600.0, 'unit': 'M', 'net_profit': 367.76}, {'period': ""Q3 '23"", 'revenue': 1470.0, 'unit': 'M', 'net_profit': 323.79}, {'period': ""Q2 '23"", 'revenue': 1280.0, 'unit': 'M', 'net_profit': 326.35}]",6.06,6.06,5644766000,5389857000,370193000,3264305000,4032411000,101481000,2257855000,370193000,358046000,0.12579992952901894,0.09999593102407647,0.09782608695652176,"[0.495, 0.38]","['2024-08-27', '2023-07-27']",__nan__,0.5782888077202846
324,JFU,9F Inc. American Depositary Shares,"9F Inc., together with its subsidiaries, operates internet securities service platform in the People's Republic of China. Its products include digital financial accounts that offer online lending, wealth management, and payment facilitation services; revolving and non-revolving loan products to borrowers, as well as traffic referral services to o financial institution partners; and a suite of online wealth management products, such as fixed income products, stocks, insurance, bank wealth management products, and mutual funds to investors in various platforms, including Wukong Licai, 9F Wallet, and 9F Puhui. The company also provides payment facilitation and other products and services that help users to pay credit card bills and household bills comprising utility bills; and other value-added services consisting of credit history search, debt consolidation, and user referral services. In addition, it offers technology empowerment services to banking, automobile, securities investment, and insurance industries; and engages in E-commerce business, which offers various categories of merchandise, including 3C products, beauty and skin care products, rice, noodle and oils, household appliances, jewelry, and liquor and beverages. It provides its services to borrowers, investors, and financial institutions partners. The company was formerly known as JIUFU Financial Technology Service Limited and changed its name to 9F Inc. in June 2014. 9F Inc. was founded in 2006 and is headquartered in Beijing, the People's Republic of China.",Mr. Lei  Liu,Information Technology Services,1.01,USD,594552,https://images.financialmodelingprep.com/symbol/JFU.png,6800,6.31,-0.07,14539,-175988000,-140190000,"[{'period': '2023', 'revenue': 412.45, 'unit': 'M', 'net_profit': -140.19}, {'period': '2022', 'revenue': 561.67, 'unit': 'M', 'net_profit': -594.74}, {'period': '2021', 'revenue': 761.45, 'unit': 'M', 'net_profit': -234.91}, {'period': '2020', 'revenue': 1.26, 'unit': 'B', 'net_profit': -2.26}]","[{'period': ""Q2 '24"", 'revenue': 71.38, 'unit': 'M', 'net_profit': 6.25}, {'period': ""Q1 '24"", 'revenue': 71.38, 'unit': 'M', 'net_profit': 6.25}, {'period': ""Q4 '23"", 'revenue': 76.19, 'unit': 'M', 'net_profit': -2.26}, {'period': ""Q3 '23"", 'revenue': 76.19, 'unit': 'M', 'net_profit': -2.26}, {'period': ""Q2 '23"", 'revenue': 130.04, 'unit': 'M', 'net_profit': -67.84}, {'period': ""Q1 '23"", 'revenue': 130.04, 'unit': 'M', 'net_profit': -67.84}]",-0.5955,-0.5955,4039243000,2860200000,2460944000,466728000,38038000,1067444000,445958000,1686342000,56760000,-0.36129331683168314,0.7642839488113313,0.7664705882352941,__nan__,__nan__,__nan__,0.11554838369466754
325,JG,Aurora Mobile Limited American Depositary Shares,"Aurora Mobile Limited, through its subsidiaries, operates as a mobile app developer service provider in China. The company provides push notification, instant messaging, analytics, sharing and short message service, one-click verification, and other services. Its vertical applications have expanded to market intelligence, financial risk management, and location-based intelligence; and offers real-time market intelligence solutions, such as product iApp, which provides analysis and statistical results on the usage and trends of mobile apps to investment funds and corporations. The company also provides financial risk management solutions to assist financial institutions, licensed lenders, and credit card companies in making informed lending and credit decisions; and location-based intelligence solutions to help retailers and other traditional brick-and-mortar industries, such as real estate developers, track and analyze foot traffic, conduct targeted marketing, and make more informed and impactful operating decisions, such as site selection. In addition, it offers targeted marketing solutions to help advertisers to target the right audience with the right content at the right time; application programming interfaces that create connectivity and automate the process of message exchange between the mobile apps and its backend network; and an interactive web-based service dashboard that allows app developers to utilize and monitor its services through controls on an ongoing basis. The company primarily serves mobile app developers in a range of industries, such as media, entertainment, gaming, financial services, tourism, ecommerce, education, and healthcare. The company was founded in 2011 and is headquartered in Shenzhen, the People's Republic of China.",Mr. Shan-Nen  Bong,Software - Infrastructure,8.33,USD,2953885,https://images.financialmodelingprep.com/symbol/JG.png,837593,-52.06,0,32325,-570000,-7046000,"[{'period': '2024', 'revenue': 316.17, 'unit': 'M', 'net_profit': -7.05}, {'period': '2023', 'revenue': 290.23, 'unit': 'M', 'net_profit': -62.1}, {'period': '2022', 'revenue': 328.82, 'unit': 'M', 'net_profit': -107.79}, {'period': '2021', 'revenue': 357.32, 'unit': 'M', 'net_profit': -140.58}]","[{'period': ""Q4 '24"", 'revenue': 93.15, 'unit': 'M', 'net_profit': -1.07}, {'period': ""Q3 '24"", 'revenue': 79.05, 'unit': 'M', 'net_profit': -2.58}, {'period': ""Q2 '24"", 'revenue': 79.44, 'unit': 'M', 'net_profit': -1.0}, {'period': ""Q1 '24"", 'revenue': 64.52, 'unit': 'M', 'net_profit': -2.4}, {'period': ""Q4 '23"", 'revenue': 77.41, 'unit': 'M', 'net_profit': -17.25}, {'period': ""Q3 '23"", 'revenue': 74.06, 'unit': 'M', 'net_profit': -6.77}]",0,0,378033000,184615000,119171000,278635000,53865000,113506000,261633000,119171000,3561000,0.9890850599364253,0.8865341878965506,1,__nan__,__nan__,__nan__,0.7370652826605085
326,JJSF,J & J Snack Foods Corp. Common Stock,"J&J Snack Foods Corp. manufactures, markets, and distributes nutritional snack foods and beverages to the food service and retail supermarket industries in the United States, Mexico, and Canada. It operates in three segments: Food Service, Retail Supermarkets, and Frozen Beverages. The company offers soft pretzels under the SUPERPRETZEL, PRETZEL FILLERS, PRETZELFILS, GOURMET TWISTS, MR. TWISTER, SOFT PRETZEL BITES, SOFTSTIX, SOFT PRETZEL BUNS, TEXAS TWIST, BAVARIAN BAKERY, SUPERPRETZEL BAVARIAN, NEW YORK PRETZEL, KIM & SCOTT'S GOURMET PRETZELS, SERIOUSLY TWISTED!, BRAUHAUS, AUNTIE ANNE'S, and LABRIOLA, as well as under the private labels. It also provides frozen novelty under the LUIGI'S, WHOLE FRUIT, PHILLY SWIRL, SOUR PATCH, ICEE, and MINUTE MAID brands; churros under the TIO PEPE'S and CALIFORNIA CHURROS brands; and handheld products under the SUPREME STUFFERS and SWEET STUFFERS brands. In addition, the company offers bakery products, including biscuits, fig and fruit bars, cookies, breads, rolls, crumbs, muffins, and donuts under the MRS. GOODCOOKIE, READI-BAKE, COUNTRY HOME, MARY B'S, DADDY RAY'S, and HILL & VALLEY brands, as well as under private labels; and frozen beverages under the ICEE, SLUSH PUPPIE, and PARROT ICE brands. Further, it provides funnel cakes under the FUNNEL CAKE FACTORY brand, as well as various other food products; and sells machines and machine parts to other food and beverage companies. The company sells its products through a network of food brokers, independent sales distributors, and direct sales force. It serves snack bars and food stand locations in chain, department and mass merchandising stores, malls and shopping centers, fast food and casual dining restaurants, stadiums and sports arenas, leisure and theme parks, convenience stores, movie theatres, warehouse club stores, schools, colleges and other institutions, and independent retailers. The company was incorporated in 1971 and is headquartered in Pennsauken, New Jersey.",Mr. Daniel J. Fachner,Packaged Foods,133.3,USD,2598056990,https://images.financialmodelingprep.com/symbol/JJSF.png,158196,30.71,3.9,195301,191374000,86551000,"[{'period': '2024', 'revenue': 1570.0, 'unit': 'M', 'net_profit': 86.55}, {'period': '2023', 'revenue': 1560.0, 'unit': 'M', 'net_profit': 78.91}, {'period': '2022', 'revenue': 1380.0, 'unit': 'M', 'net_profit': 47.23}, {'period': '2021', 'revenue': 1140.0, 'unit': 'M', 'net_profit': 55.61}]","[{'period': ""Q1 '25"", 'revenue': 362.6, 'unit': 'M', 'net_profit': 5.14}, {'period': ""Q4 '24"", 'revenue': 426.76, 'unit': 'M', 'net_profit': 29.64}, {'period': ""Q3 '24"", 'revenue': 439.96, 'unit': 'M', 'net_profit': 36.3}, {'period': ""Q2 '24"", 'revenue': 359.73, 'unit': 'M', 'net_profit': 13.33}, {'period': ""Q1 '24"", 'revenue': 348.31, 'unit': 'M', 'net_profit': 7.28}, {'period': ""Q4 '23"", 'revenue': 443.86, 'unit': 'M', 'net_profit': 30.42}]",4.46,4.45,1365101000,450414000,73394000,408131000,189233000,0,174073000,73394000,99497000,0.09772452204638143,0.09688743568296454,0.08780487804878058,"[0.78, 0.125]","['2025-03-18', '2004-12-13']",__nan__,0.2989749476412368
327,JKHY,Jack Henry & Associates Inc. Common Stock,"Jack Henry & Associates, Inc. provides technology solutions and payment processing services primarily for financial services organizations in the United States. It operates through four segments: Core, Payments, Complementary, and Corporate and Other. The company offers information and transaction processing solutions for banks ranging from community to multi-billion-dollar asset institutions under the Jack Henry Banking brand; core data processing solutions for various credit unions under the Symitar brand; and specialized financial performance, imaging and payments processing, information security and risk management, retail delivery, and online and mobile solutions to financial institutions and corporate entities under the ProfitStars brand. It also provides a suite of integrated applications required to process deposit, loan, and general ledger transactions, as well as to maintain centralized customer/member information; and complementary products and services that enable core bank and credit union clients to respond to evolving customer/member demands. The company's Jack Henry Banking business brand offers SilverLake, a robust primarily designed for commercial-focused banks; CIF 20/20, a parameter-driven, easy-to-use system for banks; and Core Director, a cost-efficient system with point-and-click operation. Its Symitar business brand provides Episys, a robust designed for credit unions. In addition, the company offers digital products and services and electronic payment solutions; purchases and resells hardware systems, including servers, workstations, scanners, and other devices; and provides implementation, training, and support services. Jack Henry & Associates, Inc. was founded in 1976 and is headquartered in Monett, Missouri.",Mr. Gregory R. Adelson,Information Technology Services,170.71,USD,12444366367,https://images.financialmodelingprep.com/symbol/JKHY.png,682432,30.81,7.17,969030,714307000,381816000,"[{'period': '2024', 'revenue': 2220.0, 'unit': 'M', 'net_profit': 381.82}, {'period': '2023', 'revenue': 2080.0, 'unit': 'M', 'net_profit': 366.65}, {'period': '2022', 'revenue': 1940.0, 'unit': 'M', 'net_profit': 362.92}, {'period': '2021', 'revenue': 1760.0, 'unit': 'M', 'net_profit': 311.47}]","[{'period': ""Q2 '25"", 'revenue': 573.85, 'unit': 'M', 'net_profit': 97.84}, {'period': ""Q1 '25"", 'revenue': 600.98, 'unit': 'M', 'net_profit': 119.19}, {'period': ""Q4 '24"", 'revenue': 559.91, 'unit': 'M', 'net_profit': 101.07}, {'period': ""Q3 '24"", 'revenue': 538.56, 'unit': 'M', 'net_profit': 87.1}, {'period': ""Q2 '24"", 'revenue': 545.7, 'unit': 'M', 'net_profit': 91.97}, {'period': ""Q1 '24"", 'revenue': 571.37, 'unit': 'M', 'net_profit': 101.68}]",5.24,5.23,2924481000,632018000,38284000,1082117000,339182000,0,633814000,38284000,335618000,0.049875582952292344,0.041375059321525395,0.04174950298210735,"[0.58, 0.0672]","['2025-03-06', '1990-07-25']",__nan__,0.3700201847780854
328,JMPNL,JMP Group LLC 7.25% Senior Notes due 2027,,None,,25.13,USD,0,https://images.financialmodelingprep.com/symbol/JMPNL.png,3393,,0.01,3755,,,[],[],,,,,,,,,,,,,,,"[0.453, 0.453]","['2021-07-29', '2018-07-31']",__nan__,__nan__
329,JMPNZ,JMP Group LLC 6.875% Senior Notes due 2029,,None,,25.33,USD,0,https://images.financialmodelingprep.com/symbol/JMPNZ.png,5283,0,0,2763,-95572000,-4960000,"[{'period': '2020', 'revenue': 83.36, 'unit': 'M', 'net_profit': -4.96}, {'period': '2019', 'revenue': 90.77, 'unit': 'M', 'net_profit': -6.55}, {'period': '2018', 'revenue': 127.97, 'unit': 'M', 'net_profit': -2.19}, {'period': '2017', 'revenue': 7.46, 'unit': 'M', 'net_profit': -15.88}]","[{'period': ""Q2 '21"", 'revenue': 48.49, 'unit': 'M', 'net_profit': 3.64}, {'period': ""Q4 '20"", 'revenue': 7260.0, 'unit': 'K', 'net_profit': 8.81}, {'period': ""Q3 '20"", 'revenue': 26.62, 'unit': 'M', 'net_profit': -3.15}, {'period': ""Q2 '20"", 'revenue': 28.95, 'unit': 'M', 'net_profit': 1.12}, {'period': ""Q1 '20"", 'revenue': 20.53, 'unit': 'M', 'net_profit': -11.75}, {'period': ""Q4 '19"", 'revenue': 27.08, 'unit': 'M', 'net_profit': -6.45}]",-0.25,-0.25,11879000,8761000,8761000,161824000,0,0,161824000,8761000,26713000,-21.15861632566969,0.24263246297144603,0.21875000000000003,"[0.43, 0.43]","['2021-09-14', '2020-06-12']",__nan__,13.622695513090328
330,JNCE,Jounce Therapeutics Inc. Common Stock,"Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid tumors. It is also developing JTX-8064, an antibody that binds to leukocyte immunoglobulin like receptor B2, which is a cell surface receptor expressed on macrophages; JTX -1484 for myeloid; and JTX-1811, an anti-CCR8 monoclonal antibody designed to selectively deplete intra-tumoral T regulatory cells in the tumor microenvironment. Jounce Therapeutics, Inc. was incorporated in 2012 and is headquartered in Cambridge, Massachusetts.","Ms. Kimberlee Cobleigh Drapkin C.P.A., CPA",Biotechnology,1.88,USD,98954740,https://images.financialmodelingprep.com/symbol/JNCE.png,3466835,-1.9583333333333333,0,11600631,-50155000,-50919000,"[{'period': '2022', 'revenue': 82.0, 'unit': 'M', 'net_profit': -50.92}, {'period': '2021', 'revenue': 26.91, 'unit': 'M', 'net_profit': -90.87}, {'period': '2020', 'revenue': 62.34, 'unit': 'M', 'net_profit': -43.84}, {'period': '2019', 'revenue': 147.87, 'unit': 'M', 'net_profit': 56.82}]","[{'period': ""Q4 '22"", 'revenue': 82.0, 'unit': 'M', 'net_profit': 50.96}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -31.0}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -33.51}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -37.37}, {'period': ""Q4 '21"", 'revenue': 0.02691, 'unit': 'K', 'net_profit': 30.0}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -30.09}]",-0.99,-0.99,212550000,197231000,189542000,29438000,0,0,23568000,150572000,-29796000,0.4491851168511685,0.4396623822519588,0.4560439560439561,__nan__,__nan__,__nan__,0.13849917666431427
331,JOAN,JOANN Inc. Common Stock,"JOANN Inc. operates as a specialty retailer of sewing and fabrics, and arts and crafts category products in the United States. Its products in sewing category include cotton fabrics; warm fabrics, such as fleece and flannel fabrics; home decorating and utility fabrics and accessories; fashion and sportswear fabrics; special occasion fabrics; seasonally themed and licensed fabric designs; and sewing construction supplies comprising cutting implements, threads, zippers, trims, tapes, pins, elastic, and buttons, as well as patterns for sewing projects. The company's products in arts and crafts, home décor, and other category consist of yarn and yarn accessories, and needlecraft kits and supplies; paper crafting components; craft materials; fine art materials; sewing machines, craft technology, lighting, irons, organizers, and other products; artificial floral products; seasonal décor and entertaining products; home décor accessories; ready-made frames; comprehensive assortment books and magazines; and non-merchandise services. JOANN Inc. offers its products through retail stores, as well as online. As of March 21, 2022, it operated 848 retail stores in 49 states. The company was formerly known as Jo-Ann Stores Holdings Inc. and changed its name to JOANN Inc. in February 2021. JOANN Inc. was founded in 1943 and is based in Hudson, Ohio.",Mr. Scott  Sekella,Specialty Retail,0.0969,USD,4061244,https://images.financialmodelingprep.com/symbol/JOAN.png,1141937,-0.016678141135972463,-0.0131,4001792,-129400000,-198400000,"[{'period': '2023', 'revenue': 2220.0, 'unit': 'M', 'net_profit': -198.4}, {'period': '2022', 'revenue': 2420.0, 'unit': 'M', 'net_profit': 56.7}, {'period': '2021', 'revenue': 2760.0, 'unit': 'M', 'net_profit': 212.3}, {'period': '2020', 'revenue': 2240.0, 'unit': 'M', 'net_profit': -546.6}]","[{'period': ""Q3 '24"", 'revenue': 539.8, 'unit': 'M', 'net_profit': -21.6}, {'period': ""Q2 '24"", 'revenue': 453.8, 'unit': 'M', 'net_profit': -73.3}, {'period': ""Q1 '24"", 'revenue': 478.1, 'unit': 'M', 'net_profit': -51.7}, {'period': ""Q4 '23"", 'revenue': 692.8, 'unit': 'M', 'net_profit': -88.9}, {'period': ""Q3 '23"", 'revenue': 562.8, 'unit': 'M', 'net_profit': -17.5}, {'period': ""Q2 '23"", 'revenue': 463.3, 'unit': 'M', 'net_profit': -56.9}]",-4.87,-4.87,2180800000,642900000,20200000,2229900000,-3699999,7400000,501000000,20200000,-172100000,-1.6437810945273632,-4.499118165784832,-4.478571428571429,"[0.11, 0.1]","['2022-09-08', '2021-06-10']",__nan__,1.0225146735143067
332,JOBS,51job Inc. American Depositary Shares,"51job, Inc., through its subsidiaries, provides integrated human resource services in the People's Republic of China. The company offers online recruitment services through its Websites comprising 51job.com, yingjiesheng.com, 51jingying.com, lagou.com, and 51mdd.com; and mobile applications that enable job seekers to access their accounts through mobile devices and utilize functions available on their Websites. It also provides other human resource related services, such as business process outsourcing that consist of social insurance, benefits, and payroll processing, as well as compliance services with local governmental employment regulations; and conducts training seminars in the business management, leadership, sales and marketing, human resource, negotiation skills, financial planning and analysis, public administration, manufacturing, secretarial, and other skills. In addition, the company offers campus recruitment services to corporations that seek to recruit college and university students; and placement and executive search services to employers seeking to attract talent and fill job vacancies. Further, it provides professional and scientific assessment tools that assist human resource departments in evaluating capabilities and dispositions of job candidates and existing employees, as well as offers talent assessment services; conducts general and customized surveys on salary, employee retention, and other human resource related topics; organizes and hosts annual human resource conferences and events; and provides support and administrative services to employers on select recruitment projects. The company serves multinational corporations, large national Chinese corporations, and the local Chinese enterprises. It offers its services through sales offices, and a national sales and customer service call center in Wuhan. 51job, Inc. was founded in 1998 and is headquartered in Shanghai, the People's Republic of China.",Mr. Rick Yan,Staffing & Employment Services,60.9,USD,0,https://images.financialmodelingprep.com/symbol/JOBS.png,968897,42.2037422037422,-0.02999878,2196873,1009094000,608908000,"[{'period': '2021', 'revenue': 4420.0, 'unit': 'M', 'net_profit': 608.91}, {'period': '2020', 'revenue': 3.69, 'unit': 'B', 'net_profit': 1.1}, {'period': '2019', 'revenue': 4000.0, 'unit': 'M', 'net_profit': 532.32}, {'period': '2018', 'revenue': 3.74, 'unit': 'B', 'net_profit': 1.25}]","[{'period': ""Q4 '21"", 'revenue': 1350.0, 'unit': 'M', 'net_profit': 350.88}, {'period': ""Q3 '21"", 'revenue': 1080.0, 'unit': 'M', 'net_profit': 46.63}, {'period': ""Q2 '21"", 'revenue': 1100.0, 'unit': 'M', 'net_profit': 181.68}, {'period': ""Q1 '21"", 'revenue': 895.15, 'unit': 'M', 'net_profit': 57.23}, {'period': ""Q4 '20"", 'revenue': 1160.0, 'unit': 'M', 'net_profit': 342.05}, {'period': ""Q3 '20"", 'revenue': 906.11, 'unit': 'M', 'net_profit': 173.32}]",8.93,8.93,17575669000,11530880000,10587039000,4222738000,382164000,2220378000,2962891000,10539923000,1357639000,-0.29072005240732074,-0.4450730718615918,-0.44602977667493804,__nan__,__nan__,__nan__,0.24026044186426132
333,JOFF,JOFF Fintech Acquisition Corp. Class A Common Stock,"JOFF Fintech Acquisition Corp. does not have significant operations. It focuses on effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.",Mr. Joel  Leonoff,Shell Companies,10.095,USD,0,https://images.financialmodelingprep.com/symbol/JOFF.png,191857,48.07142857142857,0.005,84245,15152975,33203075,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 33.2}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.92}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.33}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.14}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 40.26}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.73}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.43}]",0.64,0.64,415473,1392.125,665.537,29983,0,414081,1226.003,665.537,-2495229,0,0,0,__nan__,__nan__,__nan__,0.07216594098774168
334,JOFFU,JOFF Fintech Acquisition Corp. Unit,"JOFF Fintech Acquisition Corp. does not have significant operations. It focuses on effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.",,Shell Companies,10.06,USD,0,https://images.financialmodelingprep.com/symbol/JOFFU.png,8462,65.32467532467533,0.01,17140,15152975,33203075,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 33.2}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.92}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.33}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.14}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 40.26}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.73}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.43}]",0.64,0.64,415473,1392.125,665.537,29983,0,414081,1226.003,665.537,-2495229,0,0,0,__nan__,__nan__,__nan__,0.07216594098774168
335,JOFFW,JOFF Fintech Acquisition Corp. Warrant,"JOFF Fintech Acquisition Corp. focuses on effectuating a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.",Mr. Joel  Leonoff,Shell Companies,0.0002,USD,0,https://images.financialmodelingprep.com/symbol/JOFFW.png,0,0,0,1644810,15152975,33203075,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 33.2}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.92}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.33}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.14}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 40.26}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.73}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -4.43}]",0.64,0.64,415473,1392.125,665.537,29983,0,414081,1226.003,665.537,-2495229,0,0,0,__nan__,__nan__,__nan__,0.07216594098774168
336,JOUT,Johnson Outdoors Inc. Class A Common Stock,"Johnson Outdoors Inc. designs, manufactures, and markets seasonal and outdoor recreational products for fishing worldwide. It operates through four segments: Fishing, Camping, Watercraft Recreation, and Diving. The Fishing segment offers electric motors for trolling, marine battery chargers, and shallow water anchors; sonar and GPS equipment for fish finding, navigation, and marine cartography; and downriggers for controlled-depth fishing. This segment sells its products under the Minn Kota, Humminbird, and Cannon brands through outdoor specialty and Internet retailers, retail store chains, original equipment manufacturers, and distributors. The Camping segment provides consumer, commercial, and military tents and accessories; camping furniture and stoves; other recreational camping products; and portable outdoor cooking systems, as well as manufactures fabric floors and insulated thermal liners and a subcontract manufacturer of military tents. This segment sells its products under the Eureka! and Jetboil brands through independent sales representatives and Internet retailers. The Watercraft Recreation segment offers kayaks, canoes, and paddles for family recreation, touring, angling, and tripping through independent specialty and outdoor retailers under the Ocean Kayaks, Old Town, and Carlisle brands. The Diving segment manufactures and markets underwater diving and snorkeling equipment, such as regulators, buoyancy compensators, dive computers and gauges, wetsuits, masks, fins, snorkels, and accessories through independent specialty dive stores and diving magazines under the SCUBAPRO brand name. This segment also provides regular maintenance, product repair, diving education, and travel program services; and sells diving gear to dive training centers, resorts, public safety units, and armed forces. It sells its products through Websites. The company was founded in 1970 and is headquartered in Racine, Wisconsin.",Ms. Helen P. Johnson-Leipold,Leisure,23.59,USD,241177696,https://images.financialmodelingprep.com/symbol/JOUT.png,47921,-5.27,1.13,52731,-10102000,-26533000,"[{'period': '2024', 'revenue': 592.85, 'unit': 'M', 'net_profit': -26.53}, {'period': '2023', 'revenue': 663.84, 'unit': 'M', 'net_profit': 19.53}, {'period': '2022', 'revenue': 743.36, 'unit': 'M', 'net_profit': 44.49}, {'period': '2021', 'revenue': 751.65, 'unit': 'M', 'net_profit': 83.38}]","[{'period': ""Q1 '25"", 'revenue': 107.65, 'unit': 'M', 'net_profit': -15.29}, {'period': ""Q4 '24"", 'revenue': 105.87, 'unit': 'M', 'net_profit': -34.27}, {'period': ""Q3 '24"", 'revenue': 172.47, 'unit': 'M', 'net_profit': 1.62}, {'period': ""Q2 '24"", 'revenue': 175.86, 'unit': 'M', 'net_profit': 2.16}, {'period': ""Q1 '24"", 'revenue': 138.64, 'unit': 'M', 'net_profit': 3.96}, {'period': ""Q4 '23"", 'revenue': 96.34, 'unit': 'M', 'net_profit': -16.01}]",-2.6,-2.6,635212000,428728000,162039000,171788000,40649000,0,90444000,145498000,18966000,-1.2389818078588157,-2.358298351592096,-2.347150259067358,"[0.33, 0.055]","['2025-04-10', '2007-07-10']",__nan__,0.2704419941688759
337,JRJC,China Finance Online Co. Limited American Depositary Shares,"China Finance Online Co. Limited, together with its subsidiaries, provides web-based financial services in the People's Republic of China and Hong Kong. The company operates through two segments: Hong Kong Brokerage Services and Financial Services. It provides online access to securities trading services, wealth management products, and securities investment advisory services to retail investors; and financial database and analytics to institutional investors, including financial, research, academic, and regulatory institutions, as well as financial software products. The company is also involved in the operation of Yinglibao, an internet-based financial platform that integrates cash management solutions and mutual fund distribution into iTougu, which facilitates communication between securities investment advisors and their clients; JRJ mobile app for financial information, securities trading, investment advisory, and wealth management; jrj.com.cn to provide access for wealth management solutions and mutual fund distribution; jrj.com, a financial information website; and iTAMP, a turnkey asset management platform that offers investment consultations and advice covering stocks, mutual funds, wealth management, insurance, trusts, and other financial products. In addition, it provides securities and futures contracts brokerage and related services to its customers, who invest in stocks listed on The Stock Exchange of Hong Kong Limited; subscription to financial analysis tools, real-time and historical data, news, research reports, and online forums; asset management and insurance brokerage services; and advertising and enterprise value-added services, as well as online P2P lending and money lending services. China Finance Online Co. Limited has a strategic partnership agreement with Citic Securities to provide internet financial services. The company was incorporated in 1998 and is based in Beijing, the People's Republic of China.",Mr. Zhiwei Zhao,Financial - Capital Markets,3.99,USD,0,https://images.financialmodelingprep.com/symbol/JRJC.png,41241,-0.7323788546255506,-2.4799998,1564050,-9612757,-10558169,"[{'period': '2020', 'revenue': 40.03, 'unit': 'M', 'net_profit': -10.56}, {'period': '2019', 'revenue': 35.52, 'unit': 'M', 'net_profit': -11.26}, {'period': '2018', 'revenue': 45.48, 'unit': 'M', 'net_profit': -19.95}, {'period': '2017', 'revenue': 42.62, 'unit': 'M', 'net_profit': -36.74}]","[{'period': ""Q4 '20"", 'revenue': 9.75, 'unit': 'M', 'net_profit': -5.63}, {'period': ""Q3 '20"", 'revenue': 10.7, 'unit': 'M', 'net_profit': -1.52}, {'period': ""Q2 '20"", 'revenue': 9.74, 'unit': 'M', 'net_profit': -1.49}, {'period': ""Q1 '20"", 'revenue': 9.84, 'unit': 'M', 'net_profit': -1.92}, {'period': ""Q4 '19"", 'revenue': 8.69, 'unit': 'M', 'net_profit': -3.41}, {'period': ""Q3 '19"", 'revenue': 8.05, 'unit': 'M', 'net_profit': -2.1}]",-0.92,-0.92,77957306,68251461,6154499,73318256,24902670,1241398,69930396,6154499,-4405248,0.02225974067715895,0.06256434889308361,0.06122448979591831,__nan__,__nan__,__nan__,0.9404924279964215
338,JRSH,Jerash Holdings (US) Inc. Common Stock,"Jerash Holdings (US), Inc., through its subsidiaries, manufactures and exports customized and readymade sport and outerwear. The company offers t-shirts; jackets and pullover; pants and shorts; crew neck, polo shirts, and tank tops made from knitted fabric, as well as personal protective equipment. It serves various brand-name retailers in the United States, Jordan, and internationally. The company was incorporated in 2016 and is headquartered in Fairfield, New Jersey.",Mr. Lin Hung  Choi,Apparel - Manufacturers,3.05,USD,37499140,https://images.financialmodelingprep.com/symbol/JRSH.png,17121,-9.84,0.12,51783,3133664,-2005901,"[{'period': '2023', 'revenue': 117.19, 'unit': 'M', 'net_profit': -2.01}, {'period': '2022', 'revenue': 138.06, 'unit': 'M', 'net_profit': 2.42}, {'period': '2021', 'revenue': 143.35, 'unit': 'M', 'net_profit': 7.92}, {'period': '2020', 'revenue': 90.21, 'unit': 'M', 'net_profit': 4.15}]","[{'period': ""Q3 '24"", 'revenue': 35380.0, 'unit': 'K', 'net_profit': -5.81}, {'period': ""Q2 '24"", 'revenue': 40240.0, 'unit': 'K', 'net_profit': 655.29}, {'period': ""Q1 '24"", 'revenue': 40.94, 'unit': 'M', 'net_profit': -1.35}, {'period': ""Q4 '23"", 'revenue': 21.57, 'unit': 'M', 'net_profit': -3.09}, {'period': ""Q3 '23"", 'revenue': 27520.0, 'unit': 'K', 'net_profit': 220.71}, {'period': ""Q2 '23"", 'revenue': 33360.0, 'unit': 'K', 'net_profit': 365.62}]",-0.16,-0.16,80245566,50919660,12428369,15814903,5417513,0,14779151,12428369,-2357633,-0.621161796731874,-1.8290138587705604,-1.8421052631578947,"[0.05, 0.05]","['2025-02-18', '2018-11-16']",__nan__,0.19708133157164098
339,JRVR,James River Group Holdings Ltd. Common Shares,"James River Group Holdings, Ltd., through its subsidiaries, provides specialty insurance and reinsurance services in the United States. It operates through Excess and Surplus Lines, Specialty Admitted Insurance, and Casualty Reinsurance segments. The Excess and Surplus Lines segment underwrites liability and property insurance on an excess and surplus commercial lines basis in all states and the District of Columbia. This segment distributes its insurance policies primarily through wholesale insurance brokers. The Specialty Admitted Insurance segment provides workers' compensation coverage for building trades, healthcare employees, goods and services, light manufacturing, specialty transportation, and agriculture, as well as fronting and program business. The Casualty Reinsurance segment offers proportional and working layer casualty reinsurance to third parties and other insurance companies. James River Group Holdings, Ltd. was founded in 2002 and is headquartered in Pembroke, Bermuda.",Mr. Frank N. D'Orazio,Insurance - Specialty,4.1,USD,187141630,https://images.financialmodelingprep.com/symbol/JRVR.png,310029,-1.58,0.14,323245,-47163000,-81120000,"[{'period': '2024', 'revenue': 707.63, 'unit': 'M', 'net_profit': -81.12}, {'period': '2023', 'revenue': 812.01, 'unit': 'M', 'net_profit': -107.68}, {'period': '2022', 'revenue': 813.7, 'unit': 'M', 'net_profit': 30.97}, {'period': '2021', 'revenue': 772.88, 'unit': 'M', 'net_profit': -172.8}]","[{'period': ""Q4 '24"", 'revenue': 126.71, 'unit': 'M', 'net_profit': -64.77}, {'period': ""Q3 '24"", 'revenue': 191.5, 'unit': 'M', 'net_profit': -39.38}, {'period': ""Q2 '24"", 'revenue': 188.29, 'unit': 'M', 'net_profit': 7.62}, {'period': ""Q1 '24"", 'revenue': 201.13, 'unit': 'M', 'net_profit': 15.4}, {'period': ""Q4 '23"", 'revenue': 218.1, 'unit': 'M', 'net_profit': -150.16}, {'period': ""Q3 '23"", 'revenue': 233.43, 'unit': 'M', 'net_profit': 19.55}]",-2.1,-2.1,5007076000,64525000,64525000,4413046000,0,1373286000,132922000,362345000,-251975000,-1.4246394035978607,0.24668474425169942,0.33121019108280253,"[0.01, 0.16]","['2025-03-10', '2015-03-12']",__nan__,0.8813618966438695
340,JSM,Navient Corporation 6% Senior Notes due December 15 2043,"Navient Corp. engages in the provision of asset management and business processing solutions for education, healthcare and government clients at the federal, state and local levels. It operates through the following segments: Federal Education Loans, Consumer Lending, Business Processing and Other. The Federal Education Loans segment owns FFELP Loans and performs servicing and asset recovery services on FFELP Loan portfolio. The Consumer Lending segment owns, originates, acquires and services high-quality private education loans. The Business Processing segment engages in the provision of government and healthcare services. The Other segment consists of corporate liquidity portfolio, gains and losses incurred on the repurchase of debt, unallocated expenses of shared services and restructuring/other reorganization expenses. The company was founded in 1973 and is headquartered in Herndon, VA.",None,Financial - Credit Services,17.6,USD,4824230400,https://images.financialmodelingprep.com/symbol/JSM.png,16260,14.63,0.22,25059,2813000000,131000000,"[{'period': '2024', 'revenue': 3810.0, 'unit': 'M', 'net_profit': 131.0}, {'period': '2023', 'revenue': 1160.0, 'unit': 'M', 'net_profit': 228.0}, {'period': '2022', 'revenue': 3220.0, 'unit': 'M', 'net_profit': 645.0}, {'period': '2021', 'revenue': 2650.0, 'unit': 'M', 'net_profit': 717.0}]","[{'period': ""Q4 '24"", 'revenue': 2350.0, 'unit': 'M', 'net_profit': 24.0}, {'period': ""Q3 '24"", 'revenue': 948.0, 'unit': 'M', 'net_profit': -2.0}, {'period': ""Q2 '24"", 'revenue': 233.0, 'unit': 'M', 'net_profit': 36.0}, {'period': ""Q1 '24"", 'revenue': 275.0, 'unit': 'M', 'net_profit': 73.0}, {'period': ""Q4 '23"", 'revenue': 175.0, 'unit': 'M', 'net_profit': -28.0}, {'period': ""Q3 '23"", 'revenue': 350.0, 'unit': 'M', 'net_profit': 79.0}]",1.2,1.2,51789000000,2103000000,2103000000,49148000000,0,0,5134000000,2103000000,459000000,86.24242424242425,-0.42543859649122806,-0.3513513513513514,"[0.375, 0.375]","['2025-03-14', '2004-02-25']",__nan__,0.9490046148796076
341,JUPW,Jupiter Wellness Inc. Common Stock,"Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores. It also manufactures, distributes, and markets a line of consumer products, such as CBD-infused sunscreen under the CaniSun brand; CBD-infused skin care lotion under the CaniSkin brand; and products for the dermatological treatments of pain and inflammation under the CaniDermRX brand. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.",Mr. Brian Scott John,Drug Manufacturers - Specialty & Generic,1.52,USD,49331144,https://images.financialmodelingprep.com/symbol/JUPW.png,1020340,-2.4126984126984126,0.16,1970467,-10967399,-17671484,"[{'period': '2022', 'revenue': 6.2, 'unit': 'M', 'net_profit': -17.67}, {'period': '2021', 'revenue': 2.88, 'unit': 'M', 'net_profit': -29.84}, {'period': '2020', 'revenue': 1.07, 'unit': 'M', 'net_profit': -6.41}, {'period': '2019', 'revenue': 6.46, 'unit': 'K', 'net_profit': -932.02}]","[{'period': ""Q3 '23"", 'revenue': 910010.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q2 '23"", 'revenue': 2370.0, 'unit': 'K', 'net_profit': -359.59}, {'period': ""Q1 '23"", 'revenue': 1.12, 'unit': 'M', 'net_profit': -1.37}, {'period': ""Q4 '22"", 'revenue': 0.90561, 'unit': 'M', 'net_profit': -9.98}, {'period': ""Q3 '22"", 'revenue': 1.57, 'unit': 'M', 'net_profit': -2.88}, {'period': ""Q2 '22"", 'revenue': 3.0, 'unit': 'M', 'net_profit': -1.44}]",-0.8,-0.8,8690763,6751489,4848441,5025169,647530,0,4505510,1931068,-6410933,0.3383537667820187,0.4077196638422708,0.5555555555555556,__nan__,__nan__,__nan__,0.5782195418284908
342,JUPWW,Jupiter Wellness Inc. Warrant,,,Drug Manufacturers - Specialty & Generic,0.32,USD,0,https://images.financialmodelingprep.com/symbol/JUPWW.png,0,0,-0.08,6817,-47807075,-49409632,"[{'period': '2024', 'revenue': 0.7019700000000001, 'unit': 'M', 'net_profit': -49.41}, {'period': '2023', 'revenue': 0.20267, 'unit': 'M', 'net_profit': -15.08}, {'period': '2022', 'revenue': 6.2, 'unit': 'M', 'net_profit': -15.22}, {'period': '2021', 'revenue': 2.88, 'unit': 'M', 'net_profit': -28.1}]","[{'period': ""Q4 '24"", 'revenue': 0.18217, 'unit': 'M', 'net_profit': -13.53}, {'period': ""Q3 '24"", 'revenue': 0.11021, 'unit': 'M', 'net_profit': -11.93}, {'period': ""Q2 '24"", 'revenue': 0.71024, 'unit': 'M', 'net_profit': -8.27}, {'period': ""Q1 '24"", 'revenue': 0.17073, 'unit': 'M', 'net_profit': -15.67}, {'period': ""Q4 '23"", 'revenue': 0.13269999999999998, 'unit': 'M', 'net_profit': -5.68}, {'period': ""Q3 '23"", 'revenue': 0.4842, 'unit': 'M', 'net_profit': -7.74}]",-0.88,-0.88,7338403,2580353,631536,9511455,795118,0,9397307,348816,-19173215,-2.923377357288983,-2.2758401969470214,-0.8333333333333334,__nan__,__nan__,__nan__,1.296120559200687
343,JVA,Coffee Holding Co. Inc. Common Stock,"Coffee Holding Co., Inc. manufactures, roasts, packages, markets, and distributes roasted and blended coffees in the United States, Australia, Canada, England, and China. The company offers wholesale green coffee products, which include unroasted raw beans of approximately 90 varieties that are sold to large, medium, and small roasters, as well as coffee shop operators. It also roasts, blends, packages, and sells coffee under private labels. As of October 31, 2021, the company supplied private label coffee under approximately 21 labels to wholesalers and retailers in cans, brick packages, and instants of various sizes. In addition, it roasts and blends company label branded coffee to supermarkets, wholesalers, and individually owned and multi-unit retail customers. Further, the company offers tabletop coffee roasting equipment, instant coffees, and tea products for its customers. Its coffee brands include Cafe Caribe, Don Manuel, S&W, Cafe Supremo, Via Roma, Premier Roasters, Harmony Bay, and Steep and Brew. The company was formerly known as Transpacific International Group Corp and changed its name to Coffee Holding Co., Inc. in April 1998. Coffee Holding Co., Inc. was founded in 1971 and is headquartered in Staten Island, New York.",Mr. Andrew  Gordon,Packaged Foods,3.32,USD,18952552,https://images.financialmodelingprep.com/symbol/JVA.png,280893,6.26,0.48,229363,4233719,2218014,"[{'period': '2024', 'revenue': 78.56, 'unit': 'M', 'net_profit': 2.22}, {'period': '2023', 'revenue': 68170.0, 'unit': 'K', 'net_profit': -835.58}, {'period': '2022', 'revenue': 65.71, 'unit': 'M', 'net_profit': -4.6}, {'period': '2021', 'revenue': 63920.0, 'unit': 'K', 'net_profit': 867.68}]","[{'period': ""Q1 '25"", 'revenue': 21.31, 'unit': 'M', 'net_profit': 1.15}, {'period': ""Q4 '24"", 'revenue': 21.21, 'unit': 'M', 'net_profit': 1.26}, {'period': ""Q3 '24"", 'revenue': 18810.0, 'unit': 'K', 'net_profit': 626.8}, {'period': ""Q2 '24"", 'revenue': 19000.0, 'unit': 'K', 'net_profit': -21.84}, {'period': ""Q1 '24"", 'revenue': 19540.0, 'unit': 'K', 'net_profit': 351.02}, {'period': ""Q4 '23"", 'revenue': 18760.0, 'unit': 'K', 'net_profit': 168.25}]",0.39,0.39,34010688,28373050,1381023,7833121,11118836,39651,6846067,1381023,5431211,10.284440618153322,3.65447308204161,3.6000000000000005,"[0.07, 0.28]","['2022-02-09', '2008-02-13']",__nan__,0.23031351203480505
344,JWEL,Jowell Global Ltd. Ordinary Shares,"Jowell Global Ltd. engages in the online retail of cosmetics, health and nutritional supplements, and household products in China. It also sells skin care, body care, and baby and children products; washing items; fragrances; food products; electronics; and apparel. In addition, it sells its products through retail stores under the Love Home brand name. As of December 31, 2021, it operated 26,043 Love Home Stores. The company also offers an online marketplace that enables third-party sellers to sell their products to the company's consumers. The company was founded in 2012 and is based in Shanghai, China.",Mr. Haiting  Li,Specialty Retail,1.81,USD,3928569,https://images.financialmodelingprep.com/symbol/JWEL.png,8444,-0.48,0.02,4217,-9524298,-11467142,"[{'period': '2023', 'revenue': 160.01, 'unit': 'M', 'net_profit': -11.47}, {'period': '2022', 'revenue': 209.98, 'unit': 'M', 'net_profit': -11.54}, {'period': '2021', 'revenue': 170.91, 'unit': 'M', 'net_profit': -6.39}, {'period': '2020', 'revenue': 96.88, 'unit': 'M', 'net_profit': 3.59}]","[{'period': ""Q4 '23"", 'revenue': 75.6, 'unit': 'M', 'net_profit': -4.38}, {'period': ""Q2 '23"", 'revenue': 84.41, 'unit': 'M', 'net_profit': -7.09}, {'period': ""Q4 '22"", 'revenue': 109.57, 'unit': 'M', 'net_profit': -3.5}, {'period': ""Q2 '22"", 'revenue': 100.41, 'unit': 'M', 'net_profit': -8.03}, {'period': ""Q4 '21"", 'revenue': 102.84, 'unit': 'M', 'net_profit': -5.69}, {'period': ""Q2 '21"", 'revenue': 68080.0, 'unit': 'K', 'net_profit': -696.99}]",-5.36,-5.36,35297927,26662514,1250281,10084608,2448096,3888377,9052373,1250281,-13508741,0.03926125092865648,0.0060017093750379235,-12.743589743589745,"[0.21, 0.21]","['2024-08-30', '2024-08-30']",__nan__,0.2856997239526276
345,JYAC,Jiya Acquisition Corp. Class A Common Stock,"Jiya Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities in the biopharmaceutical sector. Jiya Acquisition Corp. was incorporated in 2020 and is based in Palo Alto, California.",,Shell Companies,10.04,USD,0,https://images.financialmodelingprep.com/symbol/JYAC.png,28594,-71.71428571428571,0,1459,-1923038,-1902593,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': -1.9}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -264.72}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -185.82}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -281.64}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -412.14}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -594.0}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -410.97}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -451.32}]",-0.14,-0.14,104427748,884774,628006,3965216,0,103542974,342002,628006,-1208074,-6.264450228355351,-6.187217389004945,-6.36842105263158,__nan__,__nan__,__nan__,0.03797090405511761
346,JYNT,The Joint Corp. Common Stock,"The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.",Mr. Sanjiv  Razdan,Medical - Care Facilities,10.7,USD,162371430,https://images.financialmodelingprep.com/symbol/JYNT.png,57570,-107,0.18,90483,2981722,-8529843,"[{'period': '2024', 'revenue': 51.9, 'unit': 'M', 'net_profit': -8.53}, {'period': '2023', 'revenue': 117.7, 'unit': 'M', 'net_profit': -9.75}, {'period': '2022', 'revenue': 101.91, 'unit': 'M', 'net_profit': 1.18}, {'period': '2021', 'revenue': 81.19, 'unit': 'M', 'net_profit': 7.57}]","[{'period': ""Q4 '24"", 'revenue': 14450000.0, 'unit': 'M', 'net_profit': -2.72}, {'period': ""Q3 '24"", 'revenue': 30.2, 'unit': 'M', 'net_profit': -3.17}, {'period': ""Q2 '24"", 'revenue': 30.26, 'unit': 'M', 'net_profit': -3.6}, {'period': ""Q1 '24"", 'revenue': 29720.0, 'unit': 'K', 'net_profit': 946.98}, {'period': ""Q4 '23"", 'revenue': 30.61, 'unit': 'M', 'net_profit': -11.04}, {'period': ""Q3 '23"", 'revenue': 29470.0, 'unit': 'K', 'net_profit': -716.27}]",-0.57,-0.56,80421458,72194522,25051355,62476289,2586381,0,49353776,25051355,8229403,-0.6738335893026696,0.1253413974307533,0.13636363636363646,__nan__,__nan__,__nan__,0.7768609343043743
347,JZXN,Jiuzi Holdings Inc. Ordinary Shares,"Jiuzi Holdings, Inc., through its variable interest entity in Zhejiang Jiuzi New Energy Vehicles Co., Ltd., franchises and operates Jiuzi retail stores that sell new energy vehicles, plug-in electric vehicles, and related components and parts. As of March 15, 2022, it operated 37 franchise stores and 1 company-owned store in the People's Republic of China. The company was founded in 2017 and is based in Hangzhou, China.",Mr. Tao  Li,Auto - Dealerships,4.77,USD,52524378,https://images.financialmodelingprep.com/symbol/JZXN.png,105836,-0.77,0.88,211948,-16941460,-16801650,"[{'period': '2022', 'revenue': 6.22, 'unit': 'M', 'net_profit': -16.8}, {'period': '2021', 'revenue': 9540.0, 'unit': 'K', 'net_profit': 813.75}, {'period': '2020', 'revenue': 8.21, 'unit': 'M', 'net_profit': 3.45}, {'period': '2019', 'revenue': 7.98, 'unit': 'M', 'net_profit': 3.24}]","[{'period': ""Q4 '23"", 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}, {'period': ""Q2 '23"", 'revenue': 0.92576, 'unit': 'M', 'net_profit': -6.54}, {'period': ""Q4 '22"", 'revenue': 2.11, 'unit': 'M', 'net_profit': -11.56}, {'period': ""Q2 '22"", 'revenue': 4.11, 'unit': 'M', 'net_profit': -5.24}, {'period': ""Q4 '21"", 'revenue': 4930.0, 'unit': 'K', 'net_profit': -510.31}, {'period': ""Q2 '21"", 'revenue': 4.61, 'unit': 'M', 'net_profit': 1.32}]",-13.69,-13.69,15326174,12248396,3204935,9008664,7086925,1631340,8334530,2370632,-8897296,-12.693200720581435,-21.64731580531985,-21.132352941176467,__nan__,__nan__,__nan__,0.5877960148436263
348,KAII,Kismet Acquisition Two Corp. Class A Ordinary Shares,"Kismet Acquisition Two Corp. does not have significant operations. The company intends to acquire, engage in a share exchange, share reconstruction and amalgamation, contractual control arrangement with, purchase all or substantially various assets of, or engage in any other similar initial business combination with one or more businesses or entities. Kismet Acquisition Two Corp. was incorporated in 2020 and is based in Newark, Delaware.",Mr. Dimitri  Elkin,Shell Companies,10.2,USD,0,https://images.financialmodelingprep.com/symbol/KAII.png,128615,20.4,0,0,-613919,18057047,"[{'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 18.06}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.66}]","[{'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 311.87}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -458.13}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.81}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.17}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 12.66}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 2.2}]",0.79,0.79,233338881,34366,964,3303354,0,233304515,455687,964,-311412,-1.195635416211903,1.3560237958175434,1.6333333333333335,__nan__,__nan__,__nan__,0.01415689483828458
349,KAIIU,Kismet Acquisition Two Corp. Unit,"Kismet Acquisition Two Corp. does not have significant operations. The company intends to acquire, engage in a share exchange, share reconstruction and amalgamation, contractual control arrangement with, purchase all or substantially various assets of, or engage in any other similar initial business combination with one or more businesses or entities. Kismet Acquisition Two Corp. was incorporated in 2020 and is based in Newark, Delaware.",Mr. Dimitri  Elkin,Shell Companies,10.31,USD,0,https://images.financialmodelingprep.com/symbol/KAIIU.png,11646,37.904411764705884,0.03,0,-1146650,784626,"[{'period': '2023', 'revenue': 0.0, 'unit': 'K', 'net_profit': 784.63}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 18.06}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.14}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -13.4}]","[{'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 320.5}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 311.87}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -458.13}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.81}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.17}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 12.66}]",0.0676,0.0676,16963650,833,0,5194277,0,16962817,2135443,0,-762383,0.8829246407971968,-0.9565473800893357,-0.8909677419354839,__nan__,__nan__,__nan__,0.306200434458386
350,KAIIW,Kismet Acquisition Two Corp. Warrant,"Kismet Acquisition Two Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Newark, Delaware.",Mr. Ivan Vladimirovich Tavrin,Shell Companies,0.0425,USD,0,https://images.financialmodelingprep.com/symbol/KAIIW.png,0,0,0.0234,1560,-1146650,784626,"[{'period': '2023', 'revenue': 0.0, 'unit': 'K', 'net_profit': 784.63}, {'period': '2022', 'revenue': 0.0, 'unit': 'M', 'net_profit': 18.06}, {'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.14}, {'period': '2020', 'revenue': 0.0, 'unit': 'K', 'net_profit': -13.4}]","[{'period': ""Q4 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 320.5}, {'period': ""Q3 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': 311.87}, {'period': ""Q2 '23"", 'revenue': 0.0, 'unit': 'K', 'net_profit': -458.13}, {'period': ""Q1 '23"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 1.81}, {'period': ""Q4 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -5.17}, {'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 12.66}]",0.0676,0.0676,16963650,833,0,5194277,0,16962817,2135443,0,-762383,0.8829246407971968,-0.9565473800893357,-0.8909677419354839,__nan__,__nan__,__nan__,0.306200434458386
351,KAIR,Kairos Acquisition Corp. Class A Ordinary Shares,"Kairos Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus on the regulated insurance or reinsurance companies, distributors or technology, and insurance service providers that focus on specialty lines of business. Kairos Acquisition Corp. was incorporated in 2020 and is based in New York, New York.",Mr. Peter  Bang,Shell Companies,10.075,USD,0,https://images.financialmodelingprep.com/symbol/KAIR.png,281336,0,0,2704,8246339,18622693,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 18.62}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.25}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.52}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 13.66}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 29.17}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.88}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.65}]",0.54,0.54,276631,613.686,132.241,20756,0,276017,405.024,132.241,-2481139,0,0,0,__nan__,__nan__,__nan__,0.07503135946441289
352,KAIRU,Kairos Acquisition Corp. Unit,"Kairos Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus on the regulated insurance or reinsurance companies, distributors or technology, and insurance service providers that focus on specialty lines of business. Kairos Acquisition Corp. was incorporated in 2020 and is based in New York, New York.",,Shell Companies,10.0633,USD,0,https://images.financialmodelingprep.com/symbol/KAIRU.png,1293,0,0.0033,421,8246339,18622693,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 18.62}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.25}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.52}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 13.66}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 29.17}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.88}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.65}]",0.54,0.54,276631,613.686,132.241,20756,0,276017,405.024,132.241,-2481139,0,0,0,__nan__,__nan__,__nan__,0.07503135946441289
353,KAIRW,Kairos Acquisition Corp. Warrant,"Kairos Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock or share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.",Mr. Peter  Bang,Shell Companies,0.0001,USD,0,https://images.financialmodelingprep.com/symbol/KAIRW.png,0,0,0,180236,8246339,18622693,"[{'period': '2021', 'revenue': 0.0, 'unit': 'M', 'net_profit': 18.62}, {'period': '2020', 'revenue': 0.0, 'unit': '', 'net_profit': 0.0}]","[{'period': ""Q3 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 3.25}, {'period': ""Q2 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 6.52}, {'period': ""Q1 '22"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 13.66}, {'period': ""Q4 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 29.17}, {'period': ""Q3 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': 7.88}, {'period': ""Q2 '21"", 'revenue': 0.0, 'unit': 'M', 'net_profit': -11.65}]",0.54,0.54,276631,613.686,132.241,20756,0,276017,405.024,132.241,-2481139,0,0,0,__nan__,__nan__,__nan__,0.07503135946441289
